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ABSTRACT 
Abstract 
As one of the most promising developments of micro/nanotechnology, electrospinning has 
gathered a great deal of interest in the last decades. The electrospinning technique allows the 
preparation of fiber matrices in controlled conditions, with diameters ranging from micron to 
nanoscale. Basically, electrospinning can produce fibers through the action of an external 
electric field that creates an electrically charged jet from a polymer solution drop and fibers after 
the rapid evaporation of the solvent. This versatile technique has allowed processing a wide 
variety of polymers. However, a large number of variables must be taken into account as they 
can directly influence the characteristics of the resulting fibers. These variables are either related 
to the material and solution properties (e.g., solubility, molecular weight, viscosity, etc.) or to 
the specific processing parameters (applied voltage, flow rate or tip-collector distance). 
Scaffolds constituted by electrospun fibers have a large specific surface area, light weight and 
high porosity, and, consequently, are interesting for a wide variety of applications including 
nanocomposites and biomedical such as tissue templates, prosthesis and drug delivery systems. 
In this Thesis, micro/nanofibers conveniently modified were prepared by electrospinning to get 
novel materials for biomedical applications. Four blocks were mostly covered in this dissertation 
with different focus on drug delivery and/or tissue engineering. 
In the first block, polylactide (PLA) was electrospun in micro/nanofibers and loaded with four 
different molecules with antioxidant activity (i.e. vitamin B6 in pyridoxine and pyridoxal forms, 
p-coumaric acid and caffeic acid). The influence of different antioxidant molecules was studied 
regarding their physical properties, morphology, in-vitro drug release profiles and 
biocompatibility. As the antioxidant activity was previously assessed, it was interesting to test 
these new materials as an application to inhibit oxidative DNA damage caused by free radicals 
initiatiors. This damage was evaluated in-vitro and in-vivo by measuring the conversion of 
supercoiled plasmid DNA into open circular and linear forms. It was demonstrated that these 
antioxidants, in solution, could significantly inhibit the oxidative DNA damage and could 
maintain their protective role in-vitro and in-vivo against oxidative DNA damage when they 
were loaded in PLA nanofibers. Thus, these electrospun mats appear to be interesting for their 
use in the purification of plasmidic or genomic DNA. 
In the second block, PLLA matrices loaded with two or three drugs were prepared in order to 
get a multifunctional activity. Thus, antioxidant, anti-inflammatory and antimicrobial molecules 
were considered in order to prevent chain oxidation processes in different biomolecules 
(proteins, DNA, etc.), avoiding the subsequent local inflammatory process and reducing the 
potential risk of microbial infection of wounds, respectively. These matrices have a special 
interest due to the synergies and antagonisms, which may occur during the simultaneous release 
of different drugs. In all cases, antimicrobial activity was tested and the biocompatibility of 
derived scaffolds evaluated. 
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The third block deals on the possibility of preparing biodegradable scaffolds from non 
electrospinable polymers that have advantages like conductivity/electroactivity or bactericide 
activity. In the first case, PLA nanofibers were successfully loaded with 
polyhexamethylenebiguanide hydrochloride (PHMB), which is a low molecular weight polymer 
with a well-known bactericide activity. Finally 3D biodegradable scaffolds had a well proven 
antibacterial activity and a release that was highly dependent on the hydrophilicity of the 
medium. In the second case, hybrid scaffolds constituted by different ratios of polylactide as a 
biodegradable polymer and poly(3-thiophene methyl acetate) (P3TMA) as an electroactive 
polymer were studied. The incorporation of P3TMA slightly affected the fiber morphology and 
lead to a significant electroactivity when its weight percentage was close to 50 wt-%. Obviously, 
scaffolds with higher percentages were not able to be prepared due to the low molecular weight 
of the conducting polymer. 
Finally, in the fourth block, electrospun scaffolds were obtained using a sacrificial polymer (e.g., 
polyethyleneglycol (PEG)) that could easily be subsequently removed by solubilization in 
aqueous media. This block considered three possibilities: a) Preparation of scaffolds constituted 
by different ratios of PLA and PEG electrospun fibers, b) Preparation of scaffolds constituted 
electrospun fibers having different PLA and PEG contents; c) Preparation of scaffolds 
constituted by coaxial electrospun fibers with different core-shell polymer distributions. In 
general, all procedures gave interesting results since porosity of scaffolds was increased and cell 
colonization logically favoured. The three considered procedures gave also the possibility of 
preparing scaffolds with different drug release behaviors.
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1. Introduction 
1.1 Biomaterials 
The term of biomaterial refers to any material, natural or man-made, that comprises whole or 
part of a living structure or biomedical device, which performs, augments, or replaces a natural 
function.[1] To interact with biological systems, the biomaterials must be biocompatible, 
meaning that they must have the ability to perform an appropriate host response in a specific 
application. New materials are designed to elicit an effective interaction with tissues, provoking 
physiological responses such as cell growth and/or differentiation at the site of implantation.[2] 
The biomaterials used as implants can be divided into permanent or temporary biomaterials.[3] 
Permanent biomaterials are used to replace damaged tissues for an undetermined period of time, 
but in some situations the support only is needed to temporarily fill the damaged region until 
tissue recomposition is completed, or guided by the regeneration process. With temporary 
biomaterials, the term biodegradable can be applied to polymers and the solid devices that 
undergo dispersion in vivo as a result of macromolecular degradation.[4] Biodegradable polymers 
can be attacked by biological elements so that the integrity of the system is affected, forming 
fragments and other degradation products that can be removed from the site of action but not 
necessarily from the body.[4] Another revelant feature for materials used as temporary devices is 
the bioresorbability, in this case degradation is followed by a reduction in the size of the 
biomaterial and resorbed in vivo, which means that materials can be removed by cellular activity 
(e.g., phagocytosis) in the organism. 
Nowadays, biodegradable polymers have gained increasing attention due to their greater demand 
for diverse biomedical applications including regenerative medicine, tissue engineering, 
controlled drug delivery and gene therapy.[5] Some polymers of this type are polylactide (PLA), 
polycaprolactone (PCL), polyglycolide (PGL) and their copolymers [e.g., poly(lactic-co-
glycolic acid) (PLGA)] (Figure 1.1). These are the most commonly used synthetic polymers 
despite the ongoing efforts focused on designing novel biomaterials with enhanced 
performance.[6]
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FIGURE 1.1 
Scheme showing the chemical structure of some biodegradable polymer used in biomedicine.  
The synthetic polymeric biomaterials based on aliphatic polyesters are probably the most 
employed. These polymers can be classified in two main groups:  
- Poly(hydroxyalkanoate)s: Synthetized by polymerization of hydroxy acids or by ring-
opening polymerization of cyclic monomers, e.g., poly(lactic acid) (PLA) and 
poly(glycolic acid) (PGA).  
- Poly(alkylene dicarboxylate)s: Synthetized through a polycondensation reaction 
between a diol (HO-R1-OH) and a dycarboxylic acid (HOOC-R2-COOH) or the 
corresponding diester (e.g., poly(butylene succinate) (PBS) and poly(butylene adipate) 
(PBA)). 
A large number of biodegradable polyesters are commercially available but merely polymers 
with reasonably short aliphatic chains can be used as biodegradable polymers for biomedical 
applications. These polyesters are often mildly hydrophobic and degrade by bulk erosion 
through the hydrolizable ester bonds.[7] Poly(α-esters) have been the most heavily researched 
degradable biomaterials to date[7] due to their relatively easy synthesis (via both ring-opening 
and polycondensation reactions) and commercial availability. 
1.1.1 Poly(lactic acid) (PLA) 
Poly(lactic acid) offers unique features of biodegradability, biocompatibility, bioresorbability, 
thermoplastic processability and eco-friendliness. These features allow potential applications as 
ecological materials, surgical implant materials, drug delivery systems and, porous scaffolds for 
the growth of neo-tissues.[8, 9] PLA is also being used because its good performance, excellent 
properties and low price.[10] Various devices have been commercialized from different PLA 
types including degradable sutures, drug delivery microparticles, nanoparticles, and porous 
scaffolds for cellular applications.  
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The diversification of PLA applications is such that a single polymer can be useful in many 
applications by simple modifications of their physical-chemical structure. In many cases, the 
polymer can be blended or copolymerized with other polymeric or non-polymeric components 
to achieve the desired behaviour.[11] The surface properties of materials play a critical role in 
determining its applications, especially when biocompatibility is required. Different surface 
modification strategies - such as physical, chemical, plasma and  radiation[12] induced methods 
- have been employed to reduce degradation time and create desirable surface properties.[13] 
PLA can be used as biodegradable polymer implants, which remain temporarily in the body and 
disappear upon degradation. However, PLA is unsuitable for sutures because its degradation rate 
is very slow.[14] On the contrary, PLA is the preferred material for applications where a long 
retention of the strength is required. These include ligament and tendon reconstruction, and 
stents for vascular and neural reconstruction.[15] Three-dimensional porous scaffolds of PLA 
have been created for culturing different cell types, and used in cell-based gene therapy for 
cardiovascular diseases. 
1.1.2 Poly(butylene succinate) (PBS) 
Polybutylene succinate (PBS) was synthetized in 1990 and commercialized under the trademark 
Bionolle®.[16] PBS is one of the most accessible biodegradable polymers. It is an aliphatic 
polyester with good processability, and easy preparation and flexibility, with degradation 
products that are non-toxic. Thus, succinic acid is an intermediate in the biological tricarboxylic 
acid (TCA) cycle. In addition, PBS could degrade into CO2 and H2O through naturally occurring 
enzymes and microorganisms.[17-20] 
PBS is a semicrystalline polyester with a melting point higher than that of PLA. Its mechanical 
and thermal properties depend on the crystal structure and the degree of crystallinity.[21] The 
relatively poor mechanical flexibility of PBS limits the applications of 100% PBS-based 
products. However, this feature can be overcome by blending with PLA or starch in order to 
provide similar properties than polyolefins.[21] Specifically, materials with a good tensile and 
impact resistance, and moderate stiffness and strength can be achieved. By changing the polymer 
composition in the blend of PBS/PLA, the mechanical properties can be adjusted to suit the 
required application.[22] These blends, have been extensively studied for commercial 
applications in agriculture, fishery, forestry, construction, and other industrial fields as a 
conventional plastic.[23] Applications of PBS or its blends have also been proposed as a support 
for different approaches in the medical field.[24] 
PBS can be easily produced in a wide variety of forms and structures, such as yarns, non-wovens, 
films and mono-filaments that provide, as above explained, excellent mechanical properties that 
are comparable with those of polyethylene or polypropylene.[37, 40] In light of its biodegradability 
and harmless degradation products, PBS is an excellent choice to use as scaffolds support in 
tissue regeneration.[25] 
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1.1.3 Polyethylene glycol (PEG) 
Scaffolds of bio-based polymers are interesting as reinforcement for tissue engineering 
applications, but they have also some limitations. The most significant is associated to their 
dense structure that limits cell infiltration. These biomaterials are inherently resistant to non-
specific cell adhesion and protein adsorption. Thus, they provide a blank slate upon which ECM-
derived signals can be systematically introduced spatially and temporally manipulated to control 
cell behavior and tissue regeneration.  
To overcome this problem, an extensive research has been conducted to use sacrificial 
biopolymers that allow the creation of desired holes in scaffolds or templates.[26] PEG (Figure 
1.2) is a polymer with great interest because it presents outstanding properties, e.g., solubility in 
water and in organic solvents, lack of toxicity, absence of antigenicity and immunogenicity, 
which are essential for biomedical applications, including surface modification, bioconjugation, 
drug delivery and tissue engineering.[27, 28] 
FIGURE 1.2 
Chemical structure of poly(ethylene glycol). 
The combination of the above mentioned strategies may ultimately result in PEG-based scaffolds 
containing the necessary cues that recapitulate the dynamic environment of ECM and lead to the 
regeneration of tissues.[29] 
Continuous enhancement of PEG-based biomaterial strategies, towards the design of scaffolds, 
is highly reliant on their ability to a separate control of the incorporation of multiple 
biofunctional signaling molecules from alterations in degradation kinetics and mechanical 
properties. Furthermore, it is important to tune, temporally and spatially, the design of 
mechanical and biofunctional signals to promote rapid and guided neovascularization (new 
blood vessel formation) prior to complete material degradation.[29] 
The PEG-drug conjugates have several advantages: prolonged residence in the body, a decreased 
degradation by metabolic enzymes and a reduction or elimination by immunogenic protein.[30] 
While the advantages of PEG in biomedical applications are lengthy, it should be considered its 
non-degradable structure as the primary disadvantage for its use in biomedical applications.  
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1.1.4 Conducting Polymers 
Conducting polymers (CPs) provide a type of processable materials with characteristics that 
range between those of semiconductors and metals (e.g., electrical and optical properties). 
Furthermore, the attractive properties associated with conventional polymers such as low 
density, stability, lightness, easy of synthesis and processing, have given a wide range of 
applications in the microelectronics industry (e.g., batteries,[31] electrochromic devices,[32] 
supercapacitors,[33] electroluminescence[34] and photovoltaic cells[35]), in biological field (e.g., 
biomedical engineering[36] and drug delivery[37]) and mechanical and chemical sensors (e.g., 
biosensor).[38] The main focus in the use of these polymers lies in the scope of their low 
manufacturing cost. 
FIGURE 1.3 
Scheme showing the chemical structure of main conduncting polymers (CP). 
The most common CPs include polyacetylene (PA), polypyrrole (PPy), polythiophenes (PThs), 
polyaniline (PANi), and poly(p-phenylene vinylenes) (PPVs) (Figure 1.3), although not all of 
them have been considered for biomedical uses.[6] 
There is an increasing interest to explore the utility of incorporating conducting polymers into 
biomaterials to take advantage of the beneficial effect of electrical stimulation on tissue 
regeneration such as skeletal nerve or other living tissues.[6] 
Mainly, PPy and their derivatives are the most widely studied polymers due to their easy 
synthesis, good chemical and thermal stabilities, low oxidation potential and high 
conductivity.[39] Furthermore, the long-term environmental stability enhances its interest for 
many industrial applications (e.g., antistatic, electromagnetic shielding, actuator and polymer 
battery) despite some uses may be limited by the inherently poor solubility in common solvents. 
The interest of PPy for biomedical applications has been highlighted by Langer et al.[31] who 
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showed that the electrical stimulation from the application of an external electrical field through 
a PPy film could significantly improve the spreading in cultured neurons. Then, it has been 
shown its ability to improve the effect of nerve growth factor (NGF) for inducing neuronal 
differentiation of PC12 cells in electric stimulation.[40] 
However, in the last two decades some PTh derivatives with excellent electrical and 
electrochemical properties, characteristic chemical structure, as well as very high environmental 
stability, have been reported.[41, 42] Among them, PEDOT, is the most important due to its high 
conductivity (up to 400-600 S·cm-1), good thermal and chemical stability, fast redox processes 
and excellent biocompatibility.[43] Consequently, this CP has attracted considerable interest 
based on its properties and many applications have been rapidly developed, e.g., antistatic 
coatings, electrode material in supercapacitors, hole injection layer in organic light-emitting 
diodes, and solar cells.[44] Poly(3-thiophene methyl acetate) (P3TMA) is another polythiophene 
derivative that is characterized by bearing carboxylate substituents in the 3-position of the 
heterocyclic ring. The P3TMA can be easily prepared via oxidative chemical[45] and 
photochemical[46] reactions and appears a suitable candidate for being processed by 
electrospinning since has a good solubility in organic solvents like chloroform. Furthermore, it 
has currently been demonstrated that it’s very stable free-standing nanomembranes. 
Electroactive and biodegradable properties can be achieved by combining P3TMA and 
polyesters, such as poly(tetramethylene succinate), and even thermoplastic polyurethanes and 
poly(vinylidene fluoride).[47, 48] 
Finally, PANi is an electroactive conjugated polymer with three primary oxidation states 
(leucoemeraldine, emeraldine and pernigranilin[49, 50]) that shows very good environmental 
stability. PANi became an important studied subject since 1980 because of its significant 
potential for technological applications such as in batteries (as electrodes), electromagnetic 
shielding, capacitors, sensor, corrosion inhibitors, actuators and electrochromic devices.[51] For 
example, PANi and its derivatives were found to be able to function as biocompatible substrates, 
upon which both H9c2 cardiac myoblasts and PC12 pheochromocytoma cells can adhere, grow 
and differentiate.[52] 
1.2 Biomedical Applications 
Nowadays, a variety of polymers are used for biomedical applications such as tissue engineering 
scaffolds,[53] filtration membranes[54, 55] and in drug delivery systems. Naturally occurring 
polymers normally exhibit better biocompatibility and low immunogenicity than synthetic 
polymers.[56] A strong reason is the inherent capacity for binding cells since they carry specific 
protein sequences such as RGD.[57] Scaffolds fabricated from natural polymers promise better 
clinical functionality, although problems like their partial denaturation should be taken into 
account. Synthetic polymers often offer many advantages over natural polymers as they can be 
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tailored to give a wider range of properties such as necessary mechanical properties and desired 
degradation rate.[58] 
One of the main areas of research in biomedical applications is drug delivery where controlled 
release is an efficient process of delivering drugs in medical therapy. Also, the effective release 
of therapeutic agents towards alleviating medical conditions is one aspect of polymeric 
biomaterials design. 
Tissue engineering (TE) is being one of the most important areas of research in health care, 
which has revolutionized medical engineering and has the potential to push the limitations even 
further in future. TE is a growing interdisciplinary scientific area that involve the knowledge 
from biology, medicine, engineering and material science field[59] towards the development of 
biological substitutes to create, repair or replace tissue function.  
1.3 Tissue Engineering 
Human body is a complex and well organized system consisting of tissues and organs. The 
extracellular matrix (ECM) is a complex of separate different tissues, which form a supportive 
network of nanometer-sized proteins and glycosaminoglycans.[59, 60] Adequate nutrients, oxygen 
and the suitable environment for the cell growth should be available in the tissues (Figure 1.4).  
FIGURE 1.4 
Representacion of fibers forming a 3D structure in comparison with a representative ECM porous scaffold. 
It is widely understood that cell behavior is affected through indirect effects of surface chemistry 
and free surface energy on the adsorption of specific ECM proteins, required by cells for 
attachment via integrin receptor binding.[29] ECM and cell-cell interactions determine the ability 
of cells to build tissues and maintain tissue-specific functions. An important objective of tissue 
engineering is to create an appropriate temporary cellular environment until repair or 
regeneration occurs. Currently, tissue engineering is based on the use of biomaterials formed as 
scaffolds, which provide a 3D framework for the cells to attach and develop in-vitro.[61] 
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In this way, the cell and the carrier are the two main components of tissue engineered products. 
The success rate of tissue engineering depends on the carriers which are designed as scaffolds. 
The basic requirements for a functional scaffold are: (a) high degree of porosity; (b) large surface 
area-to-volume ratio; (c) biodegradability, so a second surgery is not required to remove implant 
due to the degradation rate that mimic the rate of neo-tissue formation;[62] (d) structural integrity 
to prevent the pores of the scaffold from collapsing during neo-tissue formation and provide 
appropriate mechanical properties;[63] (e) no cell toxicity and biocompatibility, meaning that it 
will integrate in the host tissue without eliciting a major immune response. Thus, the scaffold 
acts as a temporary support for the cells to adhere, proliferate, migrate and differentiate. It can 
also be understood that the scaffold mimics the ECM both architecturally and functionally.  
Nowadays, the scaffolding is essential in this endeavor to act as a three-dimensional template 
for tissue ingrowths by mimicking ECM.[64] Key scaffold characteristics can be tailored to the 
specific application by careful selection of the polymers used in its preparation, additional 
scaffold components, and the fabrication technique. Many different types of scaffolds have been 
used to achieve different goals. Typically, researchers use polymers which biodegrade slowly 
into non-toxic by-products as tissue regenerates. Scaffolds are modified to form an interface 
with healing tissue cells and usually include biopolymers, which direct the correct signals to the 
tissue regeneration cells. So, there is a large capacity for tailoring a scaffold architecture and 
biological activity towards the needs of a particular tissue. 
To improve an engineered tissue, different techniques have been used during the last few 
decades. The highlight of TE strategies aims to design templates with specific mechanical and 
biological properties in order to imitate ECM. A polymeric scaffold is designed by means of 
various processing methods such as solvent casting,[65] salt leaching,[66] phase separation,[67] self-
assembly,[68] gas foaming[69] and electrospinning.[59,53-55] Table 1.1 summarizes the most 
important techniques used. 
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TABLE 1.1. Scaffold fabrication techniques in tissue engineering applications.[70] 
Method Polymers Unique factors Applications 
Biodegradable porous scaffold fabrication 
Solvent casting/  
Particulate-leaching. 
Absorbable polymers (PLLA, PLGA, 
collagen, etc.). 
Biodegradable controlled 
porous scaffold. 
Cardiac and vascular tissue 
engineering. 
Gas foaming. PLLA, PLGA and PDLLA. 
Controlled porosity and 
pore structure sponge. 
Drug delivery and tissue 
engineering. 
Microsphere fabrication 
Solvent evaporation 
technique. 
PLGA and PLAGA. 
High-density cell culture, 
due to the extended 
surface area. 
Bone repair. 
Freeze drying. 
PLGA, PLLA, PGA, PLGA/PPF, 
Collagen and Chitosan. 
3D porous sponge 
structure, 
durable and flexible. 
Tissue engineering 
scaffolds. 
Injectable gel scaffold fabrication 
Hydrogel-based 
injectable scaffolds. 
Hydrophilic/hydrophobic diblock and 
triblock copolymer combinations of 
PLA, PGA, PLGA, and PEG. 
Copolymers of PEO and PPO and 
polyoxamer, alginates, collagen, 
chitosan, HA and fibroin. 
Biomimetically, exhibit 
biocompatibility and 
cause minimal 
inflammatory 
responses, thrombosis, 
and tissue damage. 
Cartilage, bone tissue 
engineering, and drug 
delivery. 
Hydrogel scaffold fabrication 
Micromolding. Alginate, PMMA, HA and PEG. 
Microgels, biologically 
degradable with 
mechanical and physical 
complexity. 
Insulin delivery, gene 
therapy, bioreactor, and 
immunoisolation. 
Photolithography. 
Chitosan, fibronectin, HA, PEG, 
PNIAAm, PAA, PMMA, PAam, and 
PDMAEM. 
Microwells, microarrays, 
controlled size and shape. 
Microdevices, biosensors, 
growth factors, matrix 
components, forces, and 
cell-cell interactions. 
Keratin scaffold fabrication 
Self-assembling. Keratin. Biocompatibility. 
Drug delivery, wound 
healing, soft tissue 
augmentation,synthetic skin, 
coatings for implants, and 
scaffolds for tissue 
engineering. 
Fibrous scaffold fabrication 
Electrospinning. 
PGA, PLA, PLGA, PCL copolymers, 
collagen and elastin. 
High surface area, 
Biomechanical 
performance and 
biocompatibility. 
Drug delivery, wound 
healing, soft tissue synthetic 
skin, and scaffolds for tissue 
engineering. 
Automation and direct organ fabrication 
Rapid prototyping 
(PR)/Computer-aided 
design (CAD). 
 
Patient-specific scaffolds 
and automated scaffold 
assembly algorithm. 
Develop a program 
algorithm that can be used to 
design scaffold internal 
architectures. 
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1.4 Drug Delivery 
Polymeric drug delivery systems are advantageous because they can be controlled to deliver 
drugs efficiently to a localized area.[65] Design of the polymeric structure is a basic point to 
stablish appropriate interactions with the drug, to get a desired degradation rate and to provide 
a good mechanism for its removal from the body. Molecular weight, crystallinity, lability of 
bonds, and degradability play an important role for achieving controlled release. Polymers may 
be excreted directly via kidney (renal clearance) or biodegraded (metabolic clearance) into 
smaller molecules. 
The goal of all sophisticated drug delivery systems is to distribute intact medications to 
specifically targeted parts of the body through a mean which can control the therapy 
administration via either a physiological or a chemical trigger. To achieve this goal, researchers 
are turning to advances in the worlds of micro- and nanotechnology. During the past decade, 
polymeric microspheres, polymer micelles and hydrogel-type materials have been shown to be 
effective in enhancing drug targeting specificity, lowering systemic drug toxicity, improving 
treatment absorption rates, and providing protection for pharmaceuticals against biochemical 
degradation.[71] 
Basically, two broad categories of polymer systems have been studied: reservoir devices and 
matrix devices. The former involves the encapsulation of a pharmaceutical product within a 
polymer shell, whereas the latter describes a system in which a drug is physically entrapped 
within a polymer network. 
Typically, drug release rates are controlled by release mechanisms of drugs. There are three 
primary mechanisms by which active substances can be released from a controlled delivery 
system: (i) diffusion, which can be different for reservoir and matrix devices (Figure 1.5). In 
the first case, the drug is surrounded by the polymer film, while in the second case, the drug is 
uniformly dispersed throughout the polymer matrix; (ii) chemical reaction: a chemical-
controlled system is a system that changes its chemical structure when exposed to biological 
fluid. This system is carried out by polymer degradation or chemical cleavage of drug molecules 
from a polymer backbone via hydrolysis or enzymatic degradation; and (iii) solvent activation: 
a polymeric matrix absorbs water or body fluid and then swells, resulting in the diffusion of drug 
through the swollen network into the external environment.  
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FIGURE 1.5 
Schematic illustration showing the release of the anti-inflammatory drug from electrospun nanofibers (a) 
without and (b) with an alginate hydrogel coating. 
Currently, modern research is aimed to explore the use of biodegradable polymer systems as the 
matrix system. These drug deliverers degrade into biologically acceptable compounds, often 
through the process of hydrolysis, which subsequently leave their incorporated medications 
behind. This erosion process occurs either in bulk (wherein the matrix degrades uniformly) or at 
the polymer surface (whereby release rates are related to the polymer surface area). For example, 
the PLGA in its degradation process involves the breakdown of polymers into lactic and glycolic 
acids. These acids are eventually reduced by the Kreb’s cycle to carbon dioxide and water, which 
the body can easily expel. Hence, a second surgery is not required to remove the reservoir or 
matrix devices.[71] 
1.5 Other Applications 
1.5.1 Surgical Fixation Devices  
In a situation of a healing wound, a broken bone or a damaged blood vessel, surgical fixation 
devices (e.g., sutures, clips, pins, plates and vascular grafts) are the corresponding support 
devices. About 40 types of biodegradable polymers and their copolymers are currently identified 
as alternatives to metal implants since these have clear disadvantages such as the sensitivity of 
patients to metal and the need for a removal operation. For instance, PGA, and PLGA 
copolymers have been successfully used as absorbable sutures because they can be processed as 
strong filaments and hydrolyzed in-vitro and in vivo. The most commercially utilized absorbable 
sutures are a multifilament PGA (Dexon®), the copolymer PLLA (8%)-co-PGA (92%) (Vicryl®) 
and poly(p-dioxanone) (PDS®).  
Related to surgical sutures, the development of materials with adequate properties to be used as 
a coating is also highly interesting. These coating could contain different agents (e.g., triclosan, 
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chlorhexidine) that could render and additional activity (e.g., antibacterial or anti-inflammatory 
responses).[72] 
1.5.2 Wound Dressings 
When the skin is injured, the human body initiates a process that eventually leads to an 
epithelialization (regeneration of epithelial tissue) of the wound area and reestablishment of the 
skin barrier function.[73] The subsequent processes are ECM degradation and re-synthesis of 
tissue cells, which eventually results in a scar. The four phases of the wound healing process are 
inflammation; reconstruction; epithelialization; and maturation. 
In the inflammatory phase, the body prepares itself for healing by removing foreign matter and 
dead cells. After any injury to the skin that breaches the epidermis, damaged blood vessels will 
constrict within seconds to limit blood loss. When a blood vessel is damaged, sub-endothelial 
tissue is exposed resulting in the aggregation of platelets (platelet plug). The platelets at the 
wound site will release growth factors, which attract white blood cells and stimulate the release 
of other chemical mediators, e.g., cytokines, which are necessary for wound healing. 
Consequently, macrophages contained within the surrounding blood vessels are readily moved 
into the tissue via vasodilation. The final and longest state, maturation phase, is a progressive 
decrease in the vascularity of the wound which becomes more organized and then gains strength 
as the collagen matures. Maturation of a wound may take months to complete and in large open 
wounds, it can take years. 
The time period for each phase depends on the wound type. All four physiological processes 
occur in the healing of all soft tissue injuries, e.g., chronic ulcerative wounds (leg ulcers, pressure 
sores), traumatic wounds (lacerations, skin flaps, abrasions, burns), and surgical wounds. 
However, concentrations of reactive oxygen species (ROS) such as hydroxyl radicals (·OH), 
singlet oxygen (O2), hydroperoxyl radicals (·OOH), and hydrogen peroxide (H2O2) can produce 
“oxidative stress”. Chronic and severe oxidative stress conditions may delay the healing 
condition due to prolonged inflammation. Thus, the wound healing process may be assisted by 
the use of antioxidant wound dressings that reacts specifically with excess ROS, leading to the 
reduction of oxidative stress. The ROS inhibitors impregnated into the wound dressings include 
flavonoids, vitamin E, carnosin, mexidol, trypsin, and dieton.[74] 
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1.6 Electrospinning 
1.6.1 Brief history 
Scientists have been interested in the use of electrostatic force to deform liquid for centuries.[75] 
In the late 1500’s William Gilbert set out to describe the behaviour of the known magnetic and 
electrostatic phenomenon.[75] He distinguished between the force arising from a loadstone and 
the force from rubber amber[76] and invented the term electricity to describe the force from 
amber. One of his more obscure observations was that when a suitably charged piece of amber 
was brought near a droplet of water it would form a cone shape and small droplets would be 
ejected from the tip of the cone. This is the first recorded observation of electrospraying. 
Throughout the 20th century, electrodynamic atomization[77-79] was studied and patents for a 
process similar to electrospinning were accepted as early as 1902 by William James Morton,[80, 
81] which demonstrate the application of high voltage electrostatic fields to both electrospray and 
electrospun colloids fluids, separating the fluids into fine particles and fibers which could be 
collected on rotating collectors (Figure 1.6 a, b). 
A series of patents were awarded to A. Formhals between 1934 and 1940[82, 83] who applied an 
electrospinning process for the production of yarns for the textile industry. The patents described 
the use of polymers dissolved in an organic solvent. Another patent awarded in 1936 by C.L. 
Norton[84] described the collection of fibers on a rotating collector (Figure 1.6 c), a process 
adopted by many electrospinning setups nowadays. 
FIGURE 1.6 
Dispersion of fluids by electrohydrodynamic atomization. Images taken from patents awarded to J.F. 
Cooley (a) and W. J. Morton (b) in 1902. A rotating collector was used as the target to collect electrospun 
filaments and fibres. Images taken from a patent awarded to C. L. Norton in 1936 (c). 
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Interest to use electrospinning for the textile research continued to increase from this point 
onwards. On 1969, Taylor performed one of the first systematic studies on how the electrostatic 
field competes with the surface tension of spherical viscous polymer droplets placed at the tip 
of a needle, pulling the droplet first into a cone shape, and then, as the field strength was 
increased, ejecting a stream of solution from the tip of the cone.[85] In 1981, Larrondo and 
Manley were the first to demonstrate that a molten polymer could be electrospun in a similar 
fashion,[86-88] a finding backed up by more recent discoveries.[89] In the late 1980’s the 
electrospinning effect was further studied by Reneker group, who established how the unstable 
whipping effect was caused by the jet elongation in the electric field and how changing the 
strength of the electric field and the proportion of solvent to polymer affected nanofibre size and 
production.[90] 
Despite these early discoveries, electrospinning did not gain a lot of interest and was not utilized 
commercially until the 90s. It is only after the emergence of nanotechnology, in the 1990s, that 
electrospinning gained increasing attention as a way of manufacturing fibers at the nanoscale 
range. Researchers have looked at the potential of electrospinning to produce complex and 
highly functionalized systems, which could be used in a variety of scientific and commercial 
applications. The possibilities presented by electrospinning in the fields of bio-medical research, 
electronics, catalysis, environmental and energy storage applications (Figure 1.7) led to an 
almost exponential increase in the number of scientific publications since the 90s[91, 92]. 
FIGURE 1.7 
Statistics on the literature published on the advanced applications of electrospun fibers in the period 2001–
2014 (search made through Web of Knowledge using as keywords: Electrospinning + area of application).  
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1.6.2 Electrospinning set-up 
Ultrathin fibers from a wide range of polymer materials can be easily prepared by 
electrospinning[92-102] (Figure 1.8). This electrostatic technique involves the use of a high voltage 
field to charge the surface of a polymer solution droplet, held at the end of a capillary tube, and 
induce the ejection of a liquid jet towards a grounded target (collector). 
FIGURE 1.8 
Scheme showing the electrospinning process.[6] 
The single jet initially formed is divided into multiple filaments by radial charge repulsion, 
which results in the formation of solidified ultrathin fibers as the solvent is evaporating. 
Morphology of fibers obtained onto the collector depends on the solution properties (e.g., 
viscosity, dielectric constant, volatility, concentration) and operational parameters (e.g., strength 
of the applied electrical field, deposition distance, flow rate).[92, 95, 97-99] Electrospinning of some 
polymers may be problematic, and may require a detailed study of appropiate experimental 
conditions for fiber production. 
Selection of the experimental conditions can lead to fibers with diameters that can range from 
several micrometers to few nanometers in an extremely rapid process (millisecond scale).[94] The 
technique is also characterized by a huge material elongation rate and high cross-sectional area 
reduction that favors molecular orientation within the fiber. Electrospinning becomes nowadays 
a simple one step approach for producing active matrices with high surface area.[94] The 
electrospun fibers can provide interconnected porous networks, which are interesting for drug, 
gene or cell delivery, artificial blood vessels, wound dressings and substrates for tissue 
regeneration, immobilization of enzymes and catalyst systems. 
Non-woven mats of electrospun nanofibers can mimic the extracellular matrices (ECM) since 
their architecture becomes similar to the collagen structure of the ECM (a 3D network of 
collagen nanofibers with diameters between 50 and 500 nm). In addition, electrospun synthetic 
materials can offer several advantages for tissue regeneration: correct and controllable 
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topography (e.g., 3D porosity, nanoscale size, and alignment), encapsulation and local sustained 
release of drugs (e.g., growth factors, antioxidants, anti-inflammatory agents), and surface 
functionalization. Electrospun nanofiber-mats can also be used for the development of complex 
nanosensory systems to detect biomolecules (e.g., glucose-recognition) in a less than nanomolar 
concentrations.[103] 
1.6.3 Electrospinning parameters 
Numerous parameters have been identified as affecting the final properties of electrospun fibers: 
polymer-solvent solution, processing and environmental parameters. Conditions are largely 
dependent on the dissolution parameters and hence the process parameters have to be empirically 
determined for each solution system.  
Most of these parameters have a range in which electrospinning of polymeric solutions is 
suitable. However, due to the sensitivity of the fiber morphology to small changes in these 
parameters, optimization is usually necessary for controlling the process and yield desired fiber 
morphologies and diameters. The optimization process can be difficult since the control of one 
parameter can lead to unwanted changes in another (e.g., adding a salt to increase conductivity 
can result in a change in the solution viscosity, making mutual optimization of these parameters 
difficult). Understanding the effects of each parameter on the electrospinning becomes a large 
part of this investigation. In this section, the key parameters of electrospinning and their effect 
on electrospun fiber morphologies is shortly discussed with reference to literature (Table 1.2). 
TABLE 1.2. Electrospinning parameters (solution, processing and environmental) and 
their effects on fiber morphology.[53] 
Parameters Effects on fiber morphology 
Solution 
Viscosity/Concentration 
 Low concentrations/viscosities yielded defects in the form of beads 
and junctions; increasing concentrations/viscosities reduced the 
defects. 
 Fiber diameter increased with the increase of concentration. 
Molecular Weight 
 The increase of molecular weight caused a reduction in the number of 
beads and droplets. 
Surface Tension 
High surface tension resulted in instability of jets. No conclusive link 
was found with fiber diameter. 
Conductivity/Surface 
Charge density 
 Increasing the conductivity aided the production of uniform bead-free 
fibers and decreased the fiber diameter. 
Dielectric constant 
 Successful spinning occurred in solvents with a high dielectric 
constant. 
Processing 
Voltage  Fiber diameter decreased with increasing voltages. 
Tip to collector distance 
 An optimal distance seems to be required to get uniform fibers. Beads 
are formed at distances either too short or too long. 
Feed Rate 
 Fiber diameters decreased by decreasing the flow rate. Beads are 
usually generated when too high flow rates are applied. 
Environmental 
Temperature 
 Fiber dimeters decreased with temperature as a consequence of the 
solution viscosity decrease. 
Humidity 
 High humidity resulted in the appearance of circular pores on the 
fibers. 
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1.6.4 Advances on the electrospinning technique 
The basic set-up for electrospinning is so simple that it has already found widespread use in 
many research laboratories. Due to the bending instability, a typical electrospinning jet deposits 
fibers in a random mat. Nevertheless, there are several applications where fibers should be 
deposited in a more controlled fashion. Thus, several techniques for influencing the layout of 
the fiber deposition have been developed. These can generally be grouped in two categories: 
mechanical and electrical.  
The collector can be further divided into the rotating device or a configuration of electrodes 
(Figure 1.9). The major category of electrospinning setups configuring aligned nanofibers 
employs a rotating device as the collector. Several geometries have also been designed and used. 
The purpose of the rotating device is to stretch mechanically the fibers and favour their 
alignment along the periphery of the drum. These configurations include a solid cylindrical 
collector, which can rotate about its axis.[104] 
Because the electrospinning jet is charged, it is also possible to exert some control over the 
deposition process using electric fields. Typically, a single grounded conducting substrate is 
used to collect the fibers (Figure 1.9 a). The grounded area can be restricted in a controlled 
fashion using a patterned electrode that induces the accumulation of fibers on the grounded 
electrode.[104] One interesting collector configuration consists on a rotating disc and a small 
aluminium table attached to the disk edge (Figure 1.9 b). This system allows obtaining double- 
and triple-layer highly aligned crossbar structures. If two conducting collecting electrodes 
separated by an insulating gap are used, the jet will dance between the electrodes and produce a 
uniaxially aligned array of fibers.[105, 106] Other collection techniques that rely on such behavior 
have been devised, such as the use of dual ring electrodes to collect a uniaxially aligned array of 
fibers (Figure 1.9 d) and the rotation of one of the collection rings that allowed the production 
of multi-filament yards. Another approach to manipulate the deposition of electrospun fibers is 
the control of the electric field using external electrodes between the tip and the collecting 
substrate (Figure 1.9 c). Taking this idea one step further, a time-varying electric field was 
applied to several electrodes to steer the electrospinning jet to “draw” individual fibers.[107] 
Another remarkable approach is based on the deposition of fibers in a circumferentially oriented 
way by employing an auxiliary electric field placed in a certain configuration. As an example, 
the production of tubular structures can be mentioned. It was reported that the indicated 
geometry can be achieved the asymmetric deposition of a rotating and charged drum between 
two charged plates or by the connexion of an auxiliary electrode (grid) made of a plurality of 
connected aluminium foil strips away from collector drum. 
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FIGURE 1.9 
Collector configurations: a) solid cylinder; b) disc collector; c) parallel plates and, d) dual rings.[104] 
The most basic electrospinning system uses a single metallic needle as the source to support the 
liquid droplet (the “spinneret” or tip). Other more complex systems have been developed and 
multicomponent fibers have been produced using electrospinning systems with modified 
spinnerets. These structures may include a core and a variable number of shells that allows 
getting bicomponent and multicomponent structures (Figure 1.10). The phenomenon mainly 
comprised of coaxially pumping out two chemically dissimilar solutions. The phenomenon 
needs a precise control of the system and processing parameters to achieve a well-defined core-
shell structure (Figure 1.10 a). Coaxial fibers, which in many cases can be subsequently 
processed into hollow tubes, may be produced using a coaxial electrospinning spinneret.[108] The 
other variation of this configuration[109] depicted in Figure 1.10 b includes gas as a shell 
material. The gas flow applies additional drawing action on the polymer jet during the 
electrospinning process. The dispensing system disperses two solutions from a single needle, 
thus fabricating bicomponent nanofibers (Figure 1.10 c). 
FIGURE 1.10 
Multicomponent fibers set-up: a) core-shell, b) gas as a shell material in core-shell structure and c) 
bicomponent electrospinning system.[104] 
One aspect of typical electrospinning setups that limits commercialization is low mass 
throughput. Electrospinning processes tend to operate at mass flow rates between μg/min to 
mg/min. Several techniques have been developed to overcome this problem, all of which use an 
  
21 
INTRODUCTION 
21 
array of multiple electrospinning spinnerets operating in parallel. This technique is usually 
manifested in systems employing an array of needles that are fed by the same electrospinning 
solution.[110] 
1.7 Electrospinning of biodegradable polymers as bioactive 
systems 
1.7.1 Biodegradable polymer loaded with drugs 
Electrospinning offers great flexibility in terms of material selection for drug delivery 
applications, being a wide variety of drugs physically or chemically formulated within 
electrospun fibers or on their surfaces. These include for example antibiotics,[111-115] anti-cancer 
drugs,[111-115] proteins,[118, 119] and DNA.[120-122] The drug release mechanism can be associated 
with polymer degradation and diffusion pathway. Specifically, the release profile of drug from 
electrospun fibers may be tuned by the polymer composition and fiber morphology.[123] 
Many strategies can be used to control the release of proteins and growth factors from fiber 
scaffolds. When biodegradable polymers are used, a common approach is to load the growth 
factors (e.g., bioactive molecules) on the material and use the combined effects of diffusion and 
erosion to mediate the release kinetics. Fiber meshes inherently have an appropriate structure to 
maximize surface area. Additionally, the hydrophilicity can be optimized by using surface-
modification methods. In general, it is accepted that hydrophobic materials are more compatible 
with the biological systems. 
The electrospinning process, being solvent based, allows the mixing of drugs and bioactive 
agents before the production of micro/nanofibers. However, the solvent needs to be harmless for 
the loaded bioactive agent, and must not compromise its functionality. Depending on the 
chemical interactions between drug and polymer carrier, different modes of interaction may be 
explored:[124] 
- Drug as particles or inclusions trapped in the fiber structure. 
- Blend of drugs and carrier materials integrated into one mesh of composite fibers. 
- Carrier material electrospun into a tubular form in which the drug particles are 
encapsulated. 
- Drug adsorbed onto fiber mats. 
Drug-release systems can be tailored to tune the release kinetics, to regulate local distribution 
and to minimize toxic side effects, thereby enhancing the effectiveness of the bioactive agent 
released.[125] Electrospinning also allows control of the fiber diameter, to some extent, and 
control the release of kinetics by the diameter of the fibers, both in diffusion- and in degradation-
controlled release. Moreover, the electrospinning process, being based in solvents, does not 
involve high temperatures which is particularly useful for heat-sensitive drugs. Furthermore, it 
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enables minimizing the initial burst release and the possibility of delivering uniform and highly 
controlled doses of bioactive agents at the wound side by tuning the surface properties of the 
fibers.[126] Table 1.3 summarizes the main electrospun fibers meshes proposed as drug-delivery. 
Specifically, the reported data suggests that many studies explored the loading of antibiotics 
onto fiber meshes, but only few reported the loading of antitumor or growth factors or other 
specific drugs. The materials that have been proposed as fiber drug carriers are restricted to the 
group of biodegradable synthetic polymers.[127] 
TABLE 1.3. Electrospinnig particles employed as drug-delivery systems.[59, 128, 129] 
Delivery Systems Incorporated Drug Scaffold Material 
Antymicotic Griseofulvin PMCA 
 Tetracycline hydrochloride PCL, PLA, PVA, PLGA, PEVA 
Antimicrobic Triclosan PS-DVB, PLA[130] 
 Chlorhexidine CA[131] 
Antibiotic Mefocin® (cefoxitin) PLA, PLGA, PLGA/PLA/PEG-b-PLA 
 Cefazolin PLGA 
 Itraconazole HPMC 
 Gentamicyn sulfate PCL 
 Biteral (ornidazol) PCL 
 Rifampin (rifadin) PLLA 
 Mupirocin PLLA[132] 
 Amphotericin B PLA-PCL[133] 
Antitumor Paclitaxel PLLA, PLGA 
 Doxorubicin PLGA 
 Curcumin PLLA[134, 135] 
Antiinflammatory Ibuprofen PLGA, PLA-g-CHN 
 Ketoprofen PVP[136], PVA[137] 
 Curcumin PCL[138] 
 Diclofenac sodium PCL, PLA-CL, PVA, PAM14 
 Dexamethasone PLA-CL[139] 
Analgesic Paracetamol PDLLA 
Anticoagulant Heparin PCL, PLGA 
Antioxidant Vitamin A and E CA 
 Resveratrol (phytoalexin) PCL 
 Curcumin PCL[138] 
 Gallic Acid PLLA[140] 
Growth Factor NGF PCLEEP 
 BMP-2 PLGA/HA[141], Chitosan 
Protein BSA PVA[142], PCL/PEG (Shell) – Dextran/BSA (core)[143] 
DNA Plasmid DNA PLA-PEG, PLGA, LEL 
Enzyme α-chymotrypsin PS, PSMA[144] 
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1.7.2 Biodegradable polymer meshed with conductive polymers 
Electrically conducting polymers are considered important because of their unique properties as 
mentioned above. Recently, several groups have demonstrated the preparation of conducting 
polymer nanofibers via electrospinning. Obtention of conductive nanofibers by electrospinning 
is not trivial and different strategies have been undertaken: (a) Incorporation of conductive 
particles [e.g., carbon nanotubes (CNT)] into the fibers, being usually necessary a surface 
treatment of particles in order to increase their affinity for the polymer matrix; (b) Direct 
electrospinning of conducting polymers with problems related to their stiffness and low 
solubility; (c) Blending the conducting polymer with another electrospinnable polymer (used as 
a carrier), being the detriment of the electronic properties the major inconvenience; and (d) 
Coating electrospun nanofibers with conductive materials.[6] 
Spin coating is a useful technique for preparing uniform thin films with thicknesses below 10 
nm. Basically a polymer solution is placed on a flat substrate, which is then rotated at high speed 
in order to spread the fluid by centrifugal force (Figure 1.11). The thickness of the film depends 
on the angular speed of spinning and the amount and concentration of the solution. Usually a 
sacrificial layer is deposited over the permanent support. The formed film is separated by 
destroying this layer after the fabrication procedure. 
FIGURE 1.11 
Spin coating process involves the following steps: (a) Solution deposition; (b) Substrate acceleration; (c) 
Constant spinning rate; and (d) Drying and separation (not shown).[6] 
It is difficult to use a conducting polymer alone in the electrospinning process due to the low 
molecular weight and its high crystallinity.[145] Therefore, despite the expected reduction in 
electrical characteristics, blends of polymers and electrospinnable additives have usually been 
used.[146] In such mixtures, the selection and composition of the conducting polymer has become 
very limited. On one hand, if the ratio of the conducting polymer is too low, the fabricated 
nanofibers tend to have poor electrical characteristics or no electrical properties at all.[147] On the 
other hand, if the ratio of the conducting polymer is too high, it becomes difficult to prepare 
conducting nanofibers because of the rigid structure of the polymer backbone and low solubility.  
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Other promising investigations about the use of polymer matrices as drug transport devices have 
also been undertaken. For example, the use of conducting/electroactive polymers as a medium-
sensing and bioactive molecule-releasing system. Drug delivery with these conducting polymer 
membranes is achieved through the controlled ionic transport of counterions (dopants) in and 
out of the membranes. Specifically, redox reactions regulate the necessary electrochemical 
switching, thus allowing electrostatically entrapped anionic dopants (such as the biological 
molecule ATP, which has been investigated for various cardiovascular therapies) to be either 
retained or released. In fact, initial studies that mainly involved a polypyrrole-based polymer 
membranes have proved quite promising. Results indicated that the drug delivery rate, chemical 
sensing, and electrochemical triggering can all be and precisely controlled.[6]  
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2. Objectives 
The present doctoral dissertation mainly aims to investigate the functionalization of three-
dimensional templates of micro/nanofibers obtained from biodegradable polymers. These 
matrices will be loaded with bioactive molecules with a specific activity, such as antimicrobial, 
anti-inflammatory, antioxidant and/or anticancerigen. The incorporation of these molecules in 
the fibers is intended to provide a pharmacological functionality to the matrix and a controlled 
release of the loaded drugs. Moreover, the incorporation of polymers with specific properties 
like conductivity, and electroactivity while biodegradability is mantained will be also 
considered. Therefore, four specific objectives will be considered: 
First Block: Antioxidant loaded biodegradable scaffolds and potential application 
for DNA purification 
Antioxidants have been chosen to be loaded into biodegradable scaffolds to prevent tissue 
damage. This process is called stress-oxidative, where cells and DNA should be controlled or 
treated in order to enhance tissue regeneration. The targets of this block are: 
i. Preparation of 3D scaffolds from electrospun polylactide nanofibers loaded with 
antioxidants (i.e., vitamin B6 in pyridoxine and pyridoxal form and two polyphenols, 
caffeic and p-coumaric acids) to prevent oxidative stress of cells colonizing the 
material.  
Study of the morphology and the physicochemical characterization of new loaded 
matrices, with the determination of drug release kinetics, and the evaluation of 
antioxidant bioactivity.  
ii. a) Evaluation of the effect of the selected compounds to inhibit oxidative damage in 
solution of plasmid DNA. 
b) Preparation of electrospun nanofiber matrices loaded with antioxidants and 
evaluation of their ability to inhibit oxidative DNA damage. 
c) Study of the application of new matrices as support for the purification of DNA 
subjected to oxidative stress. 
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Second Block: Multifunctional biodegradable fiber scaffolds  
Development of multifunctional electrospun materials for regenerative medicine applications. 
These are based on polylactide fibers that are loaded with active agents of different nature and 
with diverse therapeutic effects. The targets of this block are: 
i. Preparation of electrospun scaffolds from PLAs having slightly different ratios between 
L- and D-lactide units. 
Evaluation of dual and ternary systems involving triclosan (TCS) as an antibacterial 
agent, ketoprofen (KTP) as a conventional anti-inflammatory drug and p-coumaric 
(CUM) as an antioxidant drug. 
ii. Modulation of the therapeutic effect caused by the simultaneous incorporation of 
different drugs.  
iii. Evaluation of the influence of the polymer matrix crystallinity on the release behavior. 
Third Block: Preparation of biodegradable scaffolds that incorporate non-
electrospinable polymers 
Several polymers with highly interesting properties like conductivity/electroactivity or having 
bactericide activity cannot be electrospun directly. Therefore, the development of scaffolds 
based on blends of such polymers and biodegradable polymers may render new materials with 
highly promising properties for their application in the biomedical field. The targets of this block 
are: 
i. a) Development of biodegradable scaffolds containing PHMB as bactericide agent and 
optimization of electrospinning conditions for different PLA/PHMB ratios. 
b) Study of micro/nanofiber morphology and physicochemical characterization of 
PLA/PHMB scaffolds. 
c) Evaluation of the release kinetics, antimicrobial activity against both Gram negative 
and Gram positive bacteria (i.e. E. coli and M. luteus) and biocompatibility of 
PLA/PHMB scaffolds. 
ii. Establishment of the electrospun conditions required to get continuous micro/nanofibers 
from mixtures of P3TMA with PLA as well as performing a basic characterization of 
morphology and properties (e.g., ability to store charge and biocompatibility) of the 
derived scaffolds.  
Fourth Block: Biodegradable polymer matrices incorporating polyethylene glycol 
as a sacrificial polymer 
PEG can be considered a good sacrificial polymer due to its high solubility in aqueuos media. 
Scaffolds incorporating PEG will increase their porosity and favour cell colonization after 
exposure to such media. The targets of this block are: 
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i. a) Optimization of electrospinning conditions to get PLA/PEG scaffolds from polymer 
mixtures in a wide range of compositions (i.e., PEG content varying from 10 to 70 wt-
%). 
b) Evaluation of the solubility of the newly prepared scaffolds in different aqueous 
media since scaffold texture may be drastically affected and biocompatibility altered 
depending on the composition and the washing process. 
c) Getting information concerning the distribution of PEG and PLA phases. 
d) Study of drug loading and release profiles in media with different hydrophobicity. 
ii. a) Preparation of scaffolds constituted by electrospun fibers of PLA and PEG. This 
process allows an easy modulation without any restriction of the ratio between both 
kind of fibers and even makes feasible the combination of fibers with highly different 
morphologic features. 
b) Evaluation of the biocompatibility of new scaffolds and the bactericide effect caused 
by incorporation of drugs with well-differentiated hydrophobic/hydrophilic character 
such as triclosan (TCS) and polyhexamethylene biguanide hydrochloride (PHMB).  
iii. a) Study of coaxial electrospun scaffolds constituted by PEG and PBS with different 
core-shell distributions. 
b) Evaluation of the morphological changes caused by the rapid solubilization of PEG 
in aqueous media.  
c) Evaluation of scaffolds as drug delivery systems considering the independent load 
of drugs with different characteristics (e.g., triclosan and curcumin) in the two polymer 
components. 
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Polylactide Nanofibers Loaded with Vitamin B6 
and Polyphenols as a Potential Bioactive 
Platform for Tissue Engineering 
 
 
 
 
 
 
 
Electrospun polylactide nanofibers loaded with different 
antioxidants (i.e. vitamin B6 in pyridoxine and pyridoxal 
form, p-coumaric acid and caffeic acid) are prepared from 
N,N-dimethylformamide/dimethylsulfoxide solutions. 
Morphology, structure and crystallinity are evaluated by 
TEM, SEM, X-ray diffraction and DSC techniques. Fibers 
are highly amorphous but able to cold crystallize easily due 
to the high molecular orientation induced by the 
electrospinning process. The drug molecules are 
incorporated into the polymeric matrix or formed isolated 
crystals. A fast release of loaded drug occurs within the first 
8 h in hydrophobic medium; but, a slow and sustained 
release during several days occurs in a hydrophilic medium. 
Cells attachment on the loaded scaffolds are unaffected by 
the incorporation of the antioxidants. In contrast, cells 
proliferation increases with high antioxidative activity 
against free radicals responsible for cell damage. These new 
electrospun scaffolds provide high protection of cells against 
oxidative stress and resulting in innovative 3D fibrous 
platforms for tissue growth and proliferation  
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3.1.1 Introduction 
One of the most important current problems in tissue engineering is the rejection of biomaterial 
scaffolds introduced in human body. The main cause of rejection is that the immune system 
identifies foreign material within the body and attempts to destroy it.[1] However, there is another 
problem concerning biomaterials, i.e. the generation and harmful effects of reactive oxygen 
species (ROS) in transplanted organs, which has been demonstrated experimentally.[2] 
ROS include different oxidizing molecules like hydrogen peroxide (H2O2), superoxide anions 
(O2-) and free radicals such as hydroxyl (HO.) and peroxyl (R-COO.), which are usually highly 
reactive and short-lived. ROS form as a natural by-product of the normal metabolism of oxygen 
and have important roles in cell signalling, inflammatory responses and apoptosis (or 
programmed cell death).[3] ROS levels can increase dramatically in some specific situations, 
damaging cell structures significantly. This is known as oxidative stress. This problem can affect 
cellular components including lipids (by oxidation of their polyunsaturated fatty acids), DNA, 
proteins, carbohydrates and other biological molecules, leading to many pathological 
processes.[4, 5] 
Fortunately, biological systems can protect themselves against harmful effects of ROS by 
production of molecules with antioxidant performance. Antioxidant activities essentially 
suppress the formation of ROS or oppose their reaction. Cellular antioxidants typically 
correspond to enzymes such as superoxide dismutases, catalases, lactoperoxidases, glutathione 
peroxidases and peroxiredoxins, and also to small molecules like ascorbic acid (vitamin C), 
tocopherol (vitamin E), pyridoxine (vitamin B6), pyridoxal (vitamin B6 analogue), uric acid and 
glutathione.[6] 
In recent years, there has been an increased interest in the application of antioxidants to medical 
treatment as information linking the development of human diseases to oxidative stress is 
constantly gathered. The generally accepted hypothesis is that in any biological system proper 
balance must be maintained between the formation and removal of reactive oxygen. Within this 
context, it has also been stated that success in organ transplantation may be related to the use of 
molecules with antioxidant activity.[7, 8] 
The growing need for organ replacement has led to the development of tissue engineering 
techniques. Specifically several biodegradable polymers have been designed as temporary 
support for growth and differentiation of cells to form regenerated tissues.[9-12] Thus, three-
dimensional (3D) structures can be typically produced by several methods such as particle 
leaching,[13-15] emulsion freeze-drying,[16] and phase separation.[15, 17] Despite significant 
advances, there are, however, potential limitations such as lack of desired mechanical stability 
and porosity. Electrospun scaffolds offer an attractive approach for mimicking the natural 
extracellular matrix and even for controlling final porosity.[18] These 3D structures facilitate cell 
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attachment and tissue regeneration while preserving the expression or differentiation of cellular 
phenotypes.[6, 7] 
Although very few reports about the preparation of scaffolds loaded with antioxidants are 
available, some merit attention, e.g., those concerning mats of electrospun cellulose acetate 
fibers containing asiaticoside or curcumin,[19] vitamin A acid or vitamin E,[20],as well as 
polyesters like polycaprolactone and polylactide loaded with curcumin,[21] and gallic acid,[22] 
respectively. Animals and humans require a constant supply of vitamin B6 in their diet because 
this vitamin is a vital cofactor for the metabolism of amino acids and lipids, as well as the 
synthesis of neurotransmitters (e.g., histamine and haemoglobin). Moreover, it supports DNA 
repair against free radical damage.[23, 24] Vitamin B6 or pyridoxine is the derivative of 3-hydroxy-
2-methylpyridine. It includes three chemically, metabolically, and functionally related forms, 
i.e. pyridoxol, pyridoxal and pyridoxamine, in which alcohol, aldehyde, and amine group are 
respectively located at the fourth position of the pyridine ring (as shown in Figure 3.1.1 for the 
pyridoxine and pyridoxal structures).[25] On the other hand, hydroxycinnamic acid is the major 
subgroup of phenolic compounds, which can be found in a wide variety of fruits, vegetables and 
herbs. These compounds (e.g., the caffeic[26] and p-coumaric[27] acids in Figure 3.1.1) are also 
well recognized, effective antioxidants because they assist in preventing ROS damage by 
scavenging free radicals.[28] 
FIGURE 3.1.1  
Chemical structure of polylactic acid (PLA), pyridoxine hydrochloride (PN), pyridoxal hydrochloride (PL), 
p-coumaric acid (CUM), caffeic acid (CAF), and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
or trolox (TRX). 
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The main goal of this work is to prepare 3D scaffolds from electrospun polylactide nanofibers 
loaded with antioxidants (i.e., vitamin B6 in pyridoxine and pyridoxal form and two polyphenols, 
caffeic and p-coumaric acids) to prevent oxidative stress of cells colonizing the material. For 
this purpose, the morphology and physicochemical characterization of the new loaded matrices, 
together with drug release kinetics, are studied and antioxidant bioactivity is evaluated. 
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3.1.2 Experimental Section 
Materials 
Polylactide (PLA), a product of Natureworks (polymer 2002D), was kindly supplied by Nupik 
International (Polinyà, Spain). According to the manufacturer, this PLA has a D content of 
4.25%, a residual monomer content of 0.3%, a density of 1.24 g·cm-3, a glass transition 
temperature (Tg) of 58 ºC and a melting point of 153 ºC. N,N- dimethylformamide (DMF), 
dimethylsulfoxide (DMSO), pyridoxine hydrochloride (PN).[25] pyridoxal hydrochloride 
(PL),[25] trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) (TRX), 2,2’-
azobis(2-methylpropionamidine) dihydrochloride (AAPH), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, 
USA). Caffeic acid (3,4-dihydroxycinnamic acid) (CAF) and p-coumaric acid (p-
hydroxycinnamic acid) (CUM) were purchased from Acros Organics (New Jersey, USA). HEp-
2 (epithelial cells derived from human laryngeal carcinoma), MDCK (kidney epithelial cells 
derived from Madin-Darby Canine) and Cos-7 (kidney fibroblast cells derived from African 
green monkey) and MG-63 (human osteosarcoma cells) were purchased from ATCC (USA). 
Antioxidant Loaded PLA Nanofibers from Electrospinning 
Nanofibers of PLA unloaded and loaded with an antioxidant (PN, PL, CAF or CUM) were 
prepared by the electrospinning technique under optimal operational parameters obtained 
experimentally. To this end, 1 g of PLA was dissolved in 9 mL of anhydrous DMF and the 
polymer solution was maintained for 12-16 hours at 70 ºC to obtain a clear solution. Then, 1 mL 
of DMSO containing the corresponding drug (0.1 g) was added and the mixture was vortexed to 
obtain an electrospinable solution with a 10 and 1 w/v-% concentration of PLA and antioxidant, 
respectively. Controls consisting of PLA only and a sample containing a typical drug (TRX) 
with potent antioxidant activity were prepared by the same procedure. It should be pointed out 
that TRX is a synthetic analogue derivative of vitamin E and cannot be applied to biomedical 
use (i.e., only research and not human use). A plastic syringe of 10 mL (Becton Dickson, Spain) 
was filled with the polymer solution; electrospinning was then carried out between the needle 
(18G; Terumo, Belgium) connected to the anode and the static collector connected to the 
cathode. The DC voltage was applied using a high voltage supply (ES30-5W model, Gamma 
High Voltage Research, USA). The flow was controlled using a KD100 infusion syringe pump 
(KD Scientific Inc., USA). The polymer jet was collected on an aluminium foil and on coverslips 
of 14 mm diameter to evaluate cell adhesion and proliferation. All electrospinning experiments 
were conducted at room temperature. 
  
  
48 
 
Antioxidant loaded biodegradable scaffolds and potential application for DNA purification 
Morphology and Crystallinity of Drug Loaded PLA Nanofibers 
The diameter of electrospun fibers was measured with a Philips TECNAI 10 transmission 
electron microscope (TEM) at an accelerating voltage of 80 kV and using a SIS MegaView II 
digital camera. Fibers were directly electrospun on 400 mesh Cu grids coated with a thin carbon 
film. Inspection of fiber surfaces was performed by scanning electron microscopy using a Focus 
Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany). Carbon coating was accomplished 
with a Mitec K950 Sputter Coater (dotted with a film thickness monitor k150x). Samples were 
viewed at an accelerating voltage of 5 kV. Wide angle X-ray diffraction patterns were acquired 
at the CRG beamline (BM16) of the European Synchrotron Radiation Facility of Grenoble. The 
beam was monochromatized to a wavelength of 0.098 nm. Scaffold samples were confined 
between Kapton films. The WAXD detector was calibrated with diffractions of a standard of an 
alumina (Al2O3) sample. The diffraction profiles were normalized to the beam intensity and 
corrected considering the empty sample background. Calorimetric data were obtained by 
differential scanning calorimetry with a TA Instruments Q100 series equipped with a 
refrigeration cooling system (RCS). Experiments were conducted under a flow of dry nitrogen 
with a sample weight of approximately 5 mg and the calibration of equipment was performed 
with indium. Heating runs were carried out at a rate of 20 ºC·min-1. 
Antioxidante Release Experiments 
Controlled release measurements were performed with mats of electrospun samples cut into 
square pieces (20 x 20 x 0.1 mm3). They were weighed and incubated in 50 mL tubes containing 
30 mL of the release medium at 37 ºC and orbital shaking (200 rpm) for 1 week. Sörensen’s 
buffer (pH 7.4) containing a 70 v/v-% of ethanol and alternatively TBE buffer (89 mM Tris, 89 
mM boric acid, 2 mM EDTA, pH 8.4) were assayed as release media. Drug concentration in the 
release media was evaluated by UV spectroscopy using a UV-3600 (Shimadzu, Japan). 
Calibration curves were obtained by plotting the absorbance measured at the corresponding 
wavelengths against drug concentration. Samples (1 mL) were drawn from the release medium 
at predetermined intervals and an equal volume of fresh medium was added to the release vessel. 
All the drug release tests were carried out using three replicates to control the homogeneity of 
the release, and the results obtained from the samples were averaged. 
Porosity of Antioxidant Loaded PLA Scaffolds 
The porosity of the nanofiber scaffolds was measured using the liquid intrusion method.[29] 
Scaffolds (n = 3) were weighed prior to immersion in ethanol (liquid intrusion). Vacuum was 
applied for 10 min, and the scaffolds were left on a shaker table for 1 hour to allow diffusion of 
ethanol into the void volume. The scaffolds were taken out and reweighed. The porosity was 
calculated according to Equation 1: 
𝑃 = [
(𝑆𝑤−𝑆𝑑)
𝑑𝐸𝑡𝑂𝐻
] / [
(𝑆𝑤−𝑆𝑑)
𝑑𝐸𝑡𝑂𝐻
+
𝑆𝑑
𝑑𝑃𝐿𝐴
]       (1) 
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where Sw, Sd are the weights of the wet and dry scaffolds, respectively, and dEtOH and dPLA the 
densities of ethanol (0.789 g·mL-1) and amorphous PLA (1.24 g·mL-1), respectively. The latter 
density was selected due to the low crystallinity and drug content of PLA scaffolds. 
In-vitro Biocompatibility Assays: Cell Adhesion and Proliferation 
HEp-2, MDCK, and Cos-7 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine 
at 37 ºC in a humidified atmosphere with 5% CO2 and 95% air. The culture medium was changed 
every two days and, for sub-culture, the cell monolayers were rinsed with phosphate buffered 
saline (PBS) and detached by incubation with trypsin-EDTA (0.25%) at 37 ºC for 2-5 min. Cell 
concentration was established by count with a Neubauer camera using 4% trypan-blue as dye 
vital. The detached cells with viability ≥ 95% were used for cultures the conditions for 
biocompatibility assays. 
The unloaded and antioxidant loaded electrospun PLA nanofibers were collected on circular 
coverslips (diameter 1.4 cm). These samples were placed into the wells of a multiwell culture 
plate and sterilized by UV-radiation in a laminar flux cabinet for 15 min. To fix the samples in 
the well, a small drop of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France 
SAS, Lyon, France) was used as the adhesive. The samples were incubated with 1 mL of the 
culture medium in culture conditions for 30 min to equilibrate the material. Finally, the medium 
was aspired and the material was evaluated for cell adhesion and proliferation by exposing cells 
to direct contact with the material surface. 
To assess cell adhesion, aliquots of 50-100 µL containing 5x104 cells were seeded onto the 
electrospun samples in the wells. The plate was incubated in culture conditions for 30 min to 
allow cell attachment to the material surface. Then, 1 mL of the culture medium was added to 
each well and the plate was incubated for 24 h. Finally, cell viability was determined by the 
MTT assay.[9, 10] Controls were performed by cell culture on the polystyrene surface of the plate 
(TCPS). 
Cell proliferation was evaluated by a similar procedure to the adhesion assay, but the aliquot of 
50-100 µL contained 2x104 cells. The cultures were maintained for 7 days to allow cell growth 
and adequate cell confluence in the well. The media were renewed every two days. Finally, 
viability was determined by the MTT assay. 
Each sample was evaluated using five replicates and the results were averaged and graphically 
represented. The statistical analysis was performed by one-way ANOVA to compare the means 
of all groups; t-Test was then applied to determine a statistically significant difference between 
two studied groups. The tests were performed with a confidence level of 95% (p < 0.05). 
To obtain SEM images, samples from adhesion and proliferation assays were processed as 
follows. First, they were fixed in 2.5% glutaraldehyde-PBS overnight at 4 ºC, and then 
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dehydrated by washing in an alcohol battery (30º, 50º, 70º, 90º, 95º and 100º) at 4 ºC for a 
minimum of 30 min per step. Finally, the samples were dried and covered by carbon sputtering 
for SEM examination. 
Antioxidative Effect of PLA Scaffolds Loaded with Vitamin B6 and Polyphenols 
This assay was performed to determine the protective potential of antioxidant loaded PLA 
nanofibers and to compare the results with unloaded PLA nanofibers. Samples were exposed to 
oxidative stress induced by AAPH. This water soluble compound has a well-recognized 
capability to generate free radicals at a constant rate.[30] 
MG-63 cells were cultured and manipulated as described above for other cell lines. An aliquot 
of 50-100 µL containing 2x104 cells was seeded onto the electrospun samples. The plate was 
incubated in culture conditions for 30 min to allow cell attachment to the material. Then, 1 mL 
of the culture medium was added to each well and the plate was incubated for 48 h. The medium 
was subsequently replaced with a fresh one supplemented with different concentrations of the 
AAPH radical initiator and the culture was continued for 24 h. Finally, all the media were 
replaced again with a fresh medium without AAPH and supplemented with the MTT reactive to 
determine cell viability.[9, 10] TCPS controls without and with AAPH were performed to obtain 
the highest and lowest viability, respectively. The results were statistical analyzed as described 
above. 
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3.1.3 Results and Discussion 
Morphology of Antioxidant Loaded Electrospun PLA Nanofibers 
Selection of an appropriate solvent system is crucial for a successful electrospinning process. 
DMF has the advantage of having a high dielectric constant, and furthermore is fully miscible 
with DMSO, which is essential to dissolve the antioxidants tested. A DMF/DMSO mixture (9:1, 
v/v) was consequently employed as a solvent for all experiments. It is also well known that fiber 
diameter is strongly influenced by polymer concentration which was, like drug concentration, 
kept constant (10 w/v-% and 1 w/v-%, respectively) in all the assays. 
Electrospinning experimental conditions were optimized to avoid problems like bead formation 
and obtain a similar diameter distribution in the nanometric range for all samples, which 
provides rapid release and an antioxidant effect. 
The selection of the spinning voltage was essential to ensure a stable, conical liquid jet which 
minimized bead formation. The distance between the target and the syringe tip was kept close 
to 12.5 cm, and the flow was found to be drastically affected by the viscosity of the solvent. 
Thus, a low flow (0.5 - 1 mL·h-1) was required in contrast with typical values close to 5-10 mL·h-
1, which were previously reported for electrospinning of PLA from chloroform:acetone (2:1, v/v) 
mixtures and similar concentrations.[9, 10] 
TABLE 3.1.1. Optimal spinning conditions applied for the different studied samples 
and average fiber diameter values. 
Sample 
Voltage  
[kV] 
Flow  
[mL·h-1] 
Distancea  
[cm] 
Fiber Diameterb 
[nm] 
Porosityc 
[%] 
PLA 17.5 1 12.5 92 ± 1 69 ± 10 
PLA-PN 17 0.5 12.5 101 ± 3 85 ± 5 
PLA-PL 17 0.5 12.5 124 ± 3 77 ± 12 
PLA-CUM 17.5 1 12.5 86 ± 2 49 ± 17 
PLA-CAF 19 1 12.5 81 ± 2 82 ± 5 
PLA-TRX 17.5 1 12.5 63 ± 1 84 ± 1 
a Between the syringe tip and the collector 
b Average value and standard deviation determined from TEM micrographs 
c Average value and standard deviation determined from liquid intrusion method 
Table 3.1.1 summarizes the optimized operational parameters (voltage, flow and needle-
collector distance) as well as the derived diameter size. Figure 3.1.2 contains optical 
micrographs of electrospun samples obtained under the selected optimum conditions and the 
histograms of the diameter distributions. Measured values confirm the success of 
electrospinning to obtain fibers in the nanometric scale, and specifically point out a diameter 
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range between 63 and 124 nm. Diameters of fibers were highly dependent on the characteristics 
of the added drug, and consequently the influence of operational variables cannot be discussed 
independently. For example, an unreliable conclusion could be inferred from the largest diameter 
(i.e. 101-124 nm) attained at the lowest flow (i.e. 0.5 mL·h-1) if the change of drug (i.e. vitamin 
B6 instead of polyphenols) is not taken into account.  
It is worth noting that the selected solvent system made it possible to obtain nanometric fibers 
despite working with a relatively high polymer concentration (for example, when a 
chloroform:acetone mixture was used, the PLA concentration that gave rise to fibers with a 
similar diameter was lower than 2.5 w/v-%).[10] 
Incorporation of drugs clearly influenced the diameter of electrospun PLA fibers. Specifically, 
vitamin B6 in PN and PL form increased the diameter of fibers from 92 to 101 and 123 nm, 
respectively. In contrast, larger antioxidant molecules having a carboxylic group such as CUM, 
CAF and TRX decreased the fiber diameter (86, 81 and 63 nm, respectively). Apparently, 
diameter sizes increased in the reverse order of the drug molecular volume (TRX > CUM/CAF 
> PN/PL, as shown in). The possible dissociation of TRX, CAF and CUM into ionic species can 
increase the charge density on the surface of and/or within the ejected polymer jet. The increased 
charge density should impose greater elongation and thinning forces on the jet as it travels 
through the electric field to the collector, leading to the formation of smaller fiber diameters. A 
similar explanation was proposed for the gallic acid-loaded PLA fibers, which were thinner than 
those of PLA.[22] 
Scaffolds were highly porous (70-85%) although the size of pores was small due to the reduced 
diameter of the constitutive nanofibers. However, no correlation was found between this size 
and the diameter of nanofibers (Table 3.1.1). 
SEM electron micrographs of Figure 3.1.3 compare the surface morphology of the nanofibers. 
A surface rough with multiple holes was characteristic of the unloaded PLA (Figure 3.1.3 a) 
and even of samples having PN and PL drugs. However, the micrographs of PLA-PN samples 
also highlight the presence of isolated drug crystals distributed along the fibers (Figure 3.1.3 b), 
even after the partial melting of the polymer under the electron flux (Figure 3.1.3 b, inset). PLA-
PL fibers were also characterized by the presence of protrusions that could correspond to vitamin 
B6 crystals which seemed better integrated in the fiber structure (Figure 3.1.3 c). PLA-CUM 
fibers had a rough morphology with bumps protruding above the surface (Figure 3.1.3 d) in a 
similar way to PLA-PL fibers. PLA fibers loaded with CAF again had a rough surface and 
polyphenol crystals that were perpendicularly embedded in the fibers (Figure 3.1.3 e). Finally, 
PLA-TRX fibers had a smooth appearance (Figure 3.1.3 f) where the presence of drug crystals 
could not be clearly detected. 
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FIGURE 3.1.2 
Scanning electron micrographs (images) and frequency distribution (graphics) of the fiber diameter of 
electrospun PLA (a), PLA-PN (b), PLA-PL (c), PLA-CUM (d), PLA-CAF (e) and PLA-TRX (f) 
nanofibers. 
FIGURE 3.1.3 
Representative SEM images of scaffolds showing morphological details of the fiber surfaces. (a) PLA 
fibers with holes (arrows). (b) PLA-PN fibers with PN crystals (arrows). Inset shows how the crystals 
remain embedded after partial melting of fibers under the electron flux. (c) PLA-PL fibers with large 
numbers of protrusions (arrows). (d) PLA-CUM fibers with embedded crystals protruding from the surface 
(arrows). (e) PLA-CAF fibers with flat crystals protruding perpendicularly from the surface (arrows). Inset 
shows a detail of the crystal arrangement. (f) PLA-TRX fibers with a smooth surface. 
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X-Ray Diffraction Data of Antioxidant Loaded Electrospun PLA Nanofibers 
X-ray diffraction was used to assess how antioxidants became incorporated into the PLA 
nanofiber samples (i.e. giving isolated crystals or mixing in either the amorphous or crystalline 
phases of PLA). Figure 3.1.4 compares WAXD profiles of all studied mats with those 
corresponding to isolated drug. 
FIGURE 3.1.4 
WAXD patterns (intensity, I, versus the scattering vector, q = [4/] sin () = 2/d, where  is the scattering 
angle and d the Bragg spacing) of electrospun microfibers (top black line) and the corresponding loaded 
antioxidant (bottom gray line): a) PLA, b) PLA-PN, c) PLA-PL, d) PLA-CUM, e) PLA-CAF, and f) PLA-
TRX. Arrows indicate peaks that could be associated with the PLA crystalline phase. 
The pattern of electrospun PLA nanofibers revealed the presence of dominant amorphous halos 
and the almost complete absence of crystalline PLA Bragg reflections. Predominant Bragg peaks 
associated with the expected -form (103 helical conformation) of PLA should appear at 0.542 
and 0.472 nm and corresponded to the (200)+(110) and (203) reflections.[9, 31-33] These were 
hardly observed in the PLA sample or in the drug loaded scaffolds, in agreement with the low 
degree of crystallinity determined from DSC measurements, as will be explained below. 
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No peaks associated with PL crystals were observed in the diffractograms of PLA-PL samples 
(Figure 3.1.4 c), suggesting that this drug was well mixed in the polymeric matrix, as also 
inferred from morphological observations (Figure 3.1.3 c). On the contrary, crystalline 
reflections with a relatively low intensity (Figure 3.1.4 b) were detected in the PN loaded 
scaffolds; note that in this case a low number of crystals were observed in the electron 
micrographs (Figure 3.1.3 b). 
Samples loaded with CUM and CAF polyphenols gave rise to X-ray profiles (Figures 3.1.4 d 
and 3.1.4 e) where the characteristic reflections of the corresponding drug crystals appeared with 
high intensity. Differences on the peak width allowed deducing a smaller size of CAF crystals 
(i.e. those with the higher width) according to the Scherrer equation.[34] The relative intensity of 
peaks associated with CAF crystals changed slightly in the loaded scaffold with respect to the 
powder drug (Figure 3.1.4 e), suggesting that crystals were deposited in the PLA nanofibers in 
a preferred orientation, as also suggested by the morphological observations (Figure 3.1.3 e). 
Finally, the X-ray profile of the PLA-TRX sample revealed the absence of TRX crystals, 
indicating that these antioxidant molecules were well integrated in the polylactide matrix. 
However, the appearance of new Bragg reflections also merits attention because it suggested 
that a new phase can occur by the interaction between TRX and PLA molecules. 
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Thermal Behaviour of Antioxidant Loaded Electrospun PLA Nanofibers 
Table 3.1.2 contains the main calorimetric data obtained from the heating run of antioxidant 
loaded electrospun samples. Heating traces of these samples are shown in Figure 3.1.5 together 
with the trace corresponding to the heating run of a PLA sample after being processed in a 
controlled way (i.e. cooled at a rate of 10 ºC·min-1 from the melt state). 
FIGURE 3.1.5 
DSC heating runs (20 ºC·min-1) corresponding to: PLA sample after being cooled from the melt state to 
room temperature at 10 ºC·min-1 (a), PLA-PN (b), PLA-PL (c), PLA-CUM (d), PLA-CAF (e) and PLA-
TRX (f).  
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Several features deserve attention: 
 All electrospun samples had a broad exothermic peak (70-120 ºC) indicative of the cold 
crystallization of PLA. Its appearance, enthalpy and specific temperature range depended 
on the sample nature (i.e. the antioxidant added to PLA). The high molecular orientation 
attained in the electrospun fibers facilitated the crystallization process, as previously 
reported,[9, 33] which was not observed when the PLA sample was processed by slow cooling 
from the melt state (Figure 3.1.5 a). On the contrary, unloaded electrospun PLA samples 
again were able to crystallize (Table 3.1.2).  
 Electrospun samples showed melting peaks which were mainly due to the cold 
crystallization process. The difference between melting and cold crystallization enthalpies 
was low, and consequently samples crystallized with high difficulty during the 
electrospinning process. The degree of crystallinity (c) of the electrospun samples could 
be evaluated from the above enthalpic difference and the reported melting enthalpy (106 
J·g-1) for a 100% crystalline sample.[35, 36] Significant crystallinity differences were found 
between the electrospun samples although these values were always relatively low. 
Specifically, samples loaded with TRX and PL had the highest values (i.e. 17.3 and 10.9%, 
respectively). It should be pointed out that these were the only samples where no crystals 
of the added drug were detected in the X-ray profiles. Note also that all samples attained 
moderate crystallinity (i.e. 22-34%) after the cold crystallization process. 
 The melting process, which was relatively complex, gave rise to a main peak (149-140 ºC) 
together with a small shoulder, and in some cases to an additional minor peak at a lower 
temperature. The main peak temperature changed slightly depending on the loaded drug and 
specifically on its capability to be incorporated into the crystalline structure. This capability 
was higher for the CUM molecules, as deduced from the higher decrease in the melting 
temperature and even in the crystallinity (Table 3.1.2). The shoulder and the main peak 
detected in the heating runs seem to correspond to the characteristic PLA double melting 
peak, which is associated with a recrystallization process where thinner lamellae become 
thicker. The minor peak observed in two cases (i.e. PLA-TRX and PLA-PL samples) at a 
temperature close to 120 ºC is indicative of the existence of highly defective crystals (i.e. 
those with a significantly lower thickness or a high drug content). 
 All PLA heating traces had a clear glass transition, as could be presumed for practically 
amorphous samples (i.e. those obtained before cold crystallization), and also a relaxation 
endothermic peak that usually appeared later. This peak is indicative of the trend of the 
metastable PLA glassy material to achieve equilibrium thermodynamic conditions with a 
lower specific volume, enthalpy and entropy, which logically render a material with higher 
stiffness. The glass transition temperature was practically constant for all samples, and 
consequently the incorporation of the aromatic drug molecules did not facilitate the mobility 
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of the rigid PLA molecules. However, the strong impact on the relaxation process for the 
PLA-CUM sample is worth noting.  
 The amorphous phase of PLA is complex and should usually be analyzed assuming a 
biphasic model where a mobile amorphous phase (MAP), responsible for the heat capacity 
jump in the glass transition region, and a rigid amorphous phase (RAP) associated with the 
hindered molecular motions of chains within lamellar stacks, can be distinguished. 
Specifically, these fractions are determined as MAP = Cp/CP0 and RAP = 1-c -MAP, 
where Cp and CP0 correspond to the heat capacity jump of the studied sample and a fully 
amorphous PLA (i.e. 0.623 J·g-1·ºC-1). Results in Table 3.1.2 again show significant 
differences between all loaded PLA samples and, interestingly, a loss of correlation between 
c and RAP fractions since both should change in a similar way (i.e. both should increase 
or decrease). Discrepancies suggest the existence of interfaces between drug crystals and 
PLA that increased theRAP fraction. 
Spectral Characteristics Related to the Antioxidants Release from PLA 
Electrospun 
The release of molecules loaded in an electrospun matrix is intimately related to the morphology 
and structure of the constituting fibers and also to the environment where such release occurs. 
After the analysis of the characteristics of the loaded PLA nanofibers, it seemed interesting to 
study the behavior in solution of the selected drugs. To this end, two media of different 
hydrophobicity/hydrophilicity were selected to vary the affinity with the released drug. 
Specifically, a Sörensen-ethanol (3:7, v/v; pH 7.4) mixture and a TBE buffer (pH 8.4) were taken 
as examples of hydrophobic and hydrophilic release media, respectively. UV-Vis spectroscopy 
was used to quantify the amount of released antioxidant and to detect spectral/electronic changes 
undergone by the released molecules (Figure 3.1.6). The PBS buffer was also tested as release 
hydrophilic medium (data not shown), and the release kinetic results were similar to those 
obtained in Sörensen-ethanol (3:7, v/v; pH 7.4) buffer; however, TBE buffer has the advantage 
of facilitating the detection of vitamins and polyphenols by UV-Vis spectroscopy due to 
electronic changes in these molecules by the presence of the borate ions in the buffer. For this 
reason, TBE buffer was chosen as the hydrophilic medium for release assays. 
The spectrum of PN in the hydrophobic medium (Figure 3.1.6 a) is characterized by two bands 
at 280 nm and 325 nm associated with the presence of the 3-hydroxyl group (i.e. that directly 
linked to the pyridine ring). In aqueous solution, the spectrum became clearly dependent on the 
pH.[37] A single maximum at 292 nm is characteristic when pH values are equal to or lower than 
3, but it gradually decreased and two new bands appeared at 255 and 325 nm as the pH was 
raised to 7.4, which is precisely the value of the medium tested. This splitting is characteristic 
of the presence of the hydroxyl groups since it was never observed for 3-methoxy derivatives.[37] 
In contrast, the absorption spectra of PN in the pH 8.4 TBE hydrophilic buffer (Figure 3.1.6 b) 
showed a single band at 292 nm, which can be explained by the presence of the borate ions in 
  
60 
 
Antioxidant loaded biodegradable scaffolds and potential application for DNA purification 
the buffer. The borate-PN complex, which has been reported in previous works, consisted of the 
coordination of bore atoms with two PN molecules through their oxygen atoms in positions 3 
and 4. This complex kept the physiological activity of PN and was thermostable in neutral 
solutions.[37, 38] 
The PL and PN spectra in the hydrophobic and hydrophilic media (Figures 3.1.6 c and 3.1.6 d, 
respectively) were similar, although a new band appeared near 400-410 nm, most probably 
because of the presence of the aldehyde group of PL. 
The spectra of CUM in the Sörensen-ethanol medium correspond to a single band with a 
maximum at 285 nm and a shoulder at 310 nm (Figure 3.1.6 e). This main band can be attributed 
to the 3-hydroxyl aromatic substitution and basically remains unchanged when the hydrophilic 
medium is used (Figure 3.1.6 f). The spectrum of CAF with 3 and 4- hydroxyl aromatic 
substitutions is clearly different since now two bands appear at 285 nm and 310 nm in the 
Sörensen-ethanol buffer (Figure 3.1.6 g). A notable change in the spectrum occurred in the 
hydrophilic medium since the intensity of the peaks is reversed and specifically the intensity of 
the peak at 310 nm increases significantly (Figure 3.1.6 h).  
The TRX molecules in both hydrophobic and hydrophilic media (Figures 3.1.6 i and 3.1.6 j) 
have identical spectral characteristics defined by a single band at 291 nm (Sörensen-ethanol 
buffer) and 289 nm (TBE buffer). Note that the molecule has only a hydroxyl substitution, and 
therefore a simple spectrum should be expected.  
Finally, for all antioxidants, lineal plots of absorbance (measured at the specific wavelength 
corresponding to the maximum determined for each release medium) versus drug concentration 
were obtained (insets of Figures 3.1.6 a-3.1.6 j) and used to estimate the drug concentration in 
the subsequent release experiments.  
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FIGURE 3.1.6.  
UV-Vis spectral characteristics of the antioxidants used in this work: PN (a, b), PL (c, d), CUM (e, f), CAF 
(g, h), and TRX (i, j). Antioxidants were dissolved in a Sörensen-ethanol buffer (3:7, v/v) hydrophobic 
medium (a, c, e, g, and i) and in a TBE buffer hydrophilic medium (b, d, f, h and j). The UV-Vis spectra of 
each antioxidant were recorded at different concentrations, and a regression analysis was performed for 
quantification at a characteristic wavelength of each drug (inset). 
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The release kinetics can be calculated from experimental results by several theoretical models, 
typically first-order,[39, 40] Higuchi[41, 42] and their combination.[43] The release generally occurred 
in two different steps, i.e. rapid release of molecules that should be deposited mainly on the high 
surface area of nanofibers and slow release that should involve the diffusion of molecules 
through the polymer bulk towards the release medium. In this way, a combined model based on 
the Higuchi and first-order models (Equation 2 and 3) is usually used to describe the first (0-
60%) and second (40-100%) parts of the release, respectively: 
Mt M0⁄ =kht
1 2⁄     (0 ≤ Mt M0 ≤ 0.6⁄ )    (2) 
ln(1- Mt M0⁄ ) =a-k1t   (0.4≤ Mt M0≤1.0⁄ )    (3) 
where kh is the Higuchi release constant, k1 is the first-order release constant, a takes into account 
the release in the first step, Mt is the percentage of drug released at time t, and M0 is the drug 
equilibrium percentage (considered as the maximum drug percentage). 
The release of the studied drugs in the two media is graphically shown in Figure 3.1.7, whereas 
the deduced kinetic constants are summarized in Table 3.1.3. In general, the release could be 
well fitted using only the Higuchi model, although in some specific cases (i.e. PL and TRX in 
the Sörensen-ethanol medium), this model had a limited range of application, and therefore the 
second part of the release should be fitted with a first-order kinetics.  
  
CHAPTER 3.1 
63 FIGURE 3.1.7 
Antioxidant release profiles for five loaded electrospun PLA samples: PLA-PN (a), PLA-PL (b), PLA-
CUM (c), PLA-CAF (d), and PLA-TRX (e). The concentration of drug released in a Sörensen-ethanol 
buffer mixture (3:7, v/v) (open circle) and in a TBE buffer (solid circle) was measured by UV-Vis 
spectroscopy. Results are mean ± SE (n = 3). 
Because of their hydrophobic character (due to their aromatic ring structure), all drugs were 
rapidly released in the Sörensen-ethanol medium. Thus, 100-95% of the loaded drug was 
released after only 8 h of exposure to the medium in all cases. 
By contrast, in the hydrophilic environment, the release was slower and progressive and an 
equilibrium condition was established. This was deduced from the asymptotic release percentage 
obtained in all cases. The release occurred in two different steps, as also deduced from the 
selected kinetic model. A relatively fast process over an exposure time close to 8 h was firstly 
observed, corresponding to a release between 15 and 30% of the total loaded drug, with the 
minimum value found when TRX was loaded. After this period, the release was slower until the 
above asymptotic value was reached in a period that could extend over three days. This release 
was around 50% except for the more hydrophilic CAF drug (80%). 
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TABLE 3.1.3. Release kinetikcs parameters of the Higuchi model (0-60%) for the 
antioxidant release from PLA scaffolds in hydrophilic and hydrophobic media. 
Drug 
 
Sörensen-ethanol 
  
TBE 
(Hydrophobic medium) (Hydrophilic medium) 
kH 
r range 
kH 
r range [h-0.5] [h-0.5] 
PN 1.033 0.986 0-98% 0.191b 0.987 0-100% 
PL 1.192a 0.93 0-58%  0.098a 0.987 0-100% 
CUM 0.718 0.959 0-94%  0.175b 0.986 0-95% 
CAF 0.683 0.988 0-95%  0.229b 0.985 0-98% 
TRX 0.853a) 0.936 0-76%  0.074 0.995 0-100% 
Values adjusted in kinetics with an initial gap (not release) during 5 min (a) or 60 min (b) 
Kinetic constants were logically higher for the hydrophobic medium. In this case, slight 
differences were determined for the different drugs, although the values of the kinetic constant 
found at the beginning of the process suggested a hydrophobic character that decreased in the 
order PN/PL > CUM/CAF. Similar conclusions were drawn when kinetic constants 
corresponding to the second part of the release in the hydrophilic medium were compared. Some 
discrepancies were found for the first part but in this case the process is probably mainly 
influenced by the physical state of the drug in the PLA matrix (i.e. mixed or forming isolated 
crystals). For example, CUM formed bigger crystals than CAF and was released faster at the 
beginning of the process despite its lower hydrophilicity. The peculiar behavior of TRX, which 
had practically the smallest kinetic rate constants for the two media, indicating affinity between 
the drug and the PLA matrix (as suggested by SEM, X-ray and DSC observations), is worth 
noting. Hydrogen bond interactions were probably established between hydroxyl and carboxylic 
groups of the drug and the PLA ester groups. 
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Biocompatibility of Antioxidant Loaded Electrospun PLA Nanofibers: Cell 
Adhesion and Proliferation 
PLA nanofiber matrices loaded with antioxidants were evaluated as appropriate scaffolds to 
support cell adhesion and proliferation. Thus, epithelial cells like MDCK and HEp-2, and 
fibroblast-like cells such as Cos-7 were seeded in direct contact with the studied materials 
(Figure 3.1.8). Cell adhesion was determined after 24 hours as an early event of cell colonization 
on the scaffolds while cell proliferation was determined at 7 days as an endpoint that 
demonstrated cell growth on the materials. 
Cell attachment was evaluated considering the ratio between the number of adhered cells and 
cell viability (i.e. number of cells adhered on the TCPS control) for each cultured well of the 
plate. In this way, it was clearly established that a high number of cells, close to 80%, adhered 
to the scaffold surface although this surface corresponded to only 68% of the total well surface. 
This important feature was found for all tested cells (i.e. Cos-7, MDCK and HEp-2, as shown in 
Figure 3.1.8 a, 3.1.8 c and 3.1.8 e, respectively). Specifically, the adhesion/viability ratio of the 
scaffold, together with the ratio obtained for the remaining plate surface of the well that 
contained the sample, was similar to the control. In conclusion, the obtained results clearly 
exclude any possible cytotoxic effect generated by the PLA matrices after being loaded with the 
selected antioxidants.Cell proliferation was determined as the total growth in the wells 
containing the electrospun samples. Thus, the three cell lines (Cos-7, MDCK and HEp-2 cells) 
showed a significant increase in the cell number when the well contained antioxidant loaded 
PLA scaffolds (Figure 3.1.8 b, 3.1.8 d and 3.1.8 f). This increase demonstrated that cell growth 
and/or cell culture had a self-basal oxidative stress[4, 6-8] and that the antioxidant activity of 
vitamin B6, its derivative and polyphenols released from the loaded scaffold improved the 
cellular environment considerably by their radical-scavenging capacity. It should be pointed out 
that the selected natural antioxidants gave better results than the well-recognized TRX, which 
was used as a positive control. The effect of the natural antioxidants changed slightly according 
to their nature and the cells tested. Thus, the highest proliferation was found for MDCK cells 
grown on CUM loaded scaffolds (i.e. more than 50% compared to the TCPS control), whereas 
the lowest proliferation corresponded to HEp-2 cells on PLA-CUM scaffolds (i.e. only more 
than 20% compared to the control). Changes in the antioxidant effect of vitamin B6, its derivative 
and polyphenols during prolonged culture could be related to decomposition and pro-oxidative 
effects of the products of this decomposition.[44] 
 
  
66 
 
Antioxidant loaded biodegradable scaffolds and potential application for DNA purification 
FIGURE 3.1.8 
Cell attachment and proliferation on scaffolds of electrospun nanofibers for three cell lines: Cos-7 cells (a) 
and (b), MDCK cells (c) and (d), and HEp-2 cells (e) and (f). Cell attachment (a, c, and e) was evaluated 
on the electrospun sample and on the surface of a well not covered with the electrospun sample (i.e. the 
plate, TCPS). Cell proliferation (b, d, and f) was evaluated in the whole well that contained the electrospun 
sample. Results are mean ± SD (n = 5). Values differing from controls (TCPS) are indicated by an asterisk, 
p < 0.05 (t-Test). 
Morphological observations gave evidence of the formation of a cell monolayer on all the 
electrospun samples (Figure 3.1.9 a-3.1.9 f). The increase in the number of cells grown on the 
surface of the samples does not exclude a possible alteration or occurrence of defects in the cell 
monolayer (e.g., stacking of cells in isolate clusters). The micrographs in Figure 3.1.9 show that 
representative Cos-7 cells grew normally to contact each other and formed a monolayer structure 
on the scaffold surface. Furthermore, it is clear that these scaffolds had high fiber density and 
reduced pore size that restricted the entry of cells into the matrix (Figure 3.1.9 g). Invasion and 
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colonization of the scaffolds by cells were consequently hindered because of their inherent 
geometry. 
FIGURE 3.1.9 
SEM images of the cell monolayer on PLA (a), PLA-PN (b), PLA-PL (c), PLA-CUM (d), PLA-CAF (e), 
and PLA-TRX (f) during proliferation of Cos-7 cells. The asterisk points out the electrospun nanofibers. 
Representative images of Cos-7 cells show a morphological detail of the cytoplasmic extension (arrows) 
demonstrating cell adhesion on the electrospun sample after 24 hours of culture (g), and a layer cell 
arrangement with a tissue-like morphology after 7 days of culture (h). 
Thus, the cells extended lamellipodia to adhere to the electrospun surface (Figure 3.1.9 g). 
However, the cells formed a tissue-like stratum on the scaffold surface (Figure 3.1.9 h), which 
is a promising feature about applications focused on tissue remodeling and regeneration. 
Effect of Vitamin B6 and Polyphenols Loaded PLA Electrospun Nanofibers 
against the Induction of Oxidative Stress 
The main goal for the new loaded PLA matrices is to confer a protective effect against free 
radicals responsible for cell damage and death by necrosis while the ability to support cell 
adhesion and growth is maintained or even improved. In this way, an induction experiment of 
oxidative stress in the cultured cells was carried out in the presence of the scaffold and using 
AAPH as an agent of oxidative injury.[30]  
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FIGURE 3.1.10 
Antioxidant effect of the selected drugs after being loaded into the scaffolds of PLA electrospun nanofibers. 
The MG-63 cell (fibroblasts-like) culture was performed on the electrospun samples and the control (TCPS, 
culture plate). All samples were then exposed to AAPH to induce cell oxidative stress. Cell viability was 
evaluated at 24 h after induction to determine the antioxidant effect of the drugs loaded into the PLA 
scaffolds. Results are mean ± SD (n = 5). Values differing from controls (TCPS) are indicated by an asterisk 
as p < 0.05 (t-Test). 
Figure 3.1.10 shows the effect of the selected agent on the cultured cells over the TCPS control. 
The deleterious effect of AAPH is worth noting. A decrease in cell viability is clearly deduced, 
and obviously depends on the APPH concentration in the culture. Thus, doses between 1.9 mM 
and 4.9 mM caused a decrease in close to 30-40% in cell viability, whereas a severe reduction 
(i.e. close to 60%) was found at the highest doses (5.9 mM). A similar behavior was observed 
when cells were cultured on unloaded PLA scaffolds (Figure 3.1.10, PLA group), demonstrating 
that cell growth in this matrix is unprotected against oxidative stress. However, damage in the 
cultured cells induced by AAPH could be reverted when cell growth occurred in the antioxidant 
loaded PLA matrices provided that AAPH doses were lower than the maximum concentration 
tested (5.9 mM). Note also that the antioxidant effect was obviously limited by the low amount 
of PN, PL and polyphenols loaded into the scaffolds. No significant statistical differences were 
found between the antioxidant loaded PLA scaffolds. In any case, the proposed strategy appears 
suitable to provide new materials that support both cell adhesion and growth, and additionally 
have a protective activity against oxidative stress. 
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3.1.4 Conclusions 
PLA nanofibers loaded with different antioxidants can be prepared by electrospinning from 
DMF-DMSO (9:1, v/v) mixtures under optimized conditions. Thus, diameters ranging between 
63 and 124 nm were attained using polymer and drug concentrations of 10 and 1 w/v-%, flows 
between 0.5 and 1 mL·h-1, voltages between 17 and 19 kV and a distance between the collector 
and the spinneret of 12.5 cm. Fiber morphology (diameter and texture) and crystallinity were 
dependent on the drug added, which in addition appeared well mixed into the PLA matrix (e.g., 
the PL analogue of vitamin B6) or formed isolated crystals (e.g., CUM) depending on its 
chemical nature.  
Hydrophobic medium allowed a fast, practically complete release of all studied drugs (PL, PN, 
CUM, CAF and TRX), whereas clear differences were found in the release kinetics when a 
hydrophilic medium was used. Furthermore, in this case, the amount of drug released depended 
on equilibrium conditions. Specifically, the maximum amount was obtained when the more 
hydrophilic drug (i.e. CAF) was considered. 
Cell proliferation was higher when antioxidant loaded scaffolds were used since the cellular 
environment was improved by the radical-scavenging capacity of drugs. Furthermore, the new 
loaded PLA matrices had a protective effect against free radicals responsible for cell damage 
and death by necrosis even when agents of oxidative injury were added to the cultured cells. 
In summary, the new antioxidant loaded PLA scaffolds appear suitable to support both cell 
adhesion and growth, and additionally have a protective activity against oxidative stress. 
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Inhibition of Radical-Induced Oxidative DNA 
Damage by Antioxidants Loaded in 
Electrospun Polylactide Nanofibers 
  
Polylactide (PLA) nanofibers loaded with antioxidants, i.e. 
vitamin B6 or pyridoxine (PN) and its analogue pyridoxal 
(PL), and with hydroxycinnamic acids, i.e. p-coumaric acid 
(CUM) and caffeic acid (CAF), were prepared by 
electrospinning technique. Control consisted of nanofibers 
loaded with trolox (TRX). Experimentally, these new 
materials were tested on the inhibition of oxidative DNA 
damage caused by free radicals initiated by 2,2’-azobis(2-
amidinopropane hydrochloride) (AAPH). This damage was 
assessed in-vitro and in-vivo by measuring the conversion of 
supercoiled pUC19 plasmid DNA to open circular and linear 
forms. It was found that these antioxidants, in solution, could 
inhibit oxidative DNA damage significantly and that the 
antioxidants loaded in the PLA nanofibers maintained in-vitro 
and in-vivo their protective role against oxidative DNA 
damage. Thus, electrospun mats derived from PLA nanofibers 
loaded with the considered compounds have capacity to 
protect DNA against to oxidative damage and appear 
interesting for their use in the purification of plasmidic or 
genomic DNA. 
 
3.2 
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3.2.1 Introduction 
Now there is clear evidence that free radical-induced oxidative damage of cell membranes, DNA 
and proteins is closely associated with aging and several degenerative diseases,[1, 2] such as 
cancer,[3] atherosclerosis and cataract.[4] Particularly, the oxidative DNA damage produce 
diverse lesions such as modifications of the bases and sugar cycles to form first adduct radicals 
and then strand breaks, which are considered the most significant nuclear lesion. The oxidative 
damage mainly affects the gene expression,[4] cell cycle regulation,[5] and reparation of DNA.[6] 
Antioxidants, like α-tocopherol (vitamin E), L-ascorbic acid (vitamin C) and β-carotene, might 
have beneficial effects on protecting DNA against these diseases. Thus, the supplementation of 
antioxidants has become an attractive therapeutic strategy for reducing their risk of occurrence.[7-
9] 
Vitamin B6 is a water-soluble compound that exists in three major chemical forms: pyridoxine, 
pyridoxal and pyridoxamine. It performs a wide variety of functions and is essential for good 
health; e.g., vitamin B6 is required for more than 100 enzymes involved in proteins metabolism, 
and for haemoglobin synthesis. A deficiency of this vitamin can result in a type of anaemia. 
Moreover, animal studies have shown that its deficiency can decrease antibody production and 
suppress the immune response.[10] Recent research has also revealed that DNA damage from 
deficiency of micronutrients, including vitamin B6 and other vitamins, is likely to be a major 
cause of cancer.[11] Vitamin B6 has a crucial role in 1-carbon metabolism, which involves DNA 
synthesis and DNA methylation[12] and can modulate gene expression.[13] Although not classified 
as an antioxidant compound, pyridoxine and its derivatives have recently been shown to have 
highly effective antioxidant properties.[14] 
Hydroxycinnamic acids (e.g., coumaric and caffeic acids) and their derivatives are frequently 
considered to be among the most valuable antioxidants in natural products and beverages. The 
presence of phenolic moieties confers to these compounds their free radical scavenging 
capabilities. In particular, caffeic acid is one of the most active compounds of the family because 
of the presence of two vicinal hydroxyl groups. The chemical structure of cinnamic acid 
derivatives (such as conjugated double bond or number and position of hydroxyl groups in the 
aromatic ring) was evaluated to ascertain their ability to act as free radical scavengers.[15] 
Recent advances in biomaterials are related to the use of scaffolds for drug delivery and tissue 
engineering.[16, 17] Many groups are exploring the development of biomaterial-biochemical 
composites incorporating biological agents such as growth factor and other cell regulatory 
molecules.[16, 18] These efforts are carried out to mimic the natural scaffold that for most tissues 
is the extracellular matrix (ECM).[19] The ECM has a highly porous morphology with a wide 
pore size distribution that contributes to rigidity and tensile strength of bone, resilience of 
cartilage, flexibility and hydrostatic strength of blood vessels, and elasticity of skin.  
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Different approaches use electrospinning from polymer solutions to fabricate scaffolds with 
micro structured fibres. Electrospinning occurs when the surface tension force of a polymer 
solution is overcome by an applied electrical force and tiny droplets or fibres are extruded from 
the solution. This method produces non-woven membranes with individual fibre diameters 
typically ranging from nano to micro scale. The fibres form a large and interconnected porous 
network that is ideal for drug, gene, as well as cell delivery [20]. 
We have recently prepared polylactide (PLA) nanofibers loaded with pyridoxine and pyridoxal, 
and polyphenols such as p-coumaric and caffeic acids to assess their delivery in several release 
media and to study the biocompatibility of such biomaterials for cell adhesion and growth.[21] It 
is also of great interest to extend this research study to other oxidative substrates such as DNA, 
since DNA is also a major target of free radical attack. We herein examine the effects of 
antioxidant loaded PLA scaffolds on the inhibition of AAPH-induced oxidative damage of 
plasmid DNA (in this model, the supercoiled and closed circular plasmid DNA are converted by 
oxidative damage to open circular and/or linear forms). The present work has three main goals: 
a) Evaluation of the effect of the selected compounds to inhibit oxidative damage in solution of 
plasmid DNA; b) Preparation of electrospun nanofiber matrices loaded with antioxidants and 
evaluation of their ability to inhibit oxidative DNA damage; c) Study of the application of new 
matrices as support for the purification of DNA subjected to oxidative stress. 
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3.2.2 Experimental Section 
Materials 
Pyridoxine (PN), Pyridoxal (PL), Trolox (TRX), 2,2’-Azobis(2-amidinopropane hydrochloride 
(AAPH), N,N-dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were purchased from 
Sigma-Aldrich (Sigma-Aldrich Chemical Co., USA) with the highest purity available and used 
as received. Caffeic acid (3,4-dihydroxycinnamic acid) (CAF) and p-coumaric acid (p-
hydroxycinnamic acid) (CUM) were purchased from Acros Organics (New Jersey, USA). 
Polylactide (PLA), a product of Natureworks (polymer 2002D), was kindly supplied by Nupik 
International (Polinyà, Spain).  
Preparation and characterization of electrospun PLA fibers 
Unloaded and antioxidant (PN, PL, CAF or CUM) loaded PLA nanofibers were prepared by 
electrospinning under optimal operational parameters obtained experimentally. To this end, an 
electrospinable solution were prepared with a 10 and 1 w/v-% concentration of PLA and 
antioxidant, respectively; and mixed with a DMF-DMSO 90:10 v/v mixture. The polymer 
solution was maintained overnight at 70 ºC to obtain a clear solution. Controls consisting of PLA 
and PLA loaded with TRX were prepared by the same electrospinning procedure. TRX is the 
usual antioxidant control due to its high activity. It should be pointed out that TRX is a synthetic 
analogue derivative of vitamin E which cannot be used for biomedical applications (i.e. no 
human use). A plastic syringe of 10 mL was filled with the polymer solution and then 
electrospinning was carried out between the needle (18G) connected to the anode and the static 
collector connected to the cathode. The direct current (DC voltage) was applied using a high 
voltage supply (ES30-5W model, Gamma High Voltage Research, USA). The flow was 
controlled using a KD100 infusion syringe pump (KD Scientific Inc., USA). The polymer jet 
was collected on an aluminium foil. All electrospinning procedures were conducted at room 
temperature. 
Scanning electron microscopy (SEM, Focus Ion Beam Neon-40, Carl Zeiss, Germany) was used 
to examine the morphology and surface of the electrospun fibers. Fourier transform infrared 
(FTIR) spectra were recorded on an ATR-IR spectrometer (FT-IR 4100 Serie, Jasco Inc., USA). 
Assay for oxidative DNA strand breaks 
The pUC19 plasmid (Invitrogen, USA) was cloned in Escherichia coli DH5 used as the 
competent bacterium (Invitrogen, USA). Bacterial growth was carried out in Luria-Bertani (LB) 
medium supplemented with 100 µg·mL-1 ampicillin. Plasmid DNA was purified using a 
commercial kit (Quiagen, USA). 
Induction of DNA strand breaks by AAPH was determined by measuring the conversion of 
supercoiled pUC19 plasmid DNA to open circular and linear forms.[22] Briefly, 2.7 µg of pUC19 
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plasmid DNA was incubated at 37 ºC for 90 min using 20 µL of a solution containing 3 µL of 
0.9 µg·mL-1 stock DNA, 0.5-15 µL of 100 mM AAPH stock, and 2-17 µL of phosphate- buffered 
saline (PBS, 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 and 1.5 mM KH2PO4) for 
complement. The reaction was carried out in microtubes of 200 µL at 37 ºC and 200 rpm for 90 
min. Following incubation, the samples were mixed with 4 µL of gel loading buffer and 
immediately loaded into a 1% agarose gel containing TBE (40 mM Tris, 20 mM sodium borate 
and 2 mM EDTA), and electrophoresed in a horizontal slab gel apparatus in TBE buffer for 1 h 
(90 V, constant). After electrophoresis, the gels were photographed under UV light. DNA strand 
breaks were evaluated using the untreated DNA under the same incubation conditions as a 
control. The GenoSoft software (VWR, USA) was used to quantify all DNA forms in the gel. 
Assay for inhibition of oxidative DNA strand breaks 
In the inhibition experiments, the selected antioxidants (i.e. PN, PL, CUM, CAF and TRX) were 
firstly dissolved in ethanol to 1 M concentration and then the solution was diluted with PBS to 
get a 100 mM stock. An aliquot (0.5-9 µL) of the antioxidant stock was mixed with 3 µL of 0.9 
µg·mL-1 of pUC19 plasmid DNA stock, 4 µL of 100 mM AAPH stock, and 4-17 µL of PBS for 
complement (Scheme 3.2.I a). Thus, all incubations had approximately a 20 mM AAPH final 
concentration. The reaction was carried out at 200 rpm and 37 ºC for 90 min. The products of 
the reaction were evaluated in agarose gel, as indicated above. 
Inhibition of oxidative DNA strand breaks using electrospun PLA scaffolds 
Antioxidant-loaded electrospun PLA nanofibers were tested to evaluate their inhibitory activity 
on oxidative stress induced by AAPH. In-vitro assays were performed in 1.5 mL microtubes 
containing an electrospun sample of c.a. 20 mg (a mat of 1 cm x 1cm x 0.1-0.2 cm), and 3 µL 
of 0.9 µg·mL-1 pUC19 plasmid DNA stock, 50 µL of 100 mM AAPH stock, and 200 µL of PBS. 
Thus, all incubations had approximately a 20 mM AAPH final concentration. A control test was 
performed in the absence of AAPH to determine the maximum amount of DNA recovered. A 
negative and a positive control test were conducted with an unloaded electrospun PLA scaffold 
and a TRX-loaded electrospun PLA scaffold, respectively. The reaction was carried out at 37 ºC 
and at 200 rpm for 90 min. The products of the reaction were recovered by centrifugation at 4 
ºC and 10000 rpm for 5 min. The scaffolds were washed in 100 µL of PBS and the supernatants 
were recovered by centrifugation. Supernatants from reaction and wash were mixed (350 µL in 
total), and the DNA was precipitated by addition of 70 µL of 5 M sodium acetate and 875 µL of 
pure ethanol at -20 °C for 30 min. The precipitated DNA was recovered as a pellet after 
centrifugation of the microtube at 13000 rpm for 10 min, and was then washed with 70% ethanol 
(Scheme 3.2.I b). Finally, the DNA was dried under vacuum and evaluated by electrophoresis 
using agarose gel (1%), as indicated above. 
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In-vivo assay for inhibition of oxidative DNA strand breaks 
Plasmid DNA (pUC19) was cloned in Escherichia coli DH5. A clone of pUC19 plasmid DNA 
was amplified in LB broth supplemented with ampicillin. 15 mL of cultured bacteria in log phase 
was pelleted and washed in PBS. Plasmid DNA was purified using a commercial kit (Quiagen, 
USA), and the antioxidant-loaded PLA scaffold was introduced in two different stages during 
purification. 1) An electrospun of c.a. 20 mg (a piece of 1 cm x 1 cm x 0.1-0.2 cm) was placed 
in the micro tube containing the bacterial pellet (Scheme 3.2.I c), and 200 µL of resuspension 
buffer was added to resuspend the pellet. Next, 50 µL of 100 mM AAPH stock was added to 
induce oxidative damage and the reaction was maintained at 37 ºC and 200 rpm for 2 h. Bacterial 
lysate and plasmid DNA purification were performed according to the instructions of the kit. 2) 
The electrospun mat was placed in the purification column before equilibration step according 
to the manufacturer, and settled on the filter in blend form (Scheme 3.2.I d). The neutralized 
bacterial lysate (600 µL) was subsequently loaded in the column and an aliquot of 150 µL of 
100 mM AAPH stock was added to achieve an AAPH concentration of 20 mM. In this stage, 
the column was maintained at 37 ºC for 2 h. Then, plasmid DNA was bond to the filter in the 
column by centrifugation. The purification of plasmid DNA was continued according to the 
manufacturer. Finally, the yield and integrity of purified DNA were evaluated by 1% agarose 
gel electrophoresis. 
SCHEME 3.2.I  
Assay for inhibition of oxidative DNA strand breaks. In-vitro assays: (a) using antioxidant solution; and 
(b) using antioxidant-loaded in electrospun PLA scaffolds. In-vivo assays were carried out using 
transformed E.coli DH5α with plasmid DNA: (c) the inhibition was carried out during the bacteria lysis; 
and (d) the inhibition was carried out during the binding and washing of DNA into the purification filter.  
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3.2.3 Results and Discussion 
Characterization of Antioxidant-Loaded Electrospun PLA 
The morphology and diameter of electrospun PLA nanofibers are dependent on several 
parameters such as solvent characteristics, solution concentration, flow (ϕ), applied voltage (V) 
and electrospinning distance (h) (i.e. the distance from the tip of the needle to the collector),[23, 
24] In addition, incorporation of small percentages of drug in the polymer solution can affect the 
morphology of electrospun PLA fibres and probably the operational parameters should be 
modified.[16, 24, 25] Figure 3.2.1 contains SEM images of the antioxidant-loaded electrospun PLA 
fiber mats. The fine, continuous morphology and structure of the nanofibers resulted from the 
optimization of the experimental conditions to avoid undesirable forms of fibers, such as beads 
on fiber strings, notches and local non-uniformity in the thickness of nanofibers. The best solvent 
was a mixture of DMF (good solvent for PLA) and DMSO (good solvent for the studied 
antioxidants) due to the impossibility to find a common solvent for polymer and drugs. The 
optimal experimental conditions to obtain antioxidant-loaded electrospun PLA nanofibers were 
similar for all combinations, i.e. values were in the range of 17-19 kV for V, 0.5-1 mL·h-1 for ϕ 
and 12.5 cm for h. Figure 3.2.1 g shows that, in all cases, the distribution of fibers was fitted to 
a Gaussian model. An average diameter of 92 ± 1 nm was determined for unloaded PLA fibers. 
By contrast, larger diameters were obtained for PLA loaded with PN and PL (101 ± 3 nm and 
124 ± 3 nm, respectively). PLA fibers loaded with CUM and CAF had smaller diameters than 
unloaded PLA fibers (86 ± 2 nm and 81 ± 2 nm, respectively). The diameter of TRX-loaded 
PLA fibers was the smallest one (63 ± 1 nm).  
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FIGURE 3.2.1 
SEM images of electrospun PLA nanofibers unloaded (a) and nanofibers loaded with PN (b), PL (c), CUM 
(d), CAF (e), and TRX (f). Diameter distribution of the nanofibers (g), the data are plotted in gray circles 
and fitted to a Gaussian distribution (right). In the chart-box (left), the boxes represent the percentile 25%-
75%, the bars represent the range 5%-95%, (*) indicate 1% and 99% of the distribution, and (+) indicate 
the maximum and minimal values of the data. The letters in the graphic indicate significant differences 
(Tukey test, p < 0.05) in comparison to electrospun PLA (a), and electrospun PLA loaded with PN (b), PL 
(c), CUM and CAF (d). 
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The presence of antioxidant molecules in the loaded nanofibers was corroborated by FTIR as 
shown in Figure 3.2.2.  
FIGURE 3.2.2 
FTIR-ATR spectra of unloaded and antioxidant loaded electrospun PLA scaffolds. The arrows and dotted 
circle shown representatively spectral changes produced by vitamin B6 (PN and PL), hydroxycinnamic 
acids (CUM and CAF) and trolox (TRX). (b) Molecular structure of PLA and antioxidants. 
The spectra were compared to demonstrate the incorporation of PN and the analogue PL, and al 
hydroxycinnamic acids in the electrospun PLA nanofibers. In all cases, the typical absorption 
bands of PLA[26, 27] were observed (i.e. 1759 cm-1, (C=O); 1458 cm-1, as(CH3); 1385 cm-1, 
s(CH3); 1363 cm-1, (CH); 1263 cm-1, (CH) + (C-O-C) for random conformation; 1209 cm-
1, as(C-O-C) + ras(CH3) for helical conformation; 1183 cm-1, as(C-O-C) + ras(CH3) for the 
crystalline phase; and 1128 cm-1, rs(CH3); 1082 cm-1, s(C-O-C); 1044 cm-1, (C-CH3); 867 cm-
1, ras(CH3) for the amorphous phase) together with small signals associated to the loaded drug. 
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These were clearer in the 1750-1450 cm-1 range where no PLA signals appeared (Figure 3.2.2 
a), and this is described below. Some differences were also detected in the spectra of the studied 
samples as a consequence of the different degree of crystallinity and even of the randomness or 
the helical nature of PLA chains. Thus, bands at 1263 and 867 cm-1 appeared with a variable 
intensity (see arrows in Figure 3.2.2 a) and specifically their decrease was associated with a 
lower proportion of segments with random conformation and a decrease of the amorphous 
content, respectively. 
The FTIR bands for drugs loaded in the PLA nanofiber were identified in the low energy range 
of the spectra (1750-1450 cm-1), even though their small proportion (9.1 wt-% aprox.) with 
respect to the PLA content. In detail, the PLA-PL spectrum showed characteristic bands at 1679 
and 1553, 1538 and 1505 cm-1, assigned the first to the (CO) mode for the aldehyde group and 
the other three to the tautomeric equilibrium between aromatic cycle and aldehyde group. 
Otherwise, PLA-PN, have the same bands as PLA-PL excepting the bands assigned to the 
vibration of the aldehyde group.[28, 29] In PLA-CUM spectrum, clearly shows that p-coumaric 
acid is present in PLA nanofiber due to the band of  (CC)C=C at 1669 cm-1 and the four main 
aromatic bands (CC)ar located in 1601, 1591, 1512 and 1449 cm-1.[30] The nanofiber PLA-CAF 
contained some characteristic bands for caffeic acid at 1683 cm-1, (CO), 1635 cm-1, (CC), and 
1617 and 1521 cm-1, (CC)ar.[31] Finally, infrared analysis was carried out to determine the 
structural integrity of the TRX (used as control for antioxidative drugs) loaded in the nanofibers 
PLA-TRX; two specific bands were recognized at 1718 and 1626 cm-1 for (CO) of the 
carboxylic group and (CC) of the aromatic ring, respectively.[32] 
The PLA electrospun loaded with the antioxidants were characterized by theirs capacity to the 
antioxidants release. A previous study on the release profiles of antioxidant were carried out by 
us.[21] Here is important noted that occurs with the antioxidant release during the experiments of 
DNA protection that are detailed after. Figure 3.2.3 shows that after 2 hours of incubation in a 
medium hydrophobic, high amount of antioxidant contained in the matrix was released, but this 
does not occur when the release medium is hydrophilic. 
Here it is important to note that a hydrophilic medium can be transformed into medium 
hydrophobic by the presence of different biological macromolecules (e.g., amino acids, 
polypeptides, nucleotides, oligomers, etc.). In this sense, cell extracts can be considered with 
amphipathic character due to their hydrophilic and hydrophobic components. 
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FIGURE 3.2.3 
Antioxidant release from five loaded electrospun PLA. The concentration of drug released was measured 
after 2 hours of incubation in a Sörensen-ethanol buffer mixture (3:7, v/v) (hydrophobic medium) and in a 
TBE buffer (hydrophilic medium). Results are mean ± SE (n = 3). The asterisk (*) indicates p < 0.05 
between both media. 
AAPH-Induced Oxidative Damage of Plasmid DNA 
The conversion of supercoiled and closed circular form of plasmid DNA to open circular and 
further linear forms can be used as a clear indicator of DNA damage. The formation of open 
circular form of DNA is indicative of single-strand breaks whereas the formation of linear form 
of DNA is indicative of double-strand breaks (e.g., the BamHI restriction enzyme has a single 
cutting site of both pUC19 DNA strands, resulting in linear DNA).[33, 34] Since AAPH is water-
soluble and the rate of free radical generation from AAPH can be easily controlled and measured, 
this molecule has been extensively used as a free radical initiator for biological studies.[35] 
Thermal decomposition of AAPH at physiological temperature generates alkyl radicals, which 
can react with oxygen and produce alkylperoxyl radical (ROO·). This radical can attack plasmid 
DNA, leading to oxidative DNA damage.[22] 
Figure 3.2.4 shows AAPH-induced plasmid DNA strand breaks. It is observed that, at a lower 
AAPH concentration (2.5-5 mM), the supercoiled DNA band decreases, the open circular DNA 
band (single DNA chain break) increases and a linear DNA band (double DNA chain break) 
appears between the supercoiled and the open circular band. At intermediate AAPH 
concentrations (10-30 mM), the supercoiled DNA band decreases completely and the open 
circular DNA band decreases gradually, leading to an increase in the linear DNA band. The 
smear below the linear band suggests the occurrence of multiple breaks in the DNA strands, 
leading to the formation of low molecular weight fragments. Highly fragmented DNA is 
predominant when plasmid DNA is treated with high AAPH concentrations (45-75 mM). It can 
be concluded that the oxidative damage of pUC19 DNA (in general, of plasmid DNA and by 
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extension of genomic DNA) is concentration-dependent on AAPH, as evidenced by the 
occurrence of linear DNA (r = 0.93, p > 0.02). 
FIGURE 3.2.4 
AAPH-induced oxidative damage of plasmid DNA. Electrophoretic pattern of pUC19 DNA after treatment 
with AAPH in PBS at 37 ºC and pH 7.4 for 90 min. Lane MW: molecular weight marker. Lane D: pUC19 
DNA digested with BamHI. The labels C, L and SC correspond to the forms circular, linear and supercoiled 
of pUC19 plasmid DNA, respectively. The asterisk (*) indicates a severely broken DNA. The 3D-graphic 
shows the quantification of DNA forms from the electrophoresis. 
Inhibition of AAPH-Induced DNA Strand Breaks by Vitamin B6 and 
Hydroxycinnamic Acids 
Pyridoxal (PL) is a representative analogue of vitamin B6 or pyridoxine (PN). Studies based on 
electrochemical and UV-Vis spectroscopy have revealed a supramolecular interaction between 
DNA nitrogenous bases and PL to form hydrogen bonding.[36, 37] Furthermore, PN and its 
analogue derivatives enjoy widespread recognition as antioxidant molecules. Thus, we evaluated 
the ability of PN and PL as scavengers of the free radicals generated by decomposition of AAPH 
to prevent oxidative DNA damage. As shown in Figure 3.2.4, incubation of DNA with 20 mM 
AAPH for 90 min resulted in complete disappearance of supercoiled DNA, as well as in 
formation of open circular and linear forms of plasmid DNA. Both single-strand and double-
strand DNA breakages seems to take place. The addition of PN and PL at 2.5-45 mM 
concentration (Figure 3.2.5 a and 3.2.5), respectively) to plasmid DNA attacked with AAPH 
led to partial or complete inhibition of the conversion of supercoiled DNA to open circular and 
linear forms. This feature demonstrated that PN and PL are able to protect plasmid DNA against 
AAPH-induced oxidative damage. The inhibitory concentrations of PN and PL were 10-20 mM 
and 5-10 mM, respectively. High concentrations of PN and PL not only produced inhibition of 
oxidative damage, but also promoted the formation of DNA-antioxidant complexes with high 
molecular weight. These complexes can be understood as aggregates formed by interactions 
between antioxidants and preferably circular DNA molecules. It is easy to understand that the 
supercoiled DNA conformation hardly contributes to the formation of these complexes since it 
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has a highly compact conformation where the nitrogenous bases could be too hidden to establish 
an effective interaction with PN or PL.[36, 37] 
The oxidative activity of AAPH is also inhibited by the presence of p-coumaric acid (CUM) and 
caffeic acid (CAF). The inhibitory concentration was 10-20 mM for both acids (Figure 3.2.5 c 
and 3.2.5 d), as in the case of vitamin B6 (PN) and slightly higher than for the PL analogue. High 
concentration of CUM and CAF leads to the formation of high molecular weight complexes. 
Moreover, a delay occurs in the mobility of supercoiled and circular DNA bands due to presence 
of these complexes. 
Finally, the activity of trolox (TRX) as the positive control was evaluated (Figure 3.2.5 e); TRX 
is a derivative of vitamin-E and a recognized antioxidant frequently used as control. The 
inhibitory activity of TRX occurs at the low concentration of 2.5 mM. At high concentrations 
(20-45 mM) the supercoiled DNA band was relaxed, and the intensity of circular DNA was not 
changed.[22] Thus, very few DNA-trolox complexes of high molecular weight were formed. 
These features show that the protective activity of polyphenols against DNA breakage can occur 
via a specific mechanism which may involve their interaction with DNA bases.  
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FIGURE 3.2.5  
Inhibitory effect of the antioxidants on the AAPH-induced oxidative damage of plasmid DNA. pUC19 
DNA strand breaks were induced by 20 mM AAPH in PBS at 37ºC and pH 7.4 for 90 min in the presence 
of different concentrations of antioxidants: a) PN, b) PL, c) CUM d) CAF, and e) TRX. Agarose gel 
electrophoretic pattern of plasmid DNA (left) and quantification graphic (right). Lane MW: molecular 
weight marker. Lane D: pUC19 DNA digested with BamHI. Lane Ctrl: DNA incubated without AAPH 
and antioxidant (Control).The label Cx corresponds to the formation of DNA-antioxidant complexes. 
  
  
87 
CHAPTER 3.2 
Inhibition of AAPH-Induced DNA Damage by Antioxidant Loaded Electrospun 
PLA Nanofiber Mats 
Effects on purified DNA 
After evaluation of the activity of antioxidants in solution, it was determined whether the 
electrospun nanofiber loaded with antioxidants can inhibit AAPH-induced oxidative damage of 
plasmid DNA. AAPH concentration was 20 mM, for all experiments. Figure 3.2.6 shows that 
electrospun PLA has no protective effect against this type of damage. This is obvious because 
supercoiled DNA becomes open-circular and then linear. On the other hand, no significant 
damage was observed in supercoiled DNA attacked with AAPH in the presence of electrospun 
PLA scaffolds loaded with PN, PL, CUM and CAF. Moreover, in all cases this was accompanied 
by an increase in the percentage of circular DNA. However, the absence of the linear DNA band 
suggests that this increase could correspond to the presence of relaxed DNA. In addition, no 
complexes of high molecular weight DNA were observed.  
FIGURE 3.2.6 
Inhibitory effect of antioxidant-loaded electrospun PLA on pUC19 DNA. pUC19 DNA strand breaks were 
induced by 20 mM AAPH in PBS at 37ºC and pH 7.4 for 90 min in the presence of electrospun PLA 
unloaded (lane PLA) and loaded with antioxidants (lane PN, lane PL, lane CUM, lane CAF and lane TRX). 
After incubation, the DNA was precipitated and running on an agarose gel (above) to evaluate and 
quantifying (under) the forms of plasmid DNA. Lane MW: molecular weight marker. Lane D: pUC19 
DNA digested with BamHI. Lane Ctrl: DNA incubated without AAPH and electrospun. 
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These results demonstrate that antioxidants loaded in electrospun PLA retain their scavenger 
function. Furthermore, these fibers avoid an excessive release of antioxidants,[21] preventing the 
formation of complexes of high molecular weight DNA aggregate. The protective activity of 
PN, PL, CUM and CAF on DNA is clear because a similar effect was obtained with TRX-loaded 
electrospun PLA (no band of linear DNA was observed). Furthermore, the protective effect was 
more effective for the drugs studies. Results would therefore indicate that antioxidant-loaded 
electrospun PLA is a functional structure capable of protecting in-vitro plasmid DNA against 
oxidative attack. 
Effects during Purification of Plasmid DNA from Bacteria 
We finally determined the effectiveness of antioxidant-loaded electrospun PLA in two different 
stages of plasmid DNA purification: 1) The antioxidant-loaded electrospun PLA scaffold was 
included in the preparation of bacterial lysates for the extraction of plasmid DNA, and 2) 
antioxidant-loaded electrospun PLA scaffold was settled on the filter in blend form to separate 
plasmid DNA from other components of the bacterial lysates. In both stages, we included AAPH 
20 mM to induce oxidative damage on plasmid DNA (see Scheme 3.2.I c and 3.2.I d). 
1) Figure 3.2.7 a summarizes the purification results when bacterial lysis was performed in 
the presence of antioxidant-loaded electro spun PLA (Scheme 3.2.I c). It is clear that 
unloaded electrospun PLA was not efficient in protecting plasmid DNA against AAPH-
induced oxidative damage as the linear form of plasmid DNA was observed. By contrast, 
a significant increase of the circular form of plasmid DNA occurred in presence of 
antioxidant-loaded electrospun PLA. However, the supercoiled DNA decreases about 50% 
in comparison to the control (i.e. no AAPH and electrospun PLA). The control based on 
TRX-loaded electrospun PLA gave similar yields of purified DNA to those obtained with 
the other antioxidants but the linear form of plasmid DNA was observed, indicating 
oxidative damage. Thus, it was concluded that TRX inhibits partially AAPH-induced 
oxidative damage and that the other antioxidants have protective action on plasmid DNA.  
2) In the purification column, electrospun PLA was settled on the filter of plasmid DNA 
binding. Thus, the plasmid DNA bound to the purification matrix was exposed to AAPH 
to promote oxidative damage. In comparison to the control, the presence of antioxidant-
loaded electrospun PLA resulted in a lower percentage of supercoiled DNA and a higher 
yield of circular DNA (Figure 3.2.7 b). The recovery with TRX-loaded electrospun PLA 
was similar to that of electrospun PLA loaded with PN, PL, CUM and CAF; nonetheless, 
lineal DNA was only partially recovered. 
It is known that oxidative stress is one of the most important causes of many serious diseases, 
which occurs when the body is exposed to excessive amounts of electrically charged agents, 
such as aggressive oxygen compounds. By other hand, when the cell tissue is disrupted during 
DNA purification, genetic material is highly exposed to these aggressive oxygen compounds. 
The release of the alkylperoxyl radicals (ROO·) from the cell tissue disruption attacks to plasmid 
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DNA leading to the DNA oxidative damage. Supercoiled DNA can suffer a single strand scissor 
event to convert supercoiled DNA to open-circular DNA. Progressively, a second strand scissor 
event converts open-circular DNA into linear DNA.[22] 
Finally, the results may justify the addition of antioxidants during DNA purification. Thus, the 
presence of antioxidants during cell lysate would be a preventive tool against any eventual DNA 
damage. Furthermore, an effective antioxidant level can be maintained during column binding 
DNA, preventing the oxidative DNA damage, the loading of these molecules into the nanofibers 
mats make more powerful this application in existing systems using purification columns. 
FIGURE 3.2.7 
Inhibitory effect of antioxidant-loaded electrospun PLA on pUC19 DNA purified from Escherichia coli 
DH5α. a) The oxidative DNA damage was induced with AAPH: a) in bacteria resuspended, and b) during 
the binding of DNA to the purification membrane. Electrophoretic pattern of the purified plasmid DNA 
(left) and theirs quantification (right). Lane MW: molecular weight marker. Lane D: pUC19 DNA digested 
with BamHI. Lane Ctrl: DNA incubated without AAPH and electrospun. 
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3.2.4 Conclusions 
Electrospun PLA nanofibers loaded with antioxidants, i.e. vitamin B6 or pyridoxine (PN) and 
its analogue pyridoxal (PL), and hydroxycinnamic acids, i.e. p-coumaric acid (CUM) and caffeic 
acid (CAF) were obtained by electrospinning under conditions optimized for mixtures of PLA 
in dimethylformamide and antioxidants in DMSO. 
AAPH-induced oxidative damage of plasmid DNA can be inhibited in-vitro by antioxidants (PN, 
PL, CUM, and CAF) in solution and by electrospun PLA scaffolds loaded with PN, PL, CUM, 
and CAF. 
Finally, electrospun PLA loaded with PN, PL, CUM or CAF can inhibit oxidative damage of 
plasmid DNA during purification from bacteria. Thus, in-vitro and in-vivo results clearly 
demonstrate the potential application of antioxidant-loaded electrospun PLA to inhibit oxidative 
damage of plasmid DNA during extraction and purification. This protective activity potentially 
can also be applied to other macromolecules. 
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Electrospun Scaffolds of Polylactide with a 
Different Enantiomeric Content and Loaded 
with Anti-Inflammatory and Antibacterial 
Drugs 
Polylactide (PLA) electrospun microfibers were prepared and 
loaded with triclosan (TCS), ketoprofen (KTP) or their 
combination to obtain multifunctional scaffolds with 
bactericide and anti-inflammatory properties. Continuous and 
porous fibers with diameters in the micrometer scale and an 
unimodal distribution were successfully attained using a 
chloroform:acetone:dimethylsulfoxide mixture capable of 
effectively dissolving compounds with highly different 
solubility characteristics such as PLA and the above drugs.  
Scaffolds were prepared using two PLA grades having slightly 
different D-lactide content (i.e. 2 and 4.2 wt-%). It was 
observed that small differences had a strong influence on 
physicochemical properties and drug release behavior. 
Thermal properties of new scaffolds were determined by 
differential scanning calorimetry and the release evaluated in 
two media having different hydrophilicity. Dual drug-loaded 
scaffolds showed a peculiar release that contrasted with single 
drug-loaded systems and suggested the establishment of 
intermolecular interactions that delayed TCS and KTP 
release. Antimicrobial activity of all TCS-loaded electrospun 
scaffolds was tested and demonstrated against E.coli and 
M.luteus bacteria. In addition, KTP-loaded samples showed 
slight bactericide activity. Biocompatibility of scaffolds was 
evaluated by adhesion and proliferation assays using two 
epithelial cell lines. Results correlated with drug release 
observations; interestingly, the dual drug-load systems were 
able to support high TCS doses without adverse effects. 
4.1 
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4.1.1 Introduction 
Polylactide (PLA) is currently one of most attractive biodegradable polymers because it is 
derived from renewable resources, can be easily processed and has many applications ranging 
from commodity to specialty uses.[1-5] PLA is gaining special attention in the biomedical field. 
Specifically, devices including degradable sutures, drug releasing micro/nanoparticles, and 
porous scaffolds for cellular applications can be mentioned.[6-10] The great advantages of PLA 
are due in part to its ability to degrade into the naturally occurring metabolite lactic acid under 
physiological conditions, but other exceptional qualities, like biocompatibility, FDA approval 
for clinical use, low immunogenicity and good mechanical properties must also be considered. 
PLA can be obtained by ring-opening polymerization of L-lactide and/or D-lactide, a process 
that allows obtaining a large number of stereo-copolymers by changing their L/D ratio. 
Properties of PLA are strongly dependent on its optical purity, for example, PLA can range from 
semicrystalline to completely amorphous.[11] The degree of crystallinity and even molecular 
orientation also have a strong influence on PLA biodegradability, specifically, the selection of 
adequate processing conditions is important to achieve a specific orientation for a given 
stereoregularity. For example, Lee et al. concluded that molecular orientation in amorphous PLA 
increased with decreasing stretching temperature whereas semycristalline samples required 
increasing temperatures.[12] It seems that, for amorphous samples, the most important effect 
concerns the highest orientation when molecular relaxation is hindered by a temperature 
decrease. For semicrystalline samples, the orientation phenomenon involves the deformation of 
formed spherulites, and consequently higher temperatures are needed. 
Electrospinning is currently one of the simplest methods to draw nano and microfibers from a 
polymer solution. Basically, the surface tension of a liquid droplet can be counteracted by the 
electrostatic repulsion due to the charging of the body of the liquid by a sufficiently high voltage. 
The droplet is stretched and may form a liquid jet if its molecular cohesion is sufficiently high.[13] 
Scaffolds prepared by electrospinning showed particularly good potential for drug delivery 
applications due to their large surface area and interconnected pore structure.[14, 15] Moreover, 
drug release behavior can be easily controlled by the morphology and composition of fibers.[16, 
17] Drug-loaded electrospun scaffolds can also be easily fabricated into various shapes (e.g., 
membranes or tubes) for different applications, such as wound dressing and nerve conduits.[18, 
19] To date, most studies of electrospun scaffolds for drug delivery have been focused on 
sustained release of a single drug. However, it is clear that the use of different drugs is a 
promising strategy that allows combination therapy and may even induce synergic effects. 
Studies on dual drug-loaded systems, mainly fibers fabricated by coaxial electrospinning[20] and 
multilayered electrospun polymer mats,[21] demonstrated different release kinetics from simple 
systems and/or that the severe initial burst release could be retarded or even negated. 
One of the main applications for electrospun scaffolds is its potential use as a matrix for wound 
healing. The success in wound healing can be handled by the control of various events, such as 
accelerating tissue regeneration (e.g., by promoting cell proliferation), preventing rejection of 
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the implanted material (e.g., by improving cell adhesion on the material or by local suppression 
of the immune cells), or reducing the risk of adverse effects associated with tissue damage (e.g., 
by preventing infection by opportunistic microorganisms). Thus, the release of two or more 
different drugs at the proper time and in appropriate doses may be required during treatment for 
wound healing. For example, post-surgical infection is a common problem after surgical 
procedures. This requires the release of some drugs, including antibiotics, from the drug-loaded 
biomaterial in a sustained manner to prevent infections over a short or long period. The rapid 
release of anti-inflammatory agents and analgesics is also necessary to reduce the cellular 
immune response and patient’s pain, respectively. Thus, it is highly desirable and challenging to 
develop novel drug delivery carriers that can control the release of multiple drugs with distinct 
release kinetics. 
In the present study, the feasibility of loading active agents of different nature and with diverse 
therapeutic effects into polylactide fibers is assessed with the aim of developing multifunctional 
electrospun materials for regenerative medicine applications. A system involving two drugs, 
triclosan (TCS) as the antibacterial agent and ketoprofen (KTP) as a conventional anti-
inflammatory drug, was considered. Figure 4.1.1 shows the chemical structure of compounds 
used. Modulation of the therapeutic effect is expected to occur because of the difference in 
release of these drugs from scaffolds constituted by electrospun fibers. The influence of polymer 
matrix crystallinity on the release behavior is also determined. To this end, electrospun scaffolds 
were prepared using PLAs having slightly different ratios between L- and D-lactide units. 
FIGURE 4.1.1 
Chemical structures of polylactide (PLA 2002D and PLA 4032D), triclosan (TCS) and ketoprofen (KTP). 
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4.1.2 Experimental Section 
Materials 
Two commercial PLA grades from Natureworks® with 95.8 and 98 wt-% L-lactic isomer content 
were used, i.e. PLA 2002D and PLA 4032D, respectively. According to the manufacturer, PLA 
2002D is a transparent solid with a density of 1.24 g·cc-1. Its calorimetric and mechanical 
properties are defined by a glass transition temperature (Tg) of 58 ºC, a melting point (Tm) of 153 
ºC, a tensile modulus (E) of 3500 MPa, a tensile strength () of 53-60 MPa and a tensile 
elongation () of 6%. PLA 4032D has a translucent appearance, a density of 1.24 g·cc-1 and very 
different properties from the sample with higher D-lactide content. Thus, Tg, Tm, E,  and  
values were reported to be 70 ºC, 160 ºC, 3440-3784 Ma, 103.2-144.5 MPa, 100-180%, 
respectively. Molecular weights determined by GPC were quite similar, specifically Mn, Mw and 
polydispersity index were 98,100 g·mol-1, 181,000 g·mol-1 and 1.85 for PLA 2002D and 84,200 
g·mol-1, 179,400 g·mol-1 and 2.13 for PLA 4032D.[22, 23] 
Trichloromethane (TCM), acetone, dimethylsulfoxide (DMSO), triclosan or irgasan (TCS), 
ketoprofen (KTP), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
were purchased from Sigma-Aldrich (St. Louis, USA). VERO (kidney epithelial cells extracted 
from African green monkey) and MDCK (kidney epithelial cells derived from Madin-Darby 
Canine) were purchased from ATCC (USA). Escherichia coli CECT 101 and Micrococcus 
luteus CECT 245 bacteria strains were obtained from the Spanish Collection of Type Culture 
(Valencia, Spain). 
Drug loaded PLA electrospun microfibers 
Scaffolds constituted by PLA 2002D and PLA 4032D microfibers were prepared by 
electrospinning, which also allowed loading the two selected drugs (i.e., TCS and KTP). The 
procedure consisted in dissolving the PLA grade in a chloroform-acetone mixture (2:1 v/v). For 
drug-loaded samples, 1 mL of dimethysulfoxide (DMSO) containing the corresponding drug 
was subsequently added and the mixture was vortexed to obtain an electrospinable solution. 
Final PLA concentration was 10 w/v-% whereas for drug loaded samples KTP and TCS 
concentrations were 1 w/v-% and 3 w/v-%, respectively.  
A plastic syringe of 5 mL (Becton Dickson, Spain) was filled with the corresponding solution 
and electrospinning was carried out between the tip of a 18G needle (Terumo, Belgium) 
connected to the anode and the static collector connected to the cathode. The DC voltage was 
applied using a high voltage supply (ES30-5W model, Gamma High Voltage Research, USA). 
The flow rate was controlled using a KD100 infusion syringe pump (KD Scientific Inc., USA). 
The polymer jet was collected on an aluminum foil and 14 mm diameter coverslips to evaluate 
cell adhesion and proliferation. All electrospinning procedures were conducted at room 
temperature.  
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Morphology and crystallinity of dual drug-loaded PLA microfibers 
Diameter measurements and inspection of fiber textures were performed by scanning electron 
microscopy (SEM) using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany). 
Carbon coating was accomplished with a Mitec K950 Sputter Coater (fitted with a film thickness 
monitor k150x). Samples were viewed at an accelerating voltage of 5 kV.  
Calorimetric data were obtained by differential scanning calorimetry (DSC) with a TA 
Instruments Q100 series equipped with a refrigeration cooling system (RCS). Experiments were 
conducted under a flow of dry nitrogen with a sample weight of approximately 5 mg and 
calibration was performed with indium. Heating and cooling runs were carried out at a rate of 
20 ºC·min-1 and 10 ºC·min-1, respectively. 
FTIR spectra were recorded on a FTIR 4100 Jasco spectrophotometer. The samples were placed 
in an attenuated total reflectance accessory with thermal control and a diamond crystal (Specac 
model MKII Golden Gate Heated Single Reflection Diamond ATR). 
Release experiments 
Controlled release experiments were performed with electrospun scaffolds cut into small square 
pieces (20 x 20 x 0.1 mm3). The samples were weighed and placed into polypropylene tubes. 
Two release media with different hydrophobicity and solvent ability were used: a typical 
phosphate buffer saline or (PBS) and PBS supplemented with 70 v/v-% of ethanol. The second 
one was less hydrophilic than PBS and was interesting for simulating the supplement of serum 
in the medium.[24] Drug-release was carried out in 50 mL of the release medium at 25 ºC for 1 
week. Drug concentration in the release medium was evaluated by UV-Vis spectroscopy using 
a UV-3600 spectrophotometer (Shimadzu, Japan). Calibration curves were obtained by plotting 
the absorbance measured at the corresponding wavelengths against drug concentration. Samples 
(1 mL) were drawn from the release medium at predetermined intervals and an equal volume of 
fresh medium was added to the release vessel. All the drug release tests were carried out using 
three replicates to control the homogeneity of the release, and the results obtained were averaged. 
Antimicrobial test: assay of bacterial growth and adhesion 
Escherichia coli (E.coli) and Micrococcus luteus (M.luteus) bacteria were selected to evaluate 
the antimicrobial effect of TCS and KP loaded electrospun scaffolds. The bacteria were 
previously grown aerobically to exponential phase in broth culture (5 g·L-1 beef extract, 5 g·L-1 
NaCl, 10 g·L-1 peptone, pH 7.2). 
Growth experiments were performed in tubes of 15 mL. 103 CFU (colony forming units) were 
seeded in 5 mL of broth culture in the presence of the electrospun scaffolds. The cultures were 
incubated at 37 ºC and agitated at 80 rpm. After incubation for 24 and 48 h, an aliquot of 100 
µL was diluted 10 times with distilled water and the absorbance at 600 nm was measured. The 
bacterial number was determined using a McFarland curve. 
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Adhesion experiments were carried out by seeding 107-108 CFU in 5 mL of broth culture in the 
presence of the electrospun scaffolds. The cultures were incubated at 37 ºC and agitated at 80 
rpm. After incubation, the cultures were aspired and the material washed once with distilled 
water. Then, 1 mL of sterile 0.01 M sodium thiosulfate was added and the mixture was vortexed 
for 2 min and left to repose for 30 min in order to remove the bacteria. Finally, 4 mL of broth 
culture was added and the tubes were incubated at 37 ºC for 24 h and agitated at 80 rpm. The 
bacterial number was determined as above indicated 
All assays were performed in triplicate and the results averaged. ANOVA followed by t-Student 
test were conducted as statistical analysis at a confidence level of 95 % (p < 0.05). Additionally, 
correlation coefficients (r) were calculated to evaluate the relation between antibacterial effect 
and the drug release. 
In-vitro biocompatibility assays: cell adhesion and proliferation 
MDCK, and VERO cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine 
at 37ºC in a humidified atmosphere with 5% CO2 and 95% air. The culture medium was changed 
every two days and, for sub-culture, cell monolayers were rinsed with phosphate buffered saline 
(PBS) and detached by incubation with trypsin-EDTA (0.25%) at 37ºC for 2-5 min. Cell 
concentration was determined by counting with a Neubauer chamber using 4% trypan-blue as 
dye vital. Detached cells with viability ≥ 95% were used for biocompatibility assays. 
The unloaded and antioxidant loaded electrospun PLA microfibers were cut into square pieces 
(10 x 10 x 0.1 mm3). These samples were placed into the wells of a multi-well culture plate and 
sterilized by UV-radiation in a laminar flux cabinet for 15 min. To fix the samples in the well, a 
small drop of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, 
France) was used as the adhesive. Samples were incubated with 1 mL of the culture medium 
under culture conditions for 30 min to equilibrate the material. Finally, the medium was aspired 
and the material was evaluated for cell adhesion and proliferation by exposing cells to direct 
contact with the material surface. 
To assess cell adhesion, aliquots of 50-100 µL containing 5x104 cells were seeded onto the 
electrospun scaffolds in the wells. The plate was incubated in culture conditions for 30 min to 
allow cell attachment to the material surface. Then, 1 mL of the culture medium was added to 
each well and the plate was incubated for 24 h. Finally, cell viability was determined by the 
MTT assay. Controls were performed by cell culture on the polystyrene surface of the plate 
(TCPS). 
Cell proliferation was evaluated by a similar procedure to the adhesion assay, but the aliquot of 
50-100 µL contained 2x104 cells. The cultures were maintained for 7 days to allow cell growth 
and adequate cell confluence in the well. The media were renewed every two days. Finally, cell 
viability was determined by the MTT assay. 
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Each sample was evaluated using five replicates and the results were averaged and graphically 
represented. The statistical analysis was performed by one-way ANOVA to compare the means 
of all groups; t-Student test was then applied to determine a statistically significant difference 
between two studied groups. The tests were performed with a confidence level of 95% (p < 
0.05). 
To obtain representative SEM images of samples coming from adhesion and proliferation 
assays, the following protocol was applied. First, samples were fixed in glutaraldehyde 2.5% in 
PBS overnight at 4ºC, and then dehydrated by washing in an alcohol battery (30º, 50º, 70º, 90º, 
95º and 100º) at 4ºC for a minimum of 30 min per step. Finally, samples were dried and sputter-
coated for SEM examination.  
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4.1.3 Results and Discussion 
Morphology of Dual Drug-Loaded PLA Microfibers PLA  
Morphology of electrospun fibers depends on both solution properties (e.g., viscosity, surface 
tension, dielectric constant, volatility and concentration) and operational parameters (e.g., 
strength of the applied electrical field, tip-collector distance and flow rate).[25-27] Selection of an 
appropriate solvent system is one of the most crucial points, especially in electrospinning of 
compounds with highly different characteristics (e.g., polymer and drugs). It should be pointed 
out that physicochemical properties of the solution can be affected by the incorporation of active 
drugs and that the system must be accurately chosen to support the load of one or both drugs and 
render appropriate electrospun fibers.[28]  
It was reported that the selection of solvent was also crucial to control the diameter of PLA 
electrospun fibers. Thus, diameters could be easily varied from 100 nm (i.e., nanometer scale) 
to 2 µm (i.e. micrometer scale) by using dimethyl formamide and chloroform-acetone (2:1 v/v) 
mixture as solvents, respectively, when polymer concentration was kept at 10 w/v-%.[29, 30] 
Nevertheless, PLA concentration also played a determinant role because nanofibers could again 
be obtained when it was lower than 5 w/v-%.[31] 
The above conclusions were taken into account in this study since a micrometer scale was 
preferred to detect release differences between drugs and from distinct PLA matrices. The main 
problem was to choose a solvent based on the chloroform-acetone mixture able to dissolve 10 
w/v-% of PLA and the two selected drugs with solubility characteristics different from those of 
PLA. Note the large difference between Hildebrand parameters reported for PLA[32] (i.e., 9.87 
(cal·cm-3)0.5) and TCS[33] (i.e.,14.38 (cal·cm-3)0.5). Finally, drugs were dissolved in dimethyl 
sulfoxide and subsequently added to the former PLA solution to obtain a tricomponent solvent 
mixture (chloroform:acetone:DMSO 6:3:1 v/v/v) compatible with the selected concentrations of 
PLA (10 w/v-%), TCS (3 w/v-%) and KTP (1 w/v-%). 
Figure 4.1.2 shows the SEM images of the fiber matrices and the corresponding diameter 
distribution analysis of electrospun fibers prepared under previously optimized operational 
parameters (i.e. applied voltage, flow rate and tip-collector distance of 15 kV, 10 mL·h-1 and 
12.5 cm, respectively). A unimodal Gaussian diameter distribution was always determined 
(insets of Figure 4.1.2).  
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FIGURE 4.1.2 
SEM micrographs of unloaded (a,b). triclosan loaded (c,d), ketoprofen loaded (e,f) and dual drug-loaded 
(g,h) PLA2002D (a,c,e,g) and PLA 4032D (b,d,f,h) electrospun microfibers.  
Average diameters determined for all samples are summarized in Table 4.1.1. The success of 
the electrospinning procedure to obtain fibers in the micrometer scale is confirmed in all cases. 
Differences between unloaded fibers prepared from the two PLA grades were not highly 
significant (average value of 1.76 µm). However, the incorporation of the drug always led to a 
diameter increase following the order TCS/KTP < TCS < KTP, with average diameters being 
1.98 µm, 2.82 µm and 3.33 µm, respectively. Probably, the physicochemical characteristics of 
the electrospun solutions were more influenced by the incorporation of bigger KTP molecules 
(Figure 4.1.1). These caused the largest increase on the fiber diameter despite the drug load 
percentage was the smallest. It should also be pointed out that TCS and KTP drugs caused a 
significant discrepancy between fiber diameters of samples coming from the two PLA grades, 
with higher increase being detected for PLA 4032D samples. These changes may reflect a 
different degree of molecular orientation and even different compactness of the amorphous 
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phases between the two electrospun polymers. Finally, when the drugs, TCS and KTP, were 
loaded simultaneously in both PLA samples, diameter values were only slightly higher than 
those obtained for unloaded fibers. This feature suggests some kind of interaction between TCS 
and KTP (e.g., hydrogen bonds between hydroxyl and carbonyl groups or stacking between 
aromatic groups) that could also be favored by higher total drug content with respect to the single 
drug-loaded systems. 
aFibers were obtained using the same electrospinning operational parameters: applied voltage of 15 kV, 
flow rate of 10 mL·h-1 and tip-collector distance of 12.5 cm. 
bMean value ± standard deviation.  
Figure 4.1.3 shows high-magnification SEM images of the different fibers which reveal a very 
similar porous texture for all cases. 
FIGURE 4.1.3 
High-magnification SEM micrographs showing the surface texture of unloaded (a,b), triclosan-loaded 
(c,d), ketoprofen-loaded (e,f) and dual drug-loaded (g,h) PLA 2002D (a,c,e,g) and PLA 4032D (b,d,f,h) 
electrospun microfibers. 
TABLE 4.1.1. Diameters of unloaded and drug loaded electrospun PLA fibers. 
Sample Diametera,b (µm) 
PLA 2002D 1.86 ± 0.06 
PLA 4032D 1.66 ± 0.05 
PLA 2002D + TCS 2.12 ± 0.01 
PLA 4032D + TCS 3.53 ± 0.04 
PLA 2002D + KTP 2.95 ± 0.02 
PLA 4032D + KTP 3.72 ± 0.06 
PLA 2002D + TCS/KTP 2.19 ± 0.01 
PLA 4032D + TCS/KTP 1.77 ± 0.03 
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Incorporation of Drugs Into Electrospun Microfibers 
FTIR spectra of unloaded and drug-loaded PLA 2002D samples in Figure 4.1.4 illustrate two 
interesting points. First, no significant differences exist between typical PLA absorption bands 
of scaffolds prepared from the two PLA grades or scaffolds loaded with the drugs or their 
combination. The given spectral region is sensitive to molecular conformation, consequently, it 
can be concluded that differences between electrospun samples were not large enough to be 
detected by FTIR. As will be discussed later, although the amorphous content may change 
slightly with the PLA grade and drug load, it seems that polymer chains attained a similar 
molecular conformation after the electrospinning process. In fact, processed PLA microfibers 
were always practically amorphous but a high degree of molecular orientation was induced 
during electrospinning.[34] Note, for example, that all spectra have similar intensity for the 
shoulder band at 1209 cm-1 (as (C-O-C) + ras(CH3) for a 107 helical conformation) and the band 
at 1263 cm-1 ( (CH) +  (C-O-C) for a random conformation). Also, the relative proportion 
between bands at 1385 cm-1 (s (CH3), amorphous form) and 1363 cm-1 ((CH), semycrystalline 
form) became practically invariable.[35]  
FTIR spectra were sufficiently sensitive to detect the incorporated drugs despite the relatively 
low loading percentages. More precisely, TCS was clearly identified in the microfibers through 
the characteristic peak at 1476 cm-1, attributed to the C=C stretching vibration of benzene 
rings.[36] However, lesser loaded KTP (i.e. 1 w/v-% as opposed to 3 w/v-%) could be hardly 
detected through the strongest peak at 1652 cm-1, attributed to the C=O stretching.[37] 
Unfortunately, FTIR spectra were not able to detect specific interactions in the dual drug-loaded 
system due to the low intensity of the involved peaks.  
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FIGURE 4.1.4 
FTIR spectra (1800-1000 cm-1 region) of PLA 2002D, PLA 4032D, PLA 2002D + TCS, PLA 2002D + 
KTP and PLA 2002D +TCS/KTP scaffolds. 
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Thermal Properties of Unloaded and Drug Loaded PLA Electrospun Scaffolds 
Table 4.1.2 summarizes the main calorimetric data obtained from the heating run of unloaded 
and drug-loaded scaffolds from the two PLA grades, whereas the corresponding DSC traces are 
shown in Figure 4.1.5. 
Data corresponding to the two PLA pellets are also given for comparative purposes. It is clear 
that both samples were manufactured in a semicrystalline form attained after annealing 
treatment. Values clearly reflect the impact of a small increase of D-lactide content (i.e. from 2 
wt-% to 4.2 wt-%) on both amorphous and crystalline phases, with remarkable changes in glass 
transition and melting temperatures, respectively. More interestingly, the thermal characteristics 
of electrospun samples are significantly different from the initial ones. First, both PLA 2002D 
and PLA 4032D electrospun samples became practically amorphous (degree of crystallinity, c, 
close to 0.07-0.008 as indicated in Table 4.1.2) although a remarkable degree of molecular chain 
orientation could be inferred. Note that cold crystallization peaks can be clearly observed during 
the heating run of both samples and relatively high degree of crystallinities (i.e. 0.25 and 0.29) 
could be estimated from the subsequent melting enthalpies. These values were close to those 
deduced for the corresponding commercial pellet samples and clearly higher than those obtained 
from the heating run performed with commercial samples after being slowly cooled from the 
melt state.[29] The high relaxation peak observed for the PLA 4032D electrospun sample, which 
indicates the great ability of this PLA grade to achieve the equilibrium thermodynamic 
conditions characterized by higher stiffness and lower enthalpy an volume, is also worth noting. 
In addition, this close to equilibrium condition led to a fictive glass transition temperature[38] 
clearly lower than that observed in the initial sample of PLA 4032D (i.e. 62.4 ºC as opposed to 
69.3 ºC) and close to those detected for both PLA2002D initial and electrospun samples (59.6 
ºC and 59.3 ºC). Cold crystallization took place in a narrow temperature range for PLA 4032D, 
whereas the use of PLA 2002D involved a wide temperature range suggesting greater difficulty 
for molecular rearrangement.  
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Incorporation of drugs had effects on thermal properties that depended on the polymer grade and 
the drug: 
 Incorporation of TCS led to a significant decrease in the melting temperature of the two 
PLA samples (i.e. close to 13 ºC) suggesting partial incorporation into the crystalline 
structure. Both loaded samples were practically amorphous after electrospinning but the 
cold crystallization process was more favorable for the more regular PLA 4032D simple. 
Final crystallinities were logically lower than those of unloaded samples (i.e. 0.21 as 
opposed to 0.29 for PLA 4032D and 0.09 as opposed to 0.25 for PLA2002D). TCS also had 
a plasticizing effect, as suggested by the significant decrease in the glass transition 
temperature. In addition, the trend to achieve the compact arrangement characteristic of an 
equilibrium condition was practically supressed for PLA 4032D derived scaffolds since the 
enthalpy relaxation peak was hardly detected. 
 The melting point decrease was less significant (i.e. close to 6 ºC) for scaffolds containing 
KTP as consequence of their lower drug load. In this case, the most significant feature was 
the high crystallinity attained after the cold crystallization process, being in the case of PLA 
4032 scaffolds, was even greater than for the unloaded sample. It seems that KTP could also 
act as a nucleating agent, as deduced from the decrease of the cold crystallization 
temperature and even for the narrower temperature range for the less crystalline PLA 2002D 
scaffold. Glass transition temperatures and enthalpy relaxation peaks decreased too, 
suggesting again a plasticizing effect of KTP and greater difficulty in the more compact 
equilibrium arrangement. Nevertheless, this trend was not completely supressed in the case 
of PLA 4032D. 
 The dual drug-loaded samples showed peculiar DSC traces, which were the result of the 
effect caused by TCS and KTP. Thus, the decrease in the melting and glass transition 
temperatures were the highest (12-17 ºC and 25-29 ºC, respectively), enthalpy relaxation 
was completely suppressed and high crystallinity was attained before (for PLA 4032D 
sample) and after cold crystallization (for both PLA grades) due to the KTP nucleating 
effect. The high crystallinity that could again be directly attained in the electrospinning of 
the PLA 4032D grade in presence of KTP is worth noting. Finally, melting peaks were, in 
this case, clearly complex due to the presence of crystals with different degrees of perfection 
(incorporation of impurities or/and different lamellar thicknesses). 
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FIGURE 4.1.5 
DSC heating runs (20 ºC·min-1) of unloaded (a) and drug-loaded (b) PLA 2002D and PLA 4032D 
electrospun scaffolds. 
Drug Release from Scaffolds of PLA with Different D-Lactide Content 
A quantitative study was also attempted to follow the release of KTP and TCS from the two 
different PLA matrices. Release in the less hydrophilic medium containing ethanol (PBS:EtOH 
3:7 v/v) was monitored through the absorbance measurement at 270 and 281 nm for KTP and 
TCS, respectively, whereas values were measured at 260 and 290 nm for KTP and TCS, 
respectively, when hydrophilic PBS medium was employed. In all cases, concentrations were 
evaluated using the coefficient of molecular extinction (ε) calculated for each drug in the 
corresponding release medium. These values were 7,610 and 6,908 M-1·cm-1 for TCS in 
PBS:EtOH and PBS media, respectively, and 23,604 22,487 M-1cm-1 for KTP in PBS:EtOH and 
PBS media, respectively. 
Drug release plots in Figures 4.1.6 and 4.1.7 highlight differences depending on the PLA grade 
and logically on the selected medium. In all cases, the release attained a maximum value that 
mainly depends on the drug equilibrium distribution between the microfibers and the release 
medium but also on the ability of microfibers to trap the drug efficiently. Hence, the final release 
percentage was always lower when the more hydrophilic PBS medium was used, in agreement 
with the hydrophobic character of the drugs and PLA. Furthermore, PLA 2002D microfibers 
showed the highest release percentages, probably as a consequence of the decrease in trapping 
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efficiency caused by their lower molecular orientation and less dense molecular arrangement. 
Thus, for example the release of TCS and KTP from PLA 2002D scaffolds after 8 h of exposure 
to PBS medium rose 40% and 30%, respectively (Figure 4.1.6 a), while these percentages 
decreased to 30% and 5% for a similar exposure time when PLA 4032D scaffolds were 
employed (Figure 4.1.6 c). A similar trend was observed in PBS:EtOH medium, specifically, 
the percentages of TCS and KTP release from PLA 2002D scaffolds after 8 h of exposure were, 
respectively 80% and 60% (Figure 4.1.7 a) and from PLA 4032D scaffolds, 50% and 30% , 
respectively (Figure 4.1.7 c). The influence of release medium and type of polymer matrix on 
drug release was also observed when dual drug-loaded scaffolds were evaluated (Figures 4.1.6 
c, 4.1.6 d, 4.1.7 c and 4.1.7 d). 
FIGURE 4.1.6 
Release curves in PBS medium of TCS (□) and KTP (○) from single drug-loaded (a,c) and dual drug-
loaded (b,d) PLA 2002D (a,b) and PLA 4032D (c,d) electrospun scaffolds.  
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FIGURE 4.1.7 
Release curves in PBS:EtOH medium of TCS (□) and KTP (○) from single drug-loaded (a,c) and dual 
drug-loaded (b,d) PLA 2002D (a,b) and PLA 4032D (c,d) electrospun scaffolds. 
An interesting observation about these dual systems is that the release profiles for each drug 
were different from those determined for single drug-loaded scaffolds. Specifically, a lower 
release percentage was always found in dual scaffolds. Note that fiber diameters were smaller 
for these dual systems, and consequently a contrary behavior should be expected if release was 
only controlled by molecular diffusion. Furthermore, drug release in dual systems seemed to be 
favored when physicochemical characteristics of the amorphous phase. Thus, decrease of the 
glass transition temperature or suppression of the aging effect may favour the release. It should 
be pointed out that crystallinity and molecular orientation seemed too similar in single and dual 
scaffolds loaded with KTP to justify the large differences found in the corresponding KTP 
release profiles. Therefore, TCS and KTP molecules should have some kind of intermolecular 
interactions inside microfibers that change equilibrium distribution or hinder molecular 
diffusion.  
Plots in Figures 4.1.6 and 4.1.7 also show that release evolves in a gradual manner (i.e. without 
a significant Burst effect indicative of the presence of drugs deposited on the microfiber surfaces 
only) until a significant delivery is attained. 
In addition to the maximum achievable release, it is also interesting to compare the release rates, 
which can be easily determined from the experimental results. Several theoretical models have 
been postulated to fit the experimental release profiles, typically first-order,[41] Higuchi[42] and 
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their combination.[43] Release generally occurs in two different steps, i.e. a rapid release of 
molecules that should be deposited mainly on the surface of fibers and a slow release that should 
involve the diffusion of molecules through the polymer bulk towards the release medium. In this 
way, a combined model based on the Higuchi and first-order models (Equations 1 and 2) is 
usually used to describe the first (0-60%) and second (40-100%) parts of the release, 
respectively: 
Mt ⁄ M0 = kH t(1⁄2)    (0 ≤ Mt ⁄ M0 ≤ 0.6)    (1) 
ln (1- Mt ⁄ M0 ) = a - k1 t (0.4 ≤ Mt ⁄ M0 ≤ 1.0)    (2) 
where kH is the Higuchi release constant, k1 is the first-order release constant, Mt is the percentage 
of drug released at time t, M0 is the drug equilibrium percentage (considered as the maximum 
drug percentage) and a is a constant. 
TABLE 4.1.3. Kinetic constants for the first (0-60%) and second part (40-100%) of 
the TCS and KTP release for selected scaffolds and media. 
Sample Drug Medium kH (h-0.5) k1 (h-1) 
PLA 2002D + TCS TCS PBS:EtOH 0.78 0.58 
PLA 4032D + TCS TCS PBS:EtOH 0.35 0.38 
PLA 2002D + TCS/KTP TCS PBS:EtOH 0.78 0.97 
PLA 4032D + TCS/KTP TCS PBS:EtOH 0.79 1.10 
PLA 2002D + TCS TCS PBS 0.47 0.29 
PLA 4032D + TCS TCS PBS 0.48 1.48 
PLA 2002D + TCS/KTP TCS PBS 0.15 1.02 
PLA 4032D + TCS/KTP TCS PBS 0.04 5.61 
PLA 2002D + KTP KTP PBS:EtOH 0.50 0.39 
PLA 4032D + KTP KTP PBS:EtOH 0.35 0.40 
PLA 2002D + TCS/KTP KTP PBS:EtOH 0.25 1.60 
PLA 4032D + TCS/KTP KTP PBS:EtOH 0.24 1.65 
PLA 2002D + KTP KTP PBS 0.30 0.37 
PLA 4032D + KTP KTP PBS 0.10 0.30 
PLA 2002D + TCS/KTP KTP PBS 0.13 1.26 
PLA 4032D + TCS/KTP KTP PBS 0.06 2.24 
Table 4.1.3 summarizes the values of kH and k1 determined for representative scaffolds and 
release media (i.e. those with a significant release). Basically, the variations of k1 reflect ability 
to reach the final equilibrium condition whereas kH values appear more interesting because they 
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quantify and allow comparing drugs release speed in the initial phase of delivery. This constant 
is similar for TCS release in PBH:EtOH medium (0.78-0.79 h-0.5) from all scaffolds except from 
the single-loaded PLA 4032D system, where a slight decrease was detected (0.60 h-0.5). This 
constant clearly decreased (0.29-0.30 h-0.5) in PBS medium. Release of KTP proceeded at a 
slower rate than TCS in both media, with values of 0.22-0.25 h-0.5 and 0.10-0.15 h-0.5 for 
PBS:EtOH and PBS media, respectively. The lower rates for each range corresponded to 
scaffolds prepared from the more regular PLA 4032D matrix. Finally, it is worth mentioning 
that release of both KTP and TCS proceeded at a very slow rate (0.06 and 0.04 h-0.5, 
respectively) when dual drug-loaded systems and the more hydrophilic PBS medium were used. 
Antibacterial Properties of TCS and KTP Loaded PLA Scaffolds 
Antibacterial activity of PLA 2002D and PLA 4032D electrospun scaffolds loaded with TCS 
and its combination with KTP were tested against M.luteus and E.coli bacteria (as representative 
of Gram-positive and Gram-negative bacteria, respectively). It is well known that TCS is a 
broad-spectrum antiseptic with documented safety and efficacy against both types of bacteria.[44, 
45] Basically, TCS blocks the active site of the enol-acyl carrier protein reductase enzyme, which 
is essential in the synthesis of fatty acids in bacteria.[46] 
FIGURE 4.1.8  
Relative growth of Escherichia coli (a) and Micrococcus luteus (b) on TCS (■,□), KTP (●,○) and TCS/KTP 
(♦,◊) loaded PLA electrospun scaffolds and polystyrene plate as postive control (▲). Full and empty 
symbols correspond to PLA 2002D and PLA 4032D samples, respectively. 
Bacterial growth curves for E.coli and M.luteus are shown in Figures 4.1.8 a and 4.1.8 b 
respectively. An initial lag phase (4-5 hours) followed by an exponential phase associated with 
binary fission that stopped at growth levels clearly lower than for the positive control is 
observed. Therefore, for both types of bacteria, the results corroborate that single and dual TCS-
loaded scaffolds were active materials for inhibition of bacterial growth. Bacterial growths 
between 5-10% and 10-20% with respect to the positive control were observed for E. coli and 
M. luteus, respectively, after 24 hours of culture. 
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Curves were essentially independent of the polymer matrix, and consequently antibacterial 
activity was not sensitive to the differences observed in the release experiments. It seems that 
the high TCS content of scaffolds (i.e. 3 wt-%) ensured a sufficient release to inhibit bacterial 
growth even for matrices with a fairly low release. It is also important to indicate that the 
incorporation of KTP did not interfere with biological activity of TCS, at least at the assayed 
concentrations, and made possible the development of multifunctional materials with 
antibacterial and anti-inflamatory activities. 
Interestingly, an intermediate level of inhibition of bacterial growth was also found for scaffolds 
only loaded with KTP, demonstrating antibacterial activity. In fact, KTP is an active ingredient 
that inhibits cyclooxygenase, leading to analgesic, anti-inflammatory and antypiretic properties 
but at the same time it has some bactericide activity through a mechanism that remains 
unclear.[47, 48] Figure 4.1.8 clearly shows that the bactericide activity of KTP-loaded scaffolds 
depended on the selected PLA matrix; specifically, the greatest activity was observed for PLA 
2002D. The result is in agreement with the lower crystallinity found for this sample and the 
higher release compared to the KTP-loaded PLA 4032D scaffold.  
Quantification of bacterial adhesion is another checkpoint for the bactericide activity. This 
activity is demonstrated for all TCS-loaded scaffolds since the percentage of attached bacteria 
was always statistically lower that than of positive controls, as shown in Figure 4.1.9. 
Nevertheless, the activity was lower against M.luteus since Gram-positive bacteria are less 
sensitive to the effect of triclosan. Figure 4.1.9 also shows that single KTP-loaded scaffolds 
were unable to inhibit bacterial adhesion on their surface. 
FIGURE 4.1.9 
Escherichia coli (light gray) and Micrococcus luteus (dark gray) adhesion on polystyrene plate as positive 
control and TCS, KTP and TCS/KTP loaded electrospun scaffolds from PLA 2002D and PLA 4032D 
grades (*p < 0.05 vs. control, Tukey’s test). 
   
118 
 
Multifunctional biodegradable fiber scaffolds 
Cell Adhesion and Proliferation on Drug Loaded Scaffolds 
Figures 4.1.10 a and 4.1.10 b show the behavior of two epithelial cell lines (MDCK and VERO) 
in terms of cell adhesion and proliferation on PLA electrospun scaffolds loaded with TCS and/or 
KTP. In general, scaffolds allowed adhesion of epithelial cells (Figure 4.1.10 a), which is an 
important event for restarting epithelialization process of a damaged tissue. Nevertheless, a low 
percentage of cells (18-36% with respect to de control) adhered to the loaded PLA scaffolds. 
This highly significant difference (p < 0.001) was due to the large percentage of loaded TCS 
(i.e. 3 w/v-%), which became cytotoxic to cells in culture.32 It is remarkable that a large 
percentage of adhesion was generally observed in dual drug-loaded scaffolds despite having the 
same TCS content. Only the PLA 2002D scaffold showed a slight significant difference 
(borderline value with p < 0.048). Cytotoxicity can therefore be modulated by incorporating 
KTP and even by modifying the PLA enantiomer composition. These results are in clear 
agreement with the release experiments, which indicated a decrease in the amount of delivered 
TCS when KTP was also incorporated into the microfibers and a higher release when the more 
amorphous PLA 2002D was employed as a matrix. Finally, a large percentage of cell adhesion 
was determined for PLA scaffolds loaded with the anti-inflammatory KTP, similarly to the 
positive control. 
Adherent cells kept their proliferative activity and ultimately colonized the material, forming a 
monolayer tissue. Figure 4.1.10 b quantifies cell growth, which was clearly related to the 
previous cell adhesion event. Thus, the percentage of cells growing on TCS-loaded PLA was 
still lower than for the positive control (i.e. 42-55%) but the difference was statistically less 
significant (p < 0.01) and relatively moderate. Again, the dual drug-loaded scaffold did not show 
any statistical difference with respect to the control, and therefore appears to be an appropriate 
3D matrix for cell growth. 
FIGURE 4.1.10 
Adhesion (a) and proliferation (b) of MDK (white) and VERO (grey) cells on polystyrene plate as positive 
control and TCS, KTP and TCS/KTP loaded electrospun scaffolds from PLA 2002D and 4032D grades (p 
< 0.001, p < 0.01 and p < 0.05 vs. positive control, ANOVA-Tukey’s test).  
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4.1.4 Conclusions 
Continuous electrospun microfibers of polylactide containing antibacterial and anti-
inflammatory agents (i.e. triclosan and ketoprofen) can be successfully prepared using optimized 
processing parameters and a mixture of chloroform, acetone and dimethylsulfoxide as solvent. 
Thermal properties of electrospun microfibers were highly dependent on small variation in the 
D-lactide content of PLA and the incorporation of small ratios of TCS and/or KTP. Specifically, 
microfibers containing KTP and prepared from the more regular PLA 4032D sample were 
crystalline as a result of the molecular orientation induced by the electrospinning process and 
the nucleating effect of the incorporated drug. 
Release of TCS and KTP from PLA electrospun scaffolds depended on the hydrophilicity of the 
media, the stereoregularity of the polymer matrix and the potential establishment of 
intermolecular interactions in dual drug-loaded scaffolds. In particular, percentages of released 
drugs and release rates were lower in dual drug-loaded scaffolds than in single systems. All 
TCS-loaded scaffolds exhibited antibacterial properties independently of the selected PLA grade 
and the presence of KTP. In addition, KTP-loaded scaffolds also showed bacteriostatic activity, 
which was more significant at higher D-lactide content of PLA.  
Cytotoxicity of TCS-loaded scaffolds could be suppressed and bactericide activity maintained 
when KTP was also incorporated into the microfibers due to the slower and reduced release from 
these dual drug-loaded systems. 
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Multifunctional electrospun scaffolds were prepared from two 
PLA grades having slightly different D-lactide content (4.2 wt-
% and 2.0 wt-%). Triclosan (TCS), ketoprofen (KTP) and p-
coumaric acid (CUM) were selected as bactericide, anti-
inflammatory and antioxidant agents, respectively. Single, 
binary and ternary drug-loaded microfibers having a unimodal 
diameter distribution could be prepared using a common 
chloroform:acetone:dimethylsulfoxide mixture and similar 
operational parameters (i.e., voltage, flow rate and tip-
collector distance). FTIR spectra were sensitive to the low 
amount of drugs loaded and even showed slight differences in 
PLA conformation. DSC heating scans clearly demonstrated 
the ability of electrospinning to induce molecular orientation 
of PLA and also the nucleation effect of incorporated drugs to 
induce crystallization. Thus, crystallinity of binary drug-loaded 
scaffolds was significantly higher than observed for unloaded 
samples.  
Release behavior of the three drugs from loaded scaffolds and 
PLA matrices in PBS:ethanol medium was evaluated. A rapid 
release was always detected, together with partial drug 
retention which was higher when the more stereoregular PLA 
matrix was employed. A strong bactericide effect was found 
when scaffolds were loaded with 3 wt-% of TCS, but 
incorporation of when a small percentage of KTP (i.e. 1 wt-%) 
had a bacteriostatic effect even in the absence of TCS. The 
inherent cytotoxicity of TCS could be well neutralized by 
enhancing cell viability by incorporation of CUM and/or KTP. 
 
4.2 
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4.2.1 Introduction 
The principle of tissue engineering and regenerative medicine is the application of material 
scaffolds to develop biomimic and bioinspired materials. These scaffolds can be specifically 
prepared to display biological activities that induce regeneration of both tissues and organs and 
restore the function of diseased or traumatized tissues in the human body.[1] 
Scaffolds are defined as three-dimensional porous solid biomaterials which should offer a 
unique combination of inherent properties, such as physical stability within implanted injury 
site. Besides promoting tissue regeneration, scaffolds have other very important 
characteristics/functions: (i) capability to favor cell-biomaterial interactions (i.e. cell adhesion 
and extracellular matrix (ECM) deposition), (ii) enhancement of cell survival (proliferation and 
differentiation), (iii) compatibility of biodegradation rate with required time for tissue 
regeneration and (iv) ability to cause minimum inflammation or toxicity in vivo resulting from 
toxic metabolic byproducts.[1] In addition, scaffolds can be used as carriers and/or delivery 
system of drugs or biomolecules to palliate different stages during replacement and regeneration 
of tissue or to avoid rejection of implanted biomaterial.  
Natural and synthetic polymers have been widely used as biomaterials for medical devices and 
tissue engineering scaffolds.[2, 3] The most commonly used synthetic polymers in tissue 
engineering are polylactide (PLA), polyglicolide (PGA) and their copolymers (PLGA).[4] These 
materials provide synthetic scaffolds characterized by excellent mechanical properties, highly 
interconnected porous structure, ability to activate their surfaces to yield specific chemical 
properties, and geometry adapted to direct tissue regeneration.[5] 
Different techniques to prepare scaffolds are currently available, but electrospinning is probably 
one of the simplest processes to obtain porous matrices constituted by fibers in the micrometer 
or nanometer scales. Furthermore, since fibers can be easily loaded with drugs during their 
preparation, electrospinning provides the most promising results for tissue engineering, tissue 
regeneration and drug delivery applications.[6, 7] Specifically, electrospun scaffolds can be used 
for musculoskeletal tissue engineering include bone and cartilage, and also as control delivery 
systems for drugs, proteins and DNA.[8] Electrospinning has been widely applied to obtain 
scaffolds from natural polymers such as collagen,[9] gelatin,[10] chitosan,[11] HA,[12] and silk 
fibroin,[13] and well as from synthetic polymers like polylactide,[14] polyurethane,[15] 
polycaprolactone,[16] poly(lactide-co-glicolide),[17] polyvinilalcohol,[18] and poly(lactide-co-
caprolactone).[5] 
Several health problems have been associated with the use of biomaterials, for example 
infecrion related to the use of catheters[19] or prosthetic bones[20] among others. Other problems 
concerning damaged tissue, such as inflammation produced by cell necrosis, must be 
considered, too. Inflammation and oxidative stress are two cellular processes in the tissue that 
must be treated to restart rapid recovery from tissue injury. In this sense, scaffolds should be 
designed to be used not only as appropriate platforms to support cell proliferation but also as 
active elements to mediate cell recovery through local tissue medication. 
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The goal of this work is the preparation of improved multiactive electrospun scaffolds for 
regeneration and repair of damaged tissue that are not rejected by the human body and can 
reduce possible bacterial activity and inflammation during tissue regeneration. To this end, 
triclosan (TCS), p-coumaric acid (CUM) and ketoprofen (KTP) (Figure 4.2.1), with 
antimicrobial, antioxidant, anti-inflammatory activities, respectively, were loaded into two 
polylactide (PLA) grades having slightly different stereoregularity, and consequently different 
thermal, degradation and mechanical properties.[21, 22] Scaffold morphology, physicochemical 
properties, drug release proﬁles, antimicrobial activity and biocompatibility of scaffolds are 
presented.  
FIGURE 4.2.1 
Chemical structures of polylactide (PLA 2002D and PLA 4032D), triclosan (TCS), p-coumaric acid 
(CUM) and ketoprofen (KTP). 
TCS has a well demonstrated antimicrobial activity against both Gram-negative and Gram-
positive bacteria. Thus, TCS has been extensively used for topical applications, and its 
controlled release from biomaterials evaluated.[23, 24] CUM is a hydroxycinnamic acid with 
recognized activity as scavenger for prevention of oxidative stress damage caused by free 
radicals.[25, 26] KTP is a non-steroidal anti-inflammatory drug (NSAID) used to control pain and 
inflammation in rheumatic diseases, as well as inflammation in flogistic diseases.[27, 28] 
  
   
126 
 
Multifunctional biodegradable fiber scaffolds 
4.2.2 Experimental Section 
Materials 
Two commercial PLA grades from Natureworks® with 95.8 and 98 wt-% of L-lactic isomer 
content were used; i.e. PLA 2002D and PLA 4032D, respectively. According to the 
manufacturer, PLA 2002D is a transparent solid with a density of 1.24 g·cc-1. Its calorimetric 
and mechanical properties are defined by a glass transition temperature (Tg) of 58 ºC, a melting 
point (Tm) of 153 ºC, a tensile modulus (E) of 3500 MPa, a tensile strength () of 53-60 MPa 
and a tensile elongation () of 6%. PLA 4032D has a translucent appearance, a density of 1.24 
g·cc-1 and highly different properties from those of the sample with higher D content. Thus, Tg, 
Tm, E,  and  values were reported to be 70 ºC, 160 ºC, 3440-3784 Ma, 103.2-144.5 MPa, 100-
180%, respectively. Molecular weights determined by GPC were quite similar, and specifically 
Mn, Mw and polydispersity index were 98,100 g·mol-1, 181,000 g·mol-1 and 1.85 for PLA 2002D 
and 84,200 g·mol-1, 179,400 g·mol-1 and 2.13 for PLA 4032D.[21, 22] 
Trichloromethane (TCM), acetone (AC), dimethylsulfoxide (DMSO), Triclosan (IrgasanTM) 
(TCS), ketoprofen (KTP) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide 
(MTT) were purchased from Sigma-Aldrich (St. Louis, USA) and p-coumaric acid (CUM) were 
purchased from Acros Organics (New Jersey, USA). VERO (African green monkey kidney 
epithelial cells), MDCK (Madin-Darby canine kidney epithelial cells) were purchased from 
ATCC (USA). 
Preparation of fibers by electrospinning 
Both PLA 2002D and PLA 4032D (1 g) were dissolved in 9 mL of a chloroform-acetone 
mixture (2:1 v/v). Then, 1 mL of dimethysulfoxide (DMSO) containing the drugs was added 
and the mixture was homogenized by vortex to obtain an electrospinable solution of 10 w/v-% 
PLA, and 3 w/v-% TCS, 1 w/v-% KTP and 1 w/v-% CUM. Furthermore, PLA samples loaded 
with one single drug and dual-drug combinations (e.g., TCS/CUM and KTP/CUM) were also 
prepared as controls. 
A plastic syringe of 5 mL (Becton Dickson, Spain) was filled with the corresponding PLA drug 
solution. Electrospinning was carried out between the needle (18G; Terumo, Belgium) 
connected to the anode and the static collector connected to the cathode. The voltage was 
applied by a high voltage supply (Gamma High Voltage Research, ES30-5W model). The flow 
rate was controlled using a KD100 infusion syringe pump (KD Scientific Inc., USA). All 
electrospinning experiments were conducted at room temperature (aprox. 25ºC). 
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Morphology and crystallinity of drug loaded PLA nanofibers 
Diameter measurements and inspection of fiber surfaces were performed by scanning electron 
microscopy using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany). Carbon 
coating was accomplished with a Mitec K950 Sputter Coater (dotted with a film thickness 
monitor k150x). Samples were viewed at an accelerating voltage of 5 kV. 
Calorimetric data were obtained by differential scanning calorimetry with a TA Instruments 
Q100 series equipped with a refrigeration cooling system (RCS). Experiments were conducted 
under a flow of dry nitrogen with a sample weight of approximately 5 mg and calibration was 
performed with indium. Heating and cooling runs were carried out at a rate of 20 ºC·min-1 and 
10 ºC·min-1, respectively. 
FTIR spectra of CUM, KTP, TCS and unloaded and drug loaded PLA both PLA 4032D and 
PLA 2002D grades were recorded on a Jasco FTIR 4100 spectrophotometer. Samples were 
placed on an attenuated total reflection accessory with thermal control and a diamond crystal 
(Specac MKII Golden Gate Heated Single Reflection Diamond ATR). 
Release experiments 
Controlled release experiments were performed with electrospun scaffolds cut into small square 
pieces (20  x 20 x 0.1 mm3). The samples were weighed and placed into polypropylene tubes. A 
typical phosphate buffer saline (PBS) supplemented with 70 v/v-% of ethanol was used as the 
release medium. This medium, which is less hydrophilic than PBS, was interesting to simulate 
the usual serum supplemented medium.[23] Drug release was carried out in 50 mL of the release 
medium at 25 ºC for 1 week. Drug concentration in the release medium was evaluated by UV-
Vis spectroscopy using a UV-3600 spectrophotometer (Shimadzu, Japan). Calibration curves 
were obtained by plotting the absorbance measured at the corresponding wavelengths against 
drug concentration. Samples (1 mL) were drawn from the release medium at predetermined 
intervals and an equal volume of fresh medium was added to the release vessel. All the drug 
release tests were carried out using three replicates to control release homogeneity, and the 
results obtained from the samples were averaged. 
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Antimicrobial test: assay of bacterial growth and adhesion 
Escherichia coli (E.coli) and Micrococcus luteus (M.luteus) were selected as representative of 
Gram-negative and Gram-positive bacteria, respectively, to evaluate the antimicrobial effect of 
CUM, TCS/CUM, KTP/CUM and TCS/KTP/CUM loaded electrospun scaffolds. The bacteria 
were previously grown aerobically to exponential phase in broth culture (5 g·L-1 beef extract, 5 
g·L-1 NaCl, 10 g·L-1 peptone, pH 7.2). 
Growth experiments were performed in tubes of 15 mL. 103 CFU (colony forming units) were 
seeded in 5 mL of broth culture in the presence of the electrospun scaffolds. The cultures were 
incubated at 37 ºC and agitated at 80 rpm. After incubation for 24 and 48 h, an aliquot of 100 
µL was diluted 10 times with distilled water and absorbance at 600 nm was measured. The 
bacterial number was determined using a McFarland curve scale. 
Adhesion experiments were carried out by seeding 107-108 CFU in 5 mL of broth culture in the 
presence of the electrospun scaffolds. The cultures were incubated at 37 ºC and agitated at 80 
rpm. After incubation, the cultures were aspired and the material washed once with distilled 
water. Then, 1 mL of sterile 0.01 M sodium thiosulfate was added and the mixture was vortexed 
for 2 min and left to repose for 30 min in order for the bacteria to be removed. Finally, 4 mL of 
broth culture was added and the tubes were incubated at 37 ºC for 24 h and agitated at 80 rpm. 
The bacterial number was determined as above described. 
All assays were performed in triplicate and the results averaged. ANOVA followed by t-Student 
test were conducted as statistical analyses at a confidence level of 95 % (p < 0.05). Additionally, 
correlation coefficients (r) were calculated to evaluate the relation between the antibacterial 
effect and the drug release. 
In-vitro biocompatibility assays: cell adhesion and proliferation 
MDCK, and VERO cells were cultured in Dulbecco’s modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine 
at 37ºC in a humidified atmosphere with 5% CO2 and 95% air. The culture medium was changed 
every two days and, for sub-culture, cell monolayers were rinsed with phosphate buffered saline 
(PBS) and detached by incubation with trypsin-EDTA (0.25%) at 37ºC for 2-5 min. Cell 
concentration was determined by counting with a Neubauer camera using 4% trypan-blue as 
dye vital. Detached cells with viability ≥ 95% were used for biocompatibility assays. 
Unloaded and drug-loaded PLA electrospun microfibers were cut into square pieces (10  x 10 x 
0.1 mm3). These samples were placed into the wells of a multi-well culture plate and sterilized 
by UV-radiation in a laminar flux cabinet for 15 min. To fix the samples in the well, a small 
drop of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, 
France) was used as the adhesive. Samples were incubated in 1 mL of the culture medium under 
culture conditions for 30 min to equilibrate the material. Finally, the medium was aspired and 
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the material was evaluated for cell adhesion and proliferation by exposing cells to direct contact 
with the material surface. 
To assess cell adhesion, aliquots of 50-100 µL containing 5x104 cells were seeded onto the 
electrospun scaffolds placed in the wells. The plate was incubated in culture conditions for 30 
min to allow cell attachment to the material surface. Then, 1 mL of the culture medium was 
added to each well and the plate was incubated for 24 h. Finally, cell viability was determined 
by the MTT assay. Positive controls were performed on unloaded PLA electrospun scaffolds 
by cell culture, whereas those loaded with 3 w/v-% of TCS were used as negative controls. 
Cell proliferation was evaluated by a similar procedure to the adhesion assay, but the aliquot of 
50-100 µL contained 2x104 cells. The cultures were maintained for 7 days to allow cell growth 
and adequate cell confluence in the well. The medium were renewed every two days. Finally, 
cell viability was determined by the MTT assay. 
Each sample was evaluated using five replicates and the results were averaged and graphically 
represented. The statistical analysis was performed by one-way ANOVA to compare the means 
of all groups; t-Student test was then applied to determine a statistically significant difference 
between two studied groups. The tests were performed with a confidence level of 95% (p < 
0.05). 
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4.2.3 Results and Discussion 
Morphology of PLA Multifunctional Electrospun Scaffolds  
The success of electrospinning process requires strict control of the operational parameters of 
each polymer (e.g., strength of the applied electrical field, tip-collector distance and flow rate) 
and solution properties (e.g., viscosity, surface tension, dielectric constant, volatility, and 
concentration).[29-31] Selection of an appropriate solvent system is probably one of the most 
crucial points, especially when compounds of highly different characteristics (e.g., polylactides 
samples and the above selected drugs) must be electrospun.[32] Note, for example, the large 
difference between reported Hildebrand parameters for PLA[33] (i.e., 9.87 (cal·cm-3)0.5) and 
TCS[34] (i.e., 14.38 (cal·cm-3)0.5). In addition, a relatively high polymer concentration is required 
to avoid formation of drops or beads[35] and obtain continuous fibers in a micrometer scale, 
which appears more appropriate for sustained drug release. These factors made us select a 
chloroform:acetone:dimethylsulfoxide mixture with a 6:3:1 v/v/v ratio, specifically, the two first 
solvents were appropriate to obtain PLA electrospun microfibers,[24] whereas the third solvent 
was essential to allow dissolution of the three selected drugs (TCS, CUM and KTP).  
With regard to operational parameters, the selection of the spinning voltage (15 kV) was 
essential to ensure a stable, conical liquid jet which minimized bead formation. The distance 
between the target and the syringe tip was kept close to 12.5 cm, and the flow rate was found 
to be drastically affected by the viscosity of the final solution. Thus, a flow rate of 10 mL·h-1 
was chosen except when the three drugs dissolved simultaneously. In this case, it was necessary 
to reduce the flow rate to 5 mL·h-1 due to increased viscosity of the final solution.  
Figure 4.2.2 shows low magnification SEM images of electrospun fibers obtained under the 
selected conditions for the different PLA grades and loaded drugs (in particular, single, binary 
and ternary drug-loaded scaffolds with CUM as a common drug). Analysis of these images 
revealed that ﬁbers had a unimodal Gaussian diameter distribution (Figure 4.2.3) with average 
diameters between 1.7 µm and 3.8 µm, as summarized in Table 4.2.1.  
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FIGURE 4.2.2 
Low magnification SEM micrographs of PLA 2002D + CUM (a), PLA 4032D + CUM (b), PLA 2002D 
+ TCS/CUM (c), PLA 4032D + TCS/CUM (d), PLA 2002D + KTP/CUM (e), PLA 4032D + TCS/CUM 
(f), PLA 2002D+ TCS/KTP/CUM (g) and PLA 4032D+ TCS/KTP/CUM (h) samples. 
FIGURE 4.2.3 
Diameter distribution for electrospun PLA + CUM (a), PLA + KTP/CUM (b), PLA + TCS/CUM (c) and 
PLA + TCS/KTP/CUM (d) microfibers.  
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TABLE 4.2.1. Diameters of unloaded and drug loaded 
electrospun PLA fibers. 
Sample Diametera,b (m) 
PLA 2002D 1.86 ± 0.06 
PLA 4032D 1.66 ± 0.05 
PLA 2002D + CUM 3.85 ± 0.01 
PLA 4032D + CUM 2.14 ± 0.03 
PLA 2002D + TCS/CUM 3.23 ± 0.01 
PLA 4032D + TCS/CUM 1.92 ± 0.06 
PLA 2002D + KTP/CUM 2.28 ± 0.01 
PLA 4032D + KTP/CUM 1.82 ± 0.03 
PLA 2002D + TCS/KTP/CUM 2.54 ± 0.01 
PLA 4032D + TCS/KTP/CUM 1.70 ± 0.01 
aFibers were obtained using the following electrospinning operational parameters: applied 
voltage of 15 kV, tip-collector distance of 12.5 cm and flow rate of 10 mL·h-1 except for 
ternary drug-loaded fiber that decreased to 5 mL·h-1. 
bMean value ± standard deviation.  
The observed variations in the diameter size can be summarized as follows: a) Microfibers 
prepared from the more stereoregular PLA 4032D sample always had smaller diameters than 
determined for PLA 2002D compared to fibers with a similar drug load, b) incorporation of 
CUM gave rise to a significant diameter increase (e.g., from 1.93 to 3.80 mm and from 1.79 to 
2.26 m for single drug-loaded PLA2002D and PLA 4032D samples, respectively), which 
seems more significant when the more amorphous PLA grade was employed. c) binary drug-
loaded samples showed a diameter decrease compared to single drug-loaded fibers, with the 
effect being less pronounced upon addition of TCS. Note, however, that the percentage of 
loaded TCS was higher than that of KTP (i.e. 3 w/v-% respect to 1 w/v-%) and d) the diameter 
of ternary drug-loaded samples increased compared to unloaded samples, as above indicated, 
but the trend was not clear since flow rate conditions were changed. In summary, the presence 
of drugs modified the physicochemical characteristics of the dissolution (e.g., viscosity was 
seriously affected for ternary TCS/KTP/CUM loaded mixtures in such a way that the flow rate 
had to be modified) and influenced the morphology of electrospun samples significantly even 
when processed under the same set of operational parameters. 
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Texture of microfibers was slightly different depending on the loaded drugs, as shown in the 
high magnification SEM micrographs of Figure 4.2.4. In general, microfibers had a porous 
structure, as is also commonly observed in unloaded PLA electrospun fibers.[35] The presence 
of longitudinal striations was also usual in most samples (Figure 4.2.4, see red arrows). 
Surfaces became smoother when TCS was loaded since pores were less defined in the ternary 
drug-loaded systems (Figures 4.2.4 g and 4.2.4 h) and even difficult to detect in the binary 
drug-loaded fibers (Figure 4.2.4 c and 4.2.4 d). CUM loaded samples were also characterized 
by the presence of embedded crystals (withe arrows), which highlighted the difficulty of p-
coumaric molecules to mix with the PLA matrix. Nevertheless, these crystals were hardly 
detected in the ternary drug-loaded systems although their fiber usually had the lowest diameter 
values. This may be an indication of improved mixing with PLA in the presence of the other 
two drugs (TCS and KTP). 
FIGURE 4.2.4 
High magnification SEM micrographs of PLA 2002D + CUM (a), PLA 4032D + CUM (b), PLA 2002D 
+ TCS/CUM (c), PLA 4032D + TCS/CUM (d), PLA 2002D + KTP/CUM (e), PLA 4032D + TCS/CUM 
(f), PLA 2002D+ TCS/KTP/CUM (g) and PLA 4032D+ TCS/KTP/CUM (h) samples. Red arrows pointed 
out longitudinal striations wheres CUM crystals are indicated by withe arrows. 
FTIR Analysis of Electrospun Drug Loaded Samples 
PLA is a semicrystalline polymer that exhibits polymorphism, with different crystalline 
arrangements depending on the crystallization conditions having been described.[26] Usually, 
the polymer crystallizes in a 107 helical conformation that gives rise to the so-called -,[36-38] 
’-[39] and ’’-[40] forms and the -crystals[41] when the polymer is complexed with solvents like 
dimethylformamide. Furthermore, PLA can adopt a 32 molecular conformation, as reported for 
and  structures prepared by stretching or by epitaxial crystallization. Nevertheless, 
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PLA hardly crystallizes under usual processing conditions, and therefore no crystallization 
peaks are usually observed in DSC cooling traces from the melt or even during a subsequent 
heating run. Thus, commercial semicrystalline samples are obtained after subjecting samples to 
an annealing process which favors crystallization. It has been reported that the electrospinning 
technique facilitates molecular orientation, hence, the derived microfibers can be easily cold 
crystallized during a subsequent heating run. This final molecular orientation should depend on 
solution properties like viscosity, operational parameters (e.g., flow rate and applied voltage), 
diameter of electrospun fibers and even the presence of drugs that could act as nucleating 
agents.[24] 
FTIR spectroscopy can give information on molecular conformation and crystallinity although 
interpretation is difficult for PLA due to its different molecular conformations and packing 
arrangements. Nevertheless, several observation can made: a) The absorbance of the carbonyl 
band around 1753 cm-1 has a smaller correlation with conformational changes of the main chain. 
Hence, this band can be used as the reference band to correct absorbance fluctuations due to 
differences in scaffold thickness,[45] b) comparison between absorbance of bands at 1263 cm-1 
((CH) + (C-O-C) for a random conformation) and 1209 cm-1 (as (C-O-C) + ras(CH3) for a 
107 helical conformation) has been reported to be highly relevant because bands should decrease 
and increase, respectively, when molecules adopt the more ordered helical conformation,[46] c) 
relative intensities between bands at 1385 cm-1 (s(CH3), amorphous form) and 1363 cm-1 ( 
(CH), semycrystalline form) and bands at 1134 cm-1 (rs(CH3)) and 1092 cm-1 (as(C–O–C)) 
changed upon annealing of samples (i.e. when crystallinity increased). Specifically, the relative 
intensity of bands at 1363 cm-1 and 1134 cm-1 was increased[47] and d) the 921 cm−1 absorption 
band is characteristic of the -form and corresponds to the coupling of C-C backbone with CH3 
rocking.[48] 
Figure 4.2.5 compares the FTIR spectra (1800-900 cm-1) of the two PLA electrospun samples 
and the PLA 4032D sample loaded with the different combinations of drugs. No significant 
differences (not shown) were detected between spectra of samples from the two PLA matrices 
independently of the loaded drugs. Therefore, the difference in stereoregularity (i.e. from 2 to 
4.2 wt-% of D-lactide) was smaller than spectral sensitivity to chain randomness. On the 
contrary, spectra of both PLA 2002D (not shown) and 4032D samples showed significant 
changes with respect to the above indicated b-d points which clearly suggested an increase of 
crystallinity and the ratio of the 107 helical conformation when, for example, PLA 2002D fibers 
were simultaneously loaded with different drugs (i.e. a decrease of 1263 cm-1 band and an 
increase of 1363. 1209, 1134 and 921 cm-1 bands were observed for all loaded samples except 
the single CUM loaded sample). 
FTIR spectrum was sufficiently sensitive to detect the presence of drugs despite the low amount 
loaded. Basically, multiple peaks were observed in the 1670-1470 cm-1 range where bands 
associated to carbonyl groups and aromatic rings should appear. These rings were common for 
the three loaded drugs (Figure 4.2.1) and consequently additional signals detected in the spectra 
of drug-loaded scaffolds were always quite similar (i.e. circles in Figure 4.2.5). 
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FIGURE 4.2.5 
FTIR spectra (1800-900 cm-1 region) of PLA 2002D, PLA 4032D, PLA 2002D + CUM, PLA 2002D + 
TCS/CUM, PLA 2002D + KTP/CUM and PLA 2002D + TCS/KTP/CUM scaffolds.  
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Thermal Analysis of Electrospun Drug Loaded Samples 
The slight difference on the D-lactide content (i.e. 4.2 wt-% compared to 2.0 wt-%) affected 
thermal properties significantly, as depicted in Table 4.2.2 for the commercial pellet samples, 
which were expressly subjected to an annealing process to increase crystallinity. DSC heating 
traces of the corresponding electrospun scaffolds (Figures 4.2.6 a and 4.2.6 b) revealed again 
differences between the two PLA grades and also interesting consequences of the different 
processing methods. Thus, after electrospinning samples became practically amorphous but 
could be easily cold crystallized during a subsequent heating run, reaching typical crystallinity 
values of commercial annealed samples. A cold crystallization peak was hardly observed in the 
heating run of samples cooled from the melt state (i.e. not subjected to a specific annealing 
treatment), as also previously reported.[24, 49] Therefore, the capability of the electrospinning 
technique to render highly aligned and oriented molecules able to easily cold crystallize has 
been postulated by different authors.[24, 49] 
FIGURE 4.2.6 
DSC heating runs (20 ºC·min-1) of PLA 2002D (a), PLA4032D (b), PLA 2002D + TCS/KTP/CUM (c) 
and PLA 4032D + TCS/KTP/CUM (d) electrospun scaffolds.  
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DSC heating runs of drug-loaded samples are more complex, especially those of ternary drug-
loaded systems (Figures 4.2.6 c and 4.2.6 d). The main thermal characteristics deduced from 
the different loaded scaffolds (summarized in Table 4.2.2) allow the following general remarks 
to be made: 
 The glass transition temperature decreases compared to that observed for the 
corresponding unloaded scaffolds, suggesting a plasticizing effect caused by the 
incorporation of the small drug molecules. In addition, the enthalpic relaxation peak 
tended to be supressed, in contrast with unloaded samples. Therefore, the compact 
arrangement characteristic of an equilibrium condition is less favored. 
 The melting peak temperature decreases dramatically compared to the value of 
unloaded scaffolds. Furthermore, this decrease is more and less significant for ternary 
and single drug-loaded scaffolds, respectively. In addition, multiple peaks could be 
observed for the more complex loaded systems. These features suggest that drugs can 
be partially incorporated into the crystalline structure and even led to different degrees 
of perfection. It should be pointed out that the melting peaks could only be associated 
with the PLA polymer matrix because the melting temperatures of TCS and KTP were 
lower (55-57 ºC and 93-96 ºC, respectively), whereas p-coumaric acid melted at a 
clearly higher temperature (i.e, 208-217 ºC). 
 Binary and ternary drug-loaded systems became highly crystalline after the 
electrospinning process. Note the reduced cold crystallization enthalpy and the high 
melting enthalpy (i.e. the relatively high Hm - Hc values). The degrees of 
crystallinity are clearly higher than determined from unloaded samples, suggesting a 
nucleating effect of incorporated drugs. This effect was more pronounced when the 
more regular PLA 4032D sample is used. Logically, all studied samples showed a 
degree of crystallinity after cold crystallization slightly lower than determined for the 
commercial annealed samples. The temperature of the cold crystallization peak tends 
to diminish for drug-loaded samples, suggesting again a nucleating effects of drugs. 
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Drug Release from Binary and Ternary Drug Loaded PLA Electrospun Scaffolds  
Drug release from electrospun fibers in a given medium is intimately related to their 
morphology and crystallinity and to possible intermolecular interactions between drugs and the 
polymer matrix. Therefore, a quantitative release study was performed considering both PLA 
2002D and PLA 4032D matrices and single, binary and ternary drug-loaded systems. According 
to our previous studies, we selected a phosphate buffer saline (PBS) supplemented with ethanol 
(PBS:EtOH 3:7 v/v) 70%) to facilitate the delivery of highly hydrophobic molecules such as 
TCS, KTP and CUM and avoid the establishment of equilibrium conditions that typically limit 
their release when only PBS is employed.[23] 
Figures 4.2.7 a and 4.2.7 b show the release peofile of CUM from the single drug-loaded PLA 
2002D and PLA 4032D scaffolds, respectively. It can be observed that a higher release 
percentage was attained from the less stereoregular PLA matrix (i.e., 80% compared to 60%), 
indicating that CUM was better retained in the presence of polymer crystalline domains. In any 
case, the release of CUM was very fast and reached values of 60-50% after only one hour of 
exposure to the medium. 
Figures 4.2.7 c-4.2.7 h show the release profiles of TCS, KTP and CUM drugs in the binary 
and ternary drug-loaded systems. The following observation can be made: a) The release 
profiles for a given scaffold are similar for the three dugs independently of the PLA grade and 
the kind of system (binary or ternary), b) the maximum release percentage is always greater 
from PLA 2002D scaffolds than from the corresponding PLA 4032D scaffolds; c) release 
percentages increase slightly when more drugs were simultaneously loaded in PLA 4032D 
scaffolds (i.e., 60%, 60-70% and 80% for CUM in single, binary and ternary drug-loaded 
scaffolds, respectively), whereas percentages remain practically constant for PLA 2002D 
scaffolds. It seems that a slight synergic effect and the release are increased in complex systems 
and matrices that had higher encapsulation efficiency (e.g., PLA 4032D). This is interesting 
since it suggests that binary and ternary drug-loaded scaffolds have greater availability for their 
local action in the host tissue. 
Release rates can be quantitatively compared considering postulated theoretical kinetic models 
in order to fit the experimental release profiles. Release generally occurs in two different steps, 
with the fast release initially observed (0-60%) being well-described by the Higuchi Equation 
1:[52, 53] 
Mt ⁄ M0 = kH t(1⁄2)    (0 ≤ Mt ⁄ M0 ≤ 0.6)     (1) 
where kH is the Higuchi release constant, Mt is the percentage of drug released at time t and M0 
is the drug equilibrium percentage (considered as the maximum drug percentage). 
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FIGURE 4.2.7 
Release curves in a PBS:EtOH medium of CUM (a,b), TCS/CUM (c,d), KTP/CUM (e,f) TCS/KTP/CUM 
(g,h) drug loaded PLA 2002D (a,c,e,g) and PLA 4032D (b,d,f,h) electrospun scaffolds. 
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Table 4.2.3 summarizes the values of kH determined for CUM from the loaded scaffolds. The 
results show small differences in the release rate but no specific trend linked to the degree of 
crystallinity, fiber diameter and complexity of the system (single, binary or ternary) can be 
derived, probably due to the multiple factors with different impact on molecular diffusion that 
are involved.  
TABLE 4.2.3. Higuchi kinetic constant and correlation factor for the first part (0-
60%) of the CUM release from the different loaded scaffolds. 
Sample kH (h-0.5) r 
PLA 2002D + CUM 0.76 0.989 
PLA 4032D + CUM 0.69 0.990 
PLA 2002D + TCS/CUM 0.57 0.990 
PLA 4032D + TCS/CUM 0.72 0.986 
PLA 2002D + KTP/CUM 1.07 0.991 
PLA 4032D + KTP/CUM 0.89 0.982 
PLA 2002D + TCS/KTP/CUM 0.41 0.985 
PLA 4032D + TCS/KTP/CUM 0.67 0.998 
 
Antibacterial Properties of Single, Binary and Ternary CUM Loaded 
Multifunctional Electrospun Scaffolds 
Bacterial growth curves for E.coli (Figures 4.2.8 a and 4.2.8 b) and M.luteus (Figures 4.2.8 c 
and 4.2.8 d) in the presence of unloaded and single, binary and ternary drug-loaded scaffolds 
of PLA 2002D and PLA 4032D were evaluated as an indication of the bactericide activity of 
loaded matrices. 
Results clearly indicate that bacterial growth was inhibited for both binary and ternary TCS-
loaded scaffolds. This is a consequence of the well-known ability of TCS to block the active 
site of the enol-acyl carrier protein reductase enzyme, which is essential in the synthesis of fatty 
acids in bacteria.[54] Thus, after 24 hours of culture, E.coli and M.luteus bacterial growths were 
8-10% and 10-12% of the corresponding growths determined for the positive control, 
respectively. Curves were essentially independent of the polymer matrix and the additional 
incorporation of CUM and KTP drugs. It seems that sufficient release was achieved by the high 
TCS content of scaffolds (i.e. 3 w/v-%) to inhibit bacterial growth. Also, this effect could not 
be improved by the presence of the other two drugs and was not influenced by morphologic and 
crystallinity changes of electrospun scaffolds. 
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FIGURE 4.2.8 
Relative growth of Escherichia coli (a,b) and Micrococcus luteus (c,d) on binary and ternary drug-loaded 
PLA 2002D (a,c) and PLA 4032D (b,d) electrospun scaffolds.  
Figure 4.2.8 also shows typical bacterial growth curves for single CUM-loaded scaffolds. Thus, 
after an initial lag phase (4-5 hours), an exponential phase associated with binary fission was 
observed during which Gram-negative and Gram-positive bacterial growth stopped at a value 
close to 90% with respect to that found for the positive control. More interestingly, the binary 
KTP/CUM-loaded scaffolds showed moderate inhibition that was slightly dependent on the 
PLA grade and the type of bacteria. Specifically, growth percentages decreased compared to 
the positive control to 40% and 50% for Gram-negative bacteria grown on matrices based on 
PLA 2002D and PLA 4032D, respectively, and to 50% and 60% for Gram-positive bacteria 
grown on matrices based on PLA 2002D and PLA 4032D, respectively. From these results two 
conclusions can be drawn: a) KTP has a bacteriostatic effect with a not yet fully clarified 
mechanism,[55, 56] and b) the less stereoregular PLA matrix has a higher inhibition effect, in 
agreement with the enhanced drug release (Figures 4.2.8 c and 4.2.8 d). 
Bactericide activity was also evaluated by quantification of bacterial adhesion, as shown in 
Figure 4.2.9. Single CUM-loaded scaffolds had a similar percentage of bacterial adhesion than 
the positive control, as expected from the bacterial growth results. In the same way, practically 
complete inhibition of bacterial adhesion was found for TCS/CUM and TCS/KTP/CUM loaded 
scaffolds. Intermediate adhesion values f were obtained for binary KTP/CUM-loaded scaffolds, 
with significant differences again being observed depending on the PLA grade. Thus, adhesions 
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of 40% and 70% were determined for PLA 2002D (Figure 4.2.9 a) and PLA 4032D (Figure 
4.2.9 b) scaffolds. The higher percentage found for the latter is in agreement with the differences 
in the release and bacterial growth. Adhesion results were similar for both Gram-negative and 
Gram-positive bacteria.  
FIGURE 4.2.9 
Escherichia coli (blue) and Micrococcus luteus (pink) adhesion on polystyrene plate as positive control 
and binary and ternary drug-loaded PLA 2002D (a) and PLA 4032D (b) electrospun scaffolds (*p<0.05 
vs. control, Tukey’s test).  
Cell Viability on Single, Binary and Ternary CUM Loaded Multifunctional 
Electrospun Scaffolds 
Figure 4.2.10 illustrates cell adhesion and proliferation behavior of two epithelial cell lines 
(MDCK and VERO) in loaded PLA 2002D and PLA 4032D electrospun scaffolds. A good cell 
response was expected for CUM and KTP according to their antioxidant and anti-inflammatory 
activity, respectively. MDCK and VERO cell lines were selected for their epithelial 
morphology and typical adherent grown which leads to formation of cell monolayers highly 
sensitive to cell damage due to their flake detachment from the culture plate. 
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FIGURE 4.2.10 
Adhesion (a,b) and proliferation (c,d) of MDCK (blue) and VERO (red) cells on polystyrene plate as 
positive control and TCS, CUM, TCS/CUM, KTP/CUM and TCS/KTP/CUM PLA 2002D (a,b) and PLA 
4032D (c,d) electrospun scaffolds from PLA 2002D and 4032D grades (†p<0.05; ‡p<0.01 vs. positive 
control, ANOVA-Tukey’s test). 
Scaffolds loaded with 3 w/v-% of TCS were used as negative control since this concentration 
was previously found to be cytotoxic for loaded PLA scaffolds.[24] Cell adhesion on these 
scaffolds decreased to 20-30% compared to unloaded PLA scaffolds (positive control) after 24 
h of culture. Note that this significant difference (p < 0.001) was independent of the PLA grade 
(Figures 4.2.10 a, and 4.2.10 b). It is highly interesting that incorporation of CUM reduced cell 
damage caused by TCS and favored cell viability. Thus, cell adhesion on binary TCS/CUM-
loaded scaffolds was increased by ca. 30% with respect to the negative control. Anti-
inflammatory KTP had a similar, additive effect. In this way, cell adhesion on ternary 
TCS/KTP/CUM-loaded scaffolds clearly increased and reached the same values as positive 
unloaded scaffolds and also as single drug-loaded PLA scaffolds (Figures 4.2.10 a and 4.2.10 
b). 
Adhered cells kept their proliferative activity and ultimately were able to colonize the material, 
forming a monolayer tissue. Figures 4.2.10 c and 4.2.10 d shows the quantification of cell 
growth, which was clearly related to the previous cell adhesion event. The cytotoxic effect of 
TCS can be reverted by the renewal of culture medium. Thus, cell viability increased, as 
demonstrated by values of 40% and 50% determined with respect to the unloaded scaffolds 
  
  
145 
CHAPTER 4.2 
after 7 days of culture, which were higher that the above adhesion percentages. Nevertheless, 
viability was still significantly lower (p < 0.01) than determined for the control. Again, positive 
effects on cell proliferation (p > 0.95) were found for binary TCS/CUM-scaffolds compared to 
the negative TCS-loaded control, resulting in an increase cell viability up to 80%. This 
represents an increase close to 30% with respect to the viable cells measured in single TCS-
loaded scaffolds. Cell proliferation in ternary TCS/KTP/CUM-loaded scaffolds was similar to 
that of positive controls, as expected from the cell adhesión results, demonstrating that cell 
damage caused by TCS could be neutralized by the positive effect on cell viability caused by 
the incorporation of CUM and KTP. Finally, it should be indicated that no significant 
differences were observed between scaffolds prepared from the two PLA grades despite slight 
differences on drug release. 
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4.2.4 Conclusions 
Bactericide, anti-inflammatory and antioxidant drugs like triclosan, ketoprofen and p-coumaric 
acid, respectively, could be simultaneously loaded into PLA microfibers by the electrospinning 
technique. Porous and continuous microfibers with an unimodal diameter distribution could be 
prepared from a 10 w/v-% solution of PLA in a chloroform:acetone:dimethylsulfoxide mixture 
and using electrospinning parameters of 15 kV, 12.5 cm and 5-10 mL·h-1 for voltage, tip-
collector distance and flow rate, respectively. 
Electrospun scaffolds had highly variable crystallinity which depended slightly on the PLA 
grade (at least when D-lactide content varied only from 4.2 to 2.0 wt-%) and strongly on the 
incorporation drugs. Thus, drugs seemed to produce a nucleating effect that, in some cases, led 
to crystallization levels of commercial annealed samples even for binary drug-loaded systems. 
Drug-loaded scaffolds also showed a decrease in the glass transition temperature that favored 
molecular diffusion processes and a decrease in the melting temperature as a consequence of 
incorporation of drugs in amorphous and crystalline phases, respectively. 
The three drugs were released in a similar and fast way from a given scaffold (i.e. for a selected 
PLA matrix and a single, binary or ternary drug-loaded system) in a PBS:ethanol medium that 
mimics a typical serum supplemented PBS medium. In all cases, a significant amount of drug 
was retained inside PLA microfibers, especially the more relevant when the more stereoregular 
polymer. The entrapping efficiency of PLA was limited and the release of a specific drug 
seemed to increase with the complexity of the system (i.e. from single to ternary drug-loaded 
scaffolds), suggesting a synergic effect. New multifunctional scaffolds appear highly interesting 
since, besides imparting their expected and specific properties (i.e., antioxidant and anti-
inflammatory), KTP and CUM can neutralize the cytotoxic effect caused by a moderate/high 
triclosan load. In summary, multifunctional PLA scaffolds with both high cell viability and 
protection against microorganism can be easily prepared by the electrospinning technique.  
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PLA Scaffolds Incorporating Bactericide 
Polybiguanide (PHMB) 
 
Polyhexamethylenebiguanide hydrochloride (PHMB), 
a low molecular weight polymer related to 
chlorohexidine (CHX), is a well-known antibacterial 
agent. In this study, polylactide (PLA) nanofibers 
loaded with PHMB were produced by electrospinning 
to obtain 3D biodegradable scaffolds with 
antibacterial properties. PLA fibers loaded with CHX 
were used as control. The electrospun fibers were 
studied and analyzed by SEM, FTIR, DSC and contact 
angle measurements. PHMB and CHX release from 
loaded scaffolds was evaluated, as well as their 
antibacterial activity and biocompatibility. The results 
showed that the nanofibers became smoother and their 
diameter smaller with increasing the amount of loaded 
PHMB, which also led to increased hydrophobicity of 
scaffolds due to the increase in scaffold surface 
roughness. PHMB release was highly dependent on 
the hydrophilicity of the medium and differed from that 
determined for CHX. Lastly, PHMB-loaded PLA 
scaffolds showed antibacterial properties since they 
inhibited adhesion and bacterial growth, and 
exhibited biocompatible characteristics for the 
adhesion and proliferation of both fibroblast and 
epithelial cell lines. 
 
5.1 
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5.1.1 Introduction 
Topical formulations containing antimicrobial agents (e.g., mouthwashes, gels or toothpastes) 
are commonly used for the treatment of infections and burn injuries.[1-3] These formulations 
ensure direct access of high concentrations of the antimicrobial agent to the site of infection. 
The agent acts locally or systematically inhibiting microorganism growth around the wound, 
reducing the probability of resistance development, minimizing deleterious host responses, and 
reducing the risk of environmental pollution.[4-6] 
Several compounds have been extensively studied for their antibacterial activity, with 
benzalkonium chlorides, cetylpyridinium chloride, aldehydes, anilides, diamidines and silver 
being the most representative examples.[7-9] Biguanide, commonly known as chlorhexidine (1,1′-
hexamethylene- bis-5-(4-chlorophenyl) biguanide, CHX), is also a widely employed 
antimicrobial agent.[10] Specifically, CHX is an important antiseptic, disinfectant, 
pharmaceutical and cosmetic preservative and antiplaque agent. The high activity of this drug 
towards microorganisms is due to the presence of secondary amines that can be protonated, and 
therefore positively charged under normal pH conditions.[11] Immobilized antimicrobial agents 
offer an alternative which eliminates patient exposure to active agents and potentially increases 
the duration of antimicrobial efficacy.[12, 13] Agents can be immobilized on a wide variety of 
materials including metals and plastics, as well as natural and man-made fabrics such as 
electrospun scaffolds (specifically, inside constituent micro/nanofibers). 
Additional advantages of biguanide compounds are related to their ability to form quadricovalent 
cationic complexes with silver ions which are stable in ambient conditions. In this way, a 
synergic effect can be derived from the combination of biguanide and silver antimicrobial 
activities.[1] 
Other chemical compounds also bearing biguanide groups, such as 
polyhexamethylenebiguanide hydrochloride (PHMB), have been developed.[14, 15] Specifically, 
PHMB is a cationic oligomer having with a average of 7-11 biguanide groups spaced by flexible 
hexamethylene segments. PHMB has chemical stability, low toxicity, high effectiveness against 
microorganisms and reasonable cost.[16, 17] Gilbert et al. demonstrated that activity increased 
with the number of biguanide groups and that maximum biocidal efficiency was obtained when 
the hexamethylene group was employed as spacer.[18, 19] 
In a recent paper, Koburger et al.[20] compared the antiseptic efficacy of several antibacterial 
agents such as triclosan, octenidine, PHMB, PVP-Iodine and chlorhexidine digluconate, 
concluding that PHMB was the best antiseptic in prolonged use. PHMB action against 
microorganisms was described as a consequence of its binding to the negatively charged 
phosphate head groups of phospholipids at the bacterial cell wall. Binding increased rigidity, 
sank non-polar segments into hydrophobic domains, and disrupted the membrane with 
subsequent cytoplasmic shedding that culminated in cell death.[18, 19] 
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Recently, micro/nanofiber nonwoven membranes produced by electrospinning have shown great 
potential in applications such as biomedical devices (e.g., scaffolds for tissue engineering) due 
to their typically high surface area and porosity. Furthermore, the unique properties of 
electrospun fibers have triggered a broad range of other potential applications, including 
composites, sensors, protective clothing, filtration membranes, magneto-responsive fibers and 
superhydrophobic membranes.[4] In addition, the electrospinning process provides a simple way 
to encapsulate drugs within a micro/nanofiber matrix that can lead to a controlled and sustained 
release. 
Several natural and synthetic biodegradable polymers have been successfully electrospun (e.g., 
polyglycolide,[21] polylactide,[21, 22] polycaprolactone,[23] collagen[24, 25] and chitosan[25, 26]). 
Polylactide (PLA) is one of the most widely used materials in biomedical applications due to the 
combination of interesting characteristics like tunable mechanical properties, degradation into 
natural metabolites, biocompatibility and low cost. Thus, biodegradable polymers containing 
active ingredients, such as antimicrobials and antibiotics, were also studied in wound dressing 
materials to protect against contaminations and infections.[27, 28] Specifically, PHMB has been 
employed as a highly effective antimicrobial agent for composites of cellulose acetate and 
polyester urethane.[29] The reported results have opened highly interesting perspectives for the 
use of PHMB in biomedical applications where a rapid release in hydrophilic systems is desired. 
In this study, the antimicrobial PHMB agent was incorporated into electrospun PLA 
micro/nanofibers to evaluate the potential application of these materials as temporary and 
medicated scaffolds. For this purpose, electrospinning conditions were optimized, morphology 
of micro/nanofibers studied and physicochemical characterization of scaffolds performed. 
Release kinetics, antimicrobial activity against Gram negative and positive bacteria (i.e. E. coli 
and M. luteus) and biocompatibility were also evaluated. 
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5.1.2 Experimental Section 
Materials 
Polylactide (PLA), a product of Natureworks (polymer 2002D), was kindly supplied by Nupik 
International (Polinyà, Spain). According to the manufacturer, this PLA has a D content of 
4.25%, a residual monomer content of 0.3%, a density of 1.24 g·cc-1, a glass transition 
temperature (Tg) of 58 ºC and a melting point of 153 ºC. 
All solvents, clorhexidine (CHX), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) and cell culture labware were purchased from Sigma-Aldrich (Spain). 
Cosmocil® (polyhexamethylenebiguanide hydrochloride, PHMB) was kindly provided by B. 
BRAUN Surgical S.A. The microbial culture was prepared with reagents and labware from 
Scharlab (Spain). 
Escherichia coli CECT 101 and Micrococcus luteus CECT 245 bacterial strains were obtained 
from Spanish Collection of Type Culture (Valencia, Spain). MDCK (Madin-Darby canine 
kidney) epithelial cells and MRC5 (human fetal lung fibroblast) cells were purchased from 
ATCC (USA). 
Electrospinning 
Mixtures of PLA with CHX or PHMB were electrospun from chloroform/acetone mixtures (1:2 
v/v) supplied with formic acid (10:1 v/v). PLA concentration in the solution was 10 w/v-%, 
whereas CHX and PHMB concentrations were 0.5 w/v-% and 0.02-0.25 w/v-%, respectively. 
Thus, processed fibers should contain 5 and 0.2-2.5 wt-% of CHX and PHMB, respectively. 
Samples will be named using the drug abbreviation and percentage, i.e. PLA-CHX 5 and PLA-
PHMB 2.5 correspond to PLA scaffolds loaded with 5 and 2.5 wt-% of CHX and PHMB, 
respectively. 
Electrospun fibers were collected on a target placed at different distances (10-25 cm) from the 
needle tip (inside diameter of 0.84 mm). The voltage was varied between 10 and 30 kV and 
applied to the target using a high-voltage supply (Gamma High Voltage Research, ES30-5W). 
Polymer solutions were delivered via a KDS100 infusion syringe pump (KD Scientific, USA) 
to control the mass-flow rate (from 0.5 to 10 mL·h-1). All electrospinning experiments were 
carried out at room temperature. Electrospun unloaded and CHX and PHMB loaded fibers were 
prepared using optimized parameters (e.g., height, voltage and flow) and solvent conditions 
(e.g., solvent ratio, and polymer and drug concentration). 
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Morphology and properties of electrospun PLA-CHX and PLA-PHMB mixtures 
Optical and scanning electron microscopy 
Optical microscopy studies were performed with a Zeiss Axioskop 40 microscope. Micrographs 
were taken with a Zeiss AxiosCam MRC5 digital camera. 
Detailed inspection of texture and morphology of electrospun samples was conducted by 
scanning electron microscopy using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, 
Germany). Carbon coating was accomplished by using a Mitec K950 Sputter Coater fitted with 
a film thickness monitor k150x. Samples were visualized at an accelerating voltage of 5 kV. 
Diameter of electrospun fibers was measured with the SmartTiff software from Carl Zeiss SMT 
Ltd. 
Fourier transform infrared spectroscopy (FTIR) 
Infrared absorption spectra were recorded with a Fourier Transform FTIR 4100 Jasco 
spectrometer in the 1850-950 cm-1 range. A Specac model MKII Golden Gate attenuated total 
reflection (ATR) equipment with a heated Diamond ATR Top-Plate was used. 
Differential scanning calorimetry (DSC) 
Calorimetric data were obtained by differential scanning calorimetry with a TA Instruments 
Q100 series equipped with a refrigeration cooling system (RCS). Experiments were conducted 
under a flow of dry nitrogen with a sample weight of approximately 5 mg and calibration of 
equipment was performed with indium. Heating runs were carried out at a rate of 20 ºC·min-1. 
Contact angle (CA) 
Contact angles (CA) were measured at room temperature with sessile drops using an OCA-15 
plus Contact Angle Microscope (Dataphysics, USA) and SCA20 software. Contact angle values 
of the right and left sides of distilled water drops were measured and averaged. Measurements 
were performed 10 s after the drop (5 L) was deposited on the sample surface. All CA data 
were an average of six measurements on different surface locations. 
Release experiments 
Controlled release measurements were made with square pieces (20 x 20 x 0.1 mm3) of the 
electrospun scaffolds. These pieces were weighed and incubated at 37 ºC in an orbital shaker at 
200 rpm in tubes of 50 mL for 1 week. PBS buffer (hydrophilic medium) and alternatively its 
mixture with different ratios of ethanol (i.e. 9:1 v/v, 5:5 v/v, 3:7 v/v and 1:9 v/v) as a more 
hydrophobic component were employed as release media. Drug concentration was evaluated by 
UV spectroscopy using a Shimadzu 3600 spectrometer. Calibration curves were obtained by 
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plotting the absorbance measured at 252 and 234 nm versus CHX and PHMB concentration, 
respectively, in the hydrophilic medium, whereas 261 (for CHX) and 236 nm (for PHMB) were 
considered when ethanol was added. Samples were withdrawn from the release medium at 
predetermined time intervals. The volume was kept constant by addition of fresh medium. All 
drug release tests were carried out using three replicates and the results were averaged. 
Antimicrobial test 
Escherichia coli (E. coli) and Micrococcus luteus (M. luteus) bacteria were selected to evaluate 
the antimicrobial effect of electrospun CHX and PHMB loaded fibers. The bacteria were 
previously grown aerobically to exponential phase in broth culture (5 g·L-1 beef extract, 5 g·L-1 
NaCl, 10 g·L-1 peptone, pH 7.2). 
Growth experiments were performed on a 24-well culture plate. Square pieces (10×10×0.1 mm3) 
of the electrospun scaffolds were placed into each well. Then, 1 mL of broth culture containing 
103 CFU was seeded on the electrospun fiber mats. The cultures were incubated at 37 ºC and 
agitated at 200 rpm. Aliquots of 50 L were taken at predetermined time intervals for absorbance 
measurement at 650 nm in a plate reader. Thus, turbidity was directly related to bacterial growth. 
Bacterial adhesion onto scaffolds was also determined. The culture media were aspirated after 
incubation and the material washed once with distilled water. Then, 0.5 mL of sterile 0.01 M 
sodium thiosulfate was added to each well. After addition of 4 mL of broth culture, the plate was 
incubated at 37 ºC and agitated at 200 rpm for 24 h. The bacterial number was determined as 
above indicated. All assays were conducted in triplicate and the results averaged. 
Scaffolds were fixed with 2.5 w/v-% formaldehyde at 4 ºC overnight. Then, they were washed 
three times with distilled water and Gram stained for observation by light microscopy. 
Cellular adhesion and proliferation assays 
MDCK and MRC-5 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) as 
previously reported.[30] Electrospun unloaded and drug loaded PLA scaffolds were collected on 
round coverslips (diameter 1.5 cm) that were placed into the wells of a multiwell culture plate. 
Samples were fixed in the wells with a small drop of silicone (Silbione® MED ADH 4300 RTV, 
Bluestar Silicones France SAS, Lyon, France) and then sterilized by UV-radiation in a laminar 
flux cabinet for 15 min. For the cell adhesion assay, aliquots of 50-100 µL containing 5x104 
cells were seeded onto the electrospun samples in each well and incubated for 24 h (adhesion 
assay) or 4 days (proliferation assay).  
Samples were evaluated by the standard adhesion and proliferation method[30] using five 
replicates and the results were averaged. Samples with adhered and grown cells on the mats were 
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fixed with 2.5 w/v-% glutaraldehyde at 4 ºC overnight. They were subsequently dehydrated and 
processed for observation by scanning electronic microscopy. 
Statistical analysis 
Values were averaged and graphically represented, together with their respective standard 
deviations. Statistical analysis was performed by one-way ANOVA test to compare the means 
of all groups, and then Tukey’s test was applied to determine a statistically significant difference 
between two groups. The test confidence level was set at 95% (p < 0.05). 
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5.1.3 Results and Discussion 
Electrospinning of PLA-CHX and PLA-PHMB Mixtures 
Several solvents and binary solvent mixtures were tested at different voltages, flow rates, 
polymer concentrations and needle tip-collector distances in order to determine the optimal 
conditions to obtain continuous fibers from all PLA-PHMB and PLA-CHX mixtures.  
In fact, the solvent plays a fundamental role in continuous micro/nanofiber production.[31, 32] A 
relatively high polymer concentration is typically required to avoid formation of droplets and 
electrospun beads when a good solvent is selected.[33] Because PLA is highly soluble in 
chloroform,[30, 34] it was selected as a starting point in the optimization of processing conditions. 
However, solubilization of CHX and PHMB required more hydrophilic solvents (e.g., DMSO, 
formic acid, water or ethanol). It is known that the alternating chemical structure of hydrophilic-
hydrophobic segments in PHMB can give rise to peculiar characteristics such as micelle 
formation in aqueous media with methylene segments pointing toward the center of the micelle 
and hydrophilic biguanide groups pointing outward. This arrangement was not found in solvents 
that establish lower interactions, for example ethanol.[16] Thus, the selection of an appropriate 
solvent system is crucial for a successful electrospinning process of the polymer loaded with the 
PHMB drug. 
CHX and PHMB have a different number of biguanide groups in their chemical structure 
(Figure 5.1.1 a) and slightly different solubility. While CHX is soluble in chloroform upon 
addition of acetone, PHMB requires an additional percentage of formic acid. Therefore, 
experiments were carried out using a common solvent mixture (i.e. chloroform/acetone/formic 
acid (1:2:0.3 v/v/v)) for PLA, CHX and PHMB. 
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a) Chemical structures of polylactide, chlorhexidine and polyhexamethylenebiguanide hydrochloride. b) 
Optical micrographs of typical morphologies (e.g., drops, ribbons and nanofibers) of PLA-CHX 5 obtained 
byelectrospinning under different operational parameters and using a chloroform/acetone/formic acid 
mixture (1:2:0.3 v/v/v) as the solvent. 
The electrospinning process was hampered by the drastic increase in viscosity of the PLA 
solution upon addition of CHX and PHMB. Maximum allowed concentrations were 0.5 w/v-% 
and 0.25 w/v-% for CHX and PHMB, respectively. Operational parameters were subsequently 
varied to avoid drop formation and produce continuous, homogeneous fibers (Table 5.1.1). 
Figure 5.1.1 b briefly illustrates all morphologies obtained and the optimization procedure 
where needle tip-collector distance, voltage and flow rate were varied in the 12.5-24.4 cm, 15-
30 kV and 1-10 mL·h-1 ranges, respectively. 
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TABLE 5.1.1. Average diameter of electrospun samples processed in this 
study. Scaffold obtained under voltage, collector distance and flow rate of 
(ª) 15 kV, 5 mL·h-1 and 12.5 cm, and (b) 20 kV, 4 mL·h-1 and 24.5 cm, 
respectively. 
Sample ø(nm) 
PLAª 1565 ± 22 
PLAb 756 ± 80, 1350 ± 55 
PLA-CHX 5b 627 ± 4 
PLA-PHMB 0.2b 565 ± 2 
PLA-PHMB 0.75b 589 ± 3 
PLA-PHMB 1.5b 595 ± 4 
PLA-PHMB 2.5b 610 ± 6 
Morphology of PLA-PHMB Fibers 
Figure 5.1.2 shows representative optical SEM micrographs of electrospun samples with 
different compositions and processed under optimal conditions. In general, long continuous 
micro/nanofibers could be obtained without bead formation. Their diameters varied in a 
relatively narrow range and showed a monomodal distribution. Table 5.1.1 summarizes the 
average diameters, which ranged between 560 and 630 nm for drug loaded samples. 
FIGURE 5.1.2 
Optical and SEM (insets) micrographs of electrospun nanofibers obtained from a 
chloroform/acetone/formic acid mixture (1:2:0.3 v/v/v) using optimized concentration, voltage, needle tip-
collector distance and flow rate: (a) PLA, (b) PLA-CHX 5 (c) PLAPHMB 2.5, (d) PLA-PHMB 1.5, (e) 
PLA-PHMB 0.75 and (f) PLA-PHMB 0.2. 
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It is interesting to note that a higher PHMB content in the electrospinning mixture led to a slight 
increase in the average diameter (i.e. values progressively increased from 565 to 610 nm when 
PHMB content increased from 0.2 to 2.5 wt-%). In fact, a linear dependence with a correlation 
coefficient of 0.95 was observed between PHMB concentration and fiber diameter. Surface 
texture of fibers also changed gradually with composition, as depicted in the high magnification 
images of the insets of Figure 5.1.2. A typical rough/porous surface of PLA fibers[35-37] and even 
of CHX loaded samples can be observed. However, scaffolds loaded with a relatively low 
PHMB concentration (e.g., 0.75 wt-%) became smooth. 
Since fibers became highly heterogeneous (a bimodal distribution could even be envisaged), 
unloaded PLA was not successfully processed under the operational conditions determined for 
drug loaded samples (Figure 5.1.3). In this case, homogeneous samples were obtained when 
needle tip-collector distance, voltage and flow rate were 12.5 cm, 15 kV and 5 mL·h-1, 
respectively. It should be pointed out that the average diameter was smaller than previously 
reported[30] (i.e. 2 m) due to the presence of formic acid, which probably modified surface 
tension and polarity.[38] 
FIGURE 5.1.3 
SEM micrograph (a) and diameter distribution (b) of electrospun PLA microfibers obtained at voltage, 
needle tip-collector distance and flow rate of 20 kV, 24.5 cm and 4 mL·h-1, respectively, and using a 
chloroform/acetone/formic acid mixture (1:2:0.3 v/v/v) as the solvent. 
FTIR Characterization of PLA-PHMB Scaffolds 
FTIR spectra of CHX and PHMB biocides (Figure 5.1.4 a) were similar and showed typical 
biguanide group signals in the 1550-1450 cm-1 region (see arrows in Figure 5.1.4 a). Thus, a 
C=N stretching band at 1490 and 1460 cm-1 and a strong NH band at 1537-1535 cm-1 were 
observed for PHMB and CHX, respectively.[16, 39] 
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FIGURE 5.1.4 
FTIR spectra (1850-950 cm-1) of CHX and PHMB drugs (a) and PLA, PLA-CHX 5 and PLA-PHMB 2.5 
scaffolds (b). 
FTIR spectra of unloaded PLA, PLA-CHX 5 and PLA-PHMB 2.5 are compared in Figure 5.1.4 
b. The presence of biguanide bands is corroborated in the loaded samples (see Figure 5.1.4 a) 
despite their low drug content. Characteristic PLA bands[40] are always observed (i.e. -C=O 
stretching at 1750 cm-1, -CH3 bending at 1449 cm-1 and –COC-vibration at 1181 cm-1 and 1083 
cm-1), with similar intensities for all bands, as expected for samples of similar crystallinity. 
According to literature, the five conjugated amines of biguanide groups can bind neighboring 
molecules by establishing multiple hydrogen bonding interactions, which may be of interest in 
supramolecular chemistry.[41] For example, hydrogen bonding between PHMB and cellulose has 
previously been described.[29, 42] 
FTIR spectra of PLA-PHMB and PLA-CHX scaffolds did not reveal any evidence of such 
interaction (e.g., a shift of the C=O absorption band towards a lower wavenumber), probably 
because of the low drug content and low sensitivity of the technique. 
Thermal Properties of PLA-PHMB Scaffolds 
Calorimetric data (i.e. glass transition, cold crystallization and melting temperatures as well as 
crystallization and melting enthalpies) of all electrospun samples are summarized in Table 5.1.2.   
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a Commercial sample included for comparison purposes. 
b Scaffold obtained under voltage, collector distance and flow rate of 20 kV, 4 mL, 24.5 cm, respectively. 
Several features deserve attention:  
a) All samples had a clear glass transition, as expected for practically amorphous samples 
b) Addition of CHX and PHMB did not affect the glass transition or melting temperatures,  
c) A broad exothermic peak (70-130 ºC) corresponding to cold crystallization of PLA is 
always observed.  
The high molecular orientation obtained in the electrospinning process facilitated PLA 
crystallization, as previously reported.[42] No samples were able to crystallize when slowly 
cooled from the melt or not even in a subsequent heating run due to lack of orientation and 
difficulty of PLA to crystallize, d) Melting enthalpy was slightly higher than crystallization 
enthalpy, indicating that even some fraction of PLA was able to crystallize during 
electrospinning. A slight difference was detected between ΔHm of unloaded and drug loaded 
PLA. This was mainly due to the lower crystallinity attained in the electrospinning of PLA alone 
since in this case the operational parameters were modified. In fact, voltage and needle tip-
collector distance were reduced and flow rate was increased. No specific trend was observed for 
cold crystallization enthalpies, suggesting that variation in fiber diameter had very little 
influence in the range between 550 and 1600 nm. 
  
TABLE 5.12. Selected calorimetric data from the heating scan performed with the 
different PLAbiguanideelectrospun samples. 
Sample 
Tg 
(ºC) 
Tc 
(ºC) 
ΔHc 
(J·g-1) 
Tm 
(ºC) 
ΔHm 
(J·g-1) 
ΔHm - ΔHc 
(J·g-1) 
PLAº,a 60.0 - - 149.8 33.4 33.4 
PLAb 58.7 113.4 19.8 146.6 20.1 0.3 
PLA-CHX 5b 58.5 110.6 19.9 146.7 24.3 4.4 
PLA-PHMB 0.2b 58.8 107.9 16.0 146.5 25.3 9.3 
PLA-PHMB 0.75b 58.5 103.4 15.2 146.0 24.6 9.4 
PLA-PHMB 1.5b 58.6 97.5 19.0 147.7 24.9 7.6 
PLA-PHMB 2.5b 58.4 108.6 18.3 146.6 24.7 7.2 
   
 
Preparation of biodegradable scaffolds incorporating non-electrospinable polymers 
168 
Contact Angles Measurements on the PLA-PHMB Scaffolds 
Although both surface energy and roughness are the dominant factors in wettability of materials, 
surface roughness is the key factor after selection of the components of materials. To clarify the 
effect of electrospinning and drug concentration on the surface properties of scaffolds, water 
contact angles were measured. For the sake of completeness, contact angle was also determined 
for smooth PLA films, see Figure 5.1.5 a. 
FIGURE 5.1.5 
a) Contact angles for PLA, PLA-CHX 5 and PLA-PHMB scaffolds loaded with drug wt-% ranging from 
0.2 to 2.5 (* p < 0.05 vs unloaded PLA, Tukey’s test). b) Correlation between contact angle and wt-% of 
PHMB in PLA scaffolds. 
Some points are worth noting: 
 Contact angle increased drastically in the PLA scaffold constituted by microfibers 
compared to the film (i.e. from 95º to 110º), showing the increase in surface area caused 
by roughness. The impact of roughness on the contact angle is given by the Wenzel 
Equation 1:[43] 
cos W = r cos Y        (1) 
which relates the contact angle on a rough surface, W, with the roughness ratio of the surface, 
r, and the contact angle on a smooth surface, Y. 
Wenzel's relation shows that surface roughness will increase the contact angle for a droplet on 
hydrophobic surfaces since the ratio between the true surface area of a rough surface and the 
surface area of a comparably sized smooth surface is always greater than one. 
 The contact angle of drug loaded scaffolds increased significantly (p < 0.05) compared 
to the unloaded PLA scaffold. This cannot be justified in terms of roughness as the 
diameter of loaded fibers was clearly smaller than that of unloaded fibers, and 
consequently a smoother surface should be expected. The hydrophobicity increase 
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seems to be a direct consequence of adding biguanide groups able to establish hydrogen 
bonding interactions with the polylactide ester groups. Note that PLA-CHX 5 and 
PLAPHMB 1.5 samples have a similar number of biguanide groups, and therefore 
similar contact angle values (131º ± 3º and 135º ± 5º). The result is surprising since 
both CHX and PHMB molecules have a hydrophilic character but increase the 
hydrophobicity of a PLA matrix when mixed. 
 The increase in PHMB content led to a linear increase of the contact angle (i.e. from 
127.8° to 140.3º for 0.2 to 2 wt-% loaded samples, respectively), as shown in Figure 
5.1.5 b. This reflects again the effect of intermolecular interactions. However, surface 
roughness should be slightly higher since fiber diameters evolved similarly with PHMB 
content (Table 5.1.1).[44] In any case, this effect should be insignificant due the low 
range of diameters (565-627 nm) compared with the small change in contact angle 
between loaded and unloaded PLA samples, whose constituent fibers are highly 
different in diameter (i.e. 1565 nm and 565-627 nm). 
Biguanide Release from Polylactide Scaffolds 
The release of biguanide complexes from an electrospun matrix is intimately related to the 
morphology and structure of constituent fibers and to the release environment. In fact, the rate 
of diffusion-controlled drug release depends on three main factors: a) Solubility of the drug in 
the release medium, b) Ability of the medium to penetrate the polymer matrix, and c) Physical 
interactions between polymer and drug.[45] 
The release of CHX and PHMB from PLA scaffolds was studied in media with different 
hydrophobicity/hydrophilicity ratios (i.e. PBS and PBS-EtOH 9:1, 5:5, 3:7 and 1:9 v/v mixtures). 
Specifically, ethanol has higher affinity with PLA than water and can have a swelling effect that 
facilitates drug release. To demonstrate the swelling action of ethanol on PLA scaffolds, a 24 h 
immersion test was carried out with PLA-PHMB 2.5. Figure 5.1.6 shows that after immersion 
the average fiber diameter increased from an initial value of 610 nm to 750 nm and maintained 
a monomodal distribution. Thus, fibers swelled homogeneously, and even the surface texture 
changed and became rougher. 
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FIGURE 5.1.6 
SEM micrographs of morphological details of PHMB 2.5 before (a) and after immersion in ethanol (b). 
Diameter distributions of PHMB 2.5 nanofibers before and after immersion in ethanol (c). 
Figure 5.1.7 compares the release of CHX and PHMB from scaffolds loaded with the maximum 
amount of drug in a representative hydrophobic medium (PBS-EtOH 3:7 v/v) and the most 
hydrophilic one (PBS buffer). 
FIGURE 5.1.7 
(a) Drug release profiles of PLA-CHX 5 and PLA-PHMB 2.5 in PBS (red line) and PBS-EtOH 3:7 v/v 
(blue line). (b) Release profiles of PHMB 2.5 in PBS (red line) and PBS-EtOH 3:7 v/v (blue line) obtained 
when the medium was renewed every 2.5 h. 
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The release kinetics can be calculated from experimental results by several theoretical models, 
typically first-order[45, 46] and Higuchi[47, 48] models. Drug release generally occurs in two steps, 
i.e., a rapid release of molecules that should deposit mainly on the high surface area of fibers 
and a slow release that should involve the diffusion of molecules through the polymer bulk 
towards the outer medium. In this way, a combined model based on the two above models is 
usually used to describe the first (0-60%) and second (40-100%) parts of the release,[49, 50] as 
stated in Equations 2 (Higuchi model) and 3 (first-order model): 
Mt/M0= kHt
1/2                                            (0 ≤ 
Mt
M0
 ≤ 0.6)                                                          (2) 
ln (1-
Mt
M0
) = a-k1t                                     (0.4 ≤ 
Mt
M0
 ≤ 1.0)                                                       (3) 
where kH and k1 are the Higuchi and first-order release constant, respectively, a takes into account 
the release in the first step, Mt is the percentage of drug released at time t, and M0 is the drug 
equilibrium percentage (considered as the maximum drug percentage). 
Kinetic data in Table 5.1.3 and release profiles in Figure 5.1.7 are worth discussing: 
 CHX and PHMB showed very different release profiles in the studied media. The fact 
that each PHMB molecule has several biguanide groups able to interact with all 
polymer chains of the matrix and the slower diffusion rate through the matrix caused 
by its higher molecular size play a fundamental role. 
 The first part of the release was clearly slower for CHX independent of the 
hydrophobic/hydrophilic character of the medium. Smaller values were determined for 
the Higuchi constant, suggesting that a greater ratio of the small CHX molecules was 
incorporated into the inner part of electrospun nanofibers whereas a higher ratio of 
PHMB molecules was incorporated into the outer part. Note that just the opposite 
release behavior was expected considering the higher binding capabilities and diffusion 
rate of PHMB. 
TABLE 5.1.3. Release kinetic parameters for PLA-CHX 5 and PLA-PHMB 2.5 scaffolds. 
Drug Media kH (h-0.5) r k1 (h-1) r 
PHMB 
PBS 0.985 0.974 0.568 0.976 
PBS-EtOH 9:1 v/v 0.527 0.971 0.679 0.973 
PBS-EtOH 5:5 v/v 0.798 0.962 0.676 0.956 
PBS-EtOH 3:7 v/v 1.107 0.973 0.756 0.996 
PBS-EtOH 1:9 v/v 1.028 0.969 0.824 0.992 
CHX 
PBS 0.609 0.990 0.737 0.982 
PBS-EtOH 3:7 v/v 0.598 0.956 1.149 0.981 
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 The release of CHX was similar but slightly greater (i.e. 58% versus 49%) in a more 
hydrophilic medium (i.e. PBS), in agreement with the hydrophilic character of CHX 
and its greater solubility in water. 
 Release constants for PHMB increased gradually with the ethanol content in release 
media because of the swelling effect of ethanol. 
 A huge difference in the final release of PHMB was found between PBS and 
PBS/ethanol mixtures. This behavior contrasts with that observed for CHX and seems 
opposite to the solubility characteristics of PHMB. Interactions of biguanide groups 
with PLA may explain this phenomenon if a competitive binding exists between PLA 
and ethanol molecules. Note also that the hydrophobic character of PLA can give rise 
to a contraction in aqueous media that hinders access of water molecules to the binding 
sites and PHMB release. 
Release profiles always reached an asymptotic value lower than 100% because of the 
establishment of equilibrium conditions. Figure 5.1.7 b clearly demonstrates that release was 
able to follow a similar profile (i.e. similar release constants) both in hydrophilic and 
hydrophobic media when the medium was renewed after reaching equilibrium. 
Antibacterial Assays of Biguanide Loaded PLA Scaffolds 
Chemical-releasing, bacteria-killing capacity of PHMB loaded scaffolds was evaluated, together 
with their effect to inhibit bacterial adhesion. Specifically, Escherichia coli and Micrococcus 
luteus were considered as examples of Gram-negative and Gram-positive bacteria, respectively. 
FIGURE 5.1.8 
Growth curves of Escherichia coli (a) and Micrococcus luteus (b) bacteria on the scaffolds. Growth on 
culture plate (PS) as positive control (■) and scaffolds of PLA (▲), PLA-CHX (▲) and PLA-PHMB 0.2 
(▼), PLA-PHMB 0.75 (◄), PLA-PHMB 1.5 (►), PLA-PHMB 2.5 (♦). 
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Figure 5.1.8 shows the bacterial growth curves for E. coli and M. luteus culture media in contact 
with scaffolds loaded with different PHMB contents. Typical bacterial growth dynamics were 
found with PLA-PHMB 0.2 and PLA-PHMB 0.75 samples. Thus, the initial lag phase (4-5 
hours), the exponential phase associated with binary fission, and the death phase associated with 
loss of viability could be detected. Total growth inhibition (i.e. growth lower than 1% compared 
to the positive control) was observed for both bacteria after 24 hours of culture. This inhibitory 
effect was similar for PLA-CHX 5, considered the positive control. It is interesting to remark 
that the inhibitory effect of bacterial growth did not occur initially, and even the bacteria had the 
ability to remain viable during the lag phase (4-5 hours) and enter the exponential growth phase 
reaching relative values of 20% and 50% with respect to the control after 7-8 hours of culture 
for E. coli and M. luteus, respectively. Furthermore, during bacterial growth, the beginning of 
the bacterial death phase was fully coincident with the PHMB release profile (see Figure 5.1.6). 
Scaffolds loaded with lower PHMB concentrations (i.e. PLA-PHMB 0.2 and PLA-PHMB 0.75) 
also showed an antibacterial effect, although no death phase could be observed after 45 hours of 
culture. In these cases, bacterial division ceased and growth curves finished in a stationary phase. 
Logistic models adjusted for growth of E. coli and M. luteus (Figure 5.1.8) showed maximum 
growths around 91-88%, 82-83% and 70-76% for the control (polystyrene plate) and scaffolds 
loaded with 0.2 and 0.75 wt-%, respectively. The results demonstrate antibacterial activity of 
PLA-PHMB scaffolds that was clearly dependent on drug concentration. 
Adhesion percentages of E. coli and M. luteus on PLA scaffolds loaded with different PHMB 
concentrations and the PLA-CHX 5 positive control are shown in Figure 5.1.9 a. The bacterial 
adhesion rate of this control, as well as the PLA matrices loaded with the higher PHMB 
concentrations, decreased dramatically (i.e. 1.5 and 2.5 wt-%). Thus, relative adhesion of E. coli 
ranged between 3 and 15% while it was slightly lower for M. luteus (e.g., 3 and 10% of relative 
adhesion were determined for the PLA-PHMB 1.5 scaffold). It should pointed out that the 
similar number of biguanide groups in the PLA-CHX 5 and PLA-PHMB 1.5 scaffolds led to a 
similar reduction of bacterial adhesion. 
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FIGURE 5.1.9 
(a) Bacterial adhesion on polystyrene plate (PS) as positive control and PLA, PLA-CHX and PLA-PHMB 
scaffolds (*p < 0.05 vs. unloaded PLA matrix, Tukey’s test. ‡p < 0.05 between two types of bacteria, t-
Test). (b) Dose-dependent curves of inhibition of bacterial adhesion on PLA-PHMB scaffolds. (c) 
Representative optical micrographs of adhesion of Micrococcus luteus on PLA and PLA-PHMB scaffolds. 
Scaffolds loaded with low PHMB concentration showed a smaller decrease in bacterial 
adhesion, which became clearly dependent on the type of bacteria (Gram-positive or Gram-
negative) and loaded drug percentage. Specifically, M. luteus exhibited a notorious and 
statistically significant (p < 0.05) reduction of adhesion compared to unloaded PLA scaffolds. 
This difference was analyzed with a dose-dependent adhesion model (Figure 5.1.9 b), which 
detected a severe decrease in the bacterial adhesion rate in the PHMB concentration range 
between 0.75 and 1.5 wt-%. Thus, the 50% inhibitory concentration (IC50) of bacterial adhesion 
can be used as a good indicator of bacterial sensitivity (Figure 5.1.9 b). Values of 0.92 wt-% 
and 1.18 wt-% were determined using the models adjusted for M. luteus, and E. coli, 
respectively, with the latter exhibiting higher resistance to the antibacterial agent.  
Lastly, PLA scaffolds are highly susceptible to be colonized by bacteria, as can be seen in the 
micrograph of Figure 5.1.9 c. This can be effectively avoided by loading a low PHMB ratio, as 
also shown in Figure 5.1.9 c for a representative sample. 
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Cell Adhesion and Growth in the Biguanide Loaded PLA Scaffolds 
PLA scaffolds prepared from electrospun micro/nanofibers had a 3D pore structure that provided 
excellent cell adhesion for both types of cells (MRC5 and MDCK), as shown in Figure 5.1.10 
a. The adhesion percentages were higher for fibroblast cells (MRC5) than for epithelial cells 
(MDCK). Low cell adhesion percentages were determined for both cell lines when cultured over 
the PLA-PHMB 2.5 scaffold because of the cytotoxic effect produced by the high PHMB 
concentration. A slightly different cytotoxic behavior was also observed in PHMB and CHX 
samples since cytotoxicity of PLA-CHX 5 was clearly higher than that of PLA-PHMB 1.5, 
which had the same number of biguanide groups, and a similar one to that found for PLA-PHMB 
2.5. This behavior shows again the difference in release behavior between small and large drugs 
containing biguanide groups. 
FIGURE 5.1.10 
Adhesion (a) and proliferation (b) of MRC-5 and MDCK cells on polystyrene plate (PS, culture plate) as 
positive control and PLA, PLA-CHX and PLA-PHMB scaffolds (*p < 0.05) vs. positive control, ** p< 0.05 
vs. PLA-CHX; ANOVA-Tukey’s test). 
The MRC-5 and MDCK cells proliferated on unloaded PLA and PLA matrices loaded with 
PHMB concentrations lower than 1.5 wt-% (Figure 5.1.10 b). Growth percentages were 
significantly (p < 0.05) higher than those determined for the positive control (PS plate) and PLA-
CHX 5 and PLA-PHMB 2.5 scaffolds. This led to the conclusion that new scaffolds were fully 
biocompatible provided that drug concentration did not exceed a certain percentage (i.e. 1.5 wt-
% for PLA-PHMB 1.5 scaffolds). Micrographs of cellular monolayers in the matrices more 
cytotoxic PLA-CHX 5 and PLA-PHMB 2.5 scaffolds are given in Figure 5.1.11.  
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FIGURE 5.1.11 
SEM micrographs of the cellular proliferation on representative scaffolds. MDCK cells (a, c) and MRC-5 
cells (b, d). The cells monolayer formation is shown on PLA-PHMB 0.75 (a, b), the inset shows detailed 
of cell spreading. The cellular growth in the PLA-PHMB 2.5 (c,d) scaffold is shown in the inset. 
Loaded scaffolds acted as controlled release systems and allowed the addition of an antibacterial 
amount higher than the cytotoxic value. Figure 5.1.12 a summarizes the evaluation results of 
PHMB cytotoxicity considering two possibilities: a) Addition of a PHMB solution to a fibroblast 
cell monolayer and b) Addition of a PHMB solution to a fibroblast cell suspension before 
attachment on the plate. Cytotoxic concentrations to reduce cell population by 50% (CC50) were 
approximately 0.01 w/v-% and 0.03 w/v-% for the first and second case, respectively. Results 
indicate that cells were more sensitive to the oligomeric drug when tissue (i.e. a monolayer) was 
formed and less sensitive in suspension (e.g., during colonization of material or cell division). 
These results are in agreement with the oligomeric structure of PHMB, which contains an 
average number of 7-11 biguanide groups. This molecule established several simultaneous cell 
interactions on a cell monolayer, facilitating cell death compared to cells in suspension, as 
schematically shown in Figure 5.1.12 b. 
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FIGURE 5.1.12 
a) Cytotoxicity curves in fibroblast cells (MRC-5 cells) forming a monolayer (○) or in suspension (●) for 
exposure to PHMB solutions. b) Scheme of the interaction of oligomeric PHMB and monomeric CHX with 
cells forming a monolayer or in suspension.  
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5.1.4 Conclusions 
PLA nanofibers loaded with PHMB and having average diameters ranging between 560 and 630 
nm were obtained by electrospinning and using a chloroform/acetone/formic acid mixture 
(1:2:0.3 v/v/v) as a solvent. The fiber diameter increased and the surface texture became 
smoother with increasing the loaded PHMB concentration. Nanofibers had a high molecular 
orientation that facilitated PLA cold crystallization during heating. 
Addition of PHMB to PLA scaffolds increased the hydrophobicity of the sample, which was 
surprising considering the hydrophilic character of PHMB. The highly-hydrophobicity of these 
scaffolds conditioned PHMB release, which was prevented in the hydrophilic medium and was 
facilitated when hydrophobicity was more hydrophobic. The molecular size of PHMB also 
resulted in a clearly different release behavior from that of the biguanide monomer. PHMB 
released from PLA scaffolds inhibited bacterial growth and prevented cell adhesion and 
colonization due to controlled and sustained release. The significant inhibition of bacterial 
growth required a PHMB concentration higher than 0.75 wt-%. 
PHMB loaded scaffolds were fully biocompatible and led to significant adhesion and 
proliferation of both fibroblast and epithelial cell lines. Controlled release made it possible to 
load scaffolds with a large amount of PHMB, which was higher than the cytotoxic dose (CC50).  
In summary, addition of PHMB to PLA scaffolds resulted in characteristics different from those 
obtained by addition of small drugs (CHX) containing a single biguanide group. These PHMB 
loaded scaffolds are particularly interesting because of their potential biomedical applications.   
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Electrospun Nanofibers from Biodegradable 
Polylactide and Conducting Poly(3-Thiophene 
Methyl Acetate) Mixtures 
 
  
  
Hybrid scaffolds constituted by polylactide (PLA) as 
a biodegradable polymer and poly(3-thiophene 
methyl acetate) (P3TMA) as an electroactive polymer 
were prepared and studied. Both polymers had a 
similar solubility and consequently could be easily 
electrospun using a common solvent. Electrospinning 
operational parameters were optimized to get 
continuous micro/nanofibers with a homogeneous 
diameter that ranged between 600 and 900 nm 
depending on the PLA/P3TMA ratio. Electrospinning 
was only effective when the P3TMA content was at 
maximum 50 wt-%. The incorporation of P3TMA 
slightly decreased the fibre diameter, led to smoother 
fibre surfaces and gave rise to some heterogeneous 
clusters inside the fibers. PLA was highly oriented 
inside the electrospun fibers and able to easily cold 
crystallize by heating. Thermal degradation was not 
highly influenced by the presence of P3TMA, although 
the onset temperature slightly increased since the first 
decomposition step of PLA was prevented. New 
scaffolds had promising electrochemical properties 
and even provided a good substrate for cell adhesion 
and cell proliferation. Therefore, these hybrids 
materials are suitable to improve the cellular 
response towards physiological processes. 
5.2 
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5.2.1 Introduction 
Polymeric materials with both biodegradable and electrically conducting properties have a 
growing interest in biomedical applications because of both the lack of long-term health risk and 
their good behavior as supportive matrix for tissue regeneration. The electrochemical response 
of conducting polymers makes feasible the local stimulation of desired tissue and the 
enhancement of either the proliferation or differentiation of various cell types.[1-4] Nevertheless, 
it remains a considerable challenge to synthesize an ideal electroactive polymer that meets the 
biocompatibility and biodegradability requirements to minimize the inflammatory reaction in 
the host tissue that could be raised by the use of non-degradable materials. An alternative 
strategy is the use of conducting polymer/biopolymer blends since unique properties that justify 
their potential technological applications in biomedical devices can be achieved. 
The requirements for materials used in tissue engineering applications are biocompatibility and 
biodegradability since they should degrade with time and should be replaced with newly 
regenerated tissues. The architecture of the biomaterial is also very important and, specifically, 
scaffolds constituted by electrospun nanofibers have promising features, such as big surface area 
for absorbing proteins and abundance of binding sites for cell membrane receptors. 
Ultrathin fibers from a wide range of polymer materials can be easily prepared by 
electrospinning.[5-11] This electrostatic technique involves the use of a high voltage field to 
charge the surface of a polymer solution droplet, held at the end of a capillary tube, and induce 
the ejection of a liquid jet towards a grounded target (collector). 
Two different approaches have been applied to develop scaffolds constituted by conducting and 
biodegradable polymers: a) By coating an electrospun mat of a well-known biocompatible and 
reabsorbable biomaterial with the conducting polymer; and b) By direct electrospinning of a 
conducting/biodegradable polymer mixture. The second option is easier to perform but requires 
a good solubility of the conducting polymer in the electrospinning solution and gives rise to 
scaffolds with lower conductivity. 
First works providing novel conductive materials well suited as biocompatible scaffolds for 
tissue engineering involved polyaniline-gelatin blend nanofibers.[12] Picciani et al.[13] considered 
the use of poly(L-lactide) as the support polymeric matrix for the preparation of polyaniline-
based conducting nanofibers and evaluated the influence of operational parameters on the 
morphology of electrospun fibers. Several polyaniline and poly(D,L-lactide) mixtures at 
different weight percents were also successfully electrospun from 1,1,1,3,3,3-
hexafluoroisopropanol solutions and their conductivity and biocompatibility evaluated.[14] 
Nanofibrous blends of HCl-doped poly(aniline-co-3-aminobenzoic acid) copolymer and 
poly(lactic acid) (PLA) were fabricated by electrospinning solutions of the polymers in a 
dimethyl sulfoxide/tetrahydrofuran mixture.[15] Scarce works concern the electrospinning of 
mixtures based on polypyrrole and basically deal with scaffolds constituted by 
polypyrrole/polycaprolactone (PCL)/gelatin nanofibers.[16] Specifically, conductive nanofibers 
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containing 15% polypyrrole exhibited the most suitable balance of electrical conductivity, 
mechanical properties and biodegradability, matching the requirements for the regeneration of 
cardiac tissue. Furthermore, such scaffold promoted cell attachment and proliferation as well as 
the interaction and expression of cardiac-specific proteins. 
Polythiophenes constitute a group of conducting polymers with high technological potential due 
to their optical, electroluminescents, electronic and, specially, electrochemical properties.[17, 18] 
Different derivatives can be considered and, specifically, several works were focused on the 
preparation of nanofibers from mixtures of poly(3-hexylthiophene) (P3HT) and PCL or 
poly(lactic-co-glycolic acid) (PLGA) as biodegradable polymers.[19, 20] Thus, P3HT domains in 
concentrated PCL solution were highly stretched from the electrospinning electrode and formed 
fibrils with very small diameters (i.e. ∼30 nm) embedded inside PCL composite fibers. 
Interestingly, fibrils became connected one to another during the volume shrinkage of the 
solution by solvent evaporation, generating PCL composite fibers with continuous P3HT fibrils 
embedded inside. On the other hand, it was found that PLGA–P3HT nanofibers have a 
significant influence on cell adhesion and proliferation. These new electrically conducting 
axially aligned nanofibers provided both electrical and structural cues and could be potentially 
used as scaffolds for neural regeneration. 
Poly(3-thiophene methyl acetate) (P3TMA) is another polythiophene derivative that is 
characterized by bearing carboxylate substituents in the 3-position of the heterocyclic ring. The 
polymer can be easily prepared via oxidative chemical[21] and photochemical[22] reactions and 
appears a suitable candidate for being processed by electrospinning since has a good solubility 
in organic solvents like chloroform. Furthermore, it has currently been demonstrated that very 
stable free-standing nanomembranes with electroactive and biodegradable properties can be 
prepared by combining P3TMA and polyesters, such as poly(tetramethylene succinate), and 
even thermoplastic polyurethanes and poly(vinylidene fluoride).[21-24] 
The main goal of the present work is the establishment of the electrospun conditions required to 
get continuous micro/nanofibers from mixtures of P3TMA with PLA as well as to perform a 
basic characterization of morphology and properties (e.g., ability to store charge and 
biocompatibility) of the derived scaffolds. PLA has been just selected as the biodegradable 
component due to its excellent properties and its wide use in the biomedical field. 
   
186 
 
Preparation of biodegradable scaffolds incorporating non-electrospinable polymers 
5.2.2 Experimental Section 
Materials 
3-Thiophene acetic acid (3TAA) (98.0%) was purchased from Fluka (Sigma-Aldrich). Iron 
chloride anhydrous (97.0%), dry methanol (99.5%), chloroform (99.9%) were purchased from 
Panreac Quimica S.A.U. (Spain) and used as received without further purification. PLA, a 
product of Natureworks (polymer 2002D), was kindly supplied by Nupik International (Polinyà, 
Spain). According to the manufacturer, this PLA has a D content of 4.25%, a residual monomer 
content of 0.3%, a density of 1.24 g·cc-1, a glass transition temperature (Tg) of 58 ºC and a 
melting point of 153 ºC. 
Kidney epithelial cells derived from African green monkey (VERO) were purchased from 
ATCC (USA). 
Synthesis of poly(3-thiophene methyl acetate) 
The 3-thiophene methyl acetate (3TMA) monomer was obtained with a 74% yield by refluxing 
3TAA in dry methanol for 24 hours at a temperature of 90 ºC.[21] The polythiophene derivative, 
P3TMA, was subsequently prepared by a chemical oxidative coupling in dry chloroform 
following the procedure described by Kim et al.[25] Anhydrous ferric chloride (FeCl3) was used 
as oxidant and dopant. The polymerization yield was ca. 61% after removing the residual oxidant 
and oligomers. 
Molecular weights and polydispersity index (PDI) were estimated by size exclusion 
chromatography (SEC) using a liquid chromatograph (Shimadzu, model LC-8A) equipped with 
an Empower computer program (Waters). A PL HFIP gel column (Polymer Lab) and a refractive 
index detector (Shimadzu RID-10A) were employed. Polymers were dissolved and eluted in 
1,1,1,3,3,3-hexafluoroisopropanol at a flow rate of 0.5 mL·min-1 (injected volume 100 µL, 
sample concentration 1.5 mg·mL-1). The number and weight average molecular weights were 
calculated using polymethyl methacrylate standards. The resulting number and weight average 
molecular weights were [Mn = 59,300 g·mol-1 and Mw = 117,500 g·mol-1] and [Mn = 10,700 
g·mol-1 and Mw = 22,500 g·mol-1] for PLA and P3TMA, respectively. 
Electrospinning 
Mixtures of PLA and P3TMA were electrospun from different solvents such as chloroform, 
acetone and chloroform/acetone mixtures at polymer concentrations of 5 w/v-% and 1-5 w/v-% 
for PLA and P3TMA, respectively. Samples will be named indicating only the PLA weight 
percentage (e.g., PLA/P3TMA-100, and PLA/P3TMA-67 corresponds to PLA alone, and a 
mixture with 67% PLA and 33% P3TMA, respectively). 
The electrospun fibers were collected on a target, which was placed at different distances (10-
20 cm) from the syringe tip (inside diameter of 0.84 mm). The voltage was varied between 10 
and 30 kV and applied to the collecting target using a high-voltage supply (Gamma High Voltage 
Research, ES30-5W). The polymer solutions were delivered via a KDS100 infusion syringe 
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pump from KD Scientific to control the mass-flow rate (from 0.5 to 10 mL·h-1). All 
electrospinning experiments were carried out at room temperature. 
Composition, morphology and properties of electrospun polylactide/poly(3-thiophene methyl 
acetate) mixtures 
1H-NMR spectra were acquired with a Bruker AMX-300 spectrometer operating at 300.1 MHz. 
Chemical shifts were calibrated using tetramethylsilane as an internal standard. Deuterated 
chloroform was used as the solvent. 
Infrared absorption spectra were recorded with a Fourier Transform FTIR 4100 Jasco 
spectrometer in the 4000-600 cm-1 range. A Specac model MKII Golden Gate attenuated total 
reflection (ATR) with a heated Diamond ATR Top-Plate was used. 
Optical morphologic observations were performed using a Zeiss Axioskop 40 microscope. 
Micrographs were taken with a Zeiss AxiosCam MRC5 digital camera. 
Inspection of the morphology of electrospun samples was conducted by scanning electron 
microscopy using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, Germany). Carbon 
coating was accomplished by using a Mitec K950 Sputter Coater fitted with a film thickness 
monitor k150x. Samples were visualized at an accelerating voltage of 5 kV. Diameter of 
electrospun fibers was measured with the SmartTiff software from Carl Zeiss SMT Ltd. 
Calorimetric data were obtained by differential scanning calorimetry with a TA Instruments 
Q100 series equipped with a refrigeration cooling system (RCS). Experiments were conducted 
under a flow of dry nitrogen with a sample weight of approximately 5 mg and calibration was 
performed with indium. Heating runs were carried out at a rate of 20 ºC·min-1 with both 
electrospun and samples slowly cooled (10 ºC·min-1) from the melt state. 
Thermal degradation was studied at a heating rate of 20 ºC/min with around 5 mg samples in a 
Q50 thermogravimetric analyzer of TA Instruments and under a flow of dry nitrogen. Test 
temperatures ranged from 50 to 600 ºC. 
X-ray powder diffraction patterns were obtained with a PANalytical X´Pert diffractometer with 
Cu Kα radiation (λ = 0.1542 nm) and a silicium monocrystal sample holder. 
Electrochemical characterization 
In order to assess the electrochemical behavior of the PLA/P3TMA scaffolds cyclic voltammetry 
(CV) studies were conducted with an Autolab PGSTAT302N galvanostat equipped with the 
ECD module (Ecochimie, The Netherlands). Measurements were performed on fiber mats, 
which were deposited by electrospinning on both sides of steel AISI 316 sheets of 1×1 cm2. All 
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electrochemical assays were performed using a threeelectrode two compartment cell under 
nitrogen atmosphere and at room temperature. 
The cell was filled with 50 mL of phosphate buffered saline (PBS, pH=7.4) with 0.1 M LiClO4 
as supporting electrolyte. Steel sheets were used as working electrode, while an Ag|AgCl 
electrode containing KCl saturated aqueous solution was the reference electrode (offset potential 
versus the standard hydrogen electrode, E0 = 0.222 V at 25 ºC). Steel AISI 316 sheets of 1×1 
cm2 were used as counter electrode. 
PLA/P3TMA fiber mats were deposited by electrospinning onto both sides of stainless steel 
sheets and electrochemical measurements were carried out i from -0.4 V to 1.1V, at scan rate of 
50 mV·s-1. 
Five consecutive oxidation-reduction cycles were conducted to assess the loss of 
electrochemical activity, which was determined as: 
LEA (%) = ΔQ/Q1·100        (1) 
where ΔQ is the difference of anodic voltammetric charge between the first cycle and the last 
cycle and Q1 is the anodic voltammetric charge corresponding to the first cycle. 
Wettability 
Contact angle measurements were performed using the water drop method at room temperature. 
Images of 0.5 μL distilled water drops were recorded after stabilization (30 s) using an OCA 20 
(DataPhysics Instruments GmbH, Filderstadt). The contact angle values were obtained as the 
average of eight independent measures for each sample. The software SCA 20 was used to 
analyze the images and acquire the contact angle values. 
Cellular adhesion and proliferation assays 
Vero cells were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 
10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine at 37ºC in a 
humidified atmosphere with 5% CO2 and 95% air. The culture medium was changed every two 
days and, for sub-culture, the cell monolayers were rinsed with phosphate buffered saline (PBS) 
and detached by incubation with trypsin-EDTA (0.25%) for 2-5 min at 37ºC. Cell concentration 
was established by count with the Neubauer camera using 4% trypan-blue as dye vital. The 
detached cells with viability ≥ 95% were used for cultures following the conditions for 
biocompatibility assays. 
PLA/P3TMA electrospun nanofibers were collected on circular coverslips (diameter 1.5 cm). 
These samples were placed into the wells of a multiwell culture plate and then sterilized by UV-
radiation for 15 min in a laminar flux cabinet. For fixing the samples on the well, a small drop 
of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, France) 
was used as adhesive. Samples were incubated with 1 mL of culture medium during 30 min 
under culture conditions to equilibrate the material. Finally, the medium was aspired and the 
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material was evaluated for cell adhesion and proliferation by exposing cells to direct contact 
with the material surface. 
For the cellular adhesion assay, aliquots of 50-100 µL containing 5×104 cells were seeded onto 
the electrospun samples placed in each well. The plate was incubated under culture conditions 
for 30 min to allow cellular attachment onto the material surface. Then, 1 mL of the culture 
medium was added to each well, and the plate was incubated during 24 h. 
Finally, the cell viability was determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide) assay. The controls were realized by cells culture on self-
polystyrene surface of the plate (TCPS). 
For the cellular proliferation assay, the procedure was similar to the adhesion assay, but the 
aliquot of 50-100 µL contained 2×104 cells. Cultures were maintained during 7 days to allow 
the cellular growth and an adequate cellular confluence in the well. The media were renewed 
each two days; and finally, the viability was determined by the MTT assay. 
Each sample was evaluated using five replicates, results being averaged and graphically 
represented. The statistical analysis was performed by one-way ANOVA test to compare the 
means of all groups. The t-Test was applied to determine a statistically significant difference 
between different groups. The tests were performed with a confidence level of 95% (p < 0.05). 
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5.2.3 Results and Discussion 
Electrospinning of Polylactide/Poly(3-Thiophene Methyl Acetate) Mixtures 
In order to select the most appropriate conditions to obtain continuous PLA/P3TMA microfibers, 
several solvents and binary mixtures were tested at different voltages, flows, polymer 
concentrations and needle tip-collector distances. Although the chemical structure (Figure 5.2.1 
a) of both polymers was quite different, their solubility characteristics were similar and, 
consequently, a common solvent could be selected for the electrospinning process.  
FIGURE 5.2.1 
Chemical structures of poly(3-thiophene methyl acetate) and polylactide (a) and optical pictures of 
conducting scaffolds with the corresponding optical micrographs (b). 
In fact, solvent plays a fundamental role for the continuous micro/nanofiber production[26, 27] 
and, in general, a relatively high polymer concentration is required to avoid the formation of 
droplets and electrospun beads when a good solvent is selected.[28] Both PLA and P3TMA are 
highly soluble in chloroform[21] and, therefore, this solvent was selected as a starting point in the 
optimization of processing conditions. However, quality of fibers improved over a wide range 
of polymer compositions when chloroform/acetone mixtures were employed. Although 
chloroform seems more appropriate for PLA considering the reported Hildebrand solubility 
parameters[29] (i.e. 18.83 MPa0.5, 19.98 MPa0.5 and 17.64 MPa0.5 for chloroform, acetone and 
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PLA, respectively), the best results were achieved when a small percentage of acetone was 
added. In fact, Hansen parameters[30] determined for dispersion, polar and hydrogen-bonding 
components suggests that the addition of acetone improves polar interactions (Table 5.2.1). 
Thus, a chloroform/acetone (70:30 v/v) mixture had closer parameters to PLA than the individual 
solvents and gave good electrospun fibers for all assayed PLA/P3TMA polymer blends. In fact, 
this solvent mixture was also previously selected as the best solution for electrospinning other 
PLA/polymer mixtures.[31] 
The low molecular weight of P3TMA precluded its processability into micro/nanofibers since 
chain entanglements were insufficient to stabilize the jet. Therefore spraying of droplets that 
coalesced into ill-defined shapes was observed (data not shown). PLA was essential to both 
render a scaffold with biodegradable properties and improve processability by increasing the 
average molecular weight of the polymer mixture. In fact a PLA content higher than 50% was 
necessary even in the most favorable electrospinning conditions to completely avoid the 
formation of droplets. Figure 5.2.2 illustrates the optimization process when a deposition 
distance of 12 cm was chosen according to a first screening, also in the Figure 5.2.1 b an optical 
pictures of conducting scaffolds with the corresponding optical micrographs are shown with the 
increasing content of conductive polymer affects to the increase colour. It can be observed that 
big drops corresponding to the conducting polymer were obtained when a relatively high flow 
(i.e. 10 mL·h-1) and low voltage (i.e. 15 kV) were employed. At an intermediate voltage (25 kV) 
the drop size decreased and at a high voltage (30 kV) beads were characteristic. The decrease of 
the flow up to 4 mL·h-1 improved considerably the morphology and, specifically, a low voltage 
led to small beads whereas continuous and homogeneous size fibers could be attained at an 
intermediate voltage. The selected electrospinning conditions for the different 
conducting/biodegradable polymer mixtures are summarized in Table 5.2.2. 
TABLE 5.2.1. Hansen parameters of polylactide and selected electrospinning solvents. 
Sample 
δd 
(MPa0.5) 
δp 
(MPa0.5) 
δh 
(MPa0.5) 
δT 
(MPa0.5) 
Chloroform 17.8 3.1 7.0 18.9 
Acetone 15.0 10.4 5.5 19.9 
Chloroform/Acetone 70:30 v/v 17.0 5.3 6.5 19.2 
Polylactide 17.6 5.3 5.8 19.3 
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FIGURE 5.2.2 
Optical micrographs showing typical morphologies obtained by electrospinning a PLA/P3TMA 67 mixture 
from a chloroform/acetone (70:30 v/v) solution and a deposition distance of 12 cm. 
 
Morphology of Polylactide/Poly(3-Thiophene Methyl Acetate) Nanofibers 
Figure 5.2.3 shows representative SEM micrographs of electrospun samples with different 
compositions. In general, long micro/nanofibers with a cylindrical morphology and randomly 
distributed in the fibrous mats could be attained. Fibers were adhered to each other forming a 
dense but porous structure. Diameter distribution was relatively wide. This feature was 
particularly remarkable for the PLA/P3TMA 50 sample, in which significant amounts of fibers 
with diameters so different as 250 nm and 2 μm were clearly distinguished. However, in all cases 
the most predominant size was in the 600-900 nm range. Figure 5.2.4 shows the monomodal 
distributions observed for the samples prepared under the optimized conditions. It is interesting 
TABLE 5.2.2. Optimal electrospinning conditions for the different studied samples.a 
Sample 
Voltage 
(kV) 
Flow Rate 
(mL·h-1) 
PLA/P3TMA 100 15-20 4-10 
PLA/P3TMA 83 20-25 4-10 
PLA/P3TMA 67 20-25 4 
PLA/P3TMA 50 20-25 4 
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to note that the increase on the P3TMA ratio in the electrospinning mixture led to a slight 
decrease on the average diameter (i.e. values progressively decreased from 864 to 633 when 
P3TMA content increased from 0 to 50 wt-%). 
FIGURE 5.2.3 
SEM micrographs taken at low (top) and high (bottom) magnification of electrospun nanofibers of 
PLA/P3TMA samples obtained from a chloroform/acetone (70:30 v/v) solution using optimized 
concentration, voltage, needle-collector distance and flow. 
FIGURE 5.2.4 
Diameter distribution of electrospun nanofibers of PLA/P3TMA samples obtained from a 
chloroform/acetone (70:30 v/v) solution using optimized concentration, voltage, needle-collector distance 
and flow. 
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Surface texture of fibers changed also gradually with composition as depicted in the high 
magnification images of Figure 5.2.3. It is clear that the typical rough/porous surface of PLA 
fibers progressively became smooth as the P3TMA content increased (e.g., an almost completely 
smooth texture was observed for PLA/P3TMA 50). Nanofibers were cut with the focused ion 
beam in order to evaluate their homogeneity through the visualization of the generated cross 
sections. Figure 5.2.5 a clearly shows that PLA nanofibers had an irregular shape as expected 
from their rough surface texture and also that the section was relatively homogeneous. However, 
the cross sections of fibers prepared from polymer mixtures (i.e. PLA/P3TMA 50 shown in 
Figure 5.2.5 b) were completely different since in some cases a relative thick and bright outer 
part could be clearly distinguished. It is possible that the inner part was constituted by some 
clusters richer in a conductive P3TMA phase, giving place to the observed contrast. In order to 
verify that fibers were not hollow, a water jet was headed towards their cross section centre. The 
inset of Figure 5.2.5 b illustrated the apparition of a small hole caused by the impact of the jet 
and consequently demonstrated a compact fibre structure. It should be pointed out that cross 
sections taken at different places of the microfibers were rather variable since homogeneous and 
heterogeneous distributions were detected, suggesting that the indicated aggregates are 
randomly distributed along themicro/nanofibers. 
FIGURE 5.2.5 
High magnification SEM micrographs showing the cross section of electrospun PLA (left) and 
PLA/P3TMA 50 (right) nanofibers. The inset shows the corresponding cross section after being exposed 
to a water jet. 
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Characterization of Electrospun Polylactide/Poly(3-Thiophene Methyl Acetate) 
Mixtures 
NMR and FTIR spectroscopies were used to assess the composition of the electrospun hybrid 
scaffolds. Thus NMR spectra revealed the presence of characteristic signals of each 
homopolymer (Figure 5.2.6), the corresponding areas being in agreement with the theoretical 
composition of the sample. Spectra always showed the characteristic quadruplet at 5.21, 5.19, 
5.17 and 5.15 ppm associated to the proton of the PLA methine group and the doublet at 1.60 
and 1.58 ppm associated to the protons of the PLA methyl group. In addition complex signals, 
which reflect sequence sensitivity, were also observed and attributed to P3TMA. Thus, 
thiophene protons gave rise to an isolated multiplet (7.18-7.15 ppm) whereas signals of 
methylene and methyl lateral groups appeared overlapped as a double duplet (3.82-3.80 ppm 
and 3.62-3.60 ppm) and a duplet (3.77 and 3.72 ppm), respectively. Splitting of the CH3 signal 
reflects the head-to-head (HH) and head-to-tail (HT) dyads produced during the chemical 
polymerization as has been previously reported.[25] Areas of dyad signals were practically 
identical, demonstrating a non-regioregular structure with a statistical disposition of the 
monomer units. HT and HH dyads corresponding to the methylene protons were splitted again 
demonstrating triad sensitivity (e.g., splitting of HH dyad gave rise to HHT and THH triads, 
whereas THT and HHT triads were derived for the HT dyad). The complex signal associated to 
the CH group can be interpreted in a similar way, the highest chemical shifts corresponding to 
the TH dyad. 
FIGURE 5.2.6 
NMR spectra of a representative electrospun PLA/ P3TMA 83 sample. 
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FTIR spectra of P3TMA samples coming directly from synthesis and from electrospinning were 
identical and showed a single C=O signal at 1732 cm-1 (Figure 5.2.7). Therefore, ester groups 
were not cleaved during processing, supporting the interpretation of the complex NMR spectra 
on the basis of sequence sensitivity. Furthermore, a broad band associated to OH groups could 
not be detected in the 3300-2500 cm-1 FTIR region (not shown). The spectra of the conducting 
polymer showed also typical signals at 1435 cm-1 (thiophene ring stretching), 1322 cm-1 (methyl 
deformation), 1198 and 1167 cm-1 (asymmetric and symmetric C-O stretching), 1012 cm-1, 839 
cm-1 (aromatic CH out of plane deformation) and 741 cm-1 (methyl rocking). 
The spectra of the scaffold samples were highly similar to that corresponding to the neat PLA 
(Figure 5.2.7), the C=O stretching vibration at 1759 cm-1 and the asymmetric and symmetric C-
O stretching at 1183 and 1082 cm-1, respectively, being the most intense bands. The intensity of 
the characteristic signals of P3TMA decreased with its ratio in the scaffold (e.g., bands at 1322 
and 839 cm-1). It should be pointed out that the strong P3TMA band at 1167 cm-1 could not be 
observed in the spectra of scaffolds even for the highest P3TMA content. This suggests a change 
in the environment of the ester groups when the P3TMA was processed together with PLA. 
However, it is also significant that the transmittance measured at 1167 cm-1 was clearly lower 
for the hybrid scaffold than for the neat PLA (see blue arrows in Figure 5.2.7), even though this 
wavenumber still corresponded to a transmittance maximum. For the sake of completeness, 
Figure 5.2.7 e shows the spectrum of a powder mixture composed by 50 wt-% of each polymer 
where the two strong PLA bands at 1183 and 1082 cm-1 can be clearly observed together with 
the strongest P3TMA band. However, the latter appears slightly shifted due to its overlapping 
with a medium intensity PLA band at 1129 cm-1. Differences between the spectra of electrospun 
samples and polymer mixtures are evident and suggest the occurrence of some specific 
interactions in the processed samples.  
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FIGURE 5.2.7 
FTIR (2000-600 cm-1) spectra of electrospun PLA (a), PLA/P3TMA 67 (b), PLA/P3TMA 50 (c) and 
P3TMA (d). For comparison purposes the spectrum of a blend containing 50 wt-% of each homopolymer 
is shown in (e). 
a Degree of crystallinity referred to the PLA content and using a heat of fusion of 106 J/g for a 100% crystalline sample.[32] 
Values on the left correspond to the crystallinity of as electrospun samples whereas those on the right correspond to the 
crystallinity attained during the heating scan. 
b Commercial sample included for comparison purposes. 
 
TABLE 5.2.3. Selected calorimetric data from the heating scan performed with the 
different PLA/P3TMA electrospun samples. 
Sample 
Tg 
(ºC) 
Tc 
(ºC) 
ΔHc 
(J·g-1) 
Tm 
(ºC) 
ΔHm 
(J·g-1) 
ΔHm - ΔHc 
(J·g-1) 
Χca 
PLAb 60.0 - - 149.8 33.4 33.4 31.5 
PLA/P3TMA 100 61.7 96.6 17.4 146.2 22.0 4.6 4.3, 20.7 
PLA/P3TMA 83 59.5 96.4 14.0 147.2 17.5 3.5 4.0, 19.9 
PLA/P3TMA 67 59.4 96.5 14.3 147.5 17.8 3.5 4.9, 25.1 
PLA/P3TMA 50 60.4 94.1 12.0 145.7 16.2 4.2 7.9, 30.6 
P3TMA 67.2 - - 111.3 11.6 11.6 - 
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Table 5.2.3 contains the main calorimetric data (i.e. glass transition, cold crystallization and 
melting temperatures as well as crystallization and melting enthalpies) obtained from the heating 
run of all electrospun scaffolds, whereas heating traces of representative samples can be seen in 
Figure 5.2.8.  
FIGURE 5.2.8 
DSC heating (a) and cooling (b) scans performed with electrospun PLA/P3TMA 100 (a,b) and 
PLA/P3TMA 67 (c) samples obtained under the corresponding optimized processing conditions. For 
comparison purposes the heating scan of a P3TMA powder sample is shown in (d). 
Several features deserve attention: 
 A broad exothermic peak (70-130 ºC) corresponding to the cold crystallization of PLA 
is always observed. The high molecular orientation attained in the electrospinning 
process facilitated the PLA crystallization, as previously reported.[32] On the contrary, 
amorphous samples (Figure 5.2.8 c) were always attained when samples were slowly 
cooled from the melt due to the lack of orientation and the difficulty of PLA to 
crystallize. 
 The degree of crystallinity referred to the PLA content tends to increase when 
nanofibers are obtained from mixtures with a higher P3TMA content, which is probably 
due to the higher orientation attained when the fibre diameter decreased. This trend was 
observed in both samples from direct electrospun (i.e. calculated through the difference 
between melting and crystallization enthalpies) and samples obtained after cold 
crystallization (i.e. considering only the melting enthalpy). 
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 All samples show a clear glass transition, as could be presumed for amorphous samples, 
and a typical relaxation endothermic peak, which indicates that metastable PLA glassy 
material achieves equilibrium thermodynamic conditions with a lower specific volume, 
enthalpy and entropy.[33] 
 Incorporation of P3TMA has a scarce influence on the characteristic glass transition, 
crystallization and melting temperatures of the final scaffold. In fact, neither the glass 
transition nor the melting peak of P3TMA (Figure 5.2.8 d) were detected in the heating 
runs of the resulting scaffolds. 
FIGURE 5.2.9 
X-ray power difractograms of a P3TMA powder sample and an electrospun P3TMA 50 scaffold before 
and after being heated up to 130 ºC. Inset shows a scheme of the molecular arrangement where for the sake 
of simplicity only a heat-to-heat distribution has been represented. 
It is interesting to note that P3TMA obtained from chemical polymerization was semicrystalline 
despite the random disposition of its repeating unit. The X-ray diffraction profile (Figure 5.2.9) 
is characterized by a strong and well defined peak at 1.17 nm that is related to the interchain 
distance (inset of Figure 5.2.9). Profiles of electrospun samples showed only amorphous halos 
without Bragg reflections associated to any of the two homopolymers. However, crystallization 
took place when the sample was heated up to 130 ºC and the diffraction profile clearly showed 
the two strongest reflections of the α-form of PLA (i.e. those appearing at 0.542 and 0.472 nm 
that correspond to the (200)+(110) and (203) indices, respectively).[34,35] Therefore, 
crystallization involved only the PLA since the main reflection of P3TMA can only be guessed. 
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Scaffolds were thermally stable up to more than 200 ºC, as deduced from TGA and DTGA 
curves (Figure 5.2.10). Incorporation of P3TMA slightly modified the degradation process, 
leading to a regular increase of both the char yield at 600 ºC and the onset degradation 
temperature. Thermal degradation of PLA has previously been explained according to a complex 
reaction process with the participation of at least two different mechanisms.[36] The DTGA curve 
of PLA is clearly asymmetric showing a shoulder in the low temperature region, which is 
associated with a minor degradation process. This shoulder disappears in the DTGA curves of 
scaffolds suggesting that the first degradation step is hindered by the presence of P3TMA. It is 
also clear that the DTGA maximum is slightly shifted to a lower temperature, which coincides 
with one of the two degradation processes observed also for P3TMA. In addition, the scaffold 
has a hardly observed minor decomposition process that corresponds to the higher temperature 
degradation step of P3TMA. 
FIGURE 5.2.10 
TGA degradation curves of the different electrospun PLA/P3TMA samples. Inset compares DTGA curves 
of PLA, PLA/P3TMA 50 and P3TMA. 
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Electrochemical Characterization of Electrospun Polylactide/Poly(3-Thiophene 
Methyl Acetate) Mixtures 
The low molecular weight of P3TMA makes unfeasible to get electrospun mats and to carry out 
the corresponding CV measurements from the neat polymer. Processability has been 
demonstrated to be possible when a high molecular weight polymer (e.g., PLA) is incorporated 
as it was also demonstrated in previous works concerning the electrochemical characterization 
of P3TMA nanomembranes prepared by spin coating.[21, 22] 
The control voltammogram recorded for PLA fibers (Figure 5.2.11 a) shows an oxidation 
shoulder with anodic potential Epa(O1) of 0.86 V and an oxidation peak with Epa(O2) higher than 
1.1 V. Both peaks have been assigned to the formation of irreversible polarons and bipolarons. 
Besides, the cathodic scan shows a weak reduction shoulder R1 with a cathodic peak potential 
Epc(R1) of -0.08 V.  
FIGURE 5.2.11 
(a) Control voltammograms collected using scan rates of 50 mV/s for electrospun mats of PLA (curve 4) 
and PLA/P3TMA with 50 wt-% (curve 1), 67 wt-% (curve 2) and 83 wt-% (curve 3) in a PBS solution 
containing 0.1 M LiClO4. Curve 5 corresponds to a steel sheet used as control. (b) Cyclic voltammograms 
of the same species after 5 consecutive oxidation–reduction cycles. 
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The voltammogram recorded for the PLA/P3TMA 83 hybrid was highly similar to that obtained 
for PLA (Figure 5.2.11 a, curves 3 and 4), but interestingly the hybrids with a lower PLA content 
(i.e. PLA/P3TMA 50 and 67 samples) showed clearly improved electrochemical properties 
(Figure 5.2.11 a, curves 1 and 2). Thus, Epa (O1) and Epa (O2) anodic potentials increased up to 
0.75 and 1.40 V for the 67 wt-% sample and 0.82 and 1.08 V for the 50 wt-% sample, 
respectively, and pointed out an increased irreversibility for the oxidation process. Furthermore, 
the weak R1 reduction shoulder was always observed (i.e. cathodic peak potentials of -0.04 V 
and -0.05 V for the PLA/P3TMA 50 and 67, respectively). Current densities (j) determined at 
1.10 V were 0.152 mA·cm-2 and 0.394 mA·cm-2 for PLA/P3TMA 83 and 50, samples, 
respectively. 
The electroactivity, which refers to the ability to store charge, was evaluated by integrating the 
cathodic and anodic areas of the voltammograms displayed in Figure 5.2.11. Specifically, the 
electroactivity increases with the similarity between such areas. Results indicate that the 
electroactivity increases significantly upon the incorporation of P3TMA, especially when the 
concentration of conducting polymer is higher than 30 wt-%. Thus, the electroactivity measured 
for PLA/P3TMA 83, 67 and 50 is 17%, 190% and 289% higher than those of PLA. In order to 
investigate the electrochemical stability of the samples, five consecutive cycles were applied by 
varying the potential in the interval defined by -0.4 V (initial and final potential) and 1.1 V 
(reversal potential) at 50 mV·s-1. The electroactivity decreases with the oxidation and reduction 
areas of consecutive voltammograms. The voltammograms recorded after such five cycles, 
which are shown in Figure 5.2.11 b, indicate that the oxidation/reduction peak distributions are 
highly similar. As it can be seen, the reduction of the cathodic and anodic areas, which reflects 
a loss of electroactivity, depends on the P3TMA content. More specifically, the LEA determined 
for PLA/P3TMA 50 and PLA/P3TMA 83 samples is 27% and 38%, respectively, evidencing 
that the electrostability increases with the P3TMA content. 
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Table 5.2.4 summarizes the cyclic voltammogram peak description for all samples including 
the values of the current densities measured at 1.10 V for the first and fifth cycles. Major 
differences in the electrochemical behavior were found when the integrated area and the current 
density were considered. Thus, independently of the number of cycle, charge and current density 
increased when the P3TMA content did. Results indicate that the incorporation of P3TMA into 
the PLA matrix provided fibers with interesting electrochemical features since an increase of 
both the electroactivity and electrostability were clearly observed. 
  
Wettability of Polylactide/Poly(3-Thiophene Methyl Acetate) Mixtures  
Figure 5.2.12 compares the contact angle measured for the different systems studied in this 
work. The average value of the contact angle determined for PLA (133.4º ± 1.5º) and P3TMA 
(88.6º ± 2.6º) reflects the hydrophobic character of the polyester and the slightly hydrophilic 
nature of the polythiophene derivative. It should be noted that the contact angle found for PLA 
is similar to that recently reported by Liu et al. for PLA nanofibers prepared using a similar 
technique.[37] The very low wetting ability of electrospun PLA nanofibers should be attributed 
to the combined effect of the surface roughness and morphology for these particular 
nanostructures. Addition of P3TMA to PLA does not produce changes in the contact angle of 
the latter, values obtained for PLA/P3TMA 83, 67 and 50 mixtures being 134.5º ± 2.4º, 135.1º 
± 1.6º and 128.7º ± 0.8º, respectively. The similarity between the contact angles of PLA and 
PLA/P3TMA combined with the electrochemical results displayed in the previous subsection 
suggest that the behavior of the mixtures as supportive matrix for the cell growth should be better 
than that of the homopolymer. Thus, the incorporation of P3TMA to the PLA matrix is expected 
to mainly affect the hydrophilicity of the surface, which in fact remains practically unaltered, 
and the ability of exchange ions across cell membranes, which was shown to be enhanced (see 
previous subsection). 
TABLE 5.2.4. Electrochemical behavior of PLA and PLA/P3TMA 83 wt-%, 67 wt-
%, and 50 wt-% samples: current density at 1.1 V and charge for the 1st cycle and 
the 5th oxidation-reduction cycles, and loss of electrochemical stability after 5 
consecutive cycles (LEA). 
Sample 
j at 1.1 V 
(mA·cm-2) 
Q 
(mc) 
LEA 
(%) 
1st cycle 5th cycle 1st cycle 5th cycle 
PLA 0.138 0.102 2.9 2.0 31 
PLA/P3TMA 83 0.152 0.098 3.1 1.9 38 
PLA/P3TMA 67 0.355 0.223 8.4 5.5 34 
PLA/P3TMA 50 0.394 0.290 11.3 8.3 27 
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FIGURE 5.2.12 
Graphical representation of the contact angles measured for PLA, P3TMA and PLA/P3TMA mixtures with 
83 wt-%, 67 wt-% and 50 wt-%. Tukey test, p < 0.05; a, b vs. other materials. 
Cell Adhesion and Growth in the PLA/P3TMA Hybrid Scaffolds 
SEM images of VERO cells adhered and grown on the PLA (control) and PLA/P3TMA matrices 
were qualitatively very similar (Figure 5.2.13). 
The VERO cells cultured during 24 h on the 3D surfaces led always to a homogeneous 
distribution and rounded morphologies (Figures 5.2.13 a and 5.2.13 c), which should 
correspond to individual cells or small groups of a few cells (insets of Figures 5.2.13 a and 
5.2.13 c). Cells appeared also adhered to the fibers by small filopodia. Cells cultured during 7 
days on the mats surface were able to form monolayers (Figures 5.2.13 b and 5.2.13 d), a typical 
indicator of cell viability and proliferation. The surface colonization progressed through a 
suitable cellular extension, which apparently was facilitated and guided by the fiber array (inset 
in the Figures 5.2.13 b and 5.2.13 d). 
In quantitative terms, the P3TMA content in the fibers did not affect the cell adhesion (Figure 
5.2.13 e) but interestingly the cellular proliferation was slightly improved in the scaffolds with 
a higher P3TMA content (Figure 5.2.13 f). In this way, the new electrospun micro/nanofibers 
constituted by the hybrid materials may improve the electrochemical properties and the cellular 
response (frequently mediated by ionic channels) to several physiological processes such as 
membrane depolarization during cell division.[38] 
In conclusion, PLA/P3TMA micro/nanofibers were well suited to provide a good substrate for 
cell adhesion and cell proliferation and offered an appropriate 3D environment. 
Furthermore, cells developed in the PLA/P3TMA matrices showed always a healthy 
morphology. 
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FIGURE 5.2.13 
SEM images of VERO cells adhering (a and c) and growing (b and d) on electrospun fibers of PLA (a and 
c) and PLA/P3TMA 50 w/w-% (b and d). The arrows indicate morphological details of the cellular 
extensions. Quantitative data of the relative adhesion (e) and proliferation (f) of cells onto the fibers mats. 
* p < 0.05 vs others fibersmats and control (tissue culture plate), Tukey test for n = 4 replicates. 
  
   
206 
 
Preparation of biodegradable scaffolds incorporating non-electrospinable polymers 
5.2.4 Conclusions 
Mixtures of PLA and P3TMA can be effectively electrospun to render hybrid micro/nanofibers 
that combine the biocompatibility and electrochemical properties of each homopolymer. 
Processing conditions (solvent, concentration, flow, voltage, collector distance) were optimized 
to allow incorporating up to 50 wt-% of P3TMA and keeping continuous fiber morphology. 
Increasing contents of the conducting polymer gave rise to smoother fiber surfaces, smaller 
diameters, higher orientation of PLA chains and the sporadic formation of cluster aggregates 
inside the fibers. 
Incorporation of P3TMA into the PLA matrix provided an increase of the electroactivity and 
electrostability, both charge and current intensity clearly increasing with the P3TMA content. 
Current density determined at 1.10 V was as high as 0.394 mA·cm-2 for fiber mats containing 
50 wt-% of P3TMA while the electroactivity of such hybrid was 289% higher than that of PLA. 
The electrostability of samples was probed since the average charge loss was less than 27% after 
performing five consecutive oxidation-reduction cycles. New hybrid scaffolds were good 
substrates for cell adhesion and cell proliferation and even the last was clearly enhanced respect 
to the parent PLA scaffolds. Cellular response to physiological processes seemed to be improved 
by the incorporation of P3TMA. 
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Scaffolds with Tuneable Hydrophilicity from 
Electrospun Microfibers of Polylactide and 
Poly(Ethylene Glycol) Mixtures: Morphology, 
Drug Release Behavior and Biocompatibility  
  
Electrospun mats were obtained from different mixtures of polylactide 
(PLA) and poly(ethylene glycol) (PEG). Processing conditions were 
optimized for all compositions and the resulting micro/nanofiber 
morphologies (i.e. diameter size and surface texture) were characterized by 
scanning electron microscopy (SEM). NMR and FTIR spectroscopies were 
employed to verify the final composition and thermal properties were 
evaluated by DSC and TGA. XPS spectroscopy revealed that PEG was 
mainly deposited on the surface of electrospun micro/nanofibers, leading to 
smooth textures. Interestingly, PLA/PEG scaffold solubility in ethanol was 
very different to that in water, since a significant amount of PEG was 
effectively retained in the PLA matrix after immersion in ethanol whereas 
only a low level of PEG was retained in the PLA matrix after immersion in 
water. The hydrophilicities of the scaffolds obtained from PLA/PEG 
mixtures were consequently higher than that of the PLA, even after the 
exposure to water. 
As PEG can be used as a sacrificial polymer because of its high solubility 
in water, it was possible to increase the porosity of PLA/PEG scaffolds. 
PLA/PEG scaffolds loaded with triclosan (TCS) had very different release 
profiles in hydrophilic (e.g., PBS) and hydrophobic (e.g., Sörensen/ethanol 
(30:70 v/v) mixture) media, while differences were small between scaffolds 
having different PLA/PEG ratios. TCS loaded scaffolds exhibited good 
antibacterial properties for all compositions and allowed adhesion of 
epithelial cells (i.e. MDCK and VERO). Significant differences in cell 
proliferation were found between unloaded and TCS loaded scaffolds due to 
the clear improvement of cell colonization by increasing PEG content. 
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6.1.1 Introduction 
Scaffolds based on biodegradable and/or biocompatible polymers for tissue engineering 
applications are receiving much attention because of their potential use as temporary templates 
for cell seeding, migration, proliferation and differentiation prior to regeneration of the natural 
extracellular matrix (ECM) or a biological functional tissue.[1-4] Several methodologies have 
been developed to prepare suitable scaffold structures, including electrospinning techniques.[5, 
6] This electrostatic process involves the use of a high voltage field to charge the surface of a 
polymer solution droplet held at the end of a capillary tube and induce the ejection of a liquid 
jet towards a grounded target (collector). Selection of appropriate experimental conditions for 
a given polymer (i.e. solvent, polymer concentration and operational parameters such as 
strength of the applied electric field, deposition distance and flow) can lead to fibers with 
diameters ranging from several micrometers to a few nanometres in an extremely rapid process 
(millisecond scale).[7-10] 
The deposition of electrospun micro/nanofibers can give rise to interconnected porous 
networks, which are interesting substrates for tissue regeneration and even for drug delivery. In 
fact, these scaffolds have morphologies similar to the structures of natural ECM, as well as large 
surface area-to-volume ratios that facilitate cell adhesion and proliferation, provide an ideal 
porous structure for nutrient and metabolic waste exchange, and promote vascularization.[11] 
Several biodegradable polymers coming from both synthetic and natural routes have been 
successfully electrospun (e.g., polyglycolide,[12] polylactide,[12-15] polycaprolactone,[16] 
collagen[17, 18] and chitosan[15, 18, 19]). Polylactide (PLA) (Figure 6.1.1 a) is one of the most 
widely used materials in clinical applications due to the combination of interesting 
characteristics like tuneable mechanical properties, degradation into natural metabolites, 
biocompatibility and low cost. However, PLA has some problems associated with its inherent 
hydrophobic nature which may reduce expression of phenotypic markers and hinder cell 
attachment and proliferation.[20, 21] In order to solve this problem, chemical modifications (e.g., 
grafting hydrophilic moieties[22] or incorporating hydrophilic blocks[23] into the PLA main 
chain) as well as the use of amphiphilic mixtures like its blends with poly(ethylene glycol) 
(PEG) have been considered (Figure 6.1.1 a).[24-26] In fact, PEG is also widely employed in the 
biomedical field due to its lack of toxicity, good biocompatibility and elimination from human 
body when its molecular weight is low.[27] 
Spasova et al.[24] were the first to prepare electrospun mats from chloroform solutions of PLA 
and a maximum PEG content of 30 wt-%. Interestingly, the scaffolds with the highest PEG 
content facilitated the arrangement of osteoblast-like cells in tissue-like structures. It was also 
demonstrated that the incorporation of PEG can favor the electrospinning process and 
particularly the production of regular and continuous fibers due to the reduction of solution 
viscosity caused by the low molecular weight PEG.[25] Finally, it should be pointed out that 
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PLA scaffolds containing 5 wt-% of PEG had excellent in-vitro osteogenic potential and in vivo 
biocompatibility with the surrounding tissues.[26] 
The present work studies the electrospinning conditions to obtain PLA/PEG scaffolds over a 
wide range of compositions (i.e. a PEG content from 10 to 70 wt-%) and characterizes the 
resulting scaffolds. Moreover, it evaluates the solubility of the newly prepared scaffolds in both 
water and a less hydrophilic medium (e.g., ethanol) since scaffold texture may be drastically 
affected (e.g., porosity may increase, favouring subsequent cell colonization processes) and 
biocompatibility may be altered depending on composition and washing process. Another goal 
of the study is to obtain information concerning the distribution of PEG and PLA phases. 
Finally, several issues related to drug loading and release are discussed, i.e. distribution of a 
hydrophobic drug like triclosan (Figure 6.1.1 a) in the hybrid PLA/PEG two-phase system, 
release profile in media with different hydrophilicity, and influence of the hybrid composition 
on the pharmacological effect. 
FIGURE 6.1.1 
Chemical structures of PEG, PLA and TCS (a). Coil of water molecules (blue) around a PEG molecular 
chain (top) and scheme of hydrogen bonding interactions between water molecules and PEG (bottom) (b).  
Projection into the hydrogen-dispersion (δh-δp) plane of the Hansen parameter solubility sphere for PEG 
(blue), PLA (garnet), solvents used in this work and TCS (c). 
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6.1.2 Experimental Section 
Materials 
Polylactide (PLA), a product of Natureworks (polymer 2002D), was kindly supplied by Nupik 
International (Polinyà, Spain). Poly(ethylene glycol) (PEG) of number average molecular 
weights of 10.000 and 35.000 g·mol-1 were purchased from Sigma-Aldrich. Solvents and 
triclosan were purchased from Sigma Aldrich and used as received. 
Escherichia coli CECT 101 and Micrococcus luteus CECT 245 bacterial strains were obtained 
from Spanish Collection of Type Culture (Valencia, Spain). MDCK (kidney epithelial cells 
derived from Madin-Darby canine) and VERO (kidney epithelial cells derived from African 
green monkey) were purchased from ATCC (USA).  
Electrospinning 
Polylactide (PLA), poly(ethylene glycol) (PEG) and their mixtures were electrospun from 
different solvents such as chloroform, dichloromethane and dichloromethane/ 
dimethylformamide mixtures, and using a polymer weight percentage of 7% for PLA, 35% for 
PEG and between 7-35% for the studied mixtures. Samples will be named indicating only the 
polylactide weight percentage (i.e. PLA/PEG-100, PLA/PEG-60 and PLA/PEG-0 correspond 
to PLA alone, a blend with 60% PLA and 40% PEG, and PEG alone, respectively). The 
electrospun fibers were collected on a target placed at different distances (10-20 cm) from the 
syringe tip (inside diameter of 0.84 mm). The voltage was varied between 10 and 30 kV, and 
the polymer solutions were delivered via infusion syringe pump with mass-flow rate from 0.5 
to 10 mL·h-1. All electrospinning experiments were carried out at room temperature. Triclosan 
loaded electrospun fibers were prepared under optimized conditions determined for the 
corresponding polymer solutions. The triclosan contents of these solutions were 3 and 0.5 w/v-
% for samples used for release and antibacterial assays, and for cytotoxicity assays, 
respectively. 
Composition, morphology and thermal properties of PLA/PEG scaffolds 
Optical morphological observations were made using a Zeiss Axioskop 40 microscope, during 
the electrospun optimization. Then, morphological details of electrospun samples was 
conducted by scanning electron microscopy using a Focus Ion Beam Zeiss Neon 40 (Carl Zeiss, 
Germany). The mats were coating with carbon and visualized at 5 kV.  
Calorimetric data were obtained by DSC with a TA Instruments Q100 series equipped with a 
refrigeration cooling system (RCS). Experiments were conducted under a flow of dry nitrogen 
with a sample weight of approximately 5 mg, and calibration was performed with indium. 
Heating runs were carried out at a rate of 20 ºC·min-1. 
  
  
CHAPTER 6.1 
217 
Thermal degradation was studied at a heating rate of 20 ºC·min-1 with around 5 mg samples in 
a Q50 thermogravimetric analyzer of TA Instruments and under a flow of dry nitrogen. Test 
temperatures ranged from 50 to 600 ºC. 
Infrared absorption spectra were recorded in the 3600 - 600 cm-1 range with a FTIR 4100 
Fourier Transform spectrometer from Jasco. A MKII Golden Gate attenuated total reflection 
(ATR) accessory from Specac was employed. 
1H-NMR spectra were acquired with a Bruker AMX-300 spectrometer operating at 300.1 MHz. 
Chemical shifts were calibrated using tetramethylsilane as an internal standard. Deuterated 
chloroform (CDCl3) was used as the solvent at room temperature. 
X-ray photoelectron spectroscopy (XPS) was performed with a SPECS system equipped with 
an Al anode XR50 source operating at 200 W and a Phoibos 150 MCD-9 detector XP. The 
overview spectra were taken with pass energy of 25 eV at 0.1 eV steps at a pressure below 
7.5x10-9 mbar and binding energies were referred to the C1s and O1s signals. 
Porosity of PLA/PGE scaffolds and PEG removal 
The porosity of microfiber scaffolds was measured by the liquid intrusion method. Scaffolds (n 
= 3) were weighed prior to immersion in ethanol or water (liquid intrusion). Vacuum was 
applied for 10 min, and the scaffolds were left for 1 h on a shaker table to allow diffusion of 
ethanol into the void volume. The scaffolds were taken out and reweighed before and after 
drying at vacuum. Porosity (P) was calculated according to Equation 1: 
𝑃=
[
(mw-md)
ds
]
{[
(mw-md)
ds
]+[
(md
PLA)
dPLA
]+[
(md
PEG)
dPEg
]}
       (1) 
where mw, md, mdPLA, mdPEG are the weights of the wet scaffold, dry scaffold, PLA fraction and 
PEG fraction in the dry scaffold, respectively, and ds, dPLA and dPEG refer to the densities of 
the solvent (i.e. 1.0 and 0.789 g·mL-1 for water and ethanol, respectively), amorphous PLA 
(1.24 g·mL-1) and semicrystalline PEG (1.07 g·mL-1), respectively. The last densities were 
estimated using DSC data of scaffolds which point to high and low crystallinity for PEG and 
PLA phases, respectively.  
Capability of water and ethanol to remove PEG from scaffolds was evaluated by the ratio of the 
initial weight and the weight after drying sample previously immersed for 24 hours in the 
selected solvent. 
Release experiments 
Controlled release measurements were made with mats of electrospun samples cut into square 
pieces (20 x 20 x 0.1 mm3). They were weighed and incubated at 37 ºC in an orbital shaker at 
60 rpm in vessels with 50 mL of phosphate buffered saline release medium (pH 7.4). After 24 
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h this hydrophilic medium was replaced by the more hydrophobic Sörensen/ethanol (30:70 v/v) 
medium. The triclosan concentration in the release media was carried out by UV spectroscopy. 
Calibration curves were obtained by plotting the absorbance measured at 283 nm against 
triclosan concentration. All drug release tests were carried out using six replicates to control the 
homogeneity of the drug release, and the results were averaged. 
Antimicrobial test: Assay of Bacterial Growth and Adhesion 
Escherichia coli (E. coli) and Micrococcus luteus (M. luteus) bacteria were selected to evaluate 
the antimicrobial effect of triclosan loaded electrospun fibers. 
Growth experiments were performed by seeding 103 CFU (colony forming units) in 5 mL of 
broth culture (Luria-Bertani medium) in the presence of the electrospun fiber mats. The cultures 
were incubated at 37 ºC and agitated at 200 rpm. After incubation for 24 and 48 h, an aliquot of 
100 µL was diluted 10 times with distilled water and absorbance at 600 nm measured. The 
bacterial number was determined by absorbance measurements at 600 nm and using a 
McFarland curve. 
Adhesion experiments were carried out by seeding 107-108 CFU in 5 mL of broth culture in the 
presence of the electrospun fiber mats. The cultures were incubated at 37 ºC and agitated at 200 
rpm. After incubation (24 h), the cultures were aspired and the material washed one time with 
distilled water. Then, 1 mL of sterile 0.01 M sodium thiosulfate was added and the mixture 
vortexed for 2 min and kept in repose for 30 min to remove the bacteria. Finally, tubes were 
incubated at 37 ºC and agitated at 200 rpm for 24 h after addition of 4 mL of broth culture. The 
bacterial number was determined as above indicated. 
All assays were conducted in triplicate and the results averaged. t-Student test was performed 
as statistical analysis at a confidence level of 95% (p < 0.05). 
In-vitro biocompatibility assays: adhesion and cellular proliferation 
MDCK and VERO cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine 
at 37 ºC in a humidified atmosphere with 5% CO2 and 95% air. 
Unloaded and triclosan loaded PLA/PEG electrospun nanofibers were collected on circular 
coverslips (diameter 1.5 cm), placed into the wells of a multiwell culture plate and sterilized by 
UV-radiation in a laminar flux cabinet for 15 min. The samples were fixed in the well using a 
small drop of silicone (Silbione® MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, 
France) as adhesive. The samples were then incubated in 1 mL of culture medium under culture 
conditions for 30 min to stabilize the material. Finally, the medium was aspired and the material 
was evaluated for cell adhesion and proliferation by exposing cells to direct contact with the 
material surface. 
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For cell adhesion assay, aliquots of 50-100 µL containing 5x104 cells were seeded onto the 
electrospun samples in the wells. The plate was incubated under culture conditions for 30 min 
to allow cell attachment to the material surface. Then, 1 mL of the culture medium was added 
to each well and the plate incubated for 24 h. Finally, cell viability was determined by MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) assay. Controls were 
conducted by cell culture on the polystyrene surface of the plate (TCPS). 
The cell proliferation assay was similar to the adhesion assay, but the aliquot of 50-100 µL 
contained 2x104 cells. Cultures were maintained for 7 days to allow cell growth and adequate 
cell confluence. The media were renewed every two days. Finally, viability was determined by 
the MTT assay. 
All samples were evaluated using five replicates and the results were averaged and graphically 
represented. The statistical analysis was performed by one-way ANOVA test to compare the 
means of all groups. A statistically significant difference between the studied groups was 
determined by t-Test, which was performed with a confidence level of 95% (p < 0.05). 
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6.1.3 Results and Discussion 
Electrospinning Conditions 
Several solvents and binary mixtures were tested at different voltages, flows, polymer 
concentrations and needle-collector distances in order to select the most appropriate conditions 
to obtain continuous microfibers from all PLA/PEG mixtures. It is well known that for a given 
polymer (i.e. with a defined chemical constitution and molecular weight) the choice of a “good” 
solvent plays a fundamental role in the success of the electrospinning process for 
micro/nanofiber production.[28, 29] It has recently been postulated that solubility and spinability 
can be correlated in such a way that solvents of high solubility require a high polymer 
concentration to avoid formation of droplets and electrospun beads, whereas the use of solvents 
of partial solubility may be appropriate to work with more diluted solutions.[30] Similar 
solubility parameters have been reported for PLA[31] (i.e. 20.18 MPa0.5) and PEG[32] (i.e. 20.08-
20.90 MPa0.5), and therefore it seems feasible to choose a common solvent for all the mixtures 
studied in this work. Suitable solvents[33, 34] are dichloromethane (DCM) and chloroform since 
their solubility parameters (i.e. 20.31 MPa0.5 and 18.83 MPa0.5, respectively) are close enough 
to those of the two studied polymers. As explained below, we also tried to use less volatile 
solvents. Thus, mixtures with dimethylformamide (DMF) (δ = 24.83 MPa0.5) were assayed. The 
final DMF content should be relatively low to obtain a final solubility parameter (e.g., 21.66 
MPa0.5 was calculated for a DCM/DMF 70:30 v/v mixture) close enough to those corresponding 
to PEG and PLA. Triclosan (TCS) loaded samples were also prepared by electrospinning. A 
higher solubility parameter[35] (i.e. 29.41 MPa0.5) was in this case estimated by van Krevelen’s 
group contribution method;[36] however, the above solvents also seem appropriate because of 
the low TCS concentration in the solution. 
It is interesting to note that PEG can be dissolved in ethanol (δ = 26.42 MPa0.5) and is completely 
soluble in water despite its significantly different solubility parameter (i.e. 47.85 MPa0.5). No 
better agreement was found, even when Hansen parameters determined by the Hoftyzer-Van 
Krevelen[37] method for dispersion, polar and hydrogen-bonding components (i.e. 16.99, 10.70, 
8.88 MPa0.5, respectively) were considered (Figure 6.1.1 c). In fact, the high solubility was 
explained by the formation of a coil of water molecules around the PEG chain. In particular, 
hydrogen bonds were postulated to be established at two sites of each ether oxygen atom of 
PEG chains with a helical conformation (Figure 6.1.1 b).[38] 
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Figure 6.1.2 shows the importance of the choice of solvent and polymer concentration to obtain 
good electrospinning results. Specifically, it was unfeasible to get low molecular weight fibers 
from PEG (e.g., Mn = 10.000 g·mol-1), but continuous fibers were obtained when Mn increased 
to 35.000 g·mol-1 if the polymer concentration in the solution was sufficiently high. Note, for 
example, that droplets (Figure 6.1.2 a) were characteristic when this concentration was low 
(e.g., close to 10 wt-%). Electrospun microfibers could be prepared when PEG (even for low 
molecular weight samples) was mixed with PLA. Thus, good solvents like DCM rendered fibers 
even at a relatively low concentration but some aggregates were also frequently formed (Figure 
6.1.2 b) due to the high volatility of the solvent. The best results were obtained when DMF was 
added to the solvent to prevent its rapid evaporation (i.e. Figure 6.1.2 c). The electrospinning 
conditions selected for mixtures containing the same amount of PLA are summarized in Table 
6.1.1. It can be observed that polymer mixtures with increasing PEG content required a higher 
PEG concentration in the solution, higher voltage and even higher flow (note that only the PEG 
sample, which had the highest molecular weight, exhibited a different behavior concerning the 
selected flow. 
FIGURE 6.1.2 
Optical micrographs of typical morphologies of PEG (Mn 35.000 g·mol-1) (a) and PLA/PEG 50 samples 
(b,c) obtained by electrospinning from polymer solutions in chloroform (a), dichloromethane (b) and a 
dichloromethane/dimethylformamide (70:30 v/v) mixture. Polymer concentrations were 10 wt-%, 9 wt-% 
and 14 wt-% for a), b) and c), respectively. 
Figure 6.1.3 shows SEM micrographs of electrospun samples prepared under the selected 
conditions and the corresponding monomodal diameter distribution, which is also summarized 
in Table 6.1.2. As expected, a higher polymer concentration led to an increase in diameter with 
the PEG content. Again, PEG fibres did not follow this trend because of the use of a higher 
molecular weight sample. 
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TABLE 6.1.1. Hansen parameters of polylactide and selected electrospinning 
solvents. 
Sample 
Composition 
Electrospinning solutiona 
(w/w/w) 
Polymer 
Concentrationb 
(wt-%) 
Voltage 
(kV) 
Flow Rate 
(mL·h-1) 
PLA/PEG 100 7.0 : 0.0 : 93.0 7.0 16 0.8 
PLA/PEG 90 7.0 : 0.8 : 92.2 7.8 17 2.0 
PLA/PEG 70 7.0 : 3.0 : 90.0 10.0 18 3.0 
PLA/PEG 50 7.0 : 7.0 : 86.0 14.0 18 3.0 
PLA/PEG 40 7.0 : 10.5 : 82.5 17.5 18 3.0 
PLA/PEG 30 7.0 : 16.3 : 79.7 23.3 20 4.0 
PLA/PEG 0 7.0 : 35.0 : 65.0 35.0 20 0.8 
Optimal distance between spinneret and collector was 15 cm.  
aPEG/PLA/(DCM/DMF) weight ratio. DCM/DMF corresponds to a 70:30 v/v solvent mixture.  
bWeight of PEG + PLA respect to the total weight of the solution. 
FIGURE 6.1.3 
SEM micrographs and diameter distribution of PLA/PEG 100 (a), PLA/PEG 70 (b), PLA/PEG 50 (c), 
PLA/PEG 40 (d), PLA/PEG 30 (e) and PLA/PEG 0 electrospun micro/nanofibers (f) obtained from a 
dichloromethane/dimethylformamide (70:30 v/v) mixture using concentration, voltage, needle-collector 
distance and flow conditions optimized for each composition. 
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TABLE 6.1.2. Variation of the fiber diameter size of electrospun PLA/PEG samples 
after extraction with water and ethanol. 
Sample 
Ø0 
(nm) 
After immersion in watera 
After immersion in 
ethanol 
Ø 
(nm) 
Øe 
(nm) 
(Ø0 – Ø) 
(nm) 
Ø 
(nm) 
(Ø0 – Ø) 
(nm) 
PLA/PEG 100 632 ± 3.39 624 ± 6.54 632 8 588 ± 7.99 44 
PLA/PEG 90 648 ± 3.91 451 ± 5.61 610 197 458 ± 2.50 190 
PLA/PEG 70 871 ± 4.46 511 ± 0.76 713 360 650 ± 4.52 221 
PLA/PEG 50 947 ± 5.30 622 ± 0.05 644 325 700 ± 1.26 247 
PLA/PEG 40 1105 ± 0.74 653 ± 0.59 670 452 885 ± 3.40 220 
PLA/PEG 30 1466 ± 8.50 933 ± 4.66 763 533 1198 ± 2.09 268 
PLA/PEG 0 958 ± 9.38 - - - - - 
aØe is the diameter estimated as [Ø02 ·ρm·x/ρPLA]0.5, where ρm, ρPLA and x are the density of the initial 
mixture, the density of PLA and the PLA wt-%, respectively. 
 
The capability to obtain continuous microfibers even at a PEG content as high as 70 wt-% and 
using the low molecular weight fraction is worth mentioning. High-magnification SEM 
micrographs revealed that PLA fibers had a typical rough surface that became progressively 
smooth with increasing the PEG content (Figure 6.1.4). In fact, the PLA/PEG 40 mixture 
rendered completely smooth fibers, as is also characteristic of PEG. These observations suggest 
that PEG was predominantly deposited on the outer part of the fiber. 
FIGURE 6.1.4 
High-magnification SEM micrographs of the surface texture of PLA/PEG 100 (a), PLA/PEG 90 (b), 
PLA/PEG 50 (c), PLA/PEG 40 (d) samples obtained under optimized conditions for each sample. 
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Composition and Thermal Properties of Electrospun PLA/PEG Mixtures 
FTIR spectra of the electrospun mixtures showed characteristic peaks associated with PLA 
(e.g., 1753 and 1182 cm-1) or PEG (e.g., 961 and 834 cm-1) (Figure 6.1.5 a) with a variable 
intensity ratio that depended on the composition. Although the absorbance ratio between, for 
example, 1753 and 834 cm-1 bands could be used to evaluate the final composition of the 
mixture, analysis of the 1H-NMR spectrum (Figure 6.1.5 b) was obviously a more precise tool. 
Thus, areas corresponding to PLA methine (quadruplet at 5.19-5.13 ppm), PEG methylene 
(singlet at 3.64 ppm) and PLA methyl (doublet at 1.59-1.57 ppm) protons were used to 
determine the molar PLA content of the electrospun fibers (Table 6.1.3) as showed in the 
Equation 2: 
PLA (molar-%) = 100 · [(
A1.59-1.57
3
) + (
A5.18-5.15
1
)] / [(
A1.59-1.57
3
) + (
A3.64
4
) + (
A5.18-5.15
1
)]              (2) 
FIGURE 6.1.5 
FTIR (2000-800 cm-1) (a) and NMR (b) spectra of PLA/PEG 70 electrospun samples before (top) and after 
immersion in water (middle) and ethanol (bottom). 
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Values in Table 6.1.3 show good agreement with the molar feed ratio in the initial 
electrospinning solutions. 
TABLE 6.1.3. Composition of PLA/PEG samples before and after being immersed in 
water and ethanol for 24 hours. 
Sample 
PLA 
(molar-%)a 
PLA 
(molar-%)b 
After immersion in water After immersion in ethanol 
PLA 
(molar-%)b 
Extracted PEG 
(molar-%)b 
PLA 
(molar-%)b 
Extracted PEG 
(molar-%)b 
PLA/PEG 100 100.0 100.0 - - - - 
PLA/PEG 90 84.6 83.3 93.0 54.5 96.8 : 3.2 78.9 
PLA/PEG 70 58.8 56.5 92.9 83.4 72.1 : 27.9 35.2 
PLA/PEG 50 37.9 35.7 92.8 88.5 66.5 : 33.5 46.6 
PLA/PEG 40 28.9 27.0 91.2 88.0 63.3 : 36.7 50.0 
PLA/PEG 30 20.7 19.2 95.2 93.9 64.8 : 35.2 55.6 
PLA/PEG 0 0.0 0.0 - - - - 
aTheoretical value from the composition of the electrospinning solution.  
bExperimental composition from analysis of 1H-RMN spectra.  
cCalculated from the final (PEGf) and the initial (PEG0) molar percentages of PEG as 100·PEGf/PEG0. 
Figure 6.1.6 shows heating and cooling runs of all electrospun samples whereas melting and 
crystallization data are summarized in Table 6.1.4. In general, distinctive peaks associated with 
melting/crystallization of each homopolymer are easily distinguished.  
Several points can be made:  
 The melting temperature and enthalpy associated with the PEG peak decreases with the 
PLA content, the change in enthalpy being highly significant, especially when PLA 
content increased from 50 to 70 wt-%. Note also that PEG was not able to crystallize at 
higher PLA contents; 
 The melting temperature associated with PLA remained practically constant for all 
samples but interestingly the melting enthalpy reached a high value when the PEG content 
was above 10 wt-% (i.e. similar to the semicrystalline commercial sample before 
electrospinning). It seems that PEG facilitated the orientation of PLA molecules in the 
electrospinning process, making it possible to achieve maximum crystallinity. It is 
interesting to note that the PLA cold crystallization peak was only detected for the PLA-
rich electrospun samples, and consequently the crystallinity observed for samples with a 
PEG content equal to or above 30 wt-% was attained in the electrospinning process (i.e. 
not during the DSC heating scan); 
 The PEG (PLA/PEG 0) electrospun sample and the non-processed sample (commercial 
PEG) showed similar melting behaviors whereas crystallinity was lower for the PLA (i.e. 
PLA/PEG 100) electrospun sample than for the commercial sample. 
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FIGURE 6.1.6 
DSC heating (a) and cooling (b) runs performed with electrospun samples obtained under the 
corresponding optimized processing conditions. Curves are labelled indicating the PLA wt-% in each 
mixture. 
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Thermal degradation of PLA/PEG samples occurred in two steps whose maximum weight 
losses at a heating rate of 20 ºC/min corresponded to 369 and 423 ºC, as is characteristic of 
degraded PLA[39] and PEG[40] homopolymers, respectively. Logically, the weight losses 
associated with each step were proportional to the content of the corresponding homopolymer 
in the mixture (Figure 6.1.7). Despite the close contact between all molecules after the 
electrospinning process, the degradation behavior of each polymer was clearly unaltered; even 
the former decomposition of PLA, which mainly gives rise to lactide, did not affect the stability 
of the remaining PEG. This is not always true, as recently reported for mixtures of 
polytrimethylene carbonate and PLA.[41] 
FIGURE 6.1.7 
TGA degradation curves of all PLA/PEG electrospun samples. Curves are labelled indicating the PLA 
wt-% in each mixture. 
Solubility of PLA/PEG Scaffolds in Water and Ethanol 
PEG is a polymer that is completely soluble in water, so it was interesting to study the effect of 
this solvent on the morphology of electrospun micro/nanofibers. FTIR (Figure 6.1.5 a) and 
NMR (Figure 6.1.5 b) spectra showed a clear decrease in the intensity of typical PEG signals 
after immersion of the samples in water. Figure 6.1.8 a illustrates the good correlation of weight 
loss after immersion with the initial PEG content, although the final molar compositions 
determined from NMR data and summarized in Table 6.1.3 demonstrate that a small amount 
of PEG always remained in the PLA matrix. This value increased with the PLA content in the 
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initial scaffold, as expected for high trapping efficiency (e.g., PLA/PEG 90 and PLA/PEG 70 
samples retained 55.5% and 8.1% of the initial PEG, respectively). 
FIGURE 6.1.8 
a) Weight loss of all PLA/PEG electrospun samples after immersion in water (black circles) and ethanol 
(white circles). b) Plot of porosity (%) versus initial PEG wt-% of electrospun samples after immersion in 
water (black circles) and ethanol (white circles). c) Carbon (left) and oxygen (right) XPS signals of PEG 
(top), and PLA/PEG 70 electrospun samples before (middle) and after (bottom) immersion in water. 
A fiber morphology was still observed after exposure to water, as shown in Figure 6.1.9 for a 
representative sample. A significant decrease in the fiber diameters was logically detected, with 
the final values being in relatively good agreement with those calculated from the measured 
weight losses and polymer densities (Table 6.1.3). A slight swelling effect was generally found, 
although a clear contraction was detected for the mixture with the highest PEG content. 
Roughness of fiber surfaces increased after water exposure, as shown in the high-magnification 
SEM micrographs (Figure 6.1.9) of samples with an initial smooth texture. It is clear that a 
significant fraction of PEG was deposited on the fiber surfaces. The reported data demonstrate 
that a small fraction of PEG can be retained in the micro/nanofibers. Thus, even after water 
exposure hydrophilicity can be enhanced compared to that of PLA samples. Furthermore, and 
more important, the size of fibers diminished drastically. Consequently, the scaffolds should 
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have bigger pores that could facilitate cell in growth. Figure 6.1.8 b illustrates this linear 
increase in scaffold porosity with the PEG content after immersion in water. 
FIGURE 6.1.9  
Low-magnification SEM micrographs (top row), diameter distribution (middle row) and high-
magnification SEM micrographs (bottom row) of PLA/PEG 50 electrospun samples before (left column) 
and after immersion in water (middle column) and ethanol (right column). 
When they were immersed in ethanol, the scaffolds behaved completely differently, despite this 
solvent’s ability to dissolve PEG. Spectroscopic data (Figure 6.1.5, Table 6.1.3) clearly 
indicate that a maximum of 55% of the initial PEG was dissolved when PLA content in the 
samples was lower than 90 wt-%. Moreover, the weight loss after immersion was clearly less 
than the initial PEG content (Figure 6.1.8 a). A fiber morphology of all PLA/PEG samples was 
logically maintained (Figure 6.1.9) although in this case a slight decrease in the fiber diameter 
was detected (Table 6.1.2). Fiber surface texture was again characterized by a roughness which 
was demonstrative of the solubilization of the PEG deposited on their surfaces. Ethanol was not 
able to form a coil of solvent molecules around the PEG chain, which could facilitate the 
diffusion of PEG outside the PLA matrix. Thus, when using ethanol instead of water, PEG was 
effectively trapped inside fibers and scaffold porosity was barely affected (Figure 6.1.8 b). 
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The composition of the surface layer of each PLA/PEG scaffolds (i.e. the surface of the 
constitutive micro/nanofibers) was studied from the analysis of C1s and O1s peaks of the XPS 
spectra (Figure 6.1.8 c). PEG spectra were characterized by C1s and O1s peaks at binding 
energies of 284.6 eV and 532 eV, respectively, whereas PLA spectra were more complicated 
since three C1s peaks were observed at 292.0 eV (CO), 290.0eV (CH) and 287.7 eV (CH3) and 
two O1 peaks at 534.8 eV (O-C) and 532.4 eV (O=C) in the deconvoluted spectra. Figure 6.1.8 
c clearly shows the correspondence of XPS spectra of PLA/PEG 70 to PEG, which strongly 
supports the idea that this polymer was preferentially deposited on the fiber surface during 
electrospinning. Note that this mixture had the highest PLA content, and is therefore the best 
sample to demonstrate a preferential deposition of PEG on the surface. Logically, XPS spectra 
of scaffolds with a higher PEG content also revealed that the fiber surface was mainly 
constituted by PEG. The spectra changed dramatically when scaffolds were immersed in water 
due to the solubilization of PEG. Thus, practically only the signals attributed to PLA were 
detected after immersion, as shown in Figure 6.1.8 c (bottom). However, very small signals 
attributed to PEG could still be observed, in agreement with NMR data, demonstrating the 
retention of a small amount of PEG in the PLA matrix. 
Triclosan Loading and Release from PLA/PEG Scaffolds 
The micro/nanofibers of samples were easily loaded with triclosan by adding the appropriate 
amount of the drug (3 w/v-%) in the initial electrospinning solutions. In this way, triclosan-
loaded scaffolds were prepared under the same processing conditions determined for the 
unloaded samples. Figure 6.1.10 illustrates the final morphology of the representative 
PLA/PEG 50 sample. The diameters of loaded fibers were generally rather similar to those 
previously determined for the unloaded samples. Variations were not significant (e.g., 947 nm 
versus 913 nm and 1105 nm versus 1181 nm for unloaded and TCS loaded PLA/PEG 50 and 
PLA/PEG 40 samples, respectively). Furthermore, the diameters were found to increase or 
decrease slightly (i.e. with no specific trend) for different compositions of the polymer mixture. 
More interestingly, the roughness of the fiber surface increased upon the addition of triclosan, 
as can be deduced by comparing the TCS loaded PLA/PEG 50 sample with the unloaded one, 
which was characterized by a smooth surface (Figure 6.1.10 c and 6.1.10 d). This change in 
the fiber surface morphology may play an important role in supporting cell attachment. 
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FIGURE 6.1.10 
Low-magnification SEM micrograph (a), diameter distribution (b) and high-magnification SEM 
micrographs (c) of triclosan loaded PLA/PEG 50 samples. For the purpose of comparison, a high-
magnification micrograph of unloaded PLA/PEG 50 samples is shown in (d). 
Figure 6.1.11 illustrates the release behaviors of several PLA/PEG samples when they were 
successively exposed to a hydrophilic PBS medium and then to a more hydrophobic 
Sörensen/ethanol (30:70 v/v) solution. Interestingly, the release profiles of all samples were 
highly similar, and therefore practically independent of the fiber composition. Profiles showed 
four different steps. First, a progressive release up to 10% of the loaded drug that extended over 
a period of 8-10 h was observed. As previously deduced for other TCS loaded matrices,[42, 43] it 
seems that an equilibrium condition was reached when the medium was highly hydrophilic and 
released triclosan reached a saturation level. Note that composition of samples varied during 
the indicated period since practically all PEG was dissolved in the medium, as previously 
demonstrated. This means that triclosan incorporated into the PEG rich phases was still retained 
in the final PLA rich micro/nanofiber. It is clear that the coil of water molecules around the 
PEG chain allowed its solubilization but did not affect the triclosan incorporated into the two 
component fiber system. In addition, TCS release profiles during this period were slightly 
different for samples containing different amounts of PEG. Thus, the inset of Figure 6.1.11 
shows that release was slightly enhanced for higher PEG contents, suggesting that TCS was 
effectively incorporated into the PEG phase on the surface, and could therefore solubilize with 
no chance of being trapped in the PLA matrix. Note also that solubility parameters (Figure 
6.1.1 c) indicate a similar interaction between triclosan and the two polymers considered. 
Second, after the initial period the amount of released triclosan was constant while the medium 
did not change (during the period between 10 and 24 h), in agreement with the establishment 
of an equilibrium condition. Third, a fast release was observed when the medium was replaced 
with the Sörensen/ethanol mixture. The release period extended over 2-5 h and a new saturation 
  
  
CHAPTER 6.1 
233 
level which increased slightly by reducing the PLA content (76% and 78% for PLA/PEG 100 
and PLA/PEG 40, respectively) was reached. Minor differences can be explained by the 
increase in the fiber diameter with PEG content, which could hinder the diffusion of TCS from 
PEG rich samples. Fourth, the amount of released triclosan remained constant as the exposure 
time was increased. It seems that an equilibrium condition was again established in the new 
more hydrophobic medium, and that the PLA content of PLA/PEG 40 micro/nanofibers was 
sufficient to retain a significant percentage (i.e. ~25%) of loaded triclosan. 
FIGURE 6.1.11 
Triclosan release curves for PLA/PEG 100 (circles), PLA/PEG 40 (squares) electrospun samples. Release 
was conducted in a PBS medium for the first 24 h and then in a Sörensen/ethanol mixture (30:70 v/v). 
Antibacterial Properties of Triclosan-Loaded PLA/PEG Scaffolds 
Triclosan is a broad-spectrum antiseptic with documented safety and efficacy against Gram-
positive and Gram-negative bacteria (e.g., M.luteus and E.coli, respectively). The antibacterial 
effect of triclosan released from micro/nanofiber mats was determined by studying bacterial 
growth and adhesion inhibition in broth medium. As shown in Figure 6.1.12 for unloaded 
samples, scaffold composition had a small effect on E.coli growth and adhesion that gradually 
diminished with increasing PEG content when M.luteus was assayed. It has been reported that 
Gram-positive bacteria were unable to metabolize PEG due to the lack of appropriate 
enzymes,[44] which is probably the main reason for the enhanced growth of Gram-positive 
bacteria in non-PEG materials. Thus, a high PEG content in the material could be beneficial in 
avoiding bacterial growth. The effect of triclosan was clearly enhanced for the Gram-negative 
bacterium (i.e. E.coli) due to its higher sensitivity to the drug. In summary, all loaded scaffolds 
were found to be unable to support bacterial adhesion since the relative values always decreased 
up to approximately 85%. The result is significant because it demonstrates the capability of the 
hydrophobic medium to facilitate TCS release and the effective avoidance of the formation of 
bacterial biofilms. 
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PEG is also an interesting component for use as a sacrificial polymer since it can be easily 
removed by solubilization in water, leading to samples with increased porosity. Figure 6.1.11 
e and 6.1.11 f compare the antibacterial growth effect of TCS loaded scaffolds before and after 
immersion in water (i.e. samples without the predominant PEG component) for both Gram-
positive and Gram-negative bacteria. No statistical differences between the two kinds of 
samples were found. Thus, triclosan could be effectively retained in the micro/nanofibers after 
removing PEG, in agreement with the above release experiments. Results also point out that the 
negative effect of PEG on M. luteus growth is insignificant compared with that of loaded TCS. 
FIGURE 6.1.12 
Relative growth (a,b) and adhesion (c,d) of Escherichia coli (a,c) and Micrococcus luteus (b,d) on control 
surfaces and unloaded and TCS loaded PLA/PEG electrospun samples. Plots of the relative growth of 
Escherichia coli (e) and Micrococcus luteus (f) before (w/PEG) and after immersion in water (wo/PEG) 
are also shown. (*p < 0.05) vs. positive control.  
  
  
CHAPTER 6.1 
235 
Biocompatibility of Unloaded and Triclosan Loaded PLA/PEG Scaffolds 
The triclosan antibacterial effect must be harmonized with the safety of eukaryotic cells because 
these should receive the antibacterial protection. Thus, adhesion and proliferation of two 
epithelial cells (MDCK and VERO) were studied for unloaded and TCS loaded scaffolds. Both 
experiments are important to follow cell development since adhesion is an early cellular event 
whereas proliferation is an evidence of metabolic cell activity. Figure 6.1.13 a compares the 
results on relative adhesion for all materials studied. No significant differences were found 
between the control, unloaded sample and TCS loaded samples. Furthermore, adhesion was 
largely independent of the cell (MDCK or VERO) and scaffold composition. In contrast, 
statistically significant differences in proliferation were observed (Figure 6.1.13 b). Thus, 
colonization increased by 20-40% in PLA/PEG scaffolds compared to the control, irrespective 
of the incorporation of triclosan. More interestingly, proliferation was enhanced for higher PEG 
contents in the initial scaffold. This is in agreement with increased porosity of scaffolds caused 
by the solubilization of PEG (used as a sacrificial polymer) and the formation of 3D structures 
that are more favorable for rapid cell colonization of the material. Other less influential factors 
include greater roughness of nanofiber surfaces and increased hydrophilicity due to the small 
amount of PEG that is always present in the PLA matrix, as mentioned above. 
FIGURE 6.1.13 
Adhesion (a) and proliferation (b) of MDCK and VERO cells on control plate surfaces and unloaded and 
TCS loaded PLA/PEG electrospun samples. 
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6.1.4 Conclusions 
Scaffolds constituted by a variable ratio of poly(ethylene glycol) and polylactide in various 
ratios were prepared by the electrospinning technique using 
dicloromethane/dimethylformamide (70:30 v/v) as the solvent. The resulting micro/nanofibers 
were found to be continuous even at a high PEG content (i.e. 70 wt-%) and have smoother 
surfaces as this content was increased. A preferential deposition of PEG on the outermost part 
of each fibers was inferred, as also demonstrated by XPS analysis. 
Most of the PEG was easily removed by exposure to water, although a small amount was always 
found to be retained in the PLA matrix. Scaffolds with different hydrophilicity, and even with 
high porosities, were thus obtained if PEG was used as a sacrificial polymer. A completely 
different behavior was observed for scaffolds exposed to ethanol as a large amount of PEG was 
retained inside the fibers and practically only the PEG deposited on the surface was effectively 
solubilized. 
The roughnesses of the triclosan-loaded samples increased, and release was marked by the 
achievement of an equilibrium condition that varied significantly with the hydrophilicity of the 
exposure medium. Slight differences in the release behavior were detected depending on the 
composition; specifically, an increase in PLA content resulted in higher retention of the drug, 
especially in a hydrophilic medium. 
Triclosan-loaded PLA/PEG scaffolds exhibited antibacterial activity regardless of the 
composition, although a slight decreasing trend with the PEG content was detected for the 
Gram-positive bacteria. Cell adhesion and proliferation were well supported by PLA/PEG 
scaffolds, even when they were loaded with triclosan. Cell proliferation was significantly 
dependent on the initial PEG content; in particular, cell colonization was enhanced in the more 
porous 3D structures attained after solubilization of PEG.  
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Scaffolds Constituted by Mixed Polylactide and 
Poly(Ethylene Glycol) Electrospun Microfibers  
 
 
  
Scaffolds constituted by different ratios of poly(ethylene glycol) 
(PEG) and polylactide (PLA) electrospun fibers have been 
prepared by using a single rotatory collector. Electrospinning 
parameters and solution conditions were optimized to obtain 
continuous fibers and a homogeneous distribution of both 
polymers in the final scaffold. Short needle-collector distances 
allowed good overlapping of the two incident and independent 
jets. The composition of the scaffold was effectively tuned by 
varying the flow rate of the PLA solution. PEG and PLA fibers 
could be well distinguished in the scaffold because of their 
smooth and rough textures, and diameters in the nanometric 
and micrometer range. Greater sizes corresponded to 
polylactide and clearly depended on the flow rate. Drugs such 
as triclosan and polyhexamethylene biguanide hydrochloride, 
which have different hydrophilic/hydrophobic character and 
molecular size, were loaded into PLA microfibers by 
electrospinning. The high water solubility of PEG justified its 
use as a sacrificial polymer. Thus, it was possible to prepare 
scaffolds with tuned porosity (from 40 to 80%) by water 
immersion of dual samples having different PEG content. 
Porosity greatly affected the release rate; specifically a 
practically instantaneous or a sustained release were 
determined for triclosan in an appropriate medium. Drug 
loaded scaffolds had a clear bactericidal effect that was more 
effective for Gram-positive bacteria. Cell proliferation studies 
indicate that fibroblast colonization increased by 20-25% in 
PLA/PEG scaffolds with high PEG content compared to the 
control, whereas this effect was not observed for epithelial cells. 
6.2 
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6.2.1 Introduction 
Electrospinning is one of the simplest procedures for generating 3D scaffolds for tissue 
engineering applications. This technique is highly versatile because it allows fibers with 
diameters varying from the micrometer to the nanometer range to be obtained from a wide 
diversity of polymers. Basically, a polymer solution is ejected from a capillary by a strong 
electrostatic potential and collected as a non-woven fibrous mat on an electrically grounded 
target. Selection of appropriate experimental conditions for a given polymer (i.e. solvent, 
polymer concentration and operational parameters such as strength of the applied electric field, 
needle-collector distance and flow rate) are basic to get homogeneous and continuous fibers 
with a selected diameter.[1-4] Furthermore, it is possible to prepare core-shell structures by using 
a coaxial spinneret[5] or even by replacing the electrospinning solution by a water-in-oil (W/O) 
emulsion.[6] 
Scaffolds usually employed in the biomedical field are based on biodegradable polyesters such 
as polycaprolactone and polylactide (PLA). However, these polymers generally have problems 
related to their inherent hydrophobic nature that may reduce expression of phenotypic markers 
and hinder cell attachment and proliferation.[7, 8] Among approaches that have been proposed 
to increase hydrophilicity of electrospun fibers, some consider the use of polyethylene glycol 
(PEG). This polymer can be easily eliminated from human body, is biocompatible and shows 
interesting properties for biomedical applications.[9] Efforts have mainly focused on decreasing 
the hydrophobicity of polylactide due to its excellent combination of characteristics like tunable 
mechanical properties, degradation into natural metabolites, biocompatibility and low cost. 
Thus, scaffolds with increased hydrophilicity have been obtained by: a) Electrospinning of 
diblock or triblock copolymers having PEG segments,[10-12] b) Emulsion electrospinning of PEG 
and PLA-b-PEG diblock copolymers,[13] c) Electrospinning of solution mixtures of PLA and 
PEG.  
Spasova et al.[14] demonstrated the possibility to easily modulate the hydrophilicity of PLA 
nanofibers by adding PEG to the spinning solutions. They also reported that osteoblasts tended 
to arrange in tissue-like structures for long-term cultures, especially in scaffolds with the highest 
PEG content. An excellent in-vitro osteogenic potential and in vivo biocompatibility with the 
surrounding tissues was found for PLA scaffolds containing 5 wt-% of PEG.[15] Electrospinning 
of PLA could also be improved by addition of low molecular weight PEG because regular and 
continuous fibers were produced due to the reduction of solution viscosity.[16] These fibers could 
be prepared up to a 79 wt-% of PEG and rendered scaffolds with enhanced cell proliferation 
because of the more porous 3D structures obtained after solubilization of PEG.[17] On the other 
hand, the use of PLA/PEG mixtures has inherent problems related to the difficulty of 
electrospinning PEG.  
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The high water solubility of PEG indicates that scaffolds constituted from either uniaxial or 
coaxial electrospun fibers based on PEG and PLA are rapidly enriched in the PLA component 
after exposure to a physiologic medium. Therefore, PEG can be considered as a sacrificial 
polymer with a remarkable function in the early stages of implantation because its 
hydrophilicity may favor cell adhesion, and also in the later stages because the increasing 
porosity of scaffolds should enhance cell colonization. Therefore, preparation of PEG/PLA 
scaffolds merits attention. Specifically, the first goal of this work evaluates a different approach 
where each polymer is independently electrospun and the resultant fibers collected together in 
a rotatory collector (Figure 6.2.1). In this case, electrospinning of PEG requires using high 
molecular weight samples (i.e. Mn greater than 30,000 g·mol-1). The method allows easy 
modulation of the ratio between PLA and PEG without any restriction and even determination 
of the final characteristics of each fiber (e.g., diameter and texture). The only limitation resulted 
from the intrinsic difficulty in electrospinning PEG because of high molecular weight samples 
(i.e. Mn close to 35,000 g·mol-1). 
FIGURE 6.2.1 
Graphical representation of dual electrospinning. 
The second goal of this work is to evaluate the biocompatibility of new scaffolds and the 
bactericide effect caused by incorporation of drugs with well-differentiated 
hydrophobic/hydrophilic character. Physicochemical interactions between drug molecules and 
polymer matrix play a fundamental role, and specifically the hydrophobic/hydrophilic 
properties of drug and polymer should be matched to achieve good drug encapsulation into 
electrospun nanofibers. Triclosan (TCS) and polyhexamethylene biguanide hydrochloride 
(PHMB) (Figure 6.2.2) were chosen as model drugs. The first is a well-known antibacterial 
and antifungal agent[18] scarcely soluble in water but well soluble in ethanol. The second is a 
hydrophilic cationic oligomer having an average of 7-11 biguanide groups spaced by flexible 
hexamethylene segments.[19-21] PHMB action against microorganisms is consequence of its 
binding to the negatively charged phosphate head groups of phospholipids on the bacterial cell 
wall. 
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FIGURE 6.2.2 
Chemical structures of PLA, PEG, TCS and PHMB. 
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6.2.2 Experimental Section 
Materials 
PEG with number average molecular weight of 35,000 g·mol-1 was purchased from Sigma-
Aldrich. Polylactide (PLA), a product of Natureworks (polymer 2002D), was kindly supplied 
by Nupik International (Polinyà, Spain). According to the manufacturer, this PLA has a D 
content of 4.25%, a residual monomer content of 0.3%, a density of 1.24 g·cc-1, a glass transition 
temperature (Tg) of 58 ºC and a melting point of 153 ºC. Solvents, Triclosan (TCS) and cell 
culture labware were purchased from Sigma-Aldrich (USA). Polyhexamethylene biguanide 
hydrochloride (PHMB) was kindly provided by B. Braun Surgical S.A. (Rubí, Spain). 
Escherichia coli CECT 101 and Micrococcus luteus CECT 245 bacterial strains were obtained 
from Spanish Collection of Type Culture (Valencia, Spain). Human fetal lung fibroblast cells 
(MRC-5) and African green monkey kidney epithelial cells (VERO) were from ATCC (USA).  
Electrospinning 
A dual electrospinning system was used to prepared scaffods constituted by a mixture of PEG 
and PLA microfibers, as depicted in Figure 6.2.1. Samples will be denoted by the experimental 
polylactide molar percentage (i.e. PLA/PEG-100, PLA/PEG-67 and PLA/PEG-0 correspond to 
PLA alone, a blend with 67 molar-% of PLA and 33 molar-% of PEG, and PEG alone, 
respectively). Electrospun fibers were collected on a rotary ground collector operating at 30 
rpm and placed at a variable distance (6-25 cm) from two equidistant needle tips (inside 
diameter of 0.84 mm). The needles were placed facing each other in order to minimize 
disturbing effects between the two electrically charged jets of PLA and PEG solutions. The 
voltage was varied between 10 and 30 kV and applied to the collector using two high-voltage 
suppliers (Gamma High Voltage Research, ES30-5W). Polymer solutions were delivered via 
two KDS100 infusion syringe pumps (KD Scientific, USA) to control the flow rate (from 0.5 
to 10 mL·h-1). All electrospinning experiments were carried out at room temperature. Unloaded 
and TCS and PHMB loaded electrospun fibers were prepared using optimized parameters (e.g., 
needle-collector distance, voltage and flow rates) and solvent conditions (e.g., solvent ratio, and 
polymer and drug concentrations). The TCS and PHMB contents of the electrospinning 
solutions were 1 and 0.25 w/v-%, respectively. 
Morphology and properties of electrospun scaffolds  
Optical microscopy studies were performed with a Zeiss Axioskop 40 microscope. Micrographs 
were taken with a Zeiss AxiosCam MRC5 digital camera. 
Detailed inspection of texture and morphology of electrospun samples was conducted by 
scanning electron microscopy using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, 
Germany). Carbon coating was accomplished by using a Mitec K950 Sputter Coater fitted with 
a k150x film thickness monitor. Samples were visualized at an accelerating voltage of 5 kV. 
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The diameter of electrospun fibers was measured with the SmartTiff software from Carl Zeiss 
SMT Ltd. 
Contact angles (CA) were measured at room temperature with sessile drops using an OCA-15 
plus Dynamic Contact Angle Microscope (Dataphysics, USA) and SCA20 software. Contact 
angle values of the right and left sides of distilled water drops were measured and averaged. 
Measurements were performed 10 s after the drop (5 mL) was deposited on the sample surface. 
All CA data were an average of six measurements on different surface locations.  
Calorimetric data were obtained by differential scanning calorimetry (DSC) with a TA 
Instruments Q100 series equipped with a refrigeration cooling system (RCS). Experiments were 
conducted under a flow of dry nitrogen with a sample weight of approximately 5 mg, and 
calibration was performed with indium. Heating runs were carried out at a rate of 20 ºC·min-1. 
Thermal degradation was studied at a heating rate of 20 ºC·min-1 with around 5 mg samples in 
a Q50 thermogravimetric analyzer (TGA) of TA Instruments and under a flow of dry nitrogen. 
Test temperatures ranged from 50 to 600 ºC. 
Porosity of PLA/PEF scaffolds 
The porosity of scaffolds was measured by the liquid intrusion method. Scaffolds (n = 3) were 
weighed prior to immersion in water (intrusion liquid). Vacuum was applied for 10 min, and 
the scaffolds were placed on a shaker table for 1 h to allow diffusion of water into the avoid 
volume. The scaffolds were taken out and reweighed. Porosity was calculated according to 
Equation 1: 
P = [(mw - md) / dw)] /[(mw - md) / dw] + [md
PLA / dPLA] + [md
PEG / dPEG]  (1) 
where mw, md, mdPLA, mdPEGare the weights of the wet scaffold, dry scaffold, PLA fraction and 
PEG fraction in the dry scaffold, respectively, and dw, dPLA and dPEG refer to the densities of the 
solvent (i.e. 1.0 g·mL-1 for water), amorphous PLA (1.24 g·mL-1) and semicrystalline PEG 
(1.07 g·mL-1), respectively. The last two densities were estimated using DSC data of scaffolds 
which point to high and low crystallinity of PEG and PLA homopolymers, respectively. 
Release experiments 
Controlled release measurements were made with square pieces (weighting approximately 200 
mg) of the electrospun scaffolds. These pieces were weighed and incubated at 37 ºC in an orbital 
shaker at 200 rpm in tubes of 50 mL for 1 week. PBS buffer (hydrophilic medium) and 
alternatively its mixture with ethanol (i.e. 3:7 v/v ratio) as a more hydrophobic component were 
employed as release media. Drug concentration was evaluated by UV spectroscopy using a 
Shimadzu 3600 spectrometer. Calibration curves were obtained by plotting the absorbance 
measured at 281 and 236 nm versus TCS and PHMB concentration. Samples were withdrawn 
from the release medium at predetermined time intervals. The volume was kept constant by 
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addition of fresh medium. All drug release tests were carried out using three replicates and the 
results were averaged. 
Antimicrobial test 
Escherichia coli (E. coli) and Micrococcus luteus (M. luteus) bacteria were selected to evaluate 
the antimicrobial effect of TCS and PHMB loaded electrospun fibers. The bacteria were 
previously grown aerobically to exponential phase in broth culture (5 g·L-1 beef extract, 5 g·L-
1 NaCl, 10 g·L-1 peptone, pH 7.2).  
Bacterial adhesion experiments were performed on a 24-well culture plate. Square pieces 
(0.5×0.5×0.1 mm3) of the electrospun scaffolds were placed into each well. Then, 1 mL of broth 
culture containing 103 CFU was seeded on the electrospun fiber mats. The cultures were 
incubated at 37 ºC and agitated at 200 rpm. The culture media were aspirated after incubation 
and the material washed once with distilled water. Then, 0.5 mL of sterile 0.01M sodium 
thiosulfate was added to each well. After addition of 4 mL of broth culture, the plate was 
incubated at 37 ºC and agitated at 200 rpm for 24 h. The bacterial number was determined as 
above indicated. All assays were conducted in triplicate and the results averaged. 
Cellular adhesion and proliferation assays 
MRC-5 and VERO cells were cultured in Dulbecco’s modified Eagle medium (DMEM) as 
previously reported.[22] 
Square pieces (0.5×0.5×0.1 mm3) of the electrospun scaffolds were placed into the wells of a 
multiwell culture plate. Samples were fixed in the wells with a small drop of silicone (Silbione® 
MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, France) and then sterilized by 
UV-radiation in a laminar flux cabinet for 15 min. For the cell adhesion and proliferation assays, 
aliquots of 50-100 µL containing 5x104 (adhesion assay) and 2x104 (proliferation assay) cells 
were seeded onto the electrospun samples in each well and incubated for 24 h (adhesion assay) 
or 4 days (proliferation assay).  
Samples were evaluated by the standard adhesion and proliferation method[22] using MTT 
reactive. The experiments were carried out using three replicates and the results were averaged. 
Samples with adhered and grown cells on the mats were fixed with 2.5 w/v-% formaldehyde at 
4 ºC overnight. They were subsequently dehydrated and processed for observation by scanning 
electronic microscopy. 
Statistical analysis 
The statistical analysis was performed by one-way ANOVA followed by Tukey test. The 
analyses were performed with a confidence level of 95% (p < 0.05).  
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6.2.3 Results and Discussion 
Electrospinning Conditions 
Solvent and polymer concentration conditions could be selected from previous works on PLA 
and PEG because each polymer was electrospun independently. Chloroform/acetone 2:1 v/v and 
dichloromethane/dimethylformamide 7:3 v/v mixtures were employed for PLA and PEG, 
respectively.[17, 22] PLA required a low polymer concentration (5-7 wt-%) due to the high 
viscosity of the final solution, whereas PEG was difficult to electrospun and a minimum 
concentration of 35 wt-% was necessary for the commercial sample with a molecular weight of 
35,000 g·mol-1. This forced the use of a PLA flow rate higher than that of PEG when scaffolds 
had to keep a structural consistency capable of dissolving PEG after exposure to aqueous 
environments. Experiments were performed with maximum (i.e. 10 wt-%) and minimum (i.e. 
35 wt-%) PLA and PEG concentrations, respectively, to minimize the difference between flow 
rates. Scaffolds with variable composition were prepared by varying the PLA flow rate (from 
0.8 to 10 mL·h-1) and keeping the rate of PEG at a minimum value (0.8 mL·h-1) to maintain 
good fiber morphology. 
The distance between the needles and the rotary collector was also fundamental to obtain 
scaffolds with a homogeneous composition. For example, ejected jets did not perfectly overlap 
onto the collector when distances were greater than 10 cm. High dispersion of compositions 
was therefore found after NMR analysis of specimens taken along a diagonal of the obtained 
scaffold. Short distances (e.g., 3 cm) were also inappropriate because of considerable defects in 
fibers caused by poor solvent evaporation. 
Optimization of the electrospinning process indicated that a needle-collector distance of 6 cm 
and voltages of 20 and 15 kV for PEG and PLA, respectively, were adequate for all the indicated 
flow rates. PLA and PEG fibers could easily be distinguished on account of their morphology 
as shown in Figures 6.2.3 and 6.2.4. 
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FIGURE 6.2.3 
Low-magnification SEM micrographs of PLA/PEG-14 (a), PLA/PEG-31 (b) PLA/PEG-48 (c), PLA/PEG-
59 (d), PLA/PEG-67 (e) and PLA/PEG-77 (f) samples. 
FIGURE 6.2.4 
High magnification SEM micrographs showing the surface texture of PLA/PEG-14 (a), PLA/PEG-31 (b), 
PLA/PEG-48 (c) and PLA/PEG-77 (d) samples.  
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Thus, a gradual change of the scaffold morphology according to the polymer composition can 
be clearly observed in the low magnification images. Specifically, samples with a high PEG 
content had a higher ratio of narrow and tortuous fibers. High magnification micrographs 
indicate that these PEG fibers had a smooth texture and high diameter distribution. In fact, two 
populations of fibers in the nanometric (100-300 nm) and micrometric (850-1200 nm) size 
range could be seen in the micrographs of samples with a high PEG content (e.g., Figure 6.2.4 
a). On the contrary, rigid microfibers having a rather homogeneous diameter distribution and a 
rough texture with abundant pores and tranversal striations were typically observed for PLA-
rich samples (Figure 6.2.4 d). Since PLA and PEG fibers could be differentiated according to 
their morphology (Figures 6.2.4 b and 6.2.4 c) a statistical analysis of their diameter 
distribution was performed, see Table 6.2.1 for PLA. Average diameters of the unimodal 
distributions were found to increase gradually from 1185 to 1830 nm with the flow rate.  
Scaffold Composition and Properties 
The experimental PLA/PEG ratio was determined from 1H-NMR spectra (Figure 6.2.5) 
because well differentiated signals could be assigned to each polymer (Figure 6.2.5). 
Homogeneity in composition was also verified with spectra from several specimens regularly 
distribute along the diagonal of each scaffold. Areas corresponding to PLA methine (quadruplet 
at 5.19-5.13 ppm), PEG methylene (singlet at 3.64 ppm) and PLA methyl (doublet at 1.59-1.57 
ppm) protons were used to determine the molar PLA content of the electrospun scaffolds (Table 
6.2.1) according to Equation 2. 
PLA (molar-%) = 100 · [(
A1.59-1.57
3
) + (
A5.18-5.15
1
)] / [(
A1.59-1.57
3
) + (
A3.64
4
) + (
A5.18-5.15
1
)]       (2) 
FIGURE 6.2.5 
1H-NMR spectra of PLA/PEG-67 electrospun samples. 
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Values summarized in Table 6.2.1 show relatively good agreement with the molar feed ratio in 
the initial electrospinning solutions. A slight deficit in the PEG content was detected in most 
cases. 
 
aThe flow rate of the PEG solution was 0.8 mL·h-1 for all scaffolds except for PLA/PEG-100. 
bAverage diameter of PEG microfiber population. 
cAverage diameter of PLA fibers. 
Composition was also evaluated from the melting enthalpies measured in the DSC heating scans 
of the different scaffolds (Table 6.2.2). Calorimetric traces showed melting peaks at 62-65 ºC 
and 150-153 ºC associated to PEG and PLA homopolymers, respectively. PEG weight 
percentages of all scaffolds could also be estimated from the melting enthalpy of the low 
temperature peak and that determined for the PLA/PEG-0 sample. Values summarized in Table 
6.2.2 indicate again good agreement with theoretical percentages and even with values 
calculated from NMR spectra.  
TABLE 6.2.1. Fiber diameter and composition of PLA/PEG scaffolds obtained from 
the indicated flow rates of the PLA solution.a 
Sample 
PLA flow rate 
(mL·h-1) 
PLA 
(mol-%) 
Ø 
(nm) 
Feed Scaffold  
PLA/PEG-0 0 0 0 958 ± 9b 
PLA/PEG-14 0.8 19.3 14 1185 ± 6c 
PLA/PEG-31 2.0 37.3 31 1195 ± 24c 
PLA/PEG-48 4.0 54.3 48 1210 ± 43C 
PLA/PEG-59 6.0 64.1 59 1273 ± 15C 
PLA/PEG-67 8.0 70.4 67 1465 ± 17C 
PLA/PEG-77 10.0 74.9 77 1501 ± 41C 
PLA/PEG-100 10.0 100 100 1830 ± 10C 
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TGA traces of PLA/PEG-x samples (Figure 6.2.6) showed two degradation steps which 
maximum weight losses at a heating rate of 20 ºC·min-1 corresponding to 369 and 423 ºC, as 
characteristic for the decomposition of PLA[23] and PEG[24] homopolymers, respectively. 
Logically, the weight loss associated with each step was proportional to the content of the 
corresponding homopolymer in the mixture and could be used as an additional indication of 
scaffold composition. 
FIGURE 6.2.6 
TGA degradation curves of PLA/PEG-x electrospun samples. Curves are labelled indicating the mol-% of 
PLA in each sample.  
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aFrom calorimetric data. 
bTheoretical values according to electrospinning flow rates. 
cFrom 1H-NMR spectra. 
Contact angle measurements could only be performed onto PLA-rich scaffolds because the high 
hydrophilicity of PEG caused spread and sorption of the sessile drop. As can be seen in Figure 
6.2.7, the sample with 77 mol-% of PLA had a similar contact angle to the PLA scaffold (125º). 
No measurements could be made on scaffolds having a lower PLA content (e.g., 65%). PLA 
rich scaffolds were more hydrophobic than PLA melt-pressed films, whose contact angle was 
close to 93º since surface roughness also becomes a dominant factor in wettability of materials. 
It is well reported that the surface area of a rough surface is greater than the surface area of a 
comparably sized smooth surface, and consequently an increase of the contact angle should be 
expected.[25] Contact angles measurements performed on samples previously immersed in water 
were in the 115º-130º for all compositions, showing the solubilization of PEG and the 
attainment of a typical PLA scaffold. 
  
TABLE 6.2.2. Selected calorimetric data from the heating scan of PLA/PEG-x 
electrospun samples and estimation of their PEG content. 
Sample 
TmPEG 
(ºC) 
∆HmPEG 
(J·g-1) 
TmPLA 
(ºC) 
∆HmPLA 
( J·g-1) 
PEG 
(wt-%)a 
PEG 
(wt-%)b 
PEG 
(wt-%)c 
PLA/PEG-0 63.8 170.1 - - 100 100 100 
PLA/PEG-14 65.7 138.3 151.7 2.5 81.3 77.8 83.7 
PLA/PEG-31 62.2 102.1 151.9 8.9 60.0 58.3 65.0 
PLA/PEG-48 62.0 87.9 152.3 10.1 51.7 41.2 47.4 
PLA/PEG-59 64.3 64.2 152.6 12.1 37.8 31.8 36.7 
PLA/PEG-67 63.2 48.2 152.2 13.2 28.3 25.9 29.1 
PLA/PEG-77 63.1 40.1 151.9 15.8 23.6 21.9 19.9 
PLA/PEG-100 - - 149.6 20.1 0 0 0 
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FIGURE 6.2.7 
Contact angles of representative PLA/PEG-x scaffolds and a PLA film (sparsed bars). Data after 
immersion on water are also given for scaffolds. 
PEG could be effectively removed by immersion of the scaffold in water, as demonstrated by 
NMR spectra (not shown). Thus, the percentage of PEG removed was practically 100% except 
for the PLA-rich scaffold (i.e. PLA/PEG 77), which had a retention or trapping efficiency close 
to 6%. Porosity of samples clearly increased after solubilization of PEG, and logically the effect 
was more significant as the initial content of PEG increased (Figure 6.2.8). A series of scaffolds 
with tuned porosity from 40 to 80% could thus be easily obtained by using PEG as a sacrificial 
polymer, which is an interesting feature for tissue engineering applications because cell growth 
is facilitated. 
FIGURE 6.2.8 
Plot of porosity (%) of PLA/PEG-x scaffolds after immersion in water versus initial molar 
percentage of PLA in the scaffold sample. 
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Triclosan and PHMB Release from PLA/PEG-x Scaffolds and Bactericide 
Properties 
PLA microfibers were easily loaded with TCS and PHMB bactericide agents by adding the 
appropriate amount of the drug (1 w/v-% and 0.25 w/v-% for TCS and PHMB, respectively) in 
the corresponding electrospinning solution. A small percentage of dimethylsulfoxide (10 v/v-
%) was also incorporated into the drug containing solutions to solubilize both drugs. In the case 
of PHMB, the process was hampered by the drastic increase in viscosity of the solution that 
limited the maximum load to a value of 0.25 w/v-%. Operational parameters previously 
optimized for the electrospinning process could still be applied for new solutions. On the 
contrary, morphology of samples was affected by the change of solvent and the presence of the 
drug. Specifically, moderate and remarkable diameter decreases were detected for all TCS and 
PHMB loaded scaffolds, respectively. For instance, the diameter decreased from 1185 nm to 
762 nm and 319 nm for PLA/PEG-14 scaffolds loaded with TCS and PHMB, respectively, as 
summarized in Table 6.2.3. The rough texture of electrospun PLA was not modified when 
fibers were loaded with TCS. However, a drastic change was observed for PHMB loaded 
samples. In this case, the obtained nanofibers had a smooth surface and could not be 
distinguished in terms of size and texture from the typical PEG nanofibers (Figure 6.2.9). 
FIGURE 6.2.9 
High magnification SEM micrographs of a PLA/PEG-48 electrospun sample loaded with TCS (a) and 
PHMB (b).  
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The release of TCS and PHMB from PLA/PEG scaffolds was studied in the hydrophilic PBS 
medium and also in its mixture with 70 v/v-% of ethanol, which could have greater affinity with 
hydrophobic drugs and even with PLA. Ethanol could also produce a swelling effect that 
facilitates drug release.  
 
Figure 6.2.10 compares the release profiles from representative PLA/PEG scaffolds. A similar 
behavior is observed for all scaffolds when PBS was employed. An asymptotic value close to 
25% was quickly reached in the case of TCS (70 min) due to the achievement of equilibrium 
conditions. The release of PHMB was slower but increased steadily and reached a similar value 
(i.e. 20-25%) after 490 min of exposure to the medium. Probably, the big size of PHMB 
molecules hindered their diffusion through the PLA fiber. 
FIGURE 6.2.10 
TCS (a) and PHMB (b) release curves in a PBS/ethanol mixture (30:70 v/v) (dashed line) and PBS medium 
(solid line) for PLA/PEG-14 (◯), PLA/PEG-48 () and PLA/PEG-77 (□). 
Profiles of release in the medium containing ethanol were clearly different from PBS and, in 
this case, revealed differences between scaffolds. Hence, a gradual increase in the TCS release 
rate by increasing the PEG content in the scaffold, which means an increase of porosity and a 
decrease on PLA diameter size, can be seen in Figure 6.2.10 a. Thus, TCS release from 
TABLE 6.2.3. Diameters of PLA microfibers in unloaded and TCS and PHMD loaded 
PLA/PEG scaffolds. 999999 
Sample 
Øunloaded 
(nm) 
ØTCS 
(nm) 
ØPHMB 
(nm) 
PLA/PEG-14 1185 ± 7 762 ± 38 319 ± 7 
PLA/PEG-48 1210 ± 43 1158 ± 24 542 ± 5 
PLA/PEG-77 1501 ± 41 1305 ± 13 1002 ± 5 
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PLA/PEG-14 and PLA/PEG-77 scaffolds was practically instantaneous and sustained, 
respectively. Specifically, a 70% release required 70 and 400 min when bicomponent scaffolds 
had the highest and lowest PEG content, respectively. 
Release of PHMB seemed to proceed at a slower rate than that TCS despite the clearly lower 
diameter of PLA electrospun fibers loaded with PHMB. This behavior is again a consequence 
of the greater molecular size of the drug, which hinders its molecular motion through the fiber 
matrix. Figure 6.2.10 b reveals that PHMB release differences between scaffolds were small 
although logically the lowest rate was observed for the least porous scaffold (i.e. that having 
the highest PLA content). 
Differences on the release rate were quantified considering the kinetic constant deduced for the 
first and fast release step, which could be fitted to a Higuchi Equation 3:[26] 
Mt / M0 = kH t1/2  (0 ≤ Mt / M0 ≤ 0.6)     (3) 
where kH is the Higuchi constant, Mt is the percentage of drug released at time t, and M0 is the 
drug equilibrium percentage (considered as the maximum drug percentage). 
TABLE 6.2.4. Higuchi kinetic parameter for the release of TCS and PHMB from 
representative PLA/PEG scaffolds in a PBS/ethanol 3:7 v/v mixture at 37 ºC. 
Sample 
TCS PHMB 
kH 
(h-0.5) 
r 
kH 
(h-0.5) 
r 
PLA/PEG-14 0.906 0.960 0.520 0.980 
PLA/PEG-48 0.424 0.949 0.474 0.961 
PLA/PEG-77 0.371 0.982 0.381 0.993 
Values reported in Table 6.2.4 indicate variations of the Higuchi constant from 0.906 to 0.371 
h-0.5 and from 0.520 to 0.381 h-0.5 for bicomponent scaffolds loaded with TCS and PHMB, 
respectively. In summary, the release of a given drug, especially those with a small molecular 
size, can be tuned by controlling the size of PLA microfibers and by modifying the PLA/PEG 
ratio of the initial scaffold because of its influence on the final porosity. Therefore, a method to 
modulate release in function of the required application is provided. 
TCS and PHMB are broad-spectrum antiseptics with documented safety and efficacy against 
Gram-positive and Gram-negative bacteria (e.g., M.luteus and E.coli, respectively). The 
bactericide effect of both drugs released from PLA/PEG scaffolds was determined by studying 
bacterial growth in broth medium. As shown in Figure 6.2.11 for unloaded samples, a high 
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growth of both bacteria was observed for all scaffolds. Similar results were obtained for the 
control, probably as a consequence of the low porosity of the scaffolds.  
Growth measurements performed with TCS and PHMB loaded scaffolds demonstrated their 
bactericide activity and indicated slightly greater efficiency for TCS. In addition to the 
difference in inherent activity between the studied drugs, the faster release of the smaller TCS 
molecules is worth noting. Figure 6.2.11 also shows a slightly different behavior between 
PLA/PEG scaffolds, with the bactericide activity being greater for those having a high ratio of 
PLA loaded microfibers. Finally, bacterial growth of PHMB loaded scaffolds was slightly 
dependent on the type of bacteria, and in particular M. luteus exhibited a higher reduction of 
growth.  
 
FIGURE 6.2.11 
Relative growth of Escherichia coli (a) and Micrococcus luteus (b) on control surfaces and PLA/PEG-x 
electrospun samples loaded with TCS or PHMB (*p < 0.05 vs. control; ANOVA-Tukey’s test). 
Biocompatibility of PLA/PEG Scaffolds 
Adhesion and proliferation of fibroblast and epithelial cells (MRC-5 and VERO cells, 
respectively) were studied for dual PLA/PEG scaffolds. Both experiments are important to 
follow cell development since adhesion is an early cellular event whereas proliferation is an 
evidence of metabolic cell activity. Figure 6.2.12 a compares the results on relative adhesion 
for the studied materials and shows higher adhesion of fibroblast cells onto the PLA/PEG 
scaffolds compared to the control. Moreover, proliferation studies (Figure 6.2.12 b) indicate 
that fibroblast colonization increased by 20-25% in the PLA/PEG scaffolds compared to the 
control when PEG content was high. This feature is in agreement with the higher porosity of 
scaffolds caused by the solubilization of PEG (used as sacrificial polymer) and the achievement 
of 3D structures more favorable for a rapid colonization of the material by fibroblast cells. 
Adhesion of epithelial cells seems slightly favored in the case of PLA/PEG scaffolds, the 
highest increase (18%) being observed for the PLA-rich scaffold. It is important to remark that 
these cells paved the surface of the scaffold and were not able to enter the porous 3D structure. 
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Thus, no significant increase of proliferation was detected for dual scaffolds and even negative 
results were detected when the PEG content was high, a feature that may be related to a surface 
instability caused by the solubilization of PEG. Figure 6.2.13 shows the development of 
epithelial film monolayers onto representative PLA/PEG scaffolds and the impossibility of 
these cells to penetrate in the porous structure. 
FIGURE 6.2.12 
Adhesion (a) and proliferation (b) of cells on control plate surfaces and not loaded scaffolds (*p < 0.05 vs. 
positive control; ANOVA-Tukey’s test). 
 
FIGURE 6.2.13 
Low-magnification (a) and high-magnification (b,c) SEM micrographs showing proliferation of VERO 
cells on representative PLA/PEG-77 (a,b) and PLA/PEG-77 (c) scaffolds.  
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6.2.4 Conclusions 
Homogeneous scaffolds constituted by PLA and PEG continuous fibers could be satisfactorily 
prepared by the electrospinning technique when independent jets produced from each 
homopolymer solution were overlapped over a single rotary collector. Final scaffold 
compositions were easily tuned by modifying the PLA flow rate while a constant and low rate 
was preferred for PEG considering the significant difference on polymer concentrations (i.e. 10 
and 35 wt-% for PLA and PEG, respectively) required to obtain electrospinable solutions. PLA 
and PEG fibers could be well distinguished in the final scaffold according to surface texture 
(rough or smooth) and diameter rage. This was clearly dependent and increased with the flow 
rate. 
Drugs of different size and hydrophilic/hydrophobic character were easily loaded into PLA 
nanofibers although a slight solvent modification that influenced fiber morphology was 
required. This change was drastic in the case of cationic PHMB that led to nanofibers instead 
of microfibers. 
The high water solubility of PEG allowed tuning scaffold porosity by varying the ratio between 
fibers of the two components and using PEG as a sacrificial polymer. The release from the 
different scaffolds was also modulated from a practically instantaneous to a sustained delivery 
according to porosity and fiber size if an appropriate release medium was selected. TCS and 
PHMB drugs loaded drugs had a bactericide effect that was lower for PHMB because only a 
limited amount of drug could be incorporated in the scaffold. The increase in the scaffold 
porosity favored rapid fibroblast cell colonization whereas a contrary effect was observed when 
epithelial like cells.  
In summary, the reported method based on the use of PEG as a sacrificial polymer allows 
preparing scaffolds with tuned porosity (from 40 to 80%) and different drug release kinetics 
and susceptibility to fibroblast cell colonization.  
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Biocompatibility and Drug Release Behavior of 
Scaffolds Prepared by Coaxial Electrospinning 
of Poly(Butylene succinate) and Polyethylene 
Glycol  
 I 
 
  
Scaffolds constituted by electrospun microfibers of poly(ethylene 
glycol) (PEG) and poly(butylene succinate) (PBS) were studied. 
Specifically, coaxial microfibers having different core-shell 
distributions and compositions were considered as well as uniaxial 
micro/nanofibers prepared from mixtures of both polymers. 
Processing conditions were optimized for all geometries and 
compositions and resulting morphologies (i.e. diameter and 
surface texture) characterized by scanning electron microscopy. 
Chemical composition, molecular interactions and thermal 
properties were evaluated by means of FTIR, NMR and XPS and 
differential scanning calorimetry. The PEG component of 
electrospun fibers could be solubilized by immersion of scaffolds 
in aqueous medium, giving rise to high porosity and hydrophobic 
samples. Nevertheless, a small amount of PEG was retained in the 
PBS matrix, suggesting some degree of mixing. Solubilization was 
slightly dependent on fiber structure; specifically, the distribution 
of PEG in the core or shell of coaxial fibers led to higher or lower 
retention levels, respectively. Scaffolds could be effectively loaded 
with hydrophobic drugs having antibacterial and anticancerigen 
activities like triclosan and curcumin, respectively. The release 
was highly dependent on their chemical structure and the medium 
composition. Thus, low and high release rates were observed in 
phosphate saline buffer solution (SS) and SS/ethanol (30:70 v/v), 
respectively. Slight differences in the release of triclosan were 
found depending on fiber distribution and composition. 
Antibacterial activity and biocompatibility were evaluated for both 
loaded and unloaded scaffolds. 
6.3 
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6.3.1 Introduction 
Electrospinning is currently one of the simplest methods of drug loading into micro/nanofiber 
scaffolds. The drug is dissolved or dispersed in a polymer solution that is subsequently exposed 
to a strong electrical potential. Electrical charges accumulate on the surface of a liquid droplet 
placed at the tip of a capillary and a charged jet is ejected towards a grounded electrode when 
the Coulombic repulsion of the charges overcomes the surface tension of the polymer droplet.[1-
4] The solvent evaporates as it travels from the tip to the grounded target and fibers with different 
morphology are collected depending on solution properties (e.g., viscosity, dielectric constant, 
volatility, concentration, etc.) and operational parameters (e.g., strength of the applied electrical 
field, deposition distance, flow rate, etc.).[5, 6] 
Electrospun scaffolds for tissue regeneration and drug delivery applications have been 
successfully been prepared from both natural polymers like collagen, gelatin, chitosan, silk 
fibroin and hyaluronic acid and synthetic homopolymers and copolymers such as poly(lactic 
acid) (PLA), poly(-caprolactone) (PCL), polyethylene glycol (PEG), poly(butylene succinate), 
poly (L-lactide-co-caprolactone) and poly(lactic-co-glycolic acid) (PLGA).[7-11] 
Drug-loaded micro/nanofibrous scaffolds can be applied topically or as an implant for 
antibiotic, antifungal, antimicrobial,[12] antioxidant[13] and anticancer[14] drug delivery. Despite 
the simplicity of this encapsulation procedure based on electrospinning, some requirements 
should be met to attain optimal results. Thus, release behavior becomes highly dependent on 
the distribution of drug molecules in electrospun fibers, as well as on the final morphology of 
the fibers. Physicochemical interactions between drug molecules and the polymer matrix play 
a fundamental role, and specifically the hydrophobic-hydrophilic properties of drug and 
polymer should be matched in order to achieve a good drug encapsulation inside the electrospun 
nanofibers. Lack of good interactions may cause drug migration during electrospinning on or 
near the fiber surface, resulting in a significant burst effect.[15] In order to achieve sustained 
release and improve molecular interactions, blending hydrophilic-hydrophobic polymers in 
different ratios has been considered.[16, 17] 
Coaxial electrospinning is a modification of the classical procedure that enables production of 
micro/nanofibers with a core-shell structure and highly different compositions. In this case, two 
polymer solutions are supplied by means of two separate syringe pumps and pipelines leading 
to a core-shell nozzle. At the exit of this special needle a core-shell droplet appears and acquires 
a shape similar to the Taylor cone. Nevertheless, the core material may be not entrained into 
the shell jet, giving rise to monolithic instead of core-shell jets.[18] In fact, electric charges 
escape very rapidly to the outer surface of the forming jet and core entrainment becomes only 
possible by viscous tractions.[19]. Successful encapsulation of drug to the core of coelectrospun 
fibers is determined by various parameters (e.g., shell polymer concentration, core polymer 
concentration, molecular weight and drug concentration) as well as the relative flow rate of the 
core and shell solutions.[20] Fiber morphology is sometimes critical and incorporation of a highly 
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hydrophilic and water soluble PEG polymer may accelerate transport of drug molecules into 
the environment.[20] Coaxial electrospun nanofibers have gained much interest as gene- and 
growth factor-delivery systems, as well as embedding media of pharmaceutical compounds 
such as antibiotic or antioxidant drugs.[21, 22] 
PEG is a highly hydrophilic polymer widely used in the biomedical field of its lack of toxicity, 
good biocompatibility and easy elimination from human body.[23] Polybutylene succinate 
(PBS), a polymer supplied by Showa High Polymers as BionolleTM is currently the most 
commonly employed poly(alkylene dicarboxylate) due to its relatively low production cost, 
good thermal and mechanical properties and easy processability.[24, 25] To the best of our 
knowledge, no studies have been performed on the preparation of coaxial core-shell structures 
constituted by these two biocompatible polymers with well-differentiated hydrophilic-
hydrophobic properties. 
Triclosan (polychlorophenoxy phenol) (Figure 6.3.1) is a well-known antibacterial and 
antifungal agent[26] scarcely soluble in water but well soluble in ethanol. At in-use 
concentrations, triclosan acts as a biocide, with multiple cytoplasmic and membrane targets.[26] 
At lower concentrations, however, triclosan appears bacteriostatic and is seen to target bacteria 
mainly by inhibiting fatty acid synthesis. Curcumin is molecule constituted by two phenol 
groups connected by α,β-unsaturated carbonyl groups (Figure 6.3.1). These diketones can form 
stable enols and are readily deprotonated to form enolates. Curcumin seems to have beneficial 
effects on various diseases, including multiple myeloma, pancreatic cancer, myelodysplastic 
syndromes, colon cancer, psoriasis, and Alzheimer's disease.[27, 28] Curcumin is also a 
pleiotropic molecule capable of interacting with molecular targets involved in inflammation. 
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FIGURE 6.3.1 
Chemical structures of polymers used to prepare electrospun coaxial microfibers and loaded drugs. 
The main goal of the present work is the study of scaffolds constituted by PEG and PBS 
microfibers. To this end, electrospinning will be performed using a solution mixture of both 
polymers and compared with coaxial electrospinning having both PEG-PBS and PBS-PEG 
core-shell distributions. Morphological changes caused by the rapid solubilisation of PEG in 
aqueous media will also be evaluated since PEG can be used as a sacrificial polymer to modify 
material porosity and cellular colonization. Finally, scaffolds will be studied as drug delivery 
systems considering the loading of triclosan and curcumin drugs in PEG and PBS components, 
respectively. This distribution should probably lead to a fast release of PEG taking into account 
its solubilisation in aqueous media, and consequently to an immediate antibactericidal effect. 
On the contrary, loading of curcumin in the non-soluble polymer should result in a slower rate, 
and therefore in a sustained anticancer effect. 
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6.3.2 Experimental Section 
Materials 
Poly(ethylene glycol) samples of number average molecular weight of 35,000 g·mol-1 weas 
purchased from Sigma-Aldrich. Polybutylene succinate is a commercial product (Bionolle® 
1001) supplied by Showa Denko K.K. (Germany). The polymer has a melt flow index of 1.6 
g·10 min-1 (measured at 190 ºC under a load of 2.16 Kg according to ASTM-D1238). Solvents, 
curcumin, triclosan and cell culture labware were purchased from Sigma-Aldrich (USA). 
Escherichia coli CECT 101 and Micrococcus luteus CECT 245 bacterial strains were obtained 
from Spanish Collection of Type Culture (Valencia, Spain). Fibroblast-like Cos-7 and 
ephithelial-like Vero cells from kidney African green monkey were purchased from ATCC 
(USA).  
Electrospinning 
Electrospun fibers were collected on a target placed at different distances (10-25 cm) from the 
needle tip (inside diameter of 0.84 mm) or the core-shell nozzle (inside diameters 1.37 mm and 
2.39 mm) for single fiber or core-shell structure preparations, respectively. The voltage was 
varied between 10 and 30 kV and applied to the target using a high-voltage supply (Gamma 
High Voltage Research, ES30-5W). Polymer solutions were delivered via a single or two 
KDS100 infusion syringe pumps (KD Scientific, USA) to control the flow rate (from 1 to 5 
mL·h-1). All electrospinning experiments were carried out at room temperature. Unloaded and 
triclosan and curcumin loaded electrospun fibers were prepared using optimized parameters 
(e.g., collector distance, voltage and flow rate) and solvent conditions (e.g., polymer and drug 
concentrations). The triclosan and curcumin contents of the electrospinning solutions were 1 
and 0.5 w/v-% for samples used for release and antibacterial assays, and for cytotoxicity assays, 
respectively. Coaxial electrospun microfibers will be denoted by subscripts s and c, which 
indicate the polymer that constitutes the shell and the core, respectively. Absence of these 
scripts indicates fibers prepared from a polymer mixture. Weight percentages of each polymer 
in the electrospinning solutions are also given in the sample abbreviation.  
Morphology, composition and properties of electrospun scaffolds  
Optical microscopy studies were performed with a Zeiss Axioskop 40 microscope. Micrographs 
were taken with a Zeiss AxiosCam MRC5 digital camera. 
Detailed inspection of texture and morphology of electrospun samples was conducted by 
scanning electron microscopy using a Focus Ion Beam Zeiss Neon 40 instrument (Carl Zeiss, 
Germany). Carbon coating was accomplished by using a Mitec K950 Sputter Coater fitted with 
a film thickness monitor k150x. Samples were visualized at an accelerating voltage of 5 kV. 
Diameter of electrospun fibers was measured with the SmartTiff software from Carl Zeiss SMT 
Ltd. 
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1H-NMR spectra were acquired with a Bruker AMX-300 spectrometer operating at 300.1 MHz. 
Chemical shifts were calibrated using tetramethylsilane as an internal standard. Deuterated 
chloroform (CDCl3) was used as the solvent at room temperature. 
Infrared absorption spectra were recorded in the 3600 - 600 cm-1 range on a Jasco FTIR 4100 
Fourier Transform spectrometer. A Specac MKII Golden Gate attenuated total reflection (ATR) 
accessory was employed. 
X-ray photoelectron spectroscopy (XPS) was performed with a SPECS system equipped with 
an Al anode XR50 source operating at 200 W and a Phoibos 150 MCD-9 detector XP. Samples 
were fixed in a special sample holder with double sided carbon adhesive tape. The overview 
spectra were recorded with pass energy of 25 eV at 0.1 eV steps at a pressure below 7.5x10-9 
mbar, with binding energies being referred to the C1s and O1s signals. The overlapping peaks 
were deconvoluted using the PeakFit v4 program by Jandel Scientific Software. 
Contact angles (CA) were measured at room temperature with sessile drops using an OCA-15 
plus Contact Angle Microscope (Dataphysics, USA) and SCA20 software. Contact angle values 
of the right and left sides of distilled water drops were measured and averaged. Measurements 
were performed 10 s after the drop (5 mL) was deposited on the sample surface. All CA data 
were an average of six measurements on different surface locations. 
Calorimetric data were obtained by differential scanning calorimetry with a TA Instruments 
Q100 series equipped with a refrigeration cooling system (RCS). Experiments were conducted 
under a flow of dry nitrogen with a sample weight of approximately 5 mg, and calibration was 
performed with indium. Heating and cooling runs were carried out at rates of 20 ºC·min-1 and 
10 ºC·min-1, respectively. 
Porosity of PLA/PGE scaffolds 
The porosity of electrospun scaffolds was measured by the liquid intrusion method. Vacuum 
dried scaffolds (n = 3) were weighed prior to immersion in water for 1 h using a shaker table to 
allow diffusion of water into the void volume. The scaffolds were taken out and reweighed. 
Porosity was calculated according to Equation 1: 
P = [(mw - md) / ds)] / (mw - md) / ds] + [mdPBS / dPBS] + [mdPEG / dPEG]   (1) 
where mw, md, mdPBS, mdPEGare the weights of the wet scaffold, dry scaffold, PBS fraction and 
PEG fraction in the dry scaffold, respectively, and ds, dPBS and dPEG refer to the densities of water 
(i.e. 1.0 g·mL-1), semicrystalline PBS (1.26 g·mL-1) and semicrystalline PEG (1.07 g·mL-1), 
respectively. The last densities were estimated using DSC data of scaffolds which pointed to a 
high crystallinity for both PEG and PBS phases.  
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Release experiments 
Controlled release measurements were made with square pieces (weighting approximately 200 
mg) of the electrospun scaffolds. These pieces were weighed and incubated at 37 ºC in an orbital 
shaker at 200 rpm in tubes of 50 mL for 1 week. Phosphate saline buffer solution (SS) and 
alternatively its mixture with ethanol (i.e. 3:7 v/v ratio) as a more hydrophobic component were 
employed as release media. Drug concentration was evaluated by UV spectroscopy using a 
Shimadzu 3600 spectrometer. Calibration curves were obtained by plotting the absorbance 
measured at 290 and 243 nm versus triclosan and curcumine concentration, respectively, in the 
hydrophilic medium, whereas 280 nm was considered for triclosan when ethanol was added in 
the medium. Samples were withdrawn from the release medium at predetermined time intervals. 
The volume was kept constant by addition of fresh medium. All drug release tests were carried 
out using three replicates and the results were averaged. 
Cellular adhesion and proliferation assays 
Human fetal lung fibroblast (MRC-5) and African green monkey kidney epithelial (Vero) cells 
were cultured in Dulbecco’s modified Eagle medium (DMEM) as previously reported.[29] 
Square pieces (0.5×0.5×0.1 mm3) of the electrospun scaffolds were placed into each well of a 
multiwell culture plate. Samples were fixed in the wells with a small drop of silicone (Silbione® 
MED ADH 4300 RTV, Bluestar Silicones France SAS, Lyon, France) and then sterilized by 
UV-radiation in a laminar flux cabinet for 15 min. For the cell adhesion assay, aliquots of 50-
100 µL containing 5x104 cells were seeded onto the electrospun samples in each well and 
incubated for 24 h (adhesion assay) or 4 days (proliferation assay).  
Samples were evaluated by the standard adhesion and proliferation method[13] using three 
replicates and the results were averaged. Samples with adhered and grown cells on the mats 
were fixed with 2.5 w/v-% formaldehyde at 4 ºC overnight. They were subsequently dehydrated 
and processed for observation by scanning electronic microscopy. 
Antimicrobial test 
Escherichia coli (E. coli) and Micrococcus luteus (M. luteus) bacteria were selected to evaluate 
the antimicrobial effect of electrospun CUM and TCS loaded fibers. The bacteria were 
previously grown aerobically to exponential phase in broth culture (5 g·L-1 beef extract, 5 g·L-
1 NaCl, 10 g·L-1 peptone, pH 7.2).  
Growth experiments were performed on a 24-well culture plate. Square pieces (0.5×0.5×0.1 
mm3) of the electrospun scaffolds were placed into each well. Then, 1 mL of broth culture 
containing 103 CFU was seeded on the electrospun fiber mats. The cultures were incubated at 
37 ºC and agitated at 200 rpm. Aliquots of 50 L were taken at predetermined time intervals 
for absorbance measurement at 650 nm in a plate reader. Thus, turbidity was directly related to 
bacterial growth.  
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Bacterial adhesion onto scaffolds was also determined. The culture media were aspirated after 
incubation and the material washed once with distilled water. Then, 0.5 mL of sterile 0.01 M 
sodium thiosulfate was added to each well. After addition of 4 mL of broth culture, the plate 
was incubated at 37 ºC and agitated at 200 rpm for 24 h. The bacterial number was determined 
as above indicated. All assays were conducted in triplicate and the results averaged. 
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6.3.3 Results and Discussion 
Electrospinning Conditions 
A common solvent like dichloromethane was chosen for both PEG and PBS polymers and the 
two drugs (triclosan and curcumin) because its solubility parameter (20.31 MPa0.5) is close to 
those reported for PEG[30] and PBS[31] (around 20 MPa0.5). Polymer concentration and 
operational parameters (voltage and flow) were selected to obtain continuous fibers and avoid 
formation of droplets and beads, while needle-collector distance could be fixed at a value of 14 
cm for all samples. In this way, concentration of the high molecular weight PBS sample was 
limited to the 5-7 wt-% range due to the high viscosity of the final solution, whereas the low 
molecular weight PEG sample required a concentration of 10-15 wt-% to avoid the typical 
formation of droplets.  
Best experimental conditions, together with the average diameter of electrospun fiber, are 
summarized in Table 6.3.1. In all cases, a unimodal narrow distribution (not shown) was 
observed. Note that fibers prepared from a common solution had significantly smaller diameters 
than coaxial fibers (0.43-0.75 µm as opposed to 1.8-4.8 µm) due to differences in the size of 
corresponding needles. Diameters of coaxial microfibers seemed to increase with polymer 
concentration in the electrospinning solution when PEG was in the fiber shell, whereas an 
unclear trend was observed when it was in the core since, in this case, a higher variation on 
processing parameter was required (e.g., flow rate changed from 5 to 1.2 mL·h-1). Logically, 
the increase in polymer concentration and the decrease in the flow rate lead to opposite effects.  
TABLE 6.3.1. Optimal electrospinning conditions for the electrospining of PBS/PEG 
microfibers.a 
Fiber 
PBS/PEG (feed) 
Voltag
e 
Flow Rate Diameter 
PBS/PEG 
(fiber) 
(w/w) (mol/mol) (kV) mL·h-1 (µm) (mol/mol) 
 5/10 14.9/85.1 20 5 4.08 ± 0.04 13.4/86.6 
PBSs/PEGc 7/10 19.6/80.4 20 2.5 2.76 ± 0.02 19.6/80.4 
 5/15 10.4/89.6 15 1.2 3.37 ± 0.04 8.7/91.3 
 5/10 14.9/85.1 25 3 1.79 ± 0.01 10.5/89.5 
PEGs/PBSc 7/10 19.6/80.4 25 5 1.96 ± 0.02 14.4/85.6 
 5/15 10.4/89.6 20 5 4.80 ± 0.07 8.1/91.9 
 5/10 14.9/85.1 25 4 0.43 ± 0.01 12.9/87.1 
PBS/PEG 7/10 19.6/80.4 25 2 0.74 ± 0.02 14.8/85.2 
 5/15 10.4/89.6 20 4 0.74 ± 0.01 11.2/88.8 
aOptical collector distance was always 14 cm. 
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SEM micrographs of representative samples allow comparing fiber surface textures for some 
representative samples (see Figure 6.3.2). In general, a significant difference can be detected 
depending on the polymer in the shell of the coaxial fiber. Thus, rough or smooth surfaces were 
characteristic of fibers having a PBS or PEG shell, respectively. Similarly, the narrowest 
nanofibers obtained from the polymer mixtures showed the smoothest surfaces, as is 
characteristic of PEG and also of mixtures with a high PEG content (e.g., higher than 55 wt-
%).[32] 
FIGURE 6.3.2 
SEM micrographs showin the texture of PBSs/PEGc 5/15 (a), PEGs/PBSc 10/7 (b) and PBS/PEG 7/10 (c) 
representative samples obtained from dichloromethane solutions and using optimized concentration 
conditions of voltage needle-collector distance and flow. 
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Composition and Properties of Electrospun PBS/PEG Fibres 
1H-NMR spectra (Figure 6.3.3) was useful to determine the composition of all electrospun 
samples. Thus, areas corresponding to methylene protons of PBS (4.11, 2.62 and 1.70 ppm) and 
PEG (3.64 ppm) were used to determine the molar PBS content of electrospun fibers as follows 
(Equation 2): 
PBS (molar-%) = 100 · (
A4.11+ A2.62 + A1.70
12
) / [(
A4.11+ A2.62 + A1.70
12
) + (
A3.64
4
)]        (2) 
FIGURE 6.3.3 
1H-NMR spectra of PBSs/PEGc 5/15 (top) and PEGs/PBSc 10/7 (bottom) electrospun samples before and 
after immersion in water (insets).  
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Composition values summarized in Table 6.3.1 show relatively good agreement with the 
polymer molar feed ratio in the initial electrospinning solutions. In particular, it was excellent 
for the coaxial fibers having PEG confined in their core, whereas a slight deficiency was 
detected in PEG when it was the component of the shell jet. An unclear trend was observed for 
uniaxial fibers but again PEG content was slightly lower than expected, chiefly when the 
PBS/PEG ratio increased. 
FTIR spectra of the electrospun fibers logically showed the characteristic peaks associated with 
PBS (e.g., 1722, 1158, 1044 and 802 cm-1) and PEG (e.g., 961 and 834 cm-1) (Figure 6.3.4) 
with a variable intensity ratio that depended on the composition. The spectra merely 
corresponded to the superposition of homopolymer spectra since no band displacements 
indicative of new intermolecular interactions were detected. 
FIGURE 6.3.4 
FTIR spectra of electrospun PBS, PBSs/PEGc 5/15, PEGs/PBSc 15/5, PBS/PEG 5/15 and PEG samples.  
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On the contrary, XPS spectra were relevant, as shown in Figure 6.3.5, because analysis of C1s 
and O1s peaks showed the establishment of interactions between PEG and PBS molecules in 
the electrospun fibers. The PBS spectrum was very complicated, as had already been 
reported,[33] because four C1s and two O1 peaks were found in the deconvoluted spectrum at 
284.5 eV (C1-CH2), 285.2-285.6 eV (C2-C=O), 286.4-286.9 (C3-O), 289.3 eV (C4=O), 531.6 
eV (O1=C) and 533.0 eV (O2-C=O), whereas the PEG spectrum was characterized by single 
C1s and O1s peaks at binding energies of 285.0 eV (C5-O) and 532.5 eV (O3-C).[34] Note in 
Figure 6.3.5 that the spectrum of a representative PBS/PEG sample clearly differs from that 
expected from a weighted addition according to the final composition of the homopolymer 
spectra. Thus, for example, peak O1 appeared shifted to a higher binding energy and the 
intensities of peaks O3 and C3 were lower and higher than expected, respectively.  
FIGURE 6.3.5  
Carbon (left) and oxygen (right) XPS signals of electrospun PEG (top), PBS/PEG 5/15 electrospun 
samples (middle) and PBS (bottom) samples. 
  
  
 
Biodegradable polymer matrices incorporating polyethylenen glycol as a sacrificial polymer 
278 
a Pellets of the commercial sample. 
Table 6.3.2 summarizes the main melting and crystallization data of the electrospun samples, 
including data from the commercial pellet of the homopolymers. Several points merit attention: 
a) Crystallinity of electrospun PBS was higher than that of the commercial sample and also than 
that attained after the cooling scan from the melt. Thus, melting enthalpies of 75.7 and 56.9 J·g-
1 were determined in the heating scans of the electrospun and commercial PBS samples, 
whereas crystallization enthalpy of 61.4 and 59.2 J·g-1 were determined in the corresponding 
cooling scans. Therefore, the electrospining process seems to favour the orientation of PBS 
molecules and facilitate the subsequent crystallization. b) Similar melting and crystallization 
enthalpies were determined for PEG commercial and electrospun samples. c) Characteristic 
PEG and PBS crystalline domains were observed in the DSC scans of the electrospun PBS/PEG 
samples. Nevertheless, a slight decrease in the melting point was found for the component 
distributed in the core of coaxial fibers (i.e. melting points of PEG and PBS decreased from 
65.0 ºC and 111.0 ºC to 56.9 and 106.5 ºC, respectively). This feature suggests that the polymer 
confined in the inner part of the microfiber had greater difficulty in forming more perfect and 
thicker lamellae as a consequence of significant retention of solvent or even a lower degree of 
orientation. d) Crystallization enthalpies associated with the PEG component in the binary 
electrospun samples were clearly lower that the corresponding melting enthalpies detected in 
the previous heating run (e.g., 103.5 and 121.3 J·g-1 for PBS/PEG 5/10, whereas better 
agreement was found between crystallization and melting enthalpies of the PBS component. In 
the case of PEG, it is likely that its crystallization from the melt was hindered by constraints 
imposed by previous crystallization of the higher melting point PBS component. 
TABLE 6.3.2. Selected calorimetric data from the heating and cooling scans 
performed with the different PBS/PEG electrospun samples. 
Sample 
PEG Component PBS Component 
Tm (ºC) 
∆Hm 
(J.g-1) 
Tc (ºC) 
∆Hc 
(J·g-1) 
Tm (ºC) 
∆Hm 
( J·g-1) 
Tc (ºC) 
∆Hc 
( J·g-
1) 
PBSa - - - - 111.0 56.9 77.7 59.2 
PBS - - - - 110.3 75.7 79.7 61.4 
PEGa 65.0 177.2 44.4 177.2 - - - - 
PEG 63.8 176.1 44.7 175.7 - - - - 
PBSs/PEGc 5/10 56.9 90.4 37.7 80.5 109.1 27.5 78.6 30.0 
PEGs/PBSc 10/5 62.3 125.3 34.6 111.7 106.5 17.7 76.3 19.2 
PBS/PEG 5/10 62.5 121.3 34.3 103.5 111.7 28.1 79.4 26.4 
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Water Solubility of PLA/PEG Scaffolds  
The high solubility of PEG in water allowed its use as a sacrificial polymer to increase the 
porosity of the scaffold after exposure to an aqueous medium. The solubilisation of PEG from 
the different electrospun scaffolds can be evaluated through 1H-NMR spectra for two different 
composition and core-shell structures, as shown in Figure 6.3.6.. A clear decrease in the 
intensity of the typical PEG signal (3.64 ppm) was always observed after immersion of the 
samples in water.  
TABLE 6.3.3. Diameter and composition of electrospun fibers after removal of PEG 
removal, variation respect to initial diameter, compositional analysis after immersion 
en % of PEG removed. 
Sample 
PBS/PEG 
(w/w-%) 
Ø 
(µm) 
ΔØa  
(µm) 
PBS/PEG 
(mol/mol) 
PEGremb 
(%) 
PBSs/PEGc 
5/10 3.30 ± 0.1 - 0.78 55.0/45.0 87 
7/10 -- -- 59.7/40.3 84 
5/15 2.63 ± 0.1 - 0.74 45.0/55.0 88 
PEGs/PBSc 
5/10 1.50 ± 0.01 - 0.29 59.8/40.2 92 
7/10 1.62 ± 0.02 -0.34 68.8/31.2 92 
5/15 3.96 ± 0.03 - 0.84 58.2/41.8 94 
PBS/PEG 
5/10 0.30 ± 0.01 - 0.13 55.8/44.2 88 
7/10 0.51 ± 0.01 - 0.22 58.0/42.0 87 
5/15 0.45 ± 0.02 - 0.29 60.7/39.3 92 
ªVariation respect to the initial diameter. 
bMolar percentage of PEG removed respect to the initial PEG content. 
Final compositions deduced from NMR spectra are summarized in Table 6.3.3, together with 
the percentage of PEG compared to the initially solubilized content. Although these values were 
always high and around 90%, some significant amount of PEG was held in the PBS matrix (e.g., 
31.2-55.0 molar-%). Solubilization slightly depended on the fiber structure, and specifically the 
lowest and highest average percentages (87 and 94%) were found for coaxial fibers with PEG 
in the core and the shell, respectively, whereas an intermediate average value of 89% was 
determined for uniaxial fibers. The fact that no complete PEG removal was observed for the 
electrospun PEGs/PBSc sample suggests the formation of a non-perfect core-shell structure and 
some degree of mixing between both polymers, probably more significant in the interphase. 
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The morphology of microfibers was logically affected by solubilisation of PEG for 
representative uniaxial and coaxial samples, as shown in Figure 6.3.6. Thus, the smooth texture 
of the uniaxial nanofibers became clearly rough (Figure 6.3.6 a) after immersion and their 
average diameter decreased between 29 and 39% of the initial value (Table 6.3.3), with the 
higher percentage being associated with fibers with an initially greater PEG content. Drastic 
changes occurred after immersion of coaxial PBSs/PEGc microfibers since longitudinal slits 
were usually observed (Figure 6.3.6 b). These slits could probably be a direct consequence of 
the release of the PEG component placed in the inner part of the fiber. Logically, the rough 
surface associated to the PBS shell remained after immersion. A significant diameter decrease 
(19-21%) was also observed, although in some cases no measurements could be performed due 
to the flat appearance of the opened fibers. This percentage was obviously lower than that found 
for the uniaxial fibers due to the greater diameter of coaxial fibers. Finally, PBSc/PEGs fibers 
exhibited a rough surface after the release of the PEG shell component (Figure 6.3.6 c) and a 
diameter decrease close to 17% comparable with that determined for PBSs/PEGc fibers with a 
similar initial diameter. Note in the given micrograph that PEG was still present in some parts 
of the fibers, giving rise to local smooth surfaces. 
FIGURE 6.3.6. 
High magnification SEM micrographs of PBS/PEG 5/15 (a), PBSs/PEGc 5/15 (b) and PEGs/PBSc 10/7 (c) 
electrospun samples after immersion in water.  
Porosity of electrospun scaffolds was high due to the solubilization of PEG and depended on 
the initial size of fibers and the distribution of the two components. Thus, lower porosities 
corresponded to the PBSs/PEGc coaxial fibers (0.62-0.77) whereas maximum values (0.77-0.94) 
were determined for uniaxial nanofibers. It is interesting to note that the core-shell distribution 
played a significant role, and thus scaffolds derived from microfibers having a PEG shell had 
significantly higher porosity (0.71-0.88) than related ones having a PEG core. In the last case, 
the external surface and probably the pore dimension of fibers should be less affected by 
solubilization. 
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Contact Angle Measurements 
Information about the distribution of hydrophilic PEG and hydrophobic PBS in coaxial 
electrospun fibers can be verified through contact angle measurements as shown in Figure 
6.3.7. 
FIGURE 6.3.7 
Contact angles for PBSs/PEGc 5/10, 7/10 and 5/15 and PEGs/PBSc 10/7 and 15/5 scaffolds before and after 
immersion. Inset show the optical micrographs of a drop deposited on a representative scaffold before 
(black) and after (grey) being immersed in water. 
The high hydrophilicity of PEG caused sessile drop spreading, and consequently angles could 
not be measured for any PEGs/PBSc sample. On the contrary, high contact angles were usually 
determined for the PBSs/PEGc samples, indicating that PEG was well confined in the fiber core. 
Thus, values between 112º and 122º could be measured because of the correct core-shell 
structure, with hydrophobic PBS in the outer part of the fiber and the effective confinement of 
PEG. Note that only the PBSs/PEGc 7/10 sample had a non-perfect distribution or confinement 
since the contact angle decreased to 40º. In fact, measurements performed with melt pressed 
PBS films indicate a contact angle close to 90º, a value obviously lower than determined for 
electrospun scaffolds because surface roughness is also a dominant factor in wettability of 
materials. The surface area of a rough surface is greater than the surface area of a comparably 
sized smooth surface, and consequently an increase of the contact angle should be expected.[35] 
The high increase of the contact suggests also that microfiber scaffolds benefit from air pocket 
formation.[36] Spreading was also characteristic for uniaxial fibers because of good mixing of 
polymers and the high PEG content. 
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Figure 6.3.7 also compares contact angle measurements of scaffolds before and after being 
immersion in water. Results clearly indicate that a hydrophobic PBS surface was attained after 
the removal of PEG, with the effect being more pronounced for PEGs/PBSc samples and even 
for the defective PBSs/PEGc 7/10 scaffold. 
Drug Load and Release from PBS/PEG Scaffolds 
The micro/nanofibers of the studied samples were easily loaded with triclosan and curcumin by 
adding the appropriate amount of the drug in the corresponding electrospinning solution (i.e. 
triclosan in the PEG solution and curcumin in the PBS solution for coaxial fibers). Studies were 
performed with representative samples of the uniaxial and the two coaxial core-shell structures. 
Specifically, uniaxial fibers with the lowest and highest PEG content (i.e. PBS/PEG 5/15 and 
7/10) were considered, together with the related coaxial samples with PEG placed in the core 
and the shell when its content was the highest and the lowest, respectively (i.e. PBSs/PEGc 5/15 
and PEGs/PBSc 10/7. In this way, PBSs/PEGc 5/15 should have the fastest and the slowest release 
rate for curcumin and triclosan, respectively, while the opposite would be expected for 
PEGs/PBSc 10/7. 
FIGURE 6.3.8 
High magnification SEM micrographs of drug loaded PBSs/PEGc 5/15 (a). PEGs/PBSs 10/7 (b); PBS/PEG 
5-15 (c) and PBS/PEG 7-10 (d) scaffolds.  
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The incorporation of the drug had some influence on the electrospinning process, and 
consequently operational parameters were slightly modified, as indicated in Table 6.3.4. 
Conditions were also optimized to obtain similar sizes for the two kinds of coaxial fibers (i.e. 
1.49-1.58 m) as well as for the uniaxial fibers with different compositions (i.e. 0.74 m). 
Figure 6.3.8 shows the different textures attained with the drug loaded samples, which, as 
expected, corresponded to rough and smooth surfaces for the coaxial fibers with a PBS shell 
and the two uniaxial fibers, respectively. The only significant change was the appearance of 
transversal ribs in the coaxial sample with a PEG shell, in contrast with the smooth surface of 
the unloaded sample. Changes in fiber surface morphology may have played a significant role 
in supporting cell attachment but they not when the polymer in the shell was highly soluble.  
Immersion of loaded fibers in aqueous media led to a decrease in the fiber diameter, a rough 
texture and solubilization of PEG (Table 6.3.4), with percentages of removed PEG being 
similar to those for unloaded samples.  
ªBefore immersion in water. 
bAfter immersion in water. 
cMolar percentage of PEG removed by immersion in water respect to the initial PEG content. 
  
TABLE 6.3.4. Optimal electrospinning conditions applied for the selected drug 
loaded samples and resulting diameters before and after immersion in water. 
Sample 
Voltage 
(kV) 
Rate 
(mL·h-1) 
Distance 
(cm) 
Øa  
(µm) 
Øb  
(µm) 
PEGremovedc 
(%) 
PBSs/PEGc 5/15 25 1.35 17 1.49 ± 0.03 0.86 83 
PEGs/PBSc 10/7 25 4 24 1.58 ± 0.01 1.14 94 
PBS/PEG 7/10 
25 1 14 0.74 ± 0.02 0.37 92 
PBS/PEG 5/15 20 2 14 0.74 ± 0.01 0.42 91 
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FIGURE 6.3.9 
Triclosan (●) and curcumin (■) release curves in Saline Buffer/Ethanol mixture (30/70 v/v) (red line) and 
Saline Buffer medium (blue line) for PBSs/PEGc 5/15 (a) PEGs/PBSs 10/7 (b). PBS/PEG 5/15 (c) and 7/10 
(d).  
Figure 6.3.9 compares the release behavior of all scaffolds when they were exposed to a 
hydrophilic SS and to a more hydrophobic SS/ethanol (30:70 v/v) mixture. Release proceeds at 
a similarly fast rate for all assayed samples until a limit value is reached. This value is highly 
dependent on the affinity between the drug and the release medium, and also varies with 
composition and structure of electrospun fibers. Some interesting features can be pointed out: 
 The amount of triclosan released in the SS medium was low (i.e. between 5-13% of 
the loaded drug) and inferior to the solubility limit. Hence, this hydrophobic drugs was 
effectively retained/adsorbed in the hydrophobic PBS component. It is remarkable that 
this adsorption was still found when the drug was only loaded in the water soluble 
PEG component placed in the shell of the coaxial fibers. Somehow the drug moved 
towards the hydrophobic component placed in the inner part of fiber. The amount of 
released drug was higher for the thin uniaxial fibers and slightly with the PEG content 
(i.e. 14%, 9%, 7 and 5% for PBS/PEG 5/15 and PBS/PEG 7/10, PBSs/PEGc 5/15, 
PEGs/PBSc 10/7 samples, respectively).   
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 The triclosan released in the medium containing ethanol was relatively high and 
strongly depended on the fiber structure and composition. Therefore, the restriction of 
maximum amount of triclosan released was not due to limited solubility. Lower release 
percentages were found for uniaxial fibers (i.e. 52% and 62%, Figures 6.3.9 c and 
6.3.9 d) despite their lower diameter, probably as a consequence of the mixed 
arrangement of PEG and PBS in the fiber. Coaxial structures gave rise to a higher 
release that was similar for both distributions (i.e. 80% and 82% for fibers having PEG 
in the core and the shell, respectively, Figures 6.3.9 a and 6.3.9 b). 
 The high difference between the release percentages of PBSs/PEGc 5/15 depending on 
the media (i.e. 7% and 82% for SS and SS/ethanol mixture, respectively) made it 
possible to discard an explanation based on a swelling effect of ethanol since triclosan 
was loaded into the PEG shell, which is soluble in both aqueous and ethanol solutions. 
A minimum release of curcumin in SS medium was observed for all assayed samples (i.e. 1%) 
due to its high hydrophobicity and excellent interaction with PBS. This high retention was even 
observed for the thin uniaxial fibers where curcumin was loaded into the matrix constituted by 
the mixture of PEG and PBS polymers. On the contrary, curcumin was completely released 
independently of the fiber structure and compostion in the medium containing 70 v-% of 
ethanol. Logically, a tuned release in function of the ethanol ratio in the media should be 
expected. 
Biocompatibility of Unloaded and Triclosan Loaded PLA/PEG Scaffolds 
Adhesion and proliferation of fibroblast (MRC-5) and epithelial (Vero) cells were studied for 
all scaffolds. Both experiments are important to follow cell development since adhesion is an 
early cellular event whereas proliferation is an evidence of metabolic cell activity. Figure 6.3.10 
a compares the results on relative adhesion for representative studied materials, which indicate 
that adhesion of fibroblast-like MRC-5 cells was well supported and even slightly improved 
when fibres were stabilized by solubilization of PEG or cross-linking with glutaraldehyde. On 
the other hand, ephitelial cells were more sensitive and in general the adhesion on the studied 
scaffolds decreased by around 50% compared to the control (Figure 6.3.10 b).  
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FIGURE 6.3.10  
Adhesion of MRC-5 (a) and Vero (b) cells on the control plate surface, selected unloaded scaffolds before 
(white) and after (light grey) being immersed in water and glutaraldehyde fixed scaffolds (grey) (*p < 
0.05) vs. positive control; ANOVA-Tukey’s test) c) SEM micrographs showing adhesion of Vero cells on 
PEGs/PBSc 10/7 scaffolds before (top) and after (bottom) being immersed in water. 
Proliferation studies indicated that MRC-5 cells were able to colonize all materials without a 
statistical difference compared to the control, whereas of Vero cells was proportional to their 
initial adhesion on the polymer scaffolds (see Figure 6.3.11). 
SEM microscopy observations of cultures allowed the evaluation of morphological 
characteristics associated with cell adhesion and proliferation onto the film surfaces (e.g., 
Figures 6.3.10 c and 6.3.11 b for representative samples and Vero cells). Cells were attached 
and spread out on film surfaces after a seeding of 24 h, even for the more problematic Vero 
cells. These exhibited large areas of cytoplasm extending on the scaffold surfaces and 
promoting their attachment onto the material. Cells proliferated and reached confluence after 4 
days of culture. Materials were effectively colonized, and specifically cells formed a monolayer 
with close contacts between them. 
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FIGURE 6.3.11 
(a) Proliferation of MRC-5 (white) and Vero (grey) cells on control plate surfaces scaffolds (*p < 0.05) 
vs. positive control; ANOVA-Tukey’s test). (b) SEM micrographs of the cellular proliferation on 
representative scaffolds/ PEGs/PBSc 10/7 (left) and PBS/PEG 7/10 (right). 
Figures 6.3.10 and 6.3.11 also revealed that the drug load necessary to perform the release 
experiments was too high to support cell adhesion and proliferation. This means that both drugs 
were effectively released during culture and that minimum doses required to produce cell 
necrosis were always attained. In fact, the required cytotoxic concentrations of curcumine and 
triclosan to reduce cell population by 50% (CC50) were approximately 14-24 g·mL-1 and 6-15 
g·mL-1, respectively. The given intervals indicated the toxicity for the more sensitive Vero 
cells (lower values) and the MRC-5 cells (higher values). Experimental cytotoxic 
concentrations were clearly lower than calculated for complete release of loaded drugs (i.e. 50 
and 100 g·mL-1 for curcumin and triclosan, respectively). 
Antibacterial Properties of Triclosan Loaded PLA/PEG Scaffolds 
Triclosan is a broad-spectrum antiseptic with documented safety and efficacy against Gram-
positive and Gram-negative bacteria (e.g., M.luteus and E.coli, respectively). The antibacterial 
effect of triclosan released from scaffolds constituted by uniaxial and coaxial electrospun fibers 
was determined by studying bacterial adhesion and growth inhibition in broth medium.  
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As shown in Figure 6.3.12 for unloaded samples, high adhesion was measured for all scaffolds 
of both bacteria. It was considerably greater than that measured for the control, probably as a 
consequence of the high specific surface and porosity of the scaffolds. Therefore, it seems 
crucial to prevent bacterial colonization by means of an antiseptic, and in this sense triclosan 
was highly effective (Figures 6.3.12 a and 6.3.12 b).  
FIGURE 6.3.12 
Adhesion (a,b) and relative growth (c,d) of Escherichia coli (a,c) and Micrococcus luteus (b,d) on control 
surfaces and unloaded (sparse) and TCS loaded (grey) PBSs/PEGc. PEGs/PBSc and PBS/PEG electrospun 
samples. 
Growth inhibition measurements made with triclosan loaded scaffolds (Figures 6.3.12 c and 
6.3.12 d) demonstrated that those constituted by coaxial fibers were more susceptible to 
colonization, whereas the core-shell structure had not significant influence. Thus, inhibitions 
between 60%-40% and 90%-75% were found for scaffolds constituted by coaxial and uniaxial 
fibre, respectively. These results agree qualitatively with the higher release observed for the 
thin uniaxial fibers SS medium and demonstrated that the low release was sufficient to inhibit 
bacterial colonization. The effect of triclosan was clearly enhanced for the Gram-negative 
bacterium (i.e. E.coli) due to its higher sensitivity to the drug.   
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6.3.4 Conclusions 
Coaxial microfibers with different core-shell distributions and constituted by PEG and PBS 
could be prepared from dichloromethane solutions and optimized processing parameters. These 
fibers had different surface textures depending on the polymer in the shell (i.e. smooth and 
rough for PEG and PBS, respectively), suggesting the success of coaxial electrospinning. This 
was also corroborated by contact angle measurements that demonstrated the hydrophilicity and 
hydrophobicity of coaxial fibers having a shell of PEG and PBS, respectively.  
Calorimetric data indicated a high crystallinity for PBS rich domains caused by a molecular 
orientation favored by the electrospinning process. A decrease in the corresponding melting 
temperature also suggested that the polymer confined in the fiber core developed more defective 
crystals.  
XPS spectroscopy revealed that establishment of new interactions between PBS and PEG were 
established in the uniaxial nanofibers prepared from a common dissolution of both polymers. 
Thus, a significant amount of PEG remained in the scaffolds after immersion in water. This 
amount was dependent on the fiber distribution, with higher and lower values being associated 
with coaxial fibers with a PBS shell and a PEG shell, respectively. 
Release of triclosan and curcumin from loaded scaffolds was highly dependent on the media 
and their hydrophobicity. Slight differences were also detected depending on the structure of 
the fiber. Specifically, the lowest release was found for PEG-rich uniaxial nanofibers exposed 
to SS medium whereas the highest value corresponded to coaxial microfibers exposed to 
SS/ethanol mixtures. Scaffolds constituted by coaxial microfibers were more susceptible to 
colonization by both Gram-positive and Gram-negative bacteria whereas the core-shell 
structure had no significant influence. 
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General Conclusions 
First Block: Antioxidant loaded biodegradable scaffolds and potential application 
The study of 3D scaffolds from electrospun polylactide nanofibers loaded with antioxidants 
(i.e., vitamin B6 in pyridoxine and pyridoxal form and two polyphenols, caffeic and p-coumaric 
acids) prepared by electrospinning under optimized conditions leads to the following 
conclusions: 
i. Fiber morphology (diameter and texture) and crystallinity were dependent on the drug 
load. Furthermore, the drug release was influenced by the kind of drug and release 
medium (hydrophobic or hydrophilic medium). 
ii. The new loaded PLA scaffolds were suitable to support both cell adhesion and growth, 
and additionally had a protective activity against the oxidative stress responsible for 
cell damage and death by necrosis. 
iii. New antioxidative scaffolds demonstrated in-vivo and in-vitro inhibition of the 
oxidative damage on DNA under both in-vivo and in-vitro conditions. Thus, they could 
be used as platform to improve the process of DNA extraction and purification. 
Second Block: Multifunctional biodegradable fiber scaffolds 
Multifunctional PLA scaffolds were obtained by loading different drugs simultaneously during 
the process of electrospinning: 
 
i. PLA scaffolds with antibacterial, antioxidant and/or anti-inflammatory activity were 
obtained by loading triclosan, ketoprofen and/or p-coumaric acid, respectively. Thus, 
the scaffolds obtained were dual or ternary drug-loaded systems. 
ii. The drug release from these multifunctional scaffolds was modulated by: first, the PLA 
enantiomeric grade, because its influence thermal, to the degradation and the 
mechanical properties of the matrix; second, the chemical structure of the drugs that 
are combined in the scaffold and their behaviours against the different release media 
(hydrophilic or hydrophobic medium). 
iii. These new materials have therapeutic advantage because they effectively respond to 
the need of procuring a simultaneous control over potential microbial infections, and 
inflammatory-oxidative processes that can occur during wound closure and tissue 
repair. 
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Third Block: Preparation of biodegradable scaffolds that incorporate non-
electrospinable polymers 
The development of fiber scaffolds from mixtures of electrospinable and non-electrospinable 
polymers allowed obtaining new hybrid materials in the biomedical field: 
i. Antibacterial scaffolds can be prepared from the mixture of PLA and PHMB 
(polyhexamethylenebiguanide hydrochloride). The antibacterial activity of PHMB 
loaded scaffolds is much greater than those loaded with chlorhexidine (CHX) 
monomer. 
ii. Conducting scaffolds were successfully prepared from mixtures of PLA and P3TMA 
(poly 3-thiophene methyl acetate). These PLA/P3TMA hybrid scaffolds maintained 
the biocompatible and current conducting (e.g., capability to store charge) properties 
of each individual component. Thus, these new matrices provide the possibility to get 
cellular growth and differentiation through electrical stimulation. 
 
Fouth Block: Biodegradable polymer matrices incorporating polyethylene glycol 
as a sacrificial polymer  
Scaffolds containing a sacrificial polymer (e.g., polyethylene glycol (PEG)) are reshaped when 
this polymer is removed. PEG is considered an appropiate sacrificial polymer in the biomedical 
field due to its non-toxicity, high biocompatibility and easy removal from the human body. The 
following specific issues were derived from the study of electrospun using PEG as a sacrificial 
polymer: 
i. Scaffolds having to different ratios of PEG and PLA were easily obtained by 
electrospinning solution mixtures of both homopolymers. A high amount of PEG (e.g., 
70 wt-%) can be supported by these fibers, giving rise after its removal to matrices that 
maintain their ability to support cell adhesion and growth. In addition, fibers can be 
loaded with hydrophobic drugs achieving a burst effect at the beginning of their 
release. 
ii. Electrospinning from independent solutions of PLA and PEG and using a single 
rotatory collector gave rise to matrices constituted by well-differentiated fibers of each 
homopolymer. The process allows an easy control to get homogeneous fibers and 
scaffolds constituted by variable ratios of PEG and PLA. Furthermore, the process 
allows loading independently each polymer with different drugs in such a way that a 
rapid or a sustained release can be achieved. The independent loading process can 
minimize the effect of the drug on the fiber morphology (e.g., size and texture) by 
modulating the processing parameters. 
iii. Coaxial microfibers with different core-shell distributions and constituted by PEG and 
poly(butylene succinate) (PBS) were successfully prepared. PEG could be easily 
solubilized even if it was placed in the core of the fibers. The corresponding 
electrospun scaffolds appear interesting to get a fast and slow release of drugs loaded 
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in the highly soluble PEG and the hydrophobic PBS component, respectively. Coaxial 
microfibers showed a slightly faster release than uniaxial fibers with similar 
composition and size. Scaffolds constituted by coaxial microfibers were also more 
susceptible to colonization by both Gram-positive and Gram-negative bacteria, 
whereas the core-shell structure had no significant influence
   
 
